METHODS AND COMPOSITIONS FOR THE MAKING AND USING OF GUIDE NUCLEIC ACIDS

INCORPORATION BY REFERENCE OF SEQUENCE LISTING

The present application is being filed with a Sequence Listing in electronic format. The content of the ASCII text file of the sequence listing named “155949-00086_Sequence_Listing.TXT” which is 797 kb in size was created on Aug. 17, 2020, and electronically submitted via EFS-Web herewith the application is incorporated herein by reference in its entirety.

BACKGROUND

Human clinical DNA samples and sample libraries such as cDNA libraries derived from RNA contain highly abundant sequences that have little informative value and increase the cost of sequencing. While methods have been developed to deplete these unwanted sequences (e.g., via hybridization capture), these methods are often time-consuming and can be inefficient.

Although a guide nucleic acid (gNA) mediated nuclease systems (such as guide RNA (gRNA)-mediated Cas systems) can efficiently deplete any target DNA, targeted depletion of very high numbers of unique DNA molecules is not feasible. For example, a sequencing library derived from human blood may contain >99% human genomic DNA. Using a gRNA-mediated Cas9 system-based method to deplete this genomic DNA to detect an infectious agent circulating in the human blood would require extremely high numbers of gRNAs (about 10-100 million gRNAs), in order to ensure that a gRNA will be present every 30-50 base pairs (bp), and that no target DNA will be missed. Very large numbers of gRNAs can be predicted computationally and then synthesized chemically, but at a prohibitively expensive cost.

Therefore, there is a need in the art to provide a cost-effective method of converting any DNA into a gNA (e.g., gRNA) library to enable, for example, genome-wide depletion of unwanted DNA sequences from those of interest, without prior knowledge about their sequences. Provided herein are methods and compositions that address this need.

SUMMARY

Provided herein are compositions and methods to generate gNAs and collections of gNAs from any source nucleic acid. For example, gRNAs and collections of gRNAs can be generated from source DNA, such as genomic DNA. Such gNAs and collections of the same are useful for a variety of applications, including depletion, partitioning, capture, or enrichment of target sequences of interest, genome-wide labeling, genome-wide editing, genome-wide functional screens, and genome-wide regulation.

In one aspect, the invention described herein provides a collection of nucleic acids, a plurality of the nucleic acids in the collection comprising: a first segment comprising a regulatory region; a second segment encoding a targeting sequence; and a third segment encoding a nucleic acid-guided nuclease system protein-binding sequence, wherein at least 10% of the nucleic acids in the collection vary in size. In another aspect, the invention described herein provides a collection of nucleic acids, a plurality of the nucleic acids in the collection comprising: a first segment comprising a regulatory region; a second segment encoding a targeting sequence, wherein the size of the second segment is greater than 21 bp; and a third segment encoding a nucleic acid-guided nuclease system protein-binding sequence. In some embodiments, the nucleic acid-guided nuclease system protein is a CRISPR/Cas system protein. In some embodiments, the size of the second segment varies from 15-250 bp across the collection of nucleic acids. In some embodiments, at least 10% of the second segments in the collection are greater than 21 bp. In some embodiments, the size of the second segment is not 20 bp. In some embodiments, the size of the second segment is not 21 bp. In some embodiments, the collection of nucleic acids is a collection of DNA. In some embodiments, the second segment is single stranded DNA. In some embodiments, the third segment is single stranded DNA. In some embodiments, the second segment is double stranded DNA. In some embodiments, the third segment is double stranded DNA. In some embodiments, the regulatory region is a region capable of binding a transcription factor. In some embodiments, the regulatory region comprises a promoter. In some embodiments, the promoter is selected from the group consisting of T7, SP6, and T3. In some embodiments, the targeting sequence is directed at a mammalian genome, eukaryotic genome, prokaryotic genome, or a viral genome. In some embodiments, the targeting sequence is directed at repetitive or abundant DNA. In some embodiments, the targeting sequence is directed at mitochondrial DNA, ribosomal DNA, Alu DNA, centromeric DNA, SINE DNA, LINE DNA, or STR DNA. In some embodiments, the sequence of the second segments is selected from Table 3 and/or Table 4. In some embodiments, the collection comprises at least 10²unique nucleic acid molecules. In some embodiments, the targeting sequence is at least 80% complementary to the strand opposite to a sequence of nucleotides 5′ to a PAM sequence. In some embodiments, the collection comprises targeting sequences directed to sequences of interest spaced about every 10,000 bp or less across the genome of an organism. In some embodiments, the PAM sequence is AGG, CGG, or TGG. In some embodiments, the PAM sequence is specific for a CRISPR/Cas system protein selected from the group consisting of Cas9, Cpf1, Cas3, Cas8a-c, Cas10, Cse1, Csy1, Csn2, Cas4, Csm2, and Cm5. In some embodiments, the third segment comprises DNA encoding a gRNA stem-loop sequence. In some embodiments, the third segment encodes for a RNA comprising the sequence GUUUUAGAGCUAGAAAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGAAAAAGUGGCA CCGAGUCGGUGCUUUUUUU (SEQ ID NO: 1) or encodes for a RNA comprising the sequence GUUUUAGAGCUAUGCUGGAAACAGCAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGA AAAAGUGGCACCGAGUCGGUGCUUUUUUUC (SEQ ID NO: 2). In some embodiments, the sequence of the third segment encodes for a crRNA and a tracrRNA. In some embodiments, the nucleic acid-guided nuclease system protein is from a bacterial species. In some embodiments, the nucleic acid-guided nuclease system protein is from an archaea species. In some embodiments, the CRISPR/Cas system protein is a Type I, Type II, or Type III protein. In some embodiments, the CRISPR/Cas system protein is selected from the group consisting of Cas9, Cpf1, Cas3, Cas8a-c, Cas10, Cse1, Csy1, Csn2, Cas4, Csm2, Cm5, dCas9 and cas9 nickase. In some embodiments, the third segment comprises DNA encoding a Cas9-binding sequence. In some embodiments, a plurality of third segments of the collection encode for a first nucleic acid-guided nuclease system protein binding sequence, and a plurality of the third segments of the collection encode for a second nucleic acid-guided nuclease system protein binding sequence. In some embodiments, the third segments of the collection encode for a plurality of different binding sequences of a plurality of different binding sequences of a plurality of different nucleic acid-guided nuclease system proteins.

In another aspect, the invention described herein provides for a collection of guide RNAs (gRNAs), comprising: a first RNA segment a targeting sequence; and a second RNA segment comprising a nucleic acid-guided nuclease system protein-binding sequence, wherein at least 10% of the gRNAs in the collection vary in size. In some embodiments, the nucleic acid-guided nuclease system protein is a CRISPR/Cas system protein. In some embodiments, the size of the first segment varies from 15-250 bp across the collection of gRNAs. In some embodiments, the at least 10% of the first segments in the collection are greater than 21 bp. In some embodiments, the size of the first segment is not 20 bp. In some embodiments, the size of the first segment is not 21 bp. In some embodiments, the targeting sequence is directed at a mammalian genome, eukaryotic genome, prokaryotic genome, or viral genome. In some embodiments, the targeting sequence is directed at repetitive or abundant DNA. In some embodiments, the targeting sequence is directed at mitochondrial DNA, ribosomal DNA, Alu DNA, centromeric DNA, SINE DNA, LINE DNA, or STR DNA. In some embodiments, the sequence of the first segments is RNA encoded by sequences selected from Table 3 and/or Table 4. In some embodiments, the collection comprises at least (unique gRNAs. In some embodiments, the gRNAs comprise cytosine, guanine, and adenine. In some embodiments, a subset of the gRNAs further comprises thymine. In some embodiments, a subset of the gRNAs further comprises uracil. In some embodiments, the first segment is at least 80% complementary to a target genomic sequence of interest. In some embodiments, the targeting sequence is at least 80% complementary to the strand opposite to a sequence of nucleotides 5′ to a PAM sequence. In some embodiments the PAM sequence is AGG, CGG, or TGG. In some embodiments, the PAM sequence is specific for a CRISPR/Cas system protein selected from the group consisting of Cas9, Cpf1, Cas3, Cas8a-c, Cas10, Cse1, Csy1, Csn2, Cas4, Csm2, and Cm5. In some embodiments, the second segment comprises a gRNA stem-loop sequence. In some embodiments, the third segment comprises DNA encoding a gRNA stem-loop sequence. In some embodiments, the third segment comprises the sequence GUUUUAGAGCUAGAAAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGAAAAAGUGGCA CCGAGUCGGUGCUUUUUUU (SEQ ID NO: 1) or comprises the sequence GUUUUAGAGCUAUGCUGGAAACAGCAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGA AAAAGUGGCACCGAGUCGGUGCUUUUUUUC (SEQ ID NO: 2). In some embodiments, the second segment comprises a crRNA and a tracrRNA. In some embodiments, the nucleic acid-guided nuclease system protein is from a bacterial species. In some embodiments, the nucleic acid-guided nuclease system protein is from an archaea species. In some embodiments, the CRISPR/Cas system protein is a Type I, Type II, or Type III protein. In some embodiments, the CRISPR/Cas system protein is selected from the group consisting of Cas9, Cpf1, Cas3, Cas8a-c, Cas10, Cse1, Csy1, Csn2, Cas4, Csm2, Cm5, dCas9 and cas9 nickase. In some embodiments, the second segment comprises a Cas9-binding sequence. In some embodiments, at least 10% of the gRNAs in the collection vary in their 5′ terminal-end sequence. In some embodiments, the collection comprises targeting sequences directed to sequences of interest spaced every 10,000 bp or less across the genome of an organism. In some embodiments, a plurality of second segments of the collection comprise a first nucleic acid-guided nuclease system protein binding sequence, and a plurality of the second segments of the collection comprise a second nucleic acid-guided nuclease system protein binding sequence. In some embodiments, the second segments of the collection comprise a plurality of different binding sequences of a plurality of different nucleic acid-guided nuclease system proteins. In some embodiments, a plurality of the gRNAs of the collection are attached to a substrate. In some embodiments, a plurality of the gRNAs of the collection comprise a label. In some particular embodiments, a plurality of the gRNAs of the collection comprise different labels.

In another aspect, the invention described herein provides nucleic acid comprising: a first segment comprising a regulatory region; a second segment encoding a targeting sequence, wherein the targeting sequence is greater than 30 bp; and a third segment encoding a nucleic acid encoding a nucleic acid-guided nuclease system protein-binding sequence. In some embodiments, the nucleic acid-guided nuclease is a CRISPR/Cas system protein. In some embodiments, the nucleic acid is DNA. In some embodiments, the second segment is single stranded DNA. In some embodiments, the third segment is single stranded DNA. In some embodiments, the second segment is double stranded DNA. In some embodiments, the third segment is double stranded DNA. In some embodiments, the regulatory region is a region capable of binding a transcription factor. In some embodiments, the regulatory region comprises a promoter. In some embodiments, the promoter is selected from the group consisting of T7, SP6, and T3. In some embodiments, the targeting sequence is directed at a mammalian genome, eukaryotic genome, prokaryotic genome, or a viral genome. In some embodiments, the targeting sequence is directed at abundant or repetitive DNA. In some embodiments, the targeting sequence is directed at mitochondrial DNA, ribosomal DNA, Alu DNA, centromeric DNA, SINE DNA, LINE DNA, or STR DNA. In some embodiments, the sequence of the second segments is selected from Table 3 and/or Table 4. In some embodiments, the targeting sequence is at least 80% complementary to the strand opposite to a sequence of nucleotides 5′ to a PAM sequence. In some embodiments, the target genomic sequence of interest is 5′ upstream of a PAM sequence. In some embodiments, the PAM sequence is specific for a CRISPR/Cas system protein selected from the group consisting of Cas9, Cpf1, Cas3, Cas8a-c, Cas10, Cse1, Csy1, Csn2, Cas4, Csm2, and Cm5. In some embodiments, the third segment comprises DNA encoding a gRNA stem-loop sequence. In some embodiments, the third segment comprises DNA encoding a gRNA stem-loop sequence. In some embodiments, the third segment encodes for a RNA comprising the sequence GUUUUAGAGCUAGAAAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGAAAAAGUGGCA CCGAGUCGGUGCUUUUUUU (SEQ ID NO: 1) or encodes for a RNA comprising the sequence GUUUUAGAGCUAUGCUGGAAACAGCAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGA AAAAGUGGCACCGAGUCGGUGCUUUUUUUC (SEQ ID NO: 2). In some embodiments, the nucleic acid-guided nuclease system protein is from a bacterial species. In some embodiments, the nucleic acid-guided nuclease system protein is from an archaea species. In some embodiments, the CRISPR/Cas system protein is a Type I, Type II, or Type III protein. In some embodiments, the CRISPR/Cas system protein is selected from the group consisting of Cas9, Cpf1, Cas3, Cas8a-c, Cas10, Cse1, Csy1, Csn2, Cas4, Csm2, Cm5, dCas9 and cas9 nickase. In some embodiments, the third segment comprises DNA encoding a Cas9-binding sequence.

In another aspect, the invention described herein provides a guide RNA comprising a first segment comprising a targeting sequence, wherein the size of the first segment is greater than 30 bp; and a second segment comprising a nucleic acid-guided nuclease system protein-binding sequence. In some embodiments, the nucleic acid-guided nuclease is a CRISPR/Cas system protein. In some embodiments, the gRNA comprises an adenine, a guanine, and a cytosine. In some embodiments, the gRNA further comprises a thymine. In some embodiments, the gRNA further comprises a uracil. In some embodiments, the size of the first RNA segment is between 30 and 250 bp. In some embodiments, the targeting sequence is directed at a mammalian genome, eukaryotic genome, prokaryotic genome, or viral genome. In some embodiments, the targeting sequence is directed at repetitive or abundant DNA. In some embodiments, the targeting sequence is directed at mitochondrial DNA, ribosomal DNA, Alu DNA, centromeric DNA, SINE DNA, LINE DNA, or STR DNA. In some embodiments, the first segment is at least 80% complementary to the target genomic sequence of interest. In some embodiments, the targeting sequence is at least 80% complementary to the strand opposite to a sequence of nucleotides 5′ to a PAM sequence. In some embodiments, the second segment comprises a gRNA stem-loop sequence. In some embodiments, the sequence of the second segment comprises GUUUUAGAGCUAGAAAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGAAAAAGUGGCA CCGAGUCGGUGCUUUUUUU (SEQ ID NO: 1) or comprises the sequence GUUUUAGAGCUAUGCUGGAAACAGCAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGA AAAAGUGGCACCGAGUCGGUGCUUUUUUUC (SEQ ID NO: 2). In some embodiments, the sequence of the third segment comprises a crRNA and a tracrRNA. In some embodiments, the nucleic acid-guided nuclease system protein is from a bacterial species. In some embodiments, the nucleic acid-guided nuclease system protein is from an archaea species. In some embodiments, the CRISPR/Cas system protein is a Type I, Type II, or Type III protein. In some embodiments, the CRISPR/Cas system protein is selected from the group consisting of Cas9, Cpf1, Cas3, Cas8a-c, Cas10, Cse1, Csy1, Csn2, Cas4, Csm2, Cm5, dCas9 and cas9 nickase. In some embodiments, the second segment is a Cas9-binding sequence.

In another aspect, the invention provides a complex comprising a nucleic acid-guided nuclease system protein and a comprising a first segment comprising a targeting sequence, wherein the size of the first segment is greater than 30 bp; and a second segment comprising a nucleic acid-guided nuclease system protein-binding sequence.

In another aspect, the invention described herein provides a method for depleting and partitioning of targeted sequences in a sample, enriching a sample for non-host nucleic acids, or serially depleting targeted nucleic acids in a sample comprising: providing nucleic acids extracted from a sample; and contacting the sample with a plurality of complexes comprising (i) any one of the collection of gRNAs provided herein; and (ii) nucleic acid-guided nuclease system proteins. In some embodiments, the nucleic acid-guided nuclease system proteins are CRISPR/Cas system proteins. In some embodiments, the CRISPR/Cas system proteins are Cas9 proteins.

In another aspect, the invention provides a method of making a collection of nucleic acids, each comprising a DNA encoding a targeting sequence ligated to a DNA encoding a nucleic acid-guided nuclease system protein-binding sequence, comprising: (a) providing double-stranded DNA molecules, each comprising a sequence of interest 5′ to a PAM sequence, and its reverse complementary sequence on the opposite strand; (b) performing an enzymatic digestion reaction on the double stranded DNA molecules, wherein cleavages are generated at the PAM sequence and/or its reverse complementary sequence on the opposite strand, but never completely remove the PAM sequence and/or its reverse complementary sequence on the opposite strand from the double stranded DNA; (c) ligating adapters comprising a recognition sequence to the resulting DNA molecules of step b; (d) contacting the DNA molecules of step c with an restriction enzyme that recognizes the recognition sequence of step c, whereby generating DNA fragments comprising blunt-ended double strand breaks immediately 5′ to the PAM sequence, whereby removing the PAM sequence and the adapter containing the enzyme recognition site; and (e) ligating the resulting double stranded DNA fragments of step d with a DNA encoding a nucleic acid-guided nuclease system protein-binding sequence, whereby generating a plurality of DNA fragments, each comprising a DNA encoding a targeting sequence ligated to a DNA encoding a nucleic acid-guided nuclease system protein-binding sequence. In some embodiments, the nucleic acid-guided nuclease is a CRISPR/Cas nucleic acid-guided nuclease system protein. In some embodiments, the starting DNA molecules of the collection further comprise a regulatory sequence upstream of the sequence of interest 5′ to the PAM sequence. In some embodiments, the regulatory sequence comprises a promoter. In some embodiments, the promoter comprises a T7, Sp6, or T3 sequence. In some embodiments, the double stranded DNA molecules are genomic DNA, intact DNA, or sheared DNA. In some embodiments, the genomic DNA is human, mouse, avian, fish, plant, insect, bacterial, or viral. In some embodiments, the DNA segments encoding a targeting sequence are at least 22 bp. In some embodiments, the DNA segments encoding a targeting sequence are 15-250 bp in size range. In some embodiments, the PAM sequence is AGG, CGG, or TGG. In some embodiments, the PAM sequence is specific for a CRISPR/Cas system protein selected from the group consisting of Cas9, Cpf1, Cas3, Cas8a-c, Cas10, Cse1, Csy1, Csn2, Cas4, Csm2, and Cm5. In some embodiments, step (b) further comprises (1) contacting the DNA molecules with an enzyme capable of creating a nick in a single strand at a CCD site, whereby generating a plurality of nicked double stranded DNA molecules, each comprising a sequence of interest followed by an HGG sequence, wherein the DNA molecules are nicked at the CCD sites; and (2) contacting the nicked double stranded DNA molecules with an endonuclease, whereby generating a plurality of double stranded DNA fragments, each comprising a sequence of interest followed by an HGG sequence wherein residual nucleotides from HGG and/or CCD sequences is (are) left behind. In some embodiments, step (d) further comprises PCR amplification of the adaptor-ligated DNA fragments from step (c) before cutting with the restriction enzyme recognizing the recognition sequence of step (c), wherein after PCR, the recognition sequence is positioned 3′ of the PAM sequence, and a regulatory sequence is positioned at the 5′ distal end of the PAM sequence. In some embodiments, the enzymatic reaction of step (b) comprises the use of a Nt.CviPII enzyme, and a T7 Endonuclease I enzyme. In some embodiments, step (c) further comprises a blunt-end reaction with a T4 DNA Polymerase, if the adapter to be ligated does not comprise an overhang. In some embodiments, the adapter of step (c) is either (1) double stranded, comprising a restriction enzyme recognition sequence in one strand, and a regulatory sequence in the other strand, if the adapter is Y-shaped and comprises an overhang; or (2) has a palindromic enzyme recognition sequence in both strands, if the adapter is not Y-shaped. In some embodiments, the restriction enzyme of step (d) is MlyI. In some embodiments, the restriction enzyme of step (d) is BaeI. In some embodiments, step (d) further comprises contacting the DNA molecules with an XhoI enzyme. In some embodiments, in step (e) the DNA encoding a nucleic acid-guided nuclease system-protein binding sequence encodes for a RNA comprising the sequence GUUUUAGAGCUAGAAAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGAAAAAGUGGCA CCGAGUCGGUGCUUUUUUU (SEQ ID NO: 1) or encodes for a RNA comprising the sequence GUUUUAGAGCUAUGCUGGAAACAGCAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGA AAAAGUGGCACCGAGUCGGUGCUUUUUUUC (SEQ ID NO: 2). In some embodiments, the targeted sequences of interest are spaced every 10,000 bp or less across the genome of an organism.

In another aspect, the invention provides a method of making a collection of nucleic acids, each comprising a DNA encoding a targeting sequence and a DNA encoding a nucleic acid-guided nuclease system protein-binding sequence, comprising: (a) providing genomic DNA comprising a plurality of sequences of interest, comprising NGG and CCN sites; (b) contacting the genomic DNA with an enzyme capable of creating nicks in the genomic DNA, whereby generating nicked genomic DNA, nicked at CCN sites; (c) contacting the nicked genomic DNA with an endonuclease, whereby generating double stranded DNA fragments, with an overhang; (d) ligating the DNA with overhangs from step c to a Y-shaped adapter, thereby introducing a restriction enzyme recognition sequence only at 3′ of the NGG site and a regulatory sequence 5′ of the sequence of interest; (e) contacting the product from step d with an enzyme that cleaves away the NGG site together with the adaptor carrying the enzyme recognition sequence; and (f) ligating the resulting double stranded DNA fragments of step e with a DNA encoding a nucleic acid-guided nuclease system protein-binding sequence, whereby generating a plurality of DNA fragments, each comprising a sequence of interest ligated to a DNA encoding a nucleic acid-guided nuclease system protein-binding sequence. In some embodiments, the nucleic acid-guided nuclease is a CRISPR/Cas system protein. In some embodiments, the NGG site comprises AGG, CGG, or TGG, and CCN site comprises CCT, CCG, or CCA. In some embodiments, the regulatory sequence comprises a promoter sequence. In some embodiments, the promoter sequence comprises a T7, SP6, or T3 sequence. In some embodiments, the DNA fragments are sheared fragments of genomic DNA.

In some embodiments, the genomic DNA is mammalian, prokaryotic, eukaryotic, or viral. In some embodiments, the fragments are at least 200 bp. In some embodiments, the enzyme in step b is a Nt.CviPII enzyme. In some embodiments, the enzyme in step c is a T7 Endonuclease I. In some embodiments, step d further comprises PCR amplification of the adaptor-ligated DNA. In some embodiments, in step f, the DNA encoding nucleic acid-guided nuclease system protein-binding sequence encodes for a RNA comprising the sequence GUUUUAGAGCUAGAAAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGAAAAAGUGGCA CCGAGUCGGUGCUUUUUUU (SEQ ID NO: 1) or encodes for a RNA comprising the sequence GUUUUAGAGCUAUGCUGGAAACAGCAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGA AAAAGUGGCACCGAGUCGGUGCUUUUUUUC (SEQ ID NO: 2). In some embodiments, the enzyme removing NGG site in step e is MlyI. In some embodiments, the target of interest of the collection is spaced every 10,000 bp or less across the genome.

In another aspect, the invention provides kits and/or reagents useful for performing a method of making a collection of nucleic acids, each comprising a DNA encoding a targeting sequence ligated to a DNA encoding a nucleic acid-guided nuclease system protein-binding sequence, as described in the embodiments herein.

In another aspect, the invention described herein provides kit comprising a collection of nucleic acids, a plurality of the nucleic acids in the collection comprising: a first segment comprising a regulatory region; a second segment encoding a targeting sequence; and a third segment encoding a CRISPR/Cas system protein-binding sequence, wherein at least 10% of the nucleic acids in the collection vary in size.

In another aspect, the invention described herein provides a kit comprising a collection of nucleic acids, a plurality of the nucleic acids in the collection comprising: a first segment comprising a regulatory region; a second segment encoding a targeting sequence, wherein the size of the second segment is greater than 21 bp; and a third segment encoding a CRISPR/Cas system protein-binding sequence.

In another aspect, the invention described herein provides a kit comprising a collection of guide RNAs comprising a first RNA segment a targeting sequence; and a second RNA segment comprising a CRISPR/Cas system protein-binding sequence, wherein at least 10% of the gRNAs in the collection vary in size.

In another aspect, the invention described herein provides a method of making a collection of guide nucleic acids, comprising: a. obtaining abundant cells in a source sample; b. collecting nucleic acids from said abundant cells; and c. preparing a collection of guide nucleic acids (gNAs) from said nucleic acids. In some embodiments, said abundant cells comprise cells from one or more most abundant bacterial species in said source sample. In some embodiments, said abundant cells comprise cells from more than one species. In some embodiments, said abundant cells comprise human cells. In some embodiments, said abundant cells comprise animal cells. In some embodiments, said abundant cells comprise plant cells. In some embodiments, said abundant cells comprise bacterial cells. In some embodiments, the method further comprises contacting nucleic acid-guided nucleases with said library of gNAs to form nucleic acid-guided nuclease-gNA complexes. In some embodiments, the method further comprises using said nucleic acid-guided nuclease-gNA complexes to cleave target nucleic acids at target sites, wherein said gNAs are complementary to said target sites. In some embodiments, said target nucleic acids are from said source sample. In some embodiments, a species of said target nucleic acids is the same as a species of said source sample. In some embodiments, said species of said target nucleic acids and said species of said source sample is human. In some embodiments, said species of said target nucleic acids and said species of said source sample is animal. In some embodiments, said species of said target nucleic acids and said species of said source sample is plant.

In another aspect, the invention described herein provides a method of making a collection of nucleic acids, each comprising a targeting sequence, comprising: a. obtaining source DNA; b. nicking said source DNA with a nicking enzyme at nicking enzyme recognition sites, thereby producing double-stranded breaks at proximal nicks; and c. repairing overhangs of said double-stranded breaks, thereby producing a double-stranded fragment comprising (i) a targeting sequence and (ii) said nicking enzyme recognition site. In another aspect, the invention described herein provides a method of making a collection of nucleic acids, each comprising a targeting sequence, comprising: a. obtaining source DNA; b. nicking said source DNA with a nicking enzyme at nicking enzyme recognition sites, thereby producing a nick; and c. synthesizing a new strand from said nick, thereby producing a single-stranded fragment of said source DNA comprising a targeting sequence. In some embodiments, the method further comprises producing a double-stranded fragment comprising said targeting sequence from said single-stranded fragment. In some embodiments, said producing said double-stranded fragment comprises random priming and extension. In some embodiments, said random priming is conducted with a primer comprising a random n-mer region and a promoter region. In some embodiments, said random n-mer region is a random hexamer region. In some embodiments, said random n-mer region is a random octamer region. In some embodiments, said promoter region is a T7 promoter region. In some embodiments, the method further comprises ligating a nuclease recognition site nucleic acid comprising a nuclease recognition site to said double-stranded fragment. In some embodiments, said nuclease recognition site corresponds to a nuclease that cuts at a distance from said nuclease recognition site equal to the length of said nicking enzyme recognition sites. In some embodiments, said nuclease recognition site is a MlyI recognition site. In some embodiments, said nuclease recognition site is a BaeI recognition site. In some embodiments, the method further comprises digesting said double-stranded fragment with said nuclease, thereby removing said nicking enzyme recognition site from said double-stranded fragment. In some embodiments, the method further comprises ligating said double-stranded fragment to a nucleic acid-guided nuclease system protein recognition site nucleic acid comprising a nucleic acid-guided nuclease system protein recognition site. In some embodiments, said nucleic acid-guided nuclease system protein recognition site comprises a guide RNA stem-loop sequence. In some embodiments, said nuclease recognition site corresponds to a nuclease that cuts at a distance from said nuclease recognition site equal to a length of said targeting sequence. In some embodiments, said length of said targeting sequence is 20 base pairs. In some embodiments, said nuclease recognition site is a MmeI recognition site. In some embodiments, the method further comprises digesting said double-stranded fragment with said nuclease. In some embodiments, said nuclease recognition site corresponds to a nuclease that cuts at a distance from said nuclease recognition site equal to a length of said targeting sequence plus a length of said nicking enzyme recognition sites. In some embodiments, said length of said targeting sequence plus a length of said nicking enzyme recognition sites is 23 base pairs. In some embodiments, said nuclease recognition site is a EcoP15I recognition site. In some embodiments, the method further comprises digesting said double-stranded fragment with said nuclease. In some embodiments, the method further comprises ligating said double-stranded fragment to a nucleic acid-guided nuclease system protein recognition site nucleic acid comprising a nucleic acid-guided nuclease system protein recognition site. In some embodiments, said nucleic acid-guided nuclease system protein recognition site comprises a guide RNA stem-loop sequence.

In another aspect, the invention described herein provides a kit comprising all essential reagents and instructions for carrying out the methods of aspects of the invention described herein.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 illustrates an exemplary scheme for producing a collection of gRNAs (a gRNA library) from genomic DNA.

FIG. 2 illustrates another exemplary scheme for producing a collection of gRNAs (a gRNA library) from genomic DNA.

FIG. 3 illustrates an exemplary scheme for nicking of DNA and subsequent treatment with polymerase to generate blunt ends.

FIG. 4 illustrates an exemplary scheme for sequential production of a library of gNAs using three adapters.

FIG. 5 illustrates an exemplary scheme for sequential production of a library of gNAs using one adapter and one oligo.

FIG. 6 illustrates an exemplary scheme for generation of a large pool of DNA fragments with blunt ends using Nicking Enzyme Mediated DNA Amplification (NEMDA).

FIG. 7 illustrates an exemplary scheme for generation of a large pool of gNAs using Nicking Enzyme Mediated DNA Amplification (NEMDA).

DETAILED DESCRIPTION OF THE INVENTION

There is a need in the art for a scalable, low-cost approach to generate large numbers of diverse guide nucleic acids (gNAs) (e.g., gRNAs, gDNAs) for a variety of downstream applications.

Unless defined otherwise herein, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, the preferred methods and materials are described.

Numeric ranges are inclusive of the numbers defining the range.

For purposes of interpreting this specification, the following definitions will apply and whenever appropriate, terms used in the singular will also include the plural and vice versa. In the event that any definition set forth below conflicts with any document incorporated herein by reference, the definition set forth shall control.

As used herein, the singular form “a”, “an”, and “the” includes plural references unless indicated otherwise.

It is understood that aspects and embodiments of the invention described herein include “comprising,” “consisting,” and “consisting essentially of” aspects and embodiments.

The term “about” as used herein refers to the usual error range for the respective value readily known to the skilled person in this technical field. Reference to “about” a value or parameter herein includes (and describes) embodiments that are directed to that value or parameter per se.

The term “nucleic acid,” as used herein, refers to a molecule comprising one or more nucleic acid subunits. A nucleic acid can include one or more subunits selected from adenosine (A), cytosine (C), guanine (G), thymine (T) and uracil (U), and modified versions of the same. A nucleic acid comprises deoxyribonucleic acid (DNA), ribonucleic acid (RNA), combinations, or derivatives thereof. A nucleic acid may be single-stranded and/or double-stranded.

The nucleic acids comprise “nucleotides”, which, as used herein, is intended to include those moieties that contain purine and pyrimidine bases, and modified versions of the same. Such modifications include methylated purines or pyrimidines, acylated purines or pyrimidines, alkylated riboses or other heterocycles. In addition, the term “nucleotide” or “polynucleotide” includes those moieties that contain hapten or fluorescent labels and may contain not only conventional ribose and deoxyribose sugars, but other sugars as well. Modified nucleosides, nucleotides or polynucleotides also include modifications on the sugar moiety, e.g., wherein one or more of the hydroxyl groups are replaced with halogen atoms or aliphatic groups, or are functionalized as ethers, amines, or the like.

The term “nucleic acids” and “polynucleotides” are used interchangeably herein. Polynucleotide is used to describe a nucleic acid polymer of any length, e.g., greater than about 2 bases, greater than about 10 bases, greater than about 100 bases, greater than about 500 bases, greater than 1000 bases, up to about 10,000 or more bases composed of nucleotides, e.g., deoxyribonucleotides or ribonucleotides, and may be produced enzymatically or synthetically (e.g., PNA as described in U.S. Pat. No. 5,948,902 and the references cited therein) which can hybridize with naturally occurring nucleic acids in a sequence specific manner analogous to that of two naturally occurring nucleic acids, e.g., can participate in Watson-Crick base pairing interactions. Naturally-occurring nucleotides include guanine, cytosine, adenine and thymine (G, C, A and T, respectively). DNA and RNA have a deoxyribose and ribose sugar backbones, respectively, whereas PNA's backbone is composed of repeating N-(2-aminoethyl)-glycine units linked by peptide bonds. In PNA various purine and pyrimidine bases are linked to the backbone by methylene carbonyl bonds. A locked nucleic acid (LNA), often referred to as inaccessible RNA, is a modified RNA nucleotide. The ribose moiety of an LNA nucleotide is modified with an extra bridge connecting the 2′ oxygen and 4′ carbon. The bridge “locks” the ribose in the 3′-endo (North) conformation, which is often found in the A-form duplexes. LNA nucleotides can be mixed with DNA or RNA residues in the oligonucleotide whenever desired. The term “unstructured nucleic acid,” or “UNA” is a nucleic acid containing non-natural nucleotides that bind to each other with reduced stability. For example, an unstructured nucleic acid may contain a G′ residue and a C′ residue, where these residues correspond to non-naturally occurring forms, i.e., analogs, of G and C that base pair with each other with reduced stability, but retain an ability to base pair with naturally occurring C and G residues, respectively. Unstructured nucleic acid is described in US20050233340, which is incorporated by reference herein for disclosure of UNA.

The term “oligonucleotide” as used herein denotes a single-stranded multimer of nucleotides.

Unless otherwise indicated, nucleic acids are written left to right in 5′ to 3′ orientation; amino acid sequences are written left to right in amino to carboxy orientation, respectively.

The term “cleaving,” as used herein, refers to a reaction that breaks the phosphodiester bonds between two adjacent nucleotides in both strands of a double-stranded DNA molecule, thereby resulting in a double-stranded break in the DNA molecule.

The term “nicking” as used herein, refers to a reaction that breaks the phosphodiester bond between two adjacent nucleotides in only one strand of a double-stranded DNA molecule, thereby resulting in a break in one strand of the DNA molecule.

The term “cleavage site, as used herein, refers to the site at which a double-stranded DNA molecule has been cleaved.

The “nucleic acid-guided nuclease-gNA complex” refers to a complex comprising a nucleic acid-guided nuclease protein and a guide nucleic acid (gNA, for example a gRNA or a gDNA). For example the “Cas9-gRNA complex” refers to a complex comprising a Cas9 protein and a guide RNA (gRNA). The nucleic acid-guided nuclease may be any type of nucleic acid-guided nuclease, including but not limited to wild type nucleic acid-guided nuclease, a catalytically dead nucleic acid-guided nuclease, or a nucleic acid-guided nuclease-nickase.

The term “nucleic acid-guided nuclease-associated guide NA” refers to a guide nucleic acid (guide NA). The nucleic acid-guided nuclease-associated guide NA may exist as an isolated nucleic acid, or as part of a nucleic acid-guided nuclease-gNA complex, for example a Cas9-gRNA complex.

The terms “capture” and “enrichment” are used interchangeably herein, and refer to the process of selectively isolating a nucleic acid region containing: sequences of interest, targeted sites of interest, sequences not of interest, or targeted sites not of interest.

The term “hybridization” refers to the process by which a strand of nucleic acid joins with a complementary strand through base pairing as known in the art. A nucleic acid is considered to be “selectively hybridizable” to a reference nucleic acid sequence if the two sequences specifically hybridize to one another under moderate to high stringency hybridization and wash conditions. Moderate and high stringency hybridization conditions are known (see, e.g., Ausubel, et al., Short Protocols in Molecular Biology, 3rd ed., Wiley & Sons 1995 and Sambrook et al., Molecular Cloning: A Laboratory Manual, Third Edition, 2001 Cold Spring Harbor, N.Y.). One example of high stringency conditions includes hybridization at about 42° C. in 50% formamide, 5×SSC, 5×Denhardt's solution, 0.5% SDS and 100 μg/ml denatured carrier DNA followed by washing two times in 2×SSC and 0.5% SDS at room temperature and two additional times in 0.1×SSC and 0.5% SDS at 42° C.

The term “duplex,” or “duplexed,” as used herein, describes two complementary polynucleotides that are base-paired, i.e., hybridized together.

The term “amplifying” as used herein refers to generating one or more copies of a target nucleic acid, using the target nucleic acid as a template.

The term “genomic region,” as used herein, refers to a region of a genome, e.g., an animal or plant genome such as the genome of a human, monkey, rat, fish or insect or plant. In certain cases, an oligonucleotide used in the method described herein may be designed using a reference genomic region, i.e., a genomic region of known nucleotide sequence, e.g., a chromosomal region whose sequence is deposited at NCBI's Genbank database or other databases, for example.

The term “genomic sequence,” as used herein, refers to a sequence that occurs in a genome. Because RNAs are transcribed from a genome, this term encompasses sequence that exist in the nuclear genome of an organism, as well as sequences that are present in a cDNA copy of an RNA (e.g., an mRNA) transcribed from such a genome.

The term “genomic fragment,” as used herein, refers to a region of a genome, e.g., an animal or plant genome such as the genome of a human, monkey, rat, fish or insect or plant. A genomic fragment may be an entire chromosome, or a fragment of a chromosome. A genomic fragment may be adapter ligated (in which case it has an adapter ligated to one or both ends of the fragment, or to at least the 5 end of a molecule), or may not be adapter ligated.

In certain cases, an oligonucleotide used in the method described herein may be designed using a reference genomic region, i.e., a genomic region of known nucleotide sequence, e.g., a chromosomal region whose sequence is deposited at NCBI's Genbank database or other databases, for example. Such an oligonucleotide may be employed in an assay that uses a sample containing a test genome, where the test genome contains a binding site for the oligonucleotide.

The term “ligating,” as used herein, refers to the enzymatically catalyzed joining of the terminal nucleotide at the 5′ end of a first DNA molecule to the terminal nucleotide at the 3′ end of a second DNA molecule.

If two nucleic acids are “complementary,” each base of one of the nucleic acids base pairs with corresponding nucleotides in the other nucleic acid. The term “complementary” and “perfectly complementary” are used synonymously herein.

The term “separating,” as used herein, refers to physical separation of two elements (e.g., by size or affinity, etc.) as well as degradation of one element, leaving the other intact. For example, size exclusion can be employed to separate nucleic acids, including cleaved targeted sequences.

In a cell, DNA usually exists in a double-stranded form, and as such, has two complementary strands of nucleic acid referred to herein as the “top” and “bottom” strands. In certain cases, complementary strands of a chromosomal region may be referred to as “plus” and “minus” strands, the “first” and “second” strands, the “coding” and “noncoding” strands, the “Watson” and “Crick” strands or the “sense” and “antisense” strands. The assignment of a strand as being a top or bottom strand is arbitrary and does not imply any particular orientation, function or structure. Until they become covalently linked, the first and second strands are distinct molecules. For ease of description, the “top” and “bottom” strands of a double-stranded nucleic acid in which the top and bottom strands have been covalently linked will still be described as the “top” and “bottom” strands. In other words, for the purposes of this disclosure, the top and bottom strands of a double-stranded DNA do not need to be separated molecules. The nucleotide sequences of the first strand of several exemplary mammalian chromosomal regions (e.g., BACs, assemblies, chromosomes, etc.) is known, and may be found in NCBI's Genbank database, for example.

The term “top strand,” as used herein, refers to either strand of a nucleic acid but not both strands of a nucleic acid. When an oligonucleotide or a primer binds or anneals “only to a top strand,” it binds to only one strand but not the other. The term “bottom strand,” as used herein, refers to the strand that is complementary to the “top strand.” When an oligonucleotide binds or anneals “only to one strand,” it binds to only one strand, e.g., the first or second strand, but not the other strand. If an oligonucleotide binds or anneals to both strands of a double-stranded DNA, the oligonucleotide may have two regions, a first region that hybridizes with the top strand of the double-stranded DNA, and a second region that hybridizes with the bottom strand of the double-stranded DNA.

The term “double-stranded DNA molecule” refers to both double-stranded DNA molecules in which the top and bottom strands are not covalently linked, as well as double-stranded DNA molecules in which the top and bottom stands are covalently linked. The top and bottom strands of a double-stranded DNA are base paired with one other by Watson-Crick interactions.

The term “denaturing,” as used herein, refers to the separation of at least a portion of the base pairs of a nucleic acid duplex by placing the duplex in suitable denaturing conditions. Denaturing conditions are well known in the art. In one embodiment, in order to denature a nucleic acid duplex, the duplex may be exposed to a temperature that is above the T_mof the duplex, thereby releasing one strand of the duplex from the other. In certain embodiments, a nucleic acid may be denatured by exposing it to a temperature of at least 90° C. for a suitable amount of time (e.g., at least 30 seconds, up to 30 mins). In certain embodiments, fully denaturing conditions may be used to completely separate the base pairs of the duplex. In other embodiments, partially denaturing conditions (e.g., with a lower temperature than fully denaturing conditions) may be used to separate the base pairs of certain parts of the duplex (e.g., regions enriched for A-T base pairs may separate while regions enriched for G-C base pairs may remain paired). Nucleic acid may also be denatured chemically (e.g., using urea or NaOH).

The term “genotyping” as used herein, refers to any type of analysis of a nucleic acid sequence, and includes sequencing, polymorphism (SNP) analysis, and analysis to identify rearrangements.

The term “sequencing,” as used herein, refers to a method by which the identity of consecutive nucleotides of a polynucleotide are obtained.

The term “next-generation sequencing” refers to the so-called parallelized sequencing-by-synthesis or sequencing-by-ligation platforms, for example, those currently employed by Illumina, Life Technologies, and Roche, etc. Next-generation sequencing methods may also include nanopore sequencing methods or electronic-detection based methods such as Ion Torrent technology commercialized by Life Technologies.

The term “complementary DNA” or cDNA refers to a double-stranded DNA sample that was produced from an RNA sample by reverse transcription of RNA (using primers such as random hexamers or oligo-dT primers) followed by second-strand synthesis by digestion of the RNA with RNaseH and synthesis by DNA polymerase.

The term “RNA promoter adapter” is an adapter that contains a promoter for a bacteriophage RNA polymerase, e.g., the RNA polymerase from bacteriophage T3, T7, SP6 or the like.

Other definitions of terms may appear throughout the specification.

For any of the structural and functional characteristics described herein, methods of determining these characteristics are known in the art.

Guide Nucleic Acids (gNAs)

Provided herein are guide nucleic acids (gNAs) derivable from any nucleic acid source. The gNAs can be guide RNAs (gRNAs) or guide DNAs (gDNAs). The nucleic acid source can be DNA or RNA. Provided herein are methods to generate gNAs from any source nucleic acid, including DNA from a single organism, or mixtures of DNA from multiple organisms, or mixtures of DNA from multiple species, or DNA from clinical samples, or DNA from forensic samples, or DNA from environmental samples, or DNA from metagenomic DNA samples (for example a sample that contains more than one species of organism). Examples of any source DNA include, but are not limited to any genome, any genome fragment, cDNA, synthetic DNA, or a DNA collection (e.g. a SNP collection, DNA libraries). The gNAs provided herein can be used for genome-wide applications.

In some embodiments, the gNAs are derived from genomic sequences (e.g., genomic DNA). In some embodiments, the gNAs are derived from mammalian genomic sequences. In some embodiments, the gNAs are derived from eukaryotic genomic sequences. In some embodiments, the gNAs are derived from prokaryotic genomic sequences. In some embodiments, the gNAs are derived from viral genomic sequences. In some embodiments, the gNAs are derived from bacterial genomic sequences. In some embodiments, the gNAs are derived from plant genomic sequences. In some embodiments, the gNAs are derived from microbial genomic sequences. In some embodiments, the gNAs are derived from genomic sequences from a parasite, for example a eukaryotic parasite.

In some embodiments, the gNAs are derived from repetitive DNA. In some embodiments, the gNAs are derived from abundant DNA. In some embodiments, the gNAs are derived from mitochondrial DNA. In some embodiments, the gNAs are derived from ribosomal DNA. In some embodiments, the gNAs are derived from centromeric DNA. In some embodiments, the gNAs are derived from DNA comprising Alu elements (Alu DNA). In some embodiments, the gNAs are derived from DNA comprising long interspersed nuclear elements (LINE DNA). In some embodiments, the gNAs are derived from DNA comprising short interspersed nuclear elements (SINE DNA). In some embodiments the abundant DNA comprises ribosomal DNA. In some embodiments, the abundant DNA comprises host DNA (e.g., host genomic DNA or all host DNA). In an example, the gNAs can be derived from host DNA (e.g., human, animal, plant) for the depletion of host DNA to allow for easier analysis of other DNA that is present (e.g., bacterial, viral, or other metagenomic DNA). In another example, the gNAs can be derived from the one or more most abundant types (e.g., species) in a mixed sample, such as the one or more most abundant bacteria species in a metagenomic sample. The one or more most abundant types (e.g., species) can comprise the two, three, four, five, six, seven, eight, nine, ten, or more than ten most abundant types (e.g., species). The most abundant types can be the most abundant kingdoms, phyla or divisions, classes, orders, families, genuses, species, or other classifications. The most abundant types can be the most abundant cell types, such as epithelial cells, bone cells, muscle cells, blood cells, adipose cells, or other cell types. The most abundant types can be non-cancerous cells. The most abundant types can be cancerous cells. The most abundant types can be animal, human, plant, fungal, bacterial, or viral. gNAs can be derived from both a host and the one or more most abundant non-host types (e.g., species) in a sample, such as from both human DNA and the DNA of the one or more most abundant bacterial species. In some embodiments, the abundant DNA comprises DNA from the more abundant or most abundant cells in a sample. For example, for a specific sample, the highly abundant cells can be extracted and their DNA can be used to produce gNAs; these gNAs can be used to produce depletion library and applied to original sample to enable or enhance sequencing or detection of low abundance targets.

In some embodiments, the gNAs are derived from DNA comprising short terminal repeats (STRs).

In some embodiments, the gNAs are derived from a genomic fragment, comprising a region of the genome, or the whole genome itself. In one embodiment, the genome is a DNA genome. In another embodiment, the genome is a RNA genome.

In some embodiments, the gNAs are derived from a eukaryotic or prokaryotic organism; from a mammalian organism or a non-mammalian organism; from an animal or a plant; from a bacteria or virus; from an animal parasite; from a pathogen.

In some embodiments, the gNAs are derived from any mammalian organism. In one embodiment the mammal is a human. In another embodiment the mammal is a livestock animal, for example a horse, a sheep, a cow, a pig, or a donkey. In another embodiment, a mammalian organism is a domestic pet, for example a cat, a dog, a gerbil, a mouse, a rat. In another embodiment the mammal is a type of a monkey.

In some embodiments, the gNAs are derived from any bird or avian organism. An avian organism includes but is not limited to chicken, turkey, duck and goose.

In some embodiments, the gNAs are derived from a plant. In one embodiment, the plant is rice, maize, wheat, rose, grape, coffee, fruit, tomato, potato, or cotton.

In some embodiments, the gNAs are derived from a species of bacteria. In one embodiment, the bacteria are tuberculosis-causing bacteria.

In some embodiments, the gNAs are derived from a virus.

In some embodiments, the gNAs are derived from a species of fungi.

In some embodiments, the gNAs are derived from a species of algae.

In some embodiments, the gNAs are derived from any mammalian parasite.

In some embodiments, the gNAs are derived from any mammalian parasite. In one embodiment, the parasite is a worm. In another embodiment, the parasite is a malaria-causing parasite. In another embodiment, the parasite is a Leishmaniasis-causing parasite. In another embodiment, the parasite is an amoeba.

In some embodiments, the gNAs are derived from a nucleic acid target. Contemplated targets include, but are not limited to, pathogens; single nucleotide polymorphisms (SNPs), insertions, deletions, tandem repeats, or translocations; human SNPs or STRs; potential toxins; or animals, fungi, and plants. In some embodiments, the gRNAs are derived from pathogens, and are pathogen-specific gNAs.

In some embodiments, a guide NA of the invention comprises a first NA segment comprising a targeting sequence, wherein the targeting sequence is 15-250 bp; and a second NA segment comprising a nucleic acid guided nuclease system (e.g., CRISPR/Cas system) protein-binding sequence. In some embodiments, the targeting sequence is greater than 21 bp, greater than 22 bp, greater than 23 bp, greater than 24 bp, greater than 25 bp, greater than 26 bp, greater than 27 bp, greater than 28 bp, greater than 29 bp, greater than 30 bp, greater than 40 bp, greater than 50 bp, greater than 60 bp, greater than 70 bp, greater than 80 bp, greater than 90 bp, greater than 100 bp, greater than 110 bp, greater than 120 bp, greater than 130 bp, greater than 140 bp, or even greater than 150 bp. In an exemplary embodiment, the targeting sequence is greater than 30 bp. In some embodiments, the targeting sequences of the present invention range in size from 30-50 bp. In some embodiments, targeting sequences of the present invention range in size from 30-75 bp. In some embodiments, targeting sequences of the present invention range in size from 30-100 bp. For example, a targeting sequence can be at least 15 bp, 20 bp, 25 bp, 30 bp, 35 bp, 40 bp, 45 bp, 50 bp, 55 bp, 60 bp, 65 bp, 70 bp, 75 bp, 80 bp, 85 bp, 90 bp, 95 bp, 100 bp, 110 bp, 120 bp, 130 bp, 140 bp, 150 bp, 160 bp, 170 bp, 180 bp, 190 bp, 200 bp, 210 bp, 220 bp, 230 bp, 240 bp, or 250 bp. In specific embodiments, the targeting sequence is at least 22 bp. In specific embodiments, the targeting sequence is at least 30 bp.

In some embodiments, target-specific gNAs can comprise a nucleic acid sequence that is complementary to a region on the opposite strand of the targeted nucleic acid sequence 5′ to a PAM sequence, which can be recognized by a nucleic acid-guided nuclease system (e.g., CRISPR/Cas system) protein. In some embodiments the targeted nucleic acid sequence is immediately 5′ to a PAM sequence. In specific embodiments, the nucleic acid sequence of the gNA that is complementary to a region in a target nucleic acid is 15-250 bp. In specific embodiments, the nucleic acid sequence of the gNA that is complementary to a region in a target nucleic acid is 22, 23, 24, 25, 30, 35, 40, 45, 50, 60, 70, 75, 80, 90, or 100 bp.

In some particular embodiments, the targeting sequence is not 20 bp. In some particular embodiments, the targeting sequence is not 21 bp.

In some embodiments, the gNAs comprise any purines or pyrimidines (and/or modified versions of the same). In some embodiments, the gNAs comprise adenine, uracil, guanine, and cytosine (and/or modified versions of the same). In some embodiments, the gNAs comprise adenine, thymine, guanine, and cytosine (and/or modified versions of the same). In some embodiments, the gNAs comprise adenine, thymine, guanine, cytosine and uracil (and/or modified versions of the same).

In some embodiments, the gNAs comprise a label, are attached to a label, or are capable of being labeled. In some embodiments, the gNA comprises is a moiety that is further capable of being attached to a label. A label includes, but is not limited to, enzyme, an enzyme substrate, an antibody, an antigen binding fragment, a peptide, a chromophore, a lumiphore, a fluorophore, a chromogen, a hapten, an antigen, a radioactive isotope, a magnetic particle, a metal nanoparticle, a redox active marker group (capable of undergoing a redox reaction), an aptamer, one member of a binding pair, a member of a FRET pair (either a donor or acceptor fluorophore), and combinations thereof.

In some embodiments, the gNAs are attached to a substrate. The substrate can be made of glass, plastic, silicon, silica-based materials, functionalized polystyrene, functionalized polyethyleneglycol, functionalized organic polymers, nitrocellulose or nylon membranes, paper, cotton, and materials suitable for synthesis. Substrates need not be flat. In some embodiments, the substrate is a 2-dimensional array. In some embodiments, the 2-dimensional array is flat. In some embodiments, the 2-dimensional array is not flat, for example, the array is a wave-like array. Substrates include any type of shape including spherical shapes (e.g., beads). Materials attached to substrates may be attached to any portion of the substrates (e.g., may be attached to an interior portion of a porous substrates material). In some embodiments, the substrate is a 3-dimensional array, for example, a microsphere. In some embodiments, the microsphere is magnetic. In some embodiments, the microsphere is glass. In some embodiments, the microsphere is made of polystyrene. In some embodiments, the microsphere is silica-based. In some embodiments, the substrate is an array with interior surface, for example, is a straw, tube, capillary, cylindrical, or microfluidic chamber array. In some embodiments, the substrate comprises multiple straws, capillaries, tubes, cylinders, or chambers.

Nucleic Acids Encoding gNAs

Also provided herein are nucleic acids encoding for gNAs (e.g., gRNAs or gDNAs). In some embodiments, by encoding it is meant that a gNA results from the transcription of a nucleic acid encoding for a gNA (e.g., gRNA). In some embodiments, by encoding, it is meant that the nucleic acid is a template for the transcription of a gNA (e.g., gRNA). In some embodiments, by encoding, it is meant that a gNA results from the reverse transcription of a nucleic acid encoding for a gNA. In some embodiments, by encoding, it is meant that the nucleic acid is a template for the reverse transcription of a gNA. In some embodiments, by encoding, it is meant that a gNA results from the amplification of a nucleic acid encoding for a gNA. In some embodiments, by encoding, it is meant that the nucleic acid is a template for the amplification of a gNA.

In some embodiments the nucleic acid encoding for a gNA comprises a first segment comprising a regulatory region; a second segment comprising targeting sequence, wherein the second segment can range from 15 bp-250 bp; and a third segment comprising a nucleic acid encoding a nucleic acid-guided nuclease system (e.g., CRISPR/Cas system) protein-binding sequence.

In some embodiments, the nucleic acids encoding for gNAs comprise DNA. In some embodiments, the first segment is double stranded DNA. In some embodiments, the first segment is single stranded DNA. In some embodiments, the second segment is single stranded DNA. In some embodiments, the third segment is single stranded DNA. In some embodiments, the second segment is double stranded DNA. In some embodiments, the third segment is double stranded DNA.

In some embodiments, the nucleic acids encoding for gNAs comprise RNA.

In some embodiments the nucleic acids encoding for gNAs comprise DNA and RNA.

In some embodiments, the regulatory region is a region capable of binding a transcription factor. In some embodiments, the regulatory region comprises a promoter. In some embodiments, the promoter is selected from the group consisting of T7, SP6, and T3.

Collections of gNAs

Provided herein are collections (interchangeably referred to as libraries) of gNAs.

As used herein, a collection of gNAs denotes a mixture of gNAs containing at least 102 unique gNAs. In some embodiments a collection of gNAs contains at least 10², at least 10³, at least 10⁴, at least 10⁵, at least 10⁶, at least 10⁷, at least 10⁸, at least 10⁹, at least 10¹⁰unique gNAs. In some embodiments a collection of gNAs contains a total of at least 10², at least 10³, at least 10⁴, at least 10⁵, at least 10⁶, at least 10⁷, at least 10⁸, at least 10⁹, at least 10¹⁰gNAs.

In some embodiments, a collection of gNAs comprises a first NA segment comprising a targeting sequence; and a second NA segment comprising a nucleic acid-guided nuclease system (e.g., CRISPR/Cas system) protein-binding sequence, wherein at least 10% of the gNAs in the collection vary in size. In some embodiments, the first and second segments are in 5′- to 3-order′.

In some embodiments, the size of the first segment varies from 15-250 bp, or 30-100 bp, or 22-30 bp, or 15-50 bp, or 15-75 bp, or 15-100 bp, or 15-125 bp, or 15-150 bp, or 15-175 bp, or 15-200 bp, or 15-225 bp, or 15-250 bp, or 22-50 bp, or 22-75 bp, or 22-100 bp, or 22-125 bp, or 22-150 bp, or 22-175 bp, or 22-200 bp, or 22-225 bp, or 22-250 bp across the collection of gNAs.

In some embodiments, at least 10%, or at least 15%, or at last 20%, or at least 25%, or at least 30%, or at least 35%, or at least 40%, or at least 45%, or at least 50%, or at least 55%, or at least 60%, or at least 65%, or at least 70%, or at least 75%, or at least 80%, or at least 85%, or at least 90%, or at least 95%, or 100% of the first segments in the collection are greater than 21 bp.

In some embodiments, at least 0%, or at least 15%, or at last 20%, or at least 25%, or at least 30%, or at least 35%, or at least 40%, or at least 45%, or at least 50%, or at least 55%, or at least 60%, or at least 65%, or at least 70%, or at least 75%, or at least 80%, or at least 85%, or at least 90%, or at least 95%, or 100% of the first segments in the collection are 30-100 bp.

In some particular embodiments, the size of the first segment is not 20 bp.

In some particular embodiments, the size of the first segment is not 21 bp.

In some embodiments, the gNAs and/or the targeting sequence of the gNAs in the collection of gRNAs comprise unique 5′ ends. In some embodiments, the collection of gNAs exhibit variability in sequence of the 5′ end of the targeting sequence, across the members of the collection. In some embodiments, the collection of gNAs exhibit variability at least 5%, or at least 10%, or at least 15%, or at last 20%, or at least 25%, or at least 30%, or at least 35%, or at least 40%, or at least 45%, or at least 50%, or at least 55%, or at least 60%, or at least 65%, or at least 70%, or at least 75% variability in the sequence of the 5′ end of the targeting sequence, across the members of the collection.

In some embodiments, the 3′ end of the gNA targeting sequence can be any purine or pyrimidine (and/or modified versions of the same). In some embodiments, the 3′ end of the gNA targeting sequence is an adenine. In some embodiments, the 3′ end of the gNA targeting sequence is a guanine. In some embodiments, the 3′ end of the gNA targeting sequence is a cytosine. In some embodiments, the 3′ end of the gNA targeting sequence is a uracil. In some embodiments, the 3′ end of the gNA targeting sequence is a thymine. In some embodiments, the 3′ end of the gNA targeting sequence is not cytosine.

In some embodiments, the collection of gNAs comprises targeting sequences which can base-pair with the targeted DNA, wherein the target of interest is spaced at least every 1 bp, at least every 2 bp, at least every 3 bp, at least every 4 bp, at least every 5 bp, at least every 6 bp, at least every 7 bp, at least every 8 bp, at least every 9 bp, at least every 10 bp, at least every 11 bp, at least every 12 bp, at least every 13 bp, at least every 14 bp, at least every 15 bp, at least every 16 bp, at least every 17 bp, at least every 18 bp, at least every 19 bp, 20 bp, at least every 25 bp, at least every 30 bp, at least every 40 bp, at least every 50 bp, at least every 100 bp, at least every 200 bp, at least every 300 bp, at least every 400 bp, at least every 500 bp, at least every 600 bp, at least every 700 bp, at least every 800 bp, at least every 900 bp, at least every 1000 bp, at least every 2500 bp, at least every 5000 bp, at least every 10,000 bp, at least every 15,000 bp, at least every 20,000 bp, at least every 25,000 bp, at least every 50,000 bp, at least every 100,000 bp, at least every 250,000 bp, at least every 500,000 bp, at least every 750,000 bp, or even at least every 1,000,000 bp across a genome of interest.

In some embodiments, the collection of gNAs comprises a first NA segment comprising a targeting sequence; and a second NA segment comprising a nucleic acid-guided nuclease system (e.g., CRISPR/Cas system) protein-binding sequence, wherein the gNAs in the collection can have a variety of second NA segments with various specificities for protein members of the nucleic acid-guided nuclease system (e.g., CRISPR/Cas system). For example a collection of gNAs as provided herein, can comprise members whose second segment comprises a nucleic acid-guided nuclease system (e.g., CRISPR/Cas system) protein-binding sequence specific for a first nucleic acid-guided nuclease system (e.g., CRISPR/Cas system) protein; and also comprises members whose second segment comprises a nucleic acid-guided nuclease system (e.g., CRISPR/Cas system) protein-binding sequence specific for a second nucleic acid-guided nuclease system (e.g., CRISPR/Cas system) protein, wherein the first and second nucleic acid-guided nuclease system (e.g., CRISPR/Cas system) proteins are not the same. In some embodiments a collection of gNAs as provided herein comprises members that exhibit specificity to at least 1, at least 2, at least 3, at least 4, at least 5, at least 6, at least 7, at least 8, at least 9, at least 10, at least 11, at least 12, at least 13, at least 14, at least 15, at least 16, at least 17, at least 18, at least 19, or even at least 20 nucleic acid-guided nuclease system (e.g., CRISPR/Cas system) proteins. In one specific embodiment, a collection of gNAs as provided herein comprises members that exhibit specificity for a Cas9 protein and another protein selected from the group consisting of Cpf1, Cas3, Cas8a-c, Cas10, Cse1, Csy1, Csn2, Cas4, Csm2, and Cm5.

In some embodiments, a plurality of the gNA members of the collection are attached to a label, comprise a label or are capable of being labeled. In some embodiments, the gNA comprises is a moiety that is further capable of being attached to a label. A label includes, but is not limited to, enzyme, an enzyme substrate, an antibody, an antigen binding fragment, a peptide, a chromophore, a lumiphore, a fluorophore, a chromogen, a hapten, an antigen, a radioactive isotope, a magnetic particle, a metal nanoparticle, a redox active marker group (capable of undergoing a redox reaction), an aptamer, one member of a binding pair, a member of a FRET pair (either a donor or acceptor fluorophore), and combinations thereof.

In some embodiments, a plurality of the gNA members of the collection are attached to a substrate. The substrate can be made of glass, plastic, silicon, silica-based materials, functionalized polystyrene, functionalized polyethyleneglycol, functionalized organic polymers, nitrocellulose or nylon membranes, paper, cotton, and materials suitable for synthesis. Substrates need not be flat. In some embodiments, the substrate is a 2-dimensional array. In some embodiments, the 2-dimensional array is flat. In some embodiments, the 2-dimensional array is not flat, for example, the array is a wave-like array. Substrates include any type of shape including spherical shapes (e.g., beads). Materials attached to substrates may be attached to any portion of the substrates (e.g., may be attached to an interior portion of a porous substrates material). In some embodiments, the substrate is a 3-dimensional array, for example, a microsphere. In some embodiments, the microsphere is magnetic. In some embodiments, the microsphere is glass. In some embodiments, the microsphere is made of polystyrene. In some embodiments, the microsphere is silica-based. In some embodiments, the substrate is an array with interior surface, for example, is a straw, tube, capillary, cylindrical, or microfluidic chamber array. In some embodiments, the substrate comprises multiple straws, capillaries, tubes, cylinders, or chambers.

Collections of Nucleic Acids Encoding % NAs

Provided herein are collections (interchangeably referred to as libraries) of nucleic acids encoding for gNAs (e.g., gRNAs or gDNAs). In some embodiments, by encoding it is meant that a gNA results from the transcription of a nucleic acid encoding for a gNA. In some embodiments, by encoding, it is meant that the nucleic acid is a template for the transcription of a gNA.

As used herein, a collection of nucleic acids encoding for gNAs denotes a mixture of nucleic acids containing at least 10²unique nucleic acids. In some embodiments a collection of nucleic acids encoding for gNAs contains at least 10², at least 10³, at least 10⁴, at least 10⁵, at least 10⁶, at least 10⁷, at least 10⁸, at least 10⁹, at least 10¹⁰unique nucleic acids encoding for gNAs. In some embodiments a collection of nucleic acids encoding for gNAs contains a total of at least 10², at least 10³, at least 10⁴, at least 10⁵, at least 10⁶, at least 10⁷, at least 10⁸, at least 10⁹, at least 10¹⁰nucleic acids encoding for gNAs.

In some embodiments, a collection of nucleic acids encoding for gNAs comprises a first segment comprising a regulatory region; a second segment comprising a targeting sequence; and a third segment comprising a nucleic acid encoding a nucleic acid-guided nuclease system (e.g., CRISPR/Cas system) protein-binding sequence, wherein at least 10% of the nucleic acids in the collection vary in size.

In some embodiments, the first, second, and third segments are in 5′- to 3′-order′.

In some embodiments, the nucleic acids encoding for gNAs comprise DNA. In some embodiments, the first segment is single stranded DNA. In some embodiments, the first segment is double stranded DNA. In some embodiments, the second segment is single stranded DNA. In some embodiments, the third segment is single stranded DNA. In some embodiments, the second segment is double stranded DNA. In some embodiments, the third segment is double stranded DNA.

In some embodiments, the nucleic acids encoding for gNAs comprise RNA.

In some embodiments the nucleic acids encoding for gNAs comprise DNA and RNA.

In some embodiments, the size of the second segments (targeting sequence) in the collection varies from 15-250 bp, or 30-100 bp, or 22-30 bp, or 15-50 bp, or 15-75 bp, or 15-100 bp, or 15-125 bp, or 15-150 bp, or 15-175 bp, or 15-200 bp, or 15-225 bp, or 15-250 bp, or 22-50 bp, or 22-75 bp, or 22-100 bp, or 22-125 bp, or 22-150 bp, or 22-175 bp, or 22-200 bp, or 22-225 bp, or 22-250 bp across the collection of gNAs.

In some embodiments, at least 10%, or at least 15%, or at last 20%, or at least 25%, or at least 30%, or at least 35%, or at least 40%, or at least 45%, or at least 50%, or at least 55%, or at least 60%, or at least 65%, or at least 70%, or at least 75%, or at least 80%, or at least 85%, or at least 90%, or at least 95%, or 100% of the second segments in the collection are greater than 21 bp.

In some embodiments, at least 10%, or at least 15%, or at last 20%, or at least 25%, or at least 30%, or at least 35%, or at least 40%, or at least 45%, or at least 50%, or at least 55%, or at least 60%, or at least 65%, or at least 70%, or at least 75%, or at least 80%, or at least 85%, or at least 90%, or at least 95%, or 100% of the second segments in the collection are greater than 25 bp.

In some embodiments, at least 10%, or at least 15%, or at last 20%, or at least 25%, or at least 30%, or at least 35%, or at least 40%, or at least 45%, or at least 50%, or at least 55%, or at least 60%, or at least 65%, or at least 70%, or at least 75%, or at least 80%, or at least 85%, or at least 90%, or at least 95%, or 100% of the second segments in the collection are greater than 30 bp.

In some particular embodiments, the size of the second segment is not 20 bp.

In some particular embodiments, the size of the second segment is not 21 bp.

In some embodiments, the gNAs and/or the targeting sequence of the gNAs in the collection of gNAs comprise unique 5′ ends. In some embodiments, the collection of gNAs exhibit variability in sequence of the 5′ end of the targeting sequence, across the members of the collection. In some embodiments, the collection of gNAs exhibit variability at least 5%, or at least 10%, or at least 15%, or at last 20%, or at least 25%, or at least 30%, or at least 35%, or at least 40%, or at least 45%, or at least 50%, or at least 55%, or at least 60%, or at least 65%, or at least 70%, or at least 75% variability in the sequence of the 5′ end of the targeting sequence, across the members of the collection.

In some embodiments, the collection of nucleic acids comprises targeting sequences, wherein the target of interest is spaced at least every 1 bp, at least every 2 bp, at least every 3 bp, at least every 4 bp, at least every 5 bp, at least every 6 bp, at least every 7 bp, at least every 8 bp, at least every 9 bp, at least every 10 bp, at least every 11 bp, at least every 12 bp, at least every 13 bp, at least every 14 bp, at least every 15 bp, at least every 16 bp, at least every 17 bp, at least every 18 bp, at least every 19 bp, 20 bp, at least every 25 bp, at least every 30 bp, at least every 40 bp, at least every 50 bp, at least every 100 bp, at least every 200 bp, at least every 300 bp, at least every 400 bp, at least every 500 bp, at least every 600 bp, at least every 700 bp, at least every 800 bp, at least every 900 bp, at least every 1000 bp, at least every 2500 bp, at least every 5000 bp, at least every 10,000 bp, at least every 15,000 bp, at least every 20,000 bp, at least every 25,000 bp, at least every 50,000 bp, at least every 100,000 bp, at least every 250,000 bp, at least every 500,000 bp, at least every 750,000 bp, or even at least every 1,000,000 bp across a genome of interest.

In some embodiments, the collection of nucleic acids encoding for gNAs comprise a third segment encoding for a nucleic acid-guided nuclease system (e.g., CRISPR/Cas system) protein-binding sequence, wherein the segments in the collection vary in their specificity for protein members of the nucleic acid-guided nuclease system (e.g., CRISPR/Cas system). For example, a collection of nucleic acids encoding for gNAs as provided herein, can comprise members whose third segment encode for a nucleic acid-guided nuclease system (e.g., CRISPR/Cas system) protein-binding sequence specific for a first nucleic acid-guided nuclease system (e.g., CRISPR/Cas system) protein; and also comprises members whose third segment encodes for a nucleic acid-guided nuclease system (e.g., CRISPR/Cas system) protein-binding sequence specific for a second nucleic acid-guided nuclease system (e.g., CRISPR/Cas system) protein, wherein the first and second nucleic acid-guided nuclease system (e.g., CRISPR/Cas system) proteins are not the same. In some embodiments, a collection of nucleic acids encoding for gNAs as provided herein comprises members that exhibit specificity to at least 1, at least 2, at least 3, at least 4, at least 5, at least 6, at least 7, at least 8, at least 9, at least 10, at least 11, at least 12, at least 13, at least 14, at least 15, at least 16, at least 17, at least 18, at least 19, or even at least 20 nucleic acid-guided nuclease system (e.g., CRISPR/Cas system) proteins. In one specific embodiment, a collection of nucleic acids encoding for gNAs as provided herein comprises members that exhibit specificity for a Cas9 protein and another protein selected from the group consisting of Cpf1, Cas3, Cas8a-c, Cas10, Cse1, Csy1, Csn2, Cas4, Csm2, and Cm5.

Sequences of Interest

Provided herein are gNAs and collections of gNAs, derived from any source DNA (for example from genomic DNA, cDNA, artificial DNA, DNA libraries), that can be used to target sequences of interest in a sample for a variety of applications including, but not limited to, enrichment, depletion, capture, partitioning, labeling, regulation, and editing. The gNAs comprise a targeting sequence, directed at sequences of interest.

In some embodiments, the sequences of interest are genomic sequences (genomic DNA). In some embodiments, the sequences of interest are mammalian genomic sequences. In some embodiments, the sequences of interest are eukaryotic genomic sequences. In some embodiments, the sequences of interest are prokaryotic genomic sequences. In some embodiments, the sequences of interest are viral genomic sequences. In some embodiments, the sequences of interest are bacterial genomic sequences. In some embodiments, the sequences of interest are plant genomic sequences. In some embodiments, the sequences of interest are microbial genomic sequences. In some embodiments, the sequences of interest are genomic sequences from a parasite, for example a eukaryotic parasite. In some embodiments, the sequences of interest are host genomic sequences (e.g., the host organism of a microbiome, a parasite, or a pathogen). In some embodiments, the sequences of interest are abundant genomic sequences, such as sequences from the genome or genomes of the most abundant species in a sample.

In some embodiments, the sequences of interest comprise repetitive DNA. In some embodiments, the sequences of interest comprise abundant DNA. In some embodiments, the sequences of interest comprise mitochondrial DNA. In some embodiments, the sequences of interest comprise ribosomal DNA. In some embodiments, the sequences of interest comprise centromeric DNA. In some embodiments, the sequences of interest comprise DNA comprising Alu elements (Alu DNA). In some embodiments, the sequences of interest comprise long interspersed nuclear elements (LINE DNA). In some embodiments, the sequences of interest comprise short interspersed nuclear elements (SINE DNA). In some embodiments, the abundant DNA comprises ribosomal DNA.

In some embodiments, the sequences of interest comprise single nucleotide polymorphisms (SNPs), short tandem repeats (STRs), cancer genes, inserts, deletions, structural variations, exons, genetic mutations, or regulatory regions.

In some embodiments, the sequences of interest can be a genomic fragment, comprising a region of the genome, or the whole genome itself. In one embodiment, the genome is a DNA genome. In another embodiment, the genome is a RNA genome.

In some embodiments, the sequences of interest are from a eukaryotic or prokaryotic organism; from a mammalian organism or a non-mammalian organism; from an animal or a plant; from a bacteria or virus from an animal parasite; from a pathogen.

In some embodiments, the sequences of interest are from any mammalian organism. In one embodiment the mammal is a human. In another embodiment the mammal is a livestock animal, for example a horse, a sheep, a cow, a pig, or a donkey. In another embodiment, a mammalian organism is a domestic pet, for example a cat, a dog, a gerbil, a mouse, a rat. In another embodiment the mammal is a type of a monkey.

In some embodiments, the sequences of interest are from any bird or avian organism. An avian organism includes but is not limited to chicken, turkey, duck and goose.

In some embodiments, the sequences of interest are from a plant. In one embodiment, the plant is rice, maize, wheat, rose, grape, coffee, fruit, tomato, potato, or cotton.

In some embodiments, the sequences of interest are from a species of bacteria. In one embodiment, the bacteria are tuberculosis-causing bacteria.

In some embodiments, the sequences of interest are from a virus.

In some embodiments, the sequences of interest are from a species of fungi.

In some embodiments, the sequences of interest are from a species of algae.

In some embodiments, the sequences of interest are from any mammalian parasite.

In some embodiments, the sequences of interest are obtained from any mammalian parasite. In one embodiment, the parasite is a worm. In another embodiment, the parasite is a malaria-causing parasite. In another embodiment, the parasite is a Leishmaniasis-causing parasite. In another embodiment, the parasite is an amoeba.

In some embodiments, the sequences of interest are from a pathogen.

Targeting Sequences

As used herein, a targeting sequence is one that directs the gNA to the sequences of interest in a sample. For example, a targeting sequence targets a particular sequence of interest, for example the targeting sequence targets a genomic sequence of interest.

Provided herein are gNAs and collections of gNAs that comprise a segment that comprises a targeting sequence. Also provided herein, are nucleic acids encoding for gNAs, and collections of nucleic acids encoding for gNAs that comprise a segment encoding for a targeting sequence.

In some embodiments, the targeting sequence comprises DNA.

In some embodiments, the targeting sequence comprises RNA.

In some embodiments, the targeting sequence comprises RNA, and shares at least 70% sequence identity, at least 75% sequence identity, at least 80% sequence identity, at least 85% sequence identity, at least 90% sequence identity, at least 95% sequence identity, or shares 100% sequence identity to a sequence 5′ to a PAM sequence on a sequence of interest, except that the RNA comprises uracils instead of thymines. In some embodiments, the PAM sequence is AGG, CGG, or TGG.

In some embodiments, the targeting sequence comprises DNA, and shares at least 70% sequence identity, at least 75% sequence identity, at least 80% sequence identity, at least 85% sequence identity, at least 90% sequence identity, at least 95% sequence identity, or shares 100% sequence identity to a sequence 5′ to a PAM sequence on a sequence of interest.

In some embodiments, the targeting sequence comprises RNA and is complementary to the strand opposite to a sequence of nucleotides 5′ to a PAM sequence. In some embodiments, the targeting sequence is at least 70% complementary, at least 75% complementary, at least 80% complementary, at least 85% complementary, at least 90% complementary, at least 95% complementary, or is 100% complementary to the strand opposite to a sequence of nucleotides 5′ to a PAM sequence. In some embodiments, the PAM sequence is AGG, CGG, or TGG.

In some embodiments, the targeting sequence comprises DNA and is complementary to the strand opposite to a sequence of nucleotides 5′ to a PAM sequence. In some embodiments, the targeting sequence is at least 70% complementary, at least 75% complementary, at least 80% complementary, at least 85% complementary, at least 90% complementary, at least 95% complementary, or is 100% complementary to the strand opposite to a sequence of nucleotides 5′ to a PAM sequence. In some embodiments, the PAM sequence is AGG, CGG, or TGG.

In some embodiments, a DNA encoding for a targeting sequence of a gRNA shares at least 70% sequence identity, at least 75% sequence identity, at least 80% sequence identity, at least 85% sequence identity, at least 90% sequence identity, at least 95% sequence identity, or shares 100 sequence identity to the strand opposite to a sequence of nucleotides 5′ to a PAM sequence. In some embodiments, the PAM sequence is AGG, CGG, or TGG.

In some embodiments, a DNA encoding for a targeting sequence of a gRNA is complementary to the strand opposite to a sequence of nucleotides 5′ to a PAM sequence and is at least 70% complementary, at least 75% complementary, at least 80% complementary, at least 85% complementary, at least 90% complementary, at least 95% complementary, or is 100% complementary to a sequence 5′ to a PAM sequence on a sequence of interest. In some embodiments, the PAM sequence is AGG, CGG, or TGG.

Nucleic Acid-Guided Nuclease System Proteins

Provided herein are gNAs and collections of gNAs comprising a segment that comprises a nucleic acid-guided nuclease system (e.g., CRISPR/Cas system) protein-binding sequence. Also provided herein, are nucleic acids encoding for gNAs, and collections of nucleic acids encoding for gNAs that comprise a segment encoding a nucleic acid-guided nuclease system (e.g., CRISPR/Cas system) protein-binding sequence. A nucleic acid-guided nuclease system can be an RNA-guided nuclease system. A nucleic acid-guided nuclease system can be a DNA-guided nuclease system.

Methods of the present disclosure can utilize nucleic acid-guided nucleases. As used herein, a “nucleic acid-guided nuclease” is any nuclease that cleaves DNA, RNA or DNA/RNA hybrids, and which uses one or more nucleic acid guide nucleic acids (gNAs) to confer specificity. Nucleic acid-guided nucleases include CRISPR/Cas system proteins as well as non-CRISPR/Cas system proteins.

The nucleic acid-guided nucleases provided herein can be DNA guided DNA nucleases; DNA guided RNA nucleases; RNA guided DNA nucleases; or RNA guided RNA nucleases. The nucleases can be endonucleases. The nucleases can be exonucleases. In one embodiment, the nucleic acid-guided nuclease is a nucleic acid-guided-DNA endonuclease. In one embodiment, the nucleic acid-guided nuclease is a nucleic acid-guided-RNA endonuclease.

A nucleic acid-guided nuclease system protein-binding sequence is a nucleic acid sequence that binds any protein member of a nucleic acid-guided nuclease system. For example, a CRISPR/Cas system protein-binding sequence is a nucleic acid sequence that binds any protein member of a CRISPR/Cas system.

In some embodiments, the nucleic acid-guided nuclease is selected from the group consisting of CAS Class I Type 1, CAS Class I Type III, CAS Class 1 Type IV, CAS Class II Type 11, and CAS Class 11 Type V. In some embodiments, CRISPR/Cas system proteins include proteins from CRISPR Type I systems, CRISPR Type II systems, and CRISPR Type III systems. In some embodiments, the nucleic acid-guided nuclease is selected from the group consisting of Cas9, Cpf1, Cas3, Cas8a-c, Cas10, Cse1, Csy1, Csn2, Cas4, Csm2, Cm5, Csf1, C2c2, and NgAgo.

In some embodiments, nucleic acid-guided nuclease system proteins (e.g., CRISPR/Cas system proteins) can be from any bacterial or archaeal species.

In some embodiments, the nucleic acid-guided nuclease system proteins (e.g., CRISPR/Cas system proteins) are from, or are derived from nucleic acid-guided nuclease system proteins (e.g., CRISPR/Cas system proteins) from Streptococcus pyogenes, Staphylococcus aureus, Neisseria meningitidis, Streptococcus thermophiles, Treponema denticola, Francisella tularensis, Pasteurella multocida, Campylobacter jejuni, Campylobacter lari, Mycoplasma gallisepticum, Nitratifractor salsuginis, Parvibaculum lavamentivorans, Roseburia intestinalis, Neisseria cinerea, Gluconacetobacter diazotrophicus, Azospirillum, Sphaerochaeta globus, Flavobacterium columnare, Fluviicola taffensis, Bacteroides coprophilus, Mycoplasma mobile, Lactobacillus farciminis, Streptococcus pasteurianus, Lactobacillus johnsonii, Staphylococcus pseudintermedius, Filifactor alocis, Legionella pneumophila, Suterella wadsworthensis, or Corynebacter diphtheria.

In some embodiments, examples of nucleic acid-guided nuclease system (e.g., CRISPR/Cas system) proteins can be naturally occurring or engineered versions.

In some embodiments, naturally occurring nucleic acid-guided nuclease system (e.g., CRISPR/Cas system) proteins include Cas9, Cpf1, Cas3, Cas8a-c, Cas10, Cse1, Csy1, Csn2, Cas4, Csm2, and Cm5. Engineered versions of such proteins can also be employed.

In some embodiments, engineered examples of nucleic acid-guided nuclease system (e.g., CRISPR/Cas system) proteins include catalytically dead nucleic acid-guided nuclease system proteins. The term “catalytically dead” generally refers to a nucleic acid-guided nuclease system protein that has inactivated nucleases (e.g., HNH and RuvC nucleases). Such a protein can bind to a target site in any nucleic acid (where the target site is determined by the guide NA), but the protein is unable to cleave or nick the target nucleic acid (e.g., double-stranded DNA). In some embodiments, the nucleic acid-guided nuclease system catalytically dead protein is a catalytically dead CRISPR/Cas system protein, such as catalytically dead Cas9 (dCas9). Accordingly, the dCas9 allows separation of the mixture into unbound nucleic acids and dCas9-bound fragments. In one embodiment, a dCas9/gRNA complex binds to targets determined by the gRNA sequence. The dCas9 bound can prevent cutting by Cas9 while other manipulations proceed. In another embodiment, the dCas9 can be fused to another enzyme, such as a transposase, to target that enzyme's activity to a specific site. Naturally occurring catalytically dead nucleic acid-guided nuclease system proteins can also be employed.

In some embodiments, engineered examples of nucleic acid-guided nuclease (e.g., CRISPR/Cas) system proteins also include nucleic acid-guided nickases (e.g., Cas nickases). A nucleic acid-guided nickase refers to a modified version of a nucleic acid-guided nuclease system protein, containing a single inactive catalytic domain. In one embodiment, the nucleic acid-guided nickase is a Cas nickase, such as Cas9 nickase. A Cas9 nickase may contain a single inactive catalytic domain, for example, either the RuvC- or the HNH-domain. With only one active nuclease domain, the Cas9 nickase cuts only one strand of the target DNA, creating a single-strand break or “nick”. Depending on which mutant is used, the guide NA-hybridized strand or the non-hybridized strand may be cleaved. Nucleic acid-guided nickases bound to 2 gNAs that target opposite strands will create a double-strand break in a target double-stranded DNA. This “dual nickase” strategy can increase the specificity of cutting because it requires that both nucleic acid-guided nuclease/gNA (e.g., Cas9/gRNA) complexes be specifically bound at a site before a double-strand break is formed. Naturally occurring nickase nucleic acid-guided nuclease system proteins can also be employed.

In some embodiments, engineered examples of nucleic acid-guided nuclease system proteins also include nucleic acid-guided nuclease system fusion proteins. For example, a nucleic acid-guided nuclease (e.g., CRISPR/Cas) system protein may be fused to another protein, for example an activator, a repressor, a nuclease, a fluorescent molecule, a radioactive tag, or a transposase.

In some embodiments, the nucleic acid-guided nuclease system protein-binding sequence comprises a gNA (e.g., gRNA) stem-loop sequence.

In some embodiments, a double-stranded DNA sequence encoding the gNA (e.g., gRNA) stem-loop sequence comprises the following DNA sequence on one strand (5′>3′, GTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCG AGTCGGTGCTTTTTTT) (SEQ ID NO: 3), and its reverse-complementary DNA on the other strand (5′>3′, AAAAAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTAACTTGCTAT TTCTAGCTCTAAAAC) (SEQ ID NO: 4).

In some embodiments, a single-stranded DNA sequence encoding the gNA (e.g., gRNA) stem-loop sequence comprises the following DNA sequence: (5′>3′, AAAAAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTAACTTGCTAT TTCTAGCTCTAAAAC) (SEQ ID NO: 4), wherein the single-stranded DNA serves as a transcription template.

In some embodiments, the gNA (e.g., gRNA) stem-loop sequence comprises the following RNA sequence: (5′>3′, GUUUUAGAGCUAGAAAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGAAAAAGUGGCA CCGAGUCGGUGCUUUUUUU) (SEQ ID NO: 1)

In some embodiments, a double-stranded DNA sequence encoding the gNA (e.g., gRNA) stem-loop sequence comprises the following DNA sequence on one strand (5′>3′, GTTTTAGAGCTATGCTGGAAACAGCATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAA AGTGGCACCGAGTCGGTGCTTTTTTTC) (SEQ ID NO: 5), and its reverse-complementary DNA on the other strand (5′>3′, GAAAAAAAGCACCGACTCGGTGCCAITTCAAGTTGATAACGGACTAGCCTTATTTTAACTTGCT ATGCTGTTTCCAGCATAGCTCTAAAAC) (SEQ ID NO: 6).

In some embodiments, a single-stranded DNA sequence encoding the gNA (e.g., gRNA) stem-loop sequence comprises the following DNA sequence: (5′>3′, GAAAAAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTAACTTGCT ATGCTGTTTCCAGCATAGCTCTAAAAC) (SEQ ID NO: 6), wherein the single-stranded DNA serves as a transcription template.

In some embodiments, the gNA (e.g., gRNA) stem-loop sequence comprises the following RNA sequence: (5′>3′, GUUUUAGAGCUAUGCUGGAAACAGCAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGA AAAAGUGGCACCGAGUCGGUGCUUUUUUUC) (SEQ ID NO: 2).

In some embodiments, provided herein is a nucleic acid encoding for a gNA (e.g., gRNA) comprising a first segment comprising a regulatory region; a second segment encoding a targeting sequence; and a third segment comprising a nucleic acid encoding a nucleic acid-guided nuclease (e.g., CRISPR/Cas) system protein-binding sequence. In some embodiments, the third segment comprises a single transcribed component, which upon transcription yields a NA (e.g., RNA) stem-loop sequence. In some embodiments, the third segment comprising a single transcribed component that encodes for the gNA (e.g., gRNA) stem-loop sequence is double-stranded, comprises the following DNA sequence on one strand (5′>3′, GTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCG AGTCGGTGCTTTTTTTTT) (SEQ ID NO: 3), and its reverse-complementary DNA on the other strand (5′>3′, AAAAAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTAACTTGCTAT TTCTAGCTCTAAAAC) (SEQ ID NO: 4). In some embodiments, the third segment comprising a single transcribed component that encodes for the gNA (e.g., gRNA) stem-loop sequence is single-stranded, and comprises the following DNA sequence: (5′>3′, AAAAAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATITTAACTTGCTAT TTCTAGCTCTAAAAC) (SEQ ID NO: 4), wherein the single-stranded DNA serves as a transcription template. In some embodiments, upon transcription from the single transcribed component, the resulting gNA (e.g., gRNA) stem-loop sequence comprises the following RNA sequence: (5′>3′, GUUUUAGAGCUAGAAAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGAAAAAGUGGCA CCGAGUCGGUGCUUUUUUU) (SEQ ID NO: 1). In some embodiments, the third segment comprising a single transcribed component that encodes for the gNA (e.g., gRNA) stem-loop sequence is double-stranded, comprises the following DNA sequence on one strand (5′>3′, GTTTTAGAGCTATGCTGGAAACAGCATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAA AGTGGCACCGAGTCGGTGCTTTTTTTC) (SEQ ID NO: 5), and its reverse-complementary DNA on the other strand (5′>3′, GAAAAAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTAACTTGCT ATGCTGTTTCCAGCATAGCTCTAAAAC) (SEQ ID NO: 6). In some embodiments, the third segment comprising a single transcribed component that encodes for the gNA (e.g., gRNA) stem-loop sequence is single-stranded, and comprises the following DNA sequence: (5′>3′, GAAAAAAAGCACCGACTCGGTGCCACUITITrCAAGTTGATAACGGACTAGCCTTATTTTAACTTGCT ATGCTGTTTCCAGCATAGCTCTAAAAC) (SEQ ID NO: 6), wherein the single-stranded DNA serves as a transcription template. In some embodiments, upon transcription from the single transcribed component, the yielded gRNA stem-loop sequence comprises the following RNA sequence: (5′>3′, GUUUUAGAGCUAUGCUGGAAACAGCAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGA AAAAGUGGCACCGAGUCGGUGCUUUUUUUC) (SEQ ID NO: 2). In some embodiments, the third segment comprises two sub-segments, which encode for a crRNA and a tracrRNA upon transcription. In some embodiment, the crRNA does not comprise the N20 plus the extra sequence which can hybridize with tracrRNA. In some embodiments, the crRNA comprises the extra sequence which can hybridize with tracrRNA. In some embodiments, the two sub-segments are independently transcribed. In some embodiments, the two sub-segments are transcribed as a single unit. In some embodiments, the DNA encoding the crRNA comprises N_targetGTTTTAGAGCTATGCTGTTTTG (SEQ ID NO: 7), where N_targetrepresents the targeting sequence. In some embodiments, the DNA encoding the tracrRNA comprises the sequence GGAACCATTCAAAACAGCATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGC ACCGAGTCGGTGCTTTTTTT (SEQ ID NO: 8).

In some embodiments, provided herein is a nucleic acid encoding for a gNA (e.g., gRNA) comprising a first segment comprising a regulatory region; a second segment encoding a targeting sequence; and a third segment comprising a nucleic acid encoding a nucleic acid-guided nuclease (e.g., CRISPR/Cas) system protein-binding sequence. In some embodiments, the third segment comprises a DNA sequence, which upon transcription yields a gRNA stem-loop sequence capable of binding a nucleic acid-guided nuclease (e.g., CRISPR/Cas) system protein. In one embodiment, the DNA sequence can be double-stranded. In some embodiments, the third segment double stranded DNA comprises the following DNA sequence on one strand (5′>3′, GTITAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCG AGTCGGTGCTTTTTTT) (SEQ ID NO: 3), and its reverse-complementary DNA on the other strand (5′>3′, AAAAAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTAACTTGCTAT TTCTAGCTCTAAAAC) (SEQ ID NO: 4). In some embodiments, the third segment double stranded DNA comprises the following DNA sequence on one strand (5′>3′, GTTITAGAGCTATGCTGGAAACAGCATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAA AGTGGCACCGAGTCGGTGCTTTTTTTC) (SEQ ID NO: 5), and its reverse-complementary DNA on the other strand (5′>3′, GAAAAAAAGCACCGACTCGGTGCCACTrFITCAAGTTGATAACGGACTAGCCTTATTTAACTTGCT ATGCTGTTTCCAGCATAGCTCTAAAAC) (SEQ ID NO: 6). In one embodiment, the DNA sequence can be single-stranded. In some embodiments, the third segment single stranded DNA comprises the following DNA sequence (5′>3′, AAAAAAAGCACCGACTCGGTGCCACTITrrICAAGTTGATAACGGACTAGCCTTATTTTAACTTGCTAT TTCTAGCTCTAAAAC) (SEQ ID NO: 4), wherein the single-stranded DNA serves as a transcription template. In some embodiments, the third segment single stranded DNA comprises the following DNA sequence (5′>3′, GAAAAAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTAACTTGCT ATGCTGTTTCCAGCATAGCTCTAAAAC) (SEQ ID NO: 6), wherein the single-stranded DNA serves as a transcription template. In some embodiments, the third segment comprises a DNA sequence which, upon transcription, yields a first RNA sequence that is capable of forming a hybrid with a second RNA sequence, and which hybrid is capable of CRISPR/Cas system protein binding. In some embodiments, the third segment is double-stranded DNA comprising the DNA sequence on one strand: (5′>3′, GTTTTAGAGCTATGCTGTTTTG) (SEQ ID NO: 9) and its reverse complementary DNA sequence on the other strand: (5′>3′, CAAAACAGCATAGCTCTAAAAC) (SEQ ID NO: 10). In some embodiments, the third segment is single-stranded DNA comprising the DNA sequence of (5′>3′, CAAAACAGCATAGCTCTAAAAC) (SEQ ID NO: 10). In some embodiments, the second segment and the third segment together encode for a crRNA sequence. In some embodiments, the second RNA sequence that is capable of forming a hybrid with the first RNA sequence encoded by the third segment of the nucleic acid encoding a gRNA is a tracrRNA. In some embodiments, the tracrRNA comprises the sequence (5′>3′, GGAACCAUUCAAAACAGCAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGAAAAAGUG GCACCGAGUCGGUGCUUUUUUU) (SEQ ID NO: 11). In some embodiments, the tracrRNA is encoded by a double-stranded DNA comprising sequence of (5′>3′, GGAACCATTCAAAACAGCATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGC ACCGAGTCGGTGCTTTTTTT) (SEQ ID NO: 8), and optionally fused with a regulatory sequence at its 5′ end. In some embodiments, the regulatory sequence can be bound by a transcription factor. In some embodiments, the regulatory sequence is a promoter. In some embodiments, the regulatory sequence is a T7 promoter, comprising the sequence of (5′>3′, GCCTCGAGCTAATACGACTCACTATAGAG) (SEQ ID NO: 12).

In some embodiments, provided herein is a nucleic acid encoding for a gNA comprising a first segment comprising a regulatory region; a second segment encoding a targeting sequence; and a third segment comprising a nucleic acid encoding a nucleic acid-guided nuclease (e.g., CRISPR/Cas) system protein-binding sequence. In some embodiments, the third segment encodes for a RNA sequence that, upon post-transcriptional cleavage, yields a first RNA segment and a second RNA segment. In some embodiments, the first RNA segment comprises a crRNA and the second RNA segment comprises a tracrRNA, which can form a hybrid and together, provide for nucleic acid-guided nuclease (e.g., CRISPR/Cas) system protein binding. In some embodiments, the third segment further comprises a spacer in between the transcriptional unit for the first RNA segment and the second RNA segment, which spacer comprises an enzyme cleavage site.

In some embodiments, provided herein is a gNA (e.g., gRNA) comprising a first NA segment comprising a targeting sequence and a second NA segment comprising a nucleic acid-guided nuclease (e.g., CRISPR/Cas) system protein-binding sequence. In some embodiments, the size of the first segment is greater than 30 bp. In some embodiments, the second segment comprises a single segment, which comprises the gRNA stem-loop sequence. In some embodiments, the gRNA stem-loop sequence comprises the following RNA sequence: (5′>3′, GUUUUAGAGCUAGAAAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGAAAAAGUGGCA CCGAGUCGGUGCUUUUUUU) (SEQ ID NO: 1). In some embodiments, the gRNA stem-loop sequence comprises the following RNA sequence: (5′>3′, GUUUUAGAGCUAUGCUGGAAACAGCAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGA AAAAGUGGCACCGAGUCGGUGCUUUUUUUC) (SEQ ID NO: 2). In some embodiments, the second segment comprises two sub-segments: a first RNA sub-segment (crRNA) that forms a hybrid with a second RNA sub-segment (tracrRNA), which together act to direct nucleic acid-guided nuclease (e.g., CRISPR/Cas) system protein binding. In some embodiments, the sequence of the second sub-segment comprises GUUUUAGAGCUAUGCUGUUUUG. In some embodiments, the first RNA segment and the second RNA segment together forms a crRNA sequence. In some embodiments, the other RNA that will form a hybrid with the second RNA segment is a tracrRNA. In some embodiments the tracrRNA comprises the sequence of 5′>3′, GGAACCAUUCAAAACAGCAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGAAAAAGUG GCACCGAGUCGGUGCUUUUUUU (SEQ ID NO: 11).

CRISPR/Cas System Nucleic Acid-Guided Nucleases

In some embodiments, CRISPR/Cas system proteins are used in the embodiments provided herein. In some embodiments, CRISPR/Cas system proteins include proteins from CRISPR Type I systems, CRISPR Type II systems, and CRISPR Type III systems.

In some embodiments, CRISPR/Cas system proteins can be from any bacterial or archaeal species.

In some embodiments, the CRISPR/Cas system protein is isolated, recombinantly produced, or synthetic.

In some embodiments, the CRISPR/Cas system proteins are from, or are derived from CRISPR/Cas system proteins from Streptococcus pyogenes, Staphylococcus aureus, Neisseria meningitidis, Streptococcus thermophiles, Treponema denticola, Francisella tularensis, Pasteurella multocida, Campylobacter jejuni, Campylobacter lari, Mycoplasma gallisepticum, Nitratifractor salsuginis, Parvibaculum lavamentivorans, Roseburia intestinalis, Neisseria cinerea, Gluconacetobacter diazotrophicus, Azospirillum, Sphaerochaeta globus, Flavobacterium columnare, Fluviicola taffensis, Bacteroides coprophilus, Mycoplasma mobile, Lactobacillus farciminis, Streptococcus pasteurianus, Lactobacillus johnsonii, Staphylococcus pseudintermedius, Filifactor alocis, Legionella pneumophila, Suterella wadsworthensis, or Corynebacter diphtheria.

In some embodiments, examples of CRISPR/Cas system proteins can be naturally occurring or engineered versions.

In some embodiments, naturally occurring CRISPR/Cas system proteins can belong to CAS Class I Type I, III, or IV, or CAS Class II Type II or V, and can include Cas9, Cas3, Cas8a-c, Cas10, Cse1, Csy1, Csn2, Cas4, Csm2, Cmr5, Csf1, C2c2, and Cpf1.

In an exemplary embodiment, the CRISPR/Cas system protein comprises Cas9.

A “CRISPR/Cas system protein-gNA complex” refers to a complex comprising a CRISPR/Cas system protein and a guide NA (e.g. a gRNA or a gDNA). Where the gNA is a gRNA, the gRNA may be composed of two molecules, i.e., one RNA (“crRNA”) which hybridizes to a target and provides sequence specificity, and one RNA, the “tracrRNA”, which is capable of hybridizing to the crRNA. Alternatively, the guide RNA may be a single molecule (i.e., a gRNA) that contains crRNA and tracrRNA sequences.

A CRISPR/Cas system protein may be at least 60% identical (e.g., at least 70%, at least 80%, or 90% identical, at least 95% identical or at least 98% identical or at least 99% identical) to a wild type CRISPR/Cas system protein. The CRISPR/Cas system protein may have all the functions of a wild type CRISPR/Cas system protein, or only one or some of the functions, including binding activity, nuclease activity, and nuclease activity.

The term “CRISPR/Cas system protein-associated guide NA” refers to a guide NA. The CRISPR/Cas system protein-associated guide NA may exist as isolated NA, or as part of a CRISPR/Cas system protein-gNA complex.

Cas9

In some embodiments, the CRISPR/Cas System protein nucleic acid-guided nuclease is or comprises Cas9. The Cas9 of the present invention can be isolated, recombinantly produced, or synthetic.

Examples of Cas9 proteins that can be used in the embodiments herin can be found in F. A. Ran, L. Cong, W. X. Yan, D. A. Scott, J. S. Gootenberg, A. J. Kriz, B. Zetsche, O. Shalem, X. Wu, K. S. Makarova, E. V. Koonin, P. A. Sharp, and F. Zhang; “In vivo genome editing using Staphylococcus aureus Cas9” Nature 520, 186-191 (9 Apr. 2015) doi:10.1038/nature14299, which is incorporated herein by reference.

In some embodiments, the Cas9 is a Type II CRISPR system derived from Streptococcus pyogenes, Staphylococcus aureus, Neisseria meningitidis, Streptococcus thermophiles, Treponema denticola, Francisella tularensis, Pasteurella multocida, Campylobacter jejuni, Campylobacter lar, Mycoplasma gallisepticum, Nitratifractor salsuginis, Parvibaculum lavamentivorans, Roseburia intestinalis, Neisseria cinerea, Gluconacetobacter diazotrophicus, Azospirillum, Sphaerochaeta globus, Flavobacterium columnare, Fluviicola taffensis, Bacteroides coprophilus, Mycoplasma mobile, Lactobacillus farciminis, Streptococcus pasteurianus, Lactobacillus johnsonii, Staphylococcus pseudintermedius, Filifactor alocis, Legionella pneumophila, Suterella wadsworthensis, or Corynebacter diphtheria.

In some embodiments, the Cas9 is a Type II CRISPR system derived from S. pyogenes and the PAM sequence is NGG located on the immediate 3′ end of the target specific guide sequence. The PAM sequences of Type II CRISPR systems from exemplary bacterial species can also include: Streptococcus pyogenes (NGG), Staph aureus (NNGRRT), Neisseria meningitidis (NNNNGA TT), Streptococcus thermophilus (NNAGAA) and Treponema denticola (NAAAAC) which are all usable without deviating from the present invention.

In one exemplary embodiment, Cas9 sequence can be obtained, for example, from the pX330 plasmid (available from Addgene), re-amplified by PCR then cloned into pET30 (from EMD biosciences) to express in bacteria and purify the recombinant 6His tagged protein.

A “Cas9-gNA complex” refers to a complex comprising a Cas9 protein and a guide NA. A Cas9 protein may be at least 60% identical (e.g., at least 70%, at least 80%, or 90% identical, at least 95% identical or at least 98% identical or at least 99% identical) to a wild type Cas9 protein, e.g., to the Streptococcus pyogenes Cas9 protein. The Cas9 protein may have all the functions of a wild type Cas9 protein, or only one or some of the functions, including binding activity, nuclease activity, and nuclease activity.

The term “Cas9-associated guide NA” refers to a guide NA as described above. The Cas9-associated guide NA may exist isolated, or as part of a Cas9-gNA complex.

Non-CRISPR/Cas System Nucleic Acid-Guided Nucleases

In some embodiments, non-CRISPR/Cas system proteins are used in the embodiments provided herein.

In some embodiments, the non-CRISPR/Cas system proteins can be from any bacterial or archaeal species.

In some embodiments, the non-CRISPR/Cas system protein is isolated, recombinantly produced, or synthetic.

In some embodiments, the non-CRISPR/Cas system proteins are from, or are derived from Aquifex aeolicus, Thermus thermophilus, Streptococcus pyogenes, Staphylococcus aureus, Neisseria meningitidis, Streptococcus thermophiles, Treponema denticola, Francisella tularensis, Pasteurella multocida, Campylobacter jejuni, Campylobacter lari, Mycoplasma gallisepticum, Nitratifractor salsuginis, Parvibaculum lavamentivorans, Roseburia intestinalis, Neisseria cinerea, Gluconacetobacter diazotrophicus, Azospirillum, Sphaerochaeta globus, Flavobacterium columnare, Fluviicola taffensis, Bacteroides coprophilus, Mycoplasma mobile, Lactobacillus farciminis, Streptococcus pasteurianus, Lactobacillus johnsonii, Staphylococcus pseudintermedius, Filifactor alocis, Legionella pneumophila, Suterella wadsworthensis, Natronobacterium gregoryi, or Corynebacter diphtheria.

In some embodiments, the non-CRISPR/Cas system proteins can be naturally occurring or engineered versions.

In some embodiments, a naturally occurring non-CRISPR/Cas system protein is NgAgo (Argonaute from Natronobacterium gregoryi).

A “non-CRISPR/Cas system protein-gNA complex” refers to a complex comprising a non-CRISPR/Cas system protein and a guide NA (e.g. a gRNA or a gDNA). Where the gNA is a gRNA, the gRNA may be composed of two molecules, i.e., one RNA (“crRNA”) which hybridizes to a target and provides sequence specificity, and one RNA, the “tracrRNA”, which is capable of hybridizing to the crRNA. Alternatively, the guide RNA may be a single molecule (i.e., a gRNA) that contains crRNA and tracrRNA sequences.

A non-CRISPR/Cas system protein may be at least 60% identical (e.g., at least 70%, at least 80%, or 90% identical, at least 95% identical or at least 98% identical or at least 99% identical) to a wild type non-CRISPR/Cas system protein. The non-CRISPR/Cas system protein may have all the functions of a wild type non-CRISPR/Cas system protein, or only one or some of the functions, including binding activity, nuclease activity, and nuclease activity.

The term “non-CRISPR/Cas system protein-associated guide NA” refers to a guide NA. The non-CRISPR/Cas system protein-associated guide NA may exist as isolated NA, or as part of a non-CRISPR/Cas system protein-gNA complex.

Catalytically Dead Nucleic Acid-Guided Nucleases

In some embodiments, engineered examples of nucleic acid-guided nucleases include catalytically dead nucleic acid-guided nucleases (CRISPR/Cas system nucleic acid-guided nucleases or non-CRISPR/Cas system nucleic acid-guided nucleases). The term “catalytically dead” generally refers to a nucleic acid-guided nuclease that has inactivated nucleases, for example inactivated HNH and RuvC nucleases. Such a protein can bind to a target site in any nucleic acid (where the target site is determined by the guide NA), but the protein is unable to cleave or nick the nucleic acid.

Accordingly, the catalytically dead nucleic acid-guided nuclease allows separation of the mixture into unbound nucleic acids and catalytically dead nucleic acid-guided nuclease-bound fragments. In one exemplary embodiment, a dCas9/gRNA complex binds to the targets determined by the gRNA sequence. The dCas9 bound can prevent cutting by Cas9 while other manipulations proceed.

In another embodiment, the catalytically dead nucleic acid-guided nuclease can be fused to another enzyme, such as a transposase, to target that enzyme's activity to a specific site.

In some embodiments, the catalytically dead nucleic acid-guided nuclease is dCas9, dCpf1, dCas3, dCas8a-c, dCas10, dCse1, dCsy1, dCsn2, dCas4, dCsm2, dCm5, dCsf1, dC2C2, or dNgAgo.

In one exemplary embodiment the catalytically dead nucleic acid-guided nuclease protein is a dCas9.

Nucleic Acid-Guided Nuclease Nickases

In some embodiments, engineered examples of nucleic acid-guided nucleases include nucleic acid-guided nuclease nickases (referred to interchangeably as nickase nucleic acid-guided nucleases).

In some embodiments, engineered examples of nucleic acid-guided nucleases include CRISPR/Cas system nickases or non-CRISPR/Cas system nickases, containing a single inactive catalytic domain.

In some embodiments, the nucleic acid-guided nuclease nickase is a Cas9 nickase, Cpf1 nickase, Cas3 nickase, Cas8a-c nickase, Cas10 nickase, Cse1 nickase, Csy1 nickase, Csn2 nickase, Cas4 nickase, Csm2 nickase, Cm5 nickase, Csf1 nickase, C2C2 nickase, or a NgAgo nickase.

In one embodiment, the nucleic acid-guided nuclease nickase is a Cas9 nickase.

In some embodiments, a nucleic acid-guided nuclease nickase can be used to bind to target sequence. With only one active nuclease domain, the nucleic acid-guided nuclease nickase cuts only one strand of a target DNA, creating a single-strand break or “nick”. Depending on which mutant is used, the guide NA-hybridized strand or the non-hybridized strand may be cleaved. nucleic acid-guided nuclease nickases bound to 2 gNAs that target opposite strands can create a double-strand break in the nucleic acid. This “dual nickase” strategy increases the specificity of cutting because it requires that both nucleic acid-guided nuclease/gNA complexes be specifically bound at a site before a double-strand break is formed.

In exemplary embodiments, a Cas9 nickase can be used to bind to target sequence. The term “Cas9 nickase” refers to a modified version of the Cas9 protein, containing a single inactive catalytic domain, i.e., either the RuvC- or the HNH-domain. With only one active nuclease domain, the Cas9 nickase cuts only one strand of the target DNA, creating a single-strand break or “nick”. Depending on which mutant is used, the guide RNA-hybridized strand or the non-hybridized strand may be cleaved. Cas9 nickases bound to 2 gRNAs that target opposite strands will create a double-strand break in the DNA. This “dual nickase” strategy can increase the specificity of cutting because it requires that both Cas9/gRNA complexes be specifically bound at a site before a double-strand break is formed.

Capture of DNA can be carried out using a nucleic acid-guided nuclease nickase. In one exemplary embodiment, a nucleic acid-guided nuclease nickase cuts a single strand of double stranded nucleic acid, wherein the double stranded region comprises methylated nucleotides.

Dissociable and Thermostable Nucleic Acid-Guided Nucleases

In some embodiments, thermostable nucleic acid-guided nucleases are used in the methods provided herein (thermostable CRISPR/Cas system nucleic acid-guided nucleases or thermostable non-CRISPR/Cas system nucleic acid-guided nucleases). In such embodiments, the reaction temperature is elevated, inducing dissociation of the protein; the reaction temperature is lowered, allowing for the generation of additional cleaved target sequences. In some embodiments, thermostable nucleic acid-guided nucleases maintain at least 50% activity, at least 55% activity, at least 60% activity, at least 65% activity, at least 70% activity, at least 75% activity, at least 80% activity, at least 85% activity, at least 90% activity, at least 95% activity, at least 96% activity, at least 97% activity, at least 98% activity, at least 99% activity, or 100% activity, when maintained for at least 75° C. for at least 1 minute. In some embodiments, thermostable nucleic acid-guided nucleases maintain at least 50% activity, when maintained for at least 1 minute at least at 75° C., at least at 80° C., at least at 85° C., at least at 90° C., at least at 91° C., at least at 92° C., at least at 93° C., at least at 94° C., at least at 95° C., 96° C., at least at 97° C., at least at 98° C., at least at 99° C., or at least at 100° C. In some embodiments, thermostable nucleic acid-guided nucleases maintain at least 50% activity, when maintained at least at 75° C. for at least 1 minute, 2 minutes, 3 minutes, 4 minutes, or 5 minutes. In some embodiments, a thermostable nucleic acid-guided nuclease maintains at least 50% activity when the temperature is elevated, lowered to 25° C.-50° C. In some embodiments, the temperature is lowered to 25° C., to 30° C., to 35° C. to 40° C., to 45° C., or to 50° C. In one exemplary embodiment, a thermostable enzyme retains at least 90% activity after 1 min at 95° C.

In some embodiments, the thermostable nucleic acid-guided nuclease is thermostable Cas9, thermostable Cpf1, thermostable Cas3, thermostable Cas8a-c, thermostable Cas10, thermostable Cse1, thermostable Csy1, thermostable Csn2, thermostable Cas4, thermostable Csm2, thermostable Cm5, thermostable Csf1, thermostable C2C2, or thermostable NgAgo.

In some embodiments, the thermostable CRISPR/Cas system protein is thermostable Cas9.

Thermostable nucleic acid-guided nucleases can be isolated, for example, identified by sequence homology in the genome of thermophilic bacteria Streptococcus thermophilus and Pyrococcus furiosus. Nucleic acid-guided nuclease genes can then be cloned into an expression vector. In one exemplary embodiment, a thermostable Cas9 protein is isolated.

In another embodiment, a thermostable nucleic acid-guided nuclease can be obtained by in vitro evolution of a non-thermostable nucleic acid-guided nuclease. The sequence of a nucleic acid-guided nuclease can be mutagenized to improve its thermostability.

Methods of Making Collections of gNAs

Provided herein are methods that enable the generation of a large number of diverse gRNAs, collections of gNAs, from any source nucleic acid (e.g., DNA). Methods provided herein can employ enzymatic methods including but not limited to digestion, ligation, extension, overhang filling, transcription, reverse transcription, amplification.

Generally, the method can comprise providing a nucleic acid (e.g., DNA); employing a first enzyme (or combinations of first enzymes) that cuts at a part of the PAM sequence in the nucleic acid, in a way that a residual nucleotide sequence from the PAM sequence is left; ligating an adapter that positions a restriction enzyme typeIIS site (an enzyme that cuts outside yet near its recognition motif) at a distance to eliminate the PAM sequence; employing a second typeIIS enzyme (or combination of second enzymes) to eliminate the PAM sequence together with the adapter; and fusing a sequence that can be recognized by protein members of the nucleic acid-guided nuclease (e.g., CRISPR/Cas) system, for example, a gRNA stem-loop sequence. In some embodiments, the first enzymatic reactions cuts part of the PAM sequence in a way that residual nucleotide sequence from the PAM sequence is left, and that the nucleotide sequence immediately 5′ to the PAM sequence can be any purine or pyrimidine, not just those with a cytosine 5′ to the PAM sequence, for example, not just those that are C/NGG or C/TAG, etc.

Table 1 shows exemplary strategies/protocols to convert any source nucleic acid (e.g., DNA) into a collection of gNAs (e.g., gRNAs) using different restriction enzymes.

TABLE 1

Exemplary strategies for preparing a collection of guide nucleic acids.

First

3′ Adapter sequence with

CRISPR/Cas
PAM
Enzyme/

typeIIS enzyme site

System
Se-
Compo-

(provided with only one

Species
quence
nents
Strategy
strand sequence 5′→3′)

Streptococcus

NGG
CviPII
Nicks immediately 5′ of CCD sequence,
ggGACTCggatccctatagtc

pyogenes

nicks the other strand with T7 endonuclease
(SEQ ID NO: 4421)

(SP); SpCas9

I, blunt with T4 DNA polymerase; ligate to

adapter; cut with MlyI to remove PAM and

adapter; ligate gRNA stem-loop sequence at

3′ end

Staphylococcus

NNGRRT
AlwI
Cut, blunt with T4 DNA polymerase; ligate to
ttttagcggccgcctgctgCTCtacaa

aureus

or

adapter SA; cut with EcoP15I to remove
agacgatgacgacaagcgt

(SA); SaCas9
NNGRR

PAM and adapter; blunt end; ligate gRNA
(SEQ ID NO: 4422)

(N)

stem-loop sequence at 3′ end

Neisseria

NNNNGA
TfiI
Cut, blunt with T4 DNA polymerase; ligate to
TCgcggccgcttttattctgctgCTCt

meningitidis

TT

adapter NM; cut with EcoRI to eliminate
acaaagacgatgacgacaagcgt

(NM)

unwanted DNA and EcoP15I to remove PAM
(SEQ ID NO: 4428)

and adapter; blunt end; ligate gRNA stem-

loop sequence at 3′ end

Streptococcus

NNAGAA
BsmI
Cut, blunt with T4 DNA polymerase; ligate to
ttacggccgcttttattctgctgCTCt

thermophilus

W

adapter ST; cut with EcoP15I to remove PAM
acaaagacgatgacgacaagcgt

(ST)

and adapter; blunt end; ligate gRNA stem-
(SEQ ID NO: 4429)

loop sequence at 3′ end

Treponema

NAAAAC
Cly7489I
Cut, blunt with T4 DNA polymerase; ligate to
tttagcggccgcctgecgCTCtacaaa

denticola

I
adapter TD; cut with EcoP15I to remove
gacgatgacgacaagcgt

(TD)

PAM and adapter
(SEQ ID NO: 4430)

Table 2 shows additional exemplary strategies/protocols to convert any source nucleic acid (e.g., DNA) into a collection of gNAs (e.g., gRNAs) using different restriction enzymes.

TABLE 2

Additional exemplary strategies for preparing a collection of guide nucleic acids.

CRISPR/

First

Adapter oligo sequence (with

Cas System
PAM
Enzyme/

Inosine overhangs, all in 5′→3′

Species
Sequence
Component
Exemplary Strategy
direction)

Streptococcus

NGG
CviPII
Nicks immediately 5′ of CCD
Adapter oligo I:

pyogenes (SP);

sequence, nicks the other strand
ggggGACTCggatccctatagtgatac

SpCas9

with T7 endonuclease I; ligate to
aaagacgatgacgacaagcg

adapter; cut with MlyI to remove
(SEQ ID NO: 4404)

PAM and 3′ adapter; ligate gRNA
Adapter oligo 2:

stem-loop sequence at 3′ end
gcctcgagc*t*a*atacgactcactatag

ggatccaagtccc

(* denotes a phosphorothioate

backbone linkage)

(SEQ ID NO: 4405)

Staphylococcus

NNGRRT or
AlwI
Cut; ligate to adapter SA; cut
Adapter oligo 1:

aureus (SA),
NNGRR(N)

with EcoP15I to remove PAM and 3′
IttttagcggccgcctgctgCTCtacaaa

SaCas9

adapter; blunt end; ligate gRNA
gacgatgacgacaagcgt

stem-loop sequence at 3′ end
(SEQ ID NO: 4422)

Adapter oligo 2:

gagatcagcttctgcattgatgcGAGcag

caggcggccgctaaaa

(SEQ ID NO: 4423)

Neisseria

NNNNGATT
TfiI
Cut; ligate to adapter NM; cut
Adapter oligo 1:

meningitidis

with EcoP15I to remove PAM and
attTCgcggccgcttttattctgctgCTCt

(NM)

3′ adapter; blunt end; ligate
acaaagacgatgacgacaagcgt

gRNA stem-loop sequence at 3′
(SEQ ID NO: 4424)

end
Adapter oligo 2:

gagatcagcttctgcattgatgcGAGcag

cagaataaaagcggccgcGA

(SEQ ID NO: 4425)

Streptococcus

NNAGAAW
BsmI
Cut; ligate to adapter ST; cut
Adapter oligo 1:

thermophilus

with EcoP15I to remove PAM and 3′
gcggccgcttttattctgctgCTCtacaaa

(ST)

adapter; blunt end; ligate gRNA
gacgatgacgacaagcgt

stem-loop sequence at 3′ end
(SEQ ID NO: 4426)

Adapter oligo 2:

gagatcagcttctgcattgatgcGAGcag

cagaataaaagcggccgcIG

SEQ ID NO: 4427)

Exemplary applications of the compositions and methods described herein are provided in FIG. 1, FIG. 2, FIG. 3, FIG. 4, FIG. 5, FIG. 6, and FIG. 7. The figures depict non-limiting exemplary embodiments of the present invention that includes a method of constructing a gNA library (e.g., gRNA library) from input nucleic acids (e.g., DNA), such as genomic DNA (e.g., human genomic DNA).

In FIG. 1, the starting material can be fragmented genomic DNA (e.g., human) or other source DNA. These fragments are blunt-ended before constructing the library 101. T7 promoter adapters are ligated to the blunt-ended DNA fragments 102, which is then PCR amplified. Nt.CviPII is then used to generate a nick on one strand of the PCR product immediately 5′ to the CCD sequence 103. T7 Endonuclease I cleaves on the opposite strand 1, 2, or 3 bp 5′ of the nick 104. The resulting DNA fragments are blunt-ended with T4 DNA Polymerase, leaving HGG sequence at the end of the DNA fragment 105. The resulting DNA is cleaned and recovered on beads. An adapter carrying MlyI recognition site is ligated to the blunt-ended DNA fragment immediately 3′ of HGG sequence 106. MlyI generates a blunt-end cleavage immediately 5′ to the HGG sequence, removing HGG together with the adapter sequence 107. The resulting DNA fragments are cleaned and recovered again on beads. A gRNA stem-loop sequence is then ligated to the blunt-end cleaved by MlyI, forming a gRNA library covering the human genome 108. This library of DNA is then PCR amplified and cleaned on beads, ready for in vitro transcription.

In FIG. 2, the starting material can intact genomic DNA (e.g., human) or other source DNA 201. Nt.CviPII and T7 Endonuclease I are used to generate nicks on each strand of the human genomic DNA, resulting in smaller DNA fragments 202. DNA fragments of 200-600 bp are size selected on beads, then ligated with Y-shaped adapters carrying a GG overhang on the 5′. One strand of the Y-shaped adapter contains a MlyI recognition site, wherein the other strand contains a mutated MlyI site and a T7 promoter sequence 203. Because of these features, after PCR amplification, the T7 promoter sequence is at the distal end of the HGG sequence, and the MlyI sequence is at the rear end of HGG 204. Digestion with MlyI generates a cleavage immediately 5′ of HGG sequence 205. MlyI generates a blunt-end cleavage immediately 5′ to the HGG sequence, removing HGG together with the adapter sequence 206. A gRNA stem-loop sequence is then ligated to the blunt-end cleaved by MlyI, forming a gRNA library covering the human genome. This library of DNA is then PCR amplified and cleaned on beads, ready for in vitro transcription.

In FIG. 3, the source DNA (e.g., genomic DNA) can be nicked 301, for example with a nicking enzyme. In some cases, the nicking enzyme can have a recognition site that is three or fewer bases in length. In some cases, CviPII is used, which can recognize and nick at a sequence of CCD (where D represents a base other than C). Nicks can be proximal, surrounding a region containing the sequence (represented by the thicker line) which will be used to yield the guide RNA N20 sequence. When nicks are proximal, a double stranded break can occur and lead to 5′ or 3′ overhangs 302. These overhangs can be repaired, for example with a polymerase (e.g., T4 polymerase). In some cases, such as with 5′ strands, repair can comprise synthesizing a complementary strand. In some case, such as with 3′ strands, repair can comprise removing overhangs. Repair can result in a blunt end including the N20 guide sequence and a sequence complementary to the nick recognition sequence (e.g., HGG, where H represents a base other than G).

In FIG. 4, continuing for example from the end of FIG. 3, different combinations of adapters can be ligated to the DNA to allow for the desired cleaving. Adapters with a recognition site for a nuclease enzyme that cuts 3 base pairs from the site (e.g., MlyI) can be ligated 401, and digestion at that site can be used to remove a left over sequence, such as an HGG sequence 402. Adapters with a recognition site for a nuclease that cuts 20 base pairs from the site (e.g., MmeI) 403. These adapters can also include a second recognition site for a nuclease that cuts the proper number of nucleotides from the site to later remove the first recognition site (e.g., BsaXI). The first enzyme can be used to cut 20 nucleotides down, thereby keeping the N20 sequence 404. Then, a promoter adapter (e.g., T7) can be ligated next to the N20 sequence 405. Then, the nuclease corresponding to the second recognition site (e.g., BsaXI) can be used to remove the adapter for the site that cuts 20 nucleotides away (e.g., MmeI) 406. Finally, the guide RNA stem-loop sequence adapter can be ligated to the N20 sequence 407 to prepare for guide RNA production.

Alternatively, the protocol shown in FIG. 5 can follow the end of a protocol such as that shown in FIG. 3. Adapters with a recognition site for a nuclease enzyme that cleaves 25 nucleotides from the site (e.g., EcoP151) can be ligated to the DNA 501. These adapters can also include a second recognition site for a nuclease that cuts the proper number of nucleotides from the site to later remove the first recognition site (e.g., Bac) and any other left-over sequence, such as HGG. The enzyme corresponding to the first recognition site (e.g., EcoP15I) can then be used to cleave after the N20 sequence 502. Then, a promoter adapter (e.g., T7) can be ligated next to the N20 sequence 503. The enzyme corresponding to the second recognition site (e.g., BaeI) can then be used to remove the recognition sites and any residual sequence (e.g., HGG) 504. Finally, the guide RNA stem-loop sequence adapter can be ligated (e.g., by single strand ligation) to the N20 sequence 505.

As an alternative to protocols such as that shown in FIG. 3, the protocol shown in FIG. 6 can be used in preparation for protocols such as those shown in FIG. 4 or FIG. 5. A nick can be introduced by a nicking enzyme (e.g., CviPII) 601. In some cases, the nick recognition site is three or fewer bases in length. In some cases, CviPII is used, which can recognize and nick at a sequence of CCD. A polymerase (e.g., Bst large fragment DNA polymerase) can then be used to synthesize a new DNA strand starting from the nick while displacing the old strand 602. Because of the DNA synthesis, the nick can be sealed and made available to be nicked again 603. Subsequent cycles of nicking and synthesis can be used to yield large amounts of target sequences 604. These single stranded copies of target sequences can be made double stranded, for example by random priming and extension. These double stranded nucleic acids comprising N20 sequences can then be further processed by methods disclosed herein, such as those shown in FIG. 4 or FIG. 5.

As another alternative to protocols such as that shown in FIG. 3 or FIG. 6, the protocol shown in FIG. 7 can be used in preparation for protocols such as those shown in FIG. 4 or FIG. 5. A nick can be introduced by a nicking enzyme (e.g., CviPII) 701. In some cases, the nicking enzyme recognition site is three or fewer bases in length. In some cases, CviPII is used, which can recognize and nick at a sequence of CCD. A polymeras (e.g., Bst large fragment DNA polymerase) can then be used to synthesize a new DNA strand starting from the nick while displacing the old strand (e.g., nicking endonuclease-mediated strand-displacement DNA amplification (NEMDA)). The reaction parameters can be adjusted to control the size of the single stranded DNA produced. For example, the nickase:polymerase ratio (e.g., CviPII:Bts large fragment polymerase ratio) can be adjusted. Reaction temperature can also be adjusted. Next, an oligonucleotide can be added 704 which has (in the 5′>3′ direction) a promoter (e.g., T7 promoter) 702 followed by a random n-mer (e.g., random 6-mer, random 8-mer) 703. The random n-mer region can bind to a region of the single stranded DNA generated previously. For example, binding can be conducted by denaturing at high temperature followed by rapid cool down, which can allow the random n-mer region to bind to the single stranded DNA generated by NEMDA. In some cases, the DNA is denatured at 98° C. for 7 minutes then cooled down rapidly to 10° C. Extension and/or amplification can be used to produce double-stranded DNA. Blunt ends can be produced, for example enzymatically (e.g., by treatment with DNA polymerase I at 20° C.). This can result in one end ending at the promoter (e.g., T7 promoter) and the other end ending at any nicking enzyme recognition sites (e.g., any CCD sites). These fragments can then be purified, for example by size selection (e.g., by gel purification, capillary electrophoresis, or other fragment separation techniques). In some cases, the target fragments are about 50 base pairs in length (adapter sequence (e.g., T7 adapter)+target N20 sequence+nicking enzyme recognition site or complement (e.g., HGG)). Fragments can then be ligated to an adapter comprising a nuclease recognition site for a nuclease that cuts an appropriate distance away to remove the nicking enzyme recognition site 705. For example, for a three-nucleotide long nicking enzyme recognition site (e.g., CCD for CviPII). BaeI can be used. The appropriate nuclease (e.g., BaeI) can then be used to remove the nuclease recognition site and the nicking enzyme recognition site 706. The remaining nucleic acid sequence (e.g., the N20 site) can then be ligated to the final stem-loop sequence for the guide RNA 707. Amplification (e.g., PCR) can be conducted. Guide RNAs can be produced.

In some embodiments, a collection of gNAs (e.g., gRNAs) targeting human mitochondrial DNA (mtDNA) is created, that can be used for directing nucleic acid-guided nuclease (e.g., Cas9) proteins, comprising the nucleic acid-guided nuclease (e.g., Cas9) target sequence. In some embodiments, the targeting sequence of this collection of gNAs (e.g., gRNAs) are encoded by DNA sequences comprising at least the 20 nt sequence provided in the second column from the right of Table 3 (if the NGG sequence is on positive strand) and Table 4 (if the NGG sequence is on negative strand). In some embodiments, a collection of gRNA nucleic acids, as provided herein, with specificity for human mitochondrial DNA, comprise a plurality of members, wherein the members comprise a plurality of targeting sequences provided in the second column from the right column of Table 3 and/or the second column from the right of Table 4.

TABLE 3

gRNA target sequence for human mtDNA carrying NGG sequence on the (+) strand.

Chr end
nt sequence on the (+)

20 nt gRNA target

Chr start
position
strand containing gRNA

sequence

position
(+
target sequence followed
SEQ
(will encode the gRNA
SEQ

(+ strand)
strand)
by NGG
ID NO:
targeting sequence)
ID NO:

13
35
ATCACCCTATTAACCAC
13
ATCACCCTATTAACCA
436

TCACGG

CTCA

14
36
TCACCCTATTAACCACT
14
TCACCCTATTAACCAC
437

CACGGG

TCAC

32
54
ACGGGAGCTCTCCATGC
15
ACGGGAGCTCTCCATG
438

ATTTGG

CATT

45
67
ATGCATTTGGTATTTTC
16
ATGCATTTGGTATTTT
439

GTCTGG

CGTC

46
68
TGCATTTGGTATTTTCGT
17
TGCATTTGGTATTTTC
440

CTGGG

GTCT

47
69
GCATTTGGTATTTTCGT
18
GCATTTGGTATTTTCG
441

CTGGGG

TCTG

48
70
CATTTGGTATTTTCGTCT
19
CATTTGGTATTTTCGTC
442

GGGGG

TGG

49
71
ATTTGGTATTTTCGTCTG
20
ATTTGGTATTTTCGTCT
443

GGGGG

GGG

79
101
GCGATAGCATTGCGAGA
21
GCGATAGCATTGCGAG
444

CGCTGG

ACGC

85
107
GCATTGCGAGACGCTGG
22
GCATTGCGAGACGCTG
445

AGCCGG

GAGC

163
185
GCACCTACGTTCAATAT
23
GCACCTACGTTCAATA
446

TACAGG

TTAC

207
229
GTTAATTAATTAATGCT
24
GTTAATTAATTAATGC
447

TGTAGG

TTGT

301
323
AACCCCCCCTCCCCCGC
25
AACCCCCCCTCCCCCG
448

TTCTGG

CTTC

388
410
AGATTTCAAATTTTATC
26
AGATTTCAAATTTTAT
449

TTTTGG

CTTT

391
413
TTTCAAATTTTATCTTTT
27
TTTCAAATTTTATCTTT
450

GGCGG

TGG

604
626
ATACACTGAAAATGTTT
28
ATACACTGAAAATGTT
451

AGACGG

TAGA

605
627
TACACTGAAAATGTTTA
29
TACACTGAAAATGTTT
452

GACGGG

AGAC

631
653
ACATCACCCCATAAACA
30
ACATCACCCCATAAAC
453

AATAGG

AAAT

636
658
ACCCCATAAACAAATAG
31
ACCCCATAAACAAATA
454

GTTTGG

GGTT

727
749
TCTAAATCACCACGATC
32
TCTAAATCACCACGAT
455

AAAAGG

CAAA

788
810
TTAGCCTAGCCACACCC
33
TTAGCCTAGCCACACC
456

CCACGG

CCCA

789
811
TAGCCTAGCCACACCCC
34
TAGCCTAGCCACACCC
457

CACGGG

CCAC

851
873
AACTAAGCTATACTAAC
35
AACTAAGCTATACTAA
458

CCCAGG

CCCC

852
874
ACTAAGCTATACTAACC
36
ACTAAGCTATACTAAC
459

CCAGGG

CCCA

856
878
AGCTATACTAACCCCAG
37
AGCTATACTAACCCCA
460

GGTTGG

GGGT

880
902
CAATTTCGTGCCAGCCA
38
CAATTTCGTGCCAGCC
461

CCGCGG

ACCG

912
934
TAACCCAAGTCAATAGA
39
TAACCCAAGTCAATAG
462

AGCCGG

AAGC

1009
1031
CACAAAATAGACTACG
40
ACACAAATAGACTACG
463

AAAGTGG

AAAG

1051
1073
ACAATAGCTAAGACCCA
41
ACAATAGCTAAGACCC
464

AACTGG

AAAC

1052
1074
CAATAGCTAAGACCCAA
42
CAATAGCTAAGACCCA
465

ACTGGG

AACT

1148
1170
AGCCACAGCTTAAAACT
43
AGCCACAGCTTAAAAC
466

CAAAGG

TCAA

1154
1176
AGCTTAAAACTCAAAGG
44
AGCTTAAAACTCAAAG
467

ACCTGG

GACC

1157
1179
TTAAAACTCAAAGGACC
45
TTAAAACTCAAAGGAC
468

TGGCGG

CTGG

1178
1200
GGTGCTTCATATCCCTC
46
GGTGCTTCATATCCCT
469

TAGAGG

CTAG

1267
1289
TCTTCAGCAAACCCTGA
47
TCTTCAGCAAACCCTG
470

TGAAGG

ATGA

1306
1328
AGTACCCACGTAAAGAC
48
AGTACCCACGTAAAGA
471

GTTAGG

CGTT

1312
1334
CACGTAAAGACGTTAGG
49
CACGTAAAGACGTTAG
472

TCAAGG

GTCA

1326
1348
AGGTCAAGGTGTAGCCC
50
AGGTCAAGGTGTAGCC
473

ATGAGG

CATG

1329
1351
TCAAGGTGTAGCCCATG
51
TCAAGGTGTAGCCCAT
474

AGGTGG

GAGG

1339
1361
GCCCATGAGGTGGCAA
52
GCCCATGAGGTGGCAA
475

GAAATGG

GAAA

1340
1362
CCCATGAGGTGGCAAG
53
CCCATGAGGTGGCAAG
476

AAATGGG

AAAT

1389
1411
GATAGCCCTTATGAAAC
54
GATAGCCCTTATGAAA
477

TTAAGG

CTTA

1390
1412
ATAGCCCTTATGAAACT
55
ATAGCCCTTATGAAAC
478

TAAGGG

TTAA

1397
1419
TTATGAAACTTAAGGGT
56
TTATGAAACTTAAGGG
479

CGAAGG

TCGA

1400
1422
TGAAACTTAAGGGTCGA
57
TGAAACTTAAGGGTCG
480

AGGTGG

AAGG

1441
1463
AGTAGAGTGCTTAGTTG
58
AGTAGAGTGCTTAGTT
481

AACAGG

GAAC

1442
1464
GTAGAGTGCTTAGTTGA
59
GTAGAGTGCTTAGTTG
482

ACAGGG

AACA

1494
1516
CCTCCTCAAGTATACTT
60
CCTCCTCAAGTATACT
483

CAAAGG

TCAA

1530
1552
ACCCCTACGCATTTATA
61
ACCCCTACGCATTTAT
484

TAGAGG

ATAG

1548
1570
AGAGGAGACAAGTCGT
62
AGAGGAGACAAGTCG
485

AACATGG

TAACA

1560
1582
TCGTAACATGGTAAGTG
63
TCGTAACATGGTAAGT
486

TACTGG

GTAC

1573
1595
AGTGTACTGGAAAGTGC
64
AGTGTACTGGAAAGTG
487

ACTTGG

CACT

1620
1642
AAAGCACCCAACTTACA
65
AAAGCACCCAACTTAC
488

CTTAGG

ACTT

1726
1748
CATTTACCCAAATAAAG
66
CATTTACCCAAATAAA
489

TATAGG

GTAT

1746
1768
AGGCGATAGAAATTGA
67
AGGCGATAGAAATTG
490

AACCTGG

AAACC

1770
1792
GCAATAGATATAGTACC
68
GCAATAGATATAGTAC
491

GCAAGG

CGCA

1771
1793
CAATAGATATAGTACCG
69
CAATAGATATAGTACC
492

CAAGGG

GCAA

1809
1831
TAACCAAGCATAATATA
70
TAACCAAGCATAATAT
493

GCAAGG

AGCA

1862
1884
TAACTAGAAATAACTTT
71
TAACTAGAAATAACTT
494

GCAAGG

TGCA

1947
1969
CCGTCTATGTAGCAAAA
72
CCGTCTATGTAGCAAA
495

TAGTGG

ATAG

1948
1970
CGTCTATGTAGCAAAAT
73
CGTCTATGTAGCAAAA
496

AGTGGG

TAGT

1960
1982
AAAATAGTGGGAAGAT
74
AAAATAGTGGGAAGA
497

TTATAGG

TTTAT

1966
1988
GTGGGAAGATTTATAGG
75
GTGGGAAGATTTATAG
498

TAGAGG

GTAG

1987
2009
GGCGACAAACCTACCG
76
GGCGACAAACCTACCG
499

AGCCTGG

AGCC

1997
2019
CTACCGAGCCTGGTGAT
77
CTACCGAGCCTGGTGA
500

AGCTGG

TAGC

2086
2108
ATTTAACTGTTAGTCCA
78
ATTTAACTGTTAGTCC
501

AAGAGG

AAAG

2099
2121
TCCAAAGAGGAACAGC
79
TCCAAAGAGGAACAG
502

TCTTTGG

CTCTT

2107
2129
GGAACAGCTCTTTGGAC
80
GGAACAGCTCTTTGGA
503

ACTAGG

CACT

2152
2174
AAAAATTTAACACCCAT
81
AAAAATTTAACACCCA
504

AGTAGG

TACT

2247
2269
CTGAACTCCTCACACCC
82
CTGAACTCCTCACACC
505

AATTGG

CAAT

2414
2436
CCTCACTGTCAACCCAA
83
CCTCACTGTCAACCCA
506

CACAGG

ACAC

2427
2449
CCAACACAGGCATGCTC
84
CCAACACAGGCATGCT
507

ATAAGG

CATA

2432
2454
ACAGGCATGCTCATAAG
85
ACAGGCATGCTCATAA
508

GAAAGG

GGAA

2449
2471
GAAAGGTTAAAAAAAG
86
GAAAGGTTAAAAAAA
509

TAAAAGG

GTAAA

2456
2478
TAAAAAAAGTAAAAGG
87
TAAAAAAAGTAAAAG
510

AACTCGG

GAACT

2515
2537
TCTAGCATCACCAGTAT
88
TCTAGCATCACCAGTA
511

TAGAGG

TTAG

2546
2568
GCCCAGTGACACATGTT
89
GCCCAGTGACACATGT
512

TAACGG

TTAA

2552
2574
TGACACATGTTTAACGG
90
TGACACATGTTTAACG
513

CCGCGG

GCCG

2571
2593
GCGGTACCCTAACCGTG
91
GCGGTACCCTAACCGT
514

CAAAGG

GCAA

2599
2621
TAATCACTTGTTCCTTA
92
TAATCACTTGTTCCTT
515

AATAGG

AAAT

2600
2622
AATCACTTGTTCCTTAA
93
AATCACTTGTTCCTTA
516

ATAGGG

AATA

2614
2636
TAAATAGGGACCTGTAT
94
TAAATAGGGACCTGTA
517

GAATGG

TGAA

2624
2646
CCTGTATGAATGGCTCC
95
CCTGTATGAATGGCTC
518

ACGAGG

CACG

2625
2647
CTGTATGAATGGCTCCA
96
CTGTATGAATGGCTCC
519

CGAGGG

ACGA

2676
2698
AAATTGACCTGCCCGTG
97
AAATTGACCTGCCCGT
520

AAGAGG

GAAG

2679
2701
TTGACCTGCCCGTGAAG
98
TTGACCTGCCCGTGAA
521

AGGCGG

GAGG

2680
2702
TGACCTGCCCGTGAAGA
99
TGACCTGCCCGTGAAG
522

GGCGGG

AGGC

2711
2733
AGCAAGACGAGAAGAC
100
AGCAAGACGAGAAGA
523

CCTATGG

CCCTA

2755
2777
ACAGTACCTAACAAACC
101
ACAGTACCTAACAAAC
524

CACAGG

CCAC

2789
2811
CAAACCTGCATTAAAAA
102
CAAACCTGCATTAAAA
525

TTTCGG

ATTT

2793
2815
CCTGCATTAAAAATTTC
103
CCTGCATTAAAAATTT
526

GGTTGG

CGGT

2794
2816
CTGCATTAAAAATTTCG
104
CTGCATTAAAAATTTC
527

GTTGGG

GGTT

2795
2817
TGCATTAAAAATTTCGG
105
TGCATTAAAAATTTCG
528

TTGGGG

GTTG

2804
2826
AATTTCGGTTGGGGCGA
106
AATTTCGGTTGGGGCG
529

CCTCGG

ACCT

2895
2917
TGATCCAATAACTTGAC
107
TGATCCAATAACTTGA
530

CAACGG

CCAA

2911
2933
CCAACGGAACAAGTTAC
108
CCAACGGAACAAGTTA
531

CCTAGG

CCCT

2912
2934
CAACGGAACAAGTTACC
109
CAACGGAACAAGTTAC
532

CTAGGG

CCTA

2954
2976
CTAGAGTCCATATCAAC
110
CTAGAGTCCATATCAA
533

AATAGG

CAAT

2955
7977
TAGAGTCCATATCAACA
111
TAGAGTCCATATCAAC
534

ATAGGG

AATA

2974
2996
AGGGTTTACGACCTCGA
112
AGGGTTTACGACCTCG
535

TGTTGG

ATGT

2980
3002
TACGACCTCGATGTTGG
113
TACGACCTCGATGTTG
536

ATCAGG

GATC

2992
3014
GTTGGATCAGGACATCC
114
GTTGGATCAGGACATC
537

CGATGG

CCGA

3010
3032
GATGGTGCAGCCGCTAT
115
GATGGTGCAGCCGCTA
538

TAAAGG

TTAA

3058
3080
TACGTGATCTGAGTTCA
116
TACGTGATCTGAGTTC
539

GACCGG

AGAC

3069
3091
AGTTCAGACCGGAGTAA
117
AGTTCAGACCGGAGTA
540

TCCAGG

ATCC

3073
3095
CAGACCGGAGTAATCCA
118
CAGACCGGAGTAATCC
541

GGTCGG

AGGT

3110
3132
CAAATTCCTCCCTGTAC
119
CAAATTCCTCCCTGTA
542

GAAAGG

CGAA

3125
3147
ACGAAAGGACAAGAGA
120
ACGAAAGGACAAGAG
543

AATAAGG

AAATA

3203
3225
ACCCACACCCACCCAAG
121
ACCCACACCCACCCAA
544

AACAGG

GAAC

3204
3226
CCCACACCCACCCAAGA
122
CCCACACCCACCCAAG
545

ACAGGG

AACA

3217
3239
AAGAACAGGGTTTGTTA
123
AAGAACAGGGTTTGTT
546

AGATGG

AAGA

3227
3249
TTTGTTAAGATGGCAGA
124
TTTGTTAAGATGGCAG
547

GCCCGG

AGCC

3262
3284
ACTTAAAACTTTACAGT
125
ACTTAAAACTTTACAG
548

CAGAGG

TCAG

3294
3316
TCTTCTTAACAACATAC
126
TCTTCTTAACAACATA
549

CCATGG

CCCA

3336
3358
TGTACCCATTCTAATCG
127
TGTACCCATTCTAATC
550

CAATGG

GCAA

3370
3392
CTTACCGAACGAAAAAT
128
CTTACCGAACGAAAAA
551

TCTAGG

TTCT

3391
3413
GGCTATATACAACTACG
129
GGCTATATACAACTAC
552

CAAAGG

GCAA

3406
3428
CGCAAAGGCCCCAACGT
130
CGCAAAGGCCCCAAC
553

TGTAGG

GTTGT

3415
3437
CCCAACGTTGTAGGCCC
131
CCCAACGTTGTAGGCC
554

CTACGG

CCTA

3416
3438
CCAACGTTGTAGGCCCC
132
CCAACGTTGTAGGCCC
555

TACGGG

CTAC

3570
3592
CCTCCCCATACCCAACC
133
CCTCCCCATACCCAAC
556

CCCTGG

CCCC

3586
3608
CCCCTGGTCAACCTCAA
134
CCCCTGGTCAACCTCA
557

CCTAGG

ACCT

3643
3665
GTTTACTCAATCCTCTG
135
GTTTACTCAATCCTCT
558

ATCAGG

GATC

3644
3666
TTTACTCAATCCTCTGA
136
TTTACTCAATCCTCTG
559

TCAGGG

ATCA

3676
3698
AACTCAAACTACGCCCT
137
AACTCAAACTACGCCC
560

GATCGG

TGAT

3757
3779
CTATCAACATTACTAAT
138
CTATCAACATTACTAA
561

AAGTGG

TAAG

3828
3850
ACTCCTGCCATCATGAC
139
ACTCCTGCCATCATGA
562

CCTTGG

CCCT

3892
3914
ACCCCCTTCGACCTTGC
140
ACCCCCTTCGACCTTG
563

CGAAGG

CCGA

3893
3915
CCCCCTTCGACCTTGCC
141
CCCCCTTCGACCTTGC
564

GAAGGG

CGAA

3894
3916
CCCCTTCGACCTTGCCG
142
CCCCTTCGACCTTGCC
565

AAGGGG

GAAG

3913
3935
GGGGAGTCCGAACTAGT
143
GGGGAGTCCGAACTA
566

CTCAGG

GTCTC

3937
3959
TTCAACATCGAATACGC
144
TTCAACATCGAATACG
567

CGCAGG

CCGC

4015
4037
CTCACCACTACAATCTT
145
CTCACCACTACAATCT
568

CCTAGG

TCCT

4287
4309
ACTTTGATAGAGTAAAT
146
ACTTTGATAGAGTAAA
569

AATAGG

TAAT

4311
4333
GCTTAAACCCCCTTATT
147
GCTTAAACCCCCTTAT
570

TCTAGG

TTCT

4386
4408
TCACACCCCATCCTAAA
148
TCACACCCCATCCTAA
571

GTAAGG

AGTA

4406
4428
AGGTCAGCTAAATAAGC
149
AGGTCAGCTAAATAAG
572

TATCGG

CTAT

4407
4429
GGTCAGCTAAATAAGCT
150
GGTCAGCTAAATAAGC
573

ATCGGG

TATC

4428
4450
GGCCCATACCCCGAAAA
151
GGCCCATACCCCGAAA
574

TGTTGG

ATGT

4460
4482
TCCCGTACTAATTAATC
152
TCCCGTACTAATTAAT
575

CCCTGG

CCCC

4494
4516
ATCTACTCTACCATCTTT
153
ATCTACTCTACCATCT
576

GCAGG

TTGC

4542
4564
CACTGATTTTTTACCTG
154
CACTGATTTTTTACCT
577

AGTAGG

GAGT

4692
4714
CTCTTCAACAATATACT
155
CTCTTCAACAATATAC
578

CTCCGG

TCTC

4767
4789
ATAGCTATAGCAATAAA
156
ATAGCTATAGCAATAA
579

ACTAGG

AACT

4799
4821
CTTTCACTTCTGAGTCC
157
CTTTCACTTCTGAGTC
580

CAGAGG

CCAG

4809
4831
TGAGTCCCAGAGGTTAC
158
TGAGTCCCAGAGGTTA
581

CCAAGG

CCCA

4827
4849
CAAGGCACCCCTCTGAC
159
CAAGGCACCCCTCTGA
582

ATCCGG

CATC

4941
4963
TCAATCTTATCCATCAT
160
TCAATCTTATCCATCA
583

AGCAGG

TAGC

4950
4972
TCCATCATAGCAGGCAG
161
TCCATCATAGCAGGCA
584

TTGAGG

GTTG

4953
4975
ATCATAGCAGGCAGTTG
162
ATCATAGCAGGCAGTT
585

AGGTGG

GAGG

5010
5032
TACTCCTCAATTACCCA
163
TACTCCTCAATTACCC
586

CATAGG

ACAT

5202
5274
CCATCCACCCTCCTCTC
164
CCATCCACCCTCCTCT
587

CCTAGG

CCCT

5205
5227
TCCACCCTCCTCTCCCT
165
TCCACCCTCCTCTCCCT
588

AGGAGG

AGG

5223
5245
GGAGGCCTGCCCCCGCT
166
GGAGGCCTGCCCCCGC
589

AACCGG

TAAC

539
5261
TAACCGGCTTTTTGCCC
167
TAACCGGCTTTTTGCC
590

AAATGG

CAAA

5240
5262
AACCGGCTTTTTGCCCA
168
AACCGGCTTTTTGCCC
591

AATGGG

AAAT

5500
5522
TAATAATCTTATAGAAA
169
TAATAATCTTATAGAA
592

TTTAGG

ATTT

5569
5591
CTTAATTTCTGTAACAG
170
CTTAATTTCTGTAACA
593

CTAAGG

GCTA

5646
5668
CTAAGCCCTTACTAGAC
171
CTAAGCCCTTACTAGA
594

CAATGG

CCAA

5647
5669
TAAGCCCTTACTAGACC
172
TAAGCCCTTACTAGAC
595

AATGGG

CAAT

5697
5719
AGCTAAGCACCCTAATC
173
AGCTAAGCACCCTAAT
596

AACTGG

CAAC

5723
5745
CAATCTACTTCTCCCGC
174
CAATCTACTTCTCCCG
597

CGCCGG

CCGC

5724
5746
AATCTACTTCTCCCGCC
175
AATCTACTTCTCCCGC
598

GCCGGG

CGCC

5732
5754
TCTCCCGCCGCCGGGAA
176
TCTCCCGCCGCCGGGA
599

AAAAGG

AAAA

5735
5757
CCCGCCGCCGGGAAAA
177
CCCGCCGCCGGGAAA
600

AAGGCGG

AAAGG

5736
5758
CCGCCGCCGGGAAAAA
178
CCGCCGCCGGGAAAA
601

AGGCGGG

AAGGC

5747
5769
AAAAAAGGCGGGAGAA
179
AAAAAAGGCGGGAGA
602

GCCCCGG

AGCCC

5751
5773
AAGGCGGGAGAAGCCC
180
AAGGCGGGAGAAGCC
603

CGGCAGG

CCGGC

5800
5822
ATTCAATATGAAAATCA
181
ATTCAATATGAAAATC
604

CCTCGG

ACCT

5806
5828
TATGAAAATCACCTCGG
182
TATGAAAATCACCTCG
605

ACTCTGG

GAGC

5816
5838
ACCTCGGAGCTGGTAAA
183
ACCTCGGAGCTGGTAA
606

AAGAGG

AAAG

5928
5950
TCTACAAACCACAAAGA
184
TCTACAAACCACAAAG
607

CATTGG

ACAT

5949
5971
GGAACACTATACCTATT
185
GGAACACTATACCTAT
608

ATTCGG

TATT

5961
5983
CTATTATTCGGCGCATG
186
CTATTATTCGGCGCAT
609

AGCTGG

GAGC

5970
5992
GGCGCATGAGCTGGAGT
187
GGCGCATGAGCTGGA
610

CCTAGG

GTCCT

6005
6027
CCTCCTTATTCGAGCCG
188
CCTCCTTATTCGAGCC
611

AGCTGG

GAGC

6006
6028
CTCCTTATTCGAGCCGA
189
CTCCTTATTCGAGCCG
612

GCTGGG

AGCT

6027
6049
GGCCAGCCAGGCAACCT
190
GGCCAGCCAGGCAAC
613

TCTAGG

CTTCT

6108
3130
ATAGTAATACCCATCAT
191
ATAGTAATACCCATCA
614

AATCGG

TAAT

6111
6133
GTAATACCCATCATAAT
192
GTAATACCCATCATAA
615

CGGAGG

TCGG

6117
6139
CCCATCATAATCGGAGG
193
CCCATCATAATCGGAG
616

CTTTGG

GCTT

6144
6166
TGACTAGTTCCCCTAAT
194
TGACTAGTTCCCCTAA
617

AATCGG

TAAT

6158
6180
AATAATCGGTGCCCCCG
195
AATAATCGGTGCCCCC
618

ATATGG

GATA

6236
6258
CCTGCTCGCATCTGCTA
196
CCTGCTCGCATCTGCT
619

TAGTGG

ATAG

6239
6261
GCTCGCATCTGCTATAG
197
GCTCGCATCTGCTATA
620

TGGAGG

GTGG

6243
6265
GCATCTGCTATAGTGGA
198
GCATCTGCTATAGTGG
621

GGCCGG

AGGC

6249
6271
GCTATAGTGGAGGCCGG
199
GCTATAGTGGAGGCCG
622

AGCAGG

GAGC

6255
6277
GTGGAGGCCGGAGCAG
200
GTGGAGGCCGGAGCA
623

GAACAGG

GGAAC

6282
6304
ACAGTCTACCCTCCCTT
201
ACAGTCTACCCTCCC
624

AGCAGG

TAGC

6283
6305
CAGTCTACCCTCCCTTA
202
CAGTCTACCCTCCCTT
625

GCAGGG

AGCA

6300
6322
GCAGGGAACTACTCCCA
203
GCAGGGAACTACTCCC
626

CCCTGG

ACCC

6342
6364
ATCTTCTCCTTACACCT
204
ATCTTCTCCTTACACCT
627

AGCAGG

AGC

6360
6382
GCAGGTGTCTCCTCTAT
205
GCAGGTGTCTCCTCTA
628

CTTAGG

TCTT

6361
6383
CAGGTGTCTCCTCTATC
206
CAGGTGTCTCCTCTAT
629

TTAGGG

CTTA

6362
6384
AGGTGTCTCCTCTATCT
207
AGGTGTCTCCTCTATC
630

TAGGGG

TTAG

6495
6517
TCTCTCCCAGTCCTAGC
208
TCTCTCCCAGTCCTAG
631

TGCTGG

CTGC

6552
6574
ACCACCTTCTTCGACCC
209
ACCACCTTCTTCGACC
632

CGCCGG

CCGC

6555
6577
ACCTTCTTCGACCCCGC
210
ACCTTCTTCGACCCCG
633

CGGAGG

CCGG

6558
6580
TTCTTCGACCCCGCCGG
211
TTCTTCGACCCCGCCG
634

AGGAGG

GAGG

6597
6619
CAACACCTATTCTGATT
212
CAACACCTATTCTGAT
635

TTTCGG

TTTT

6630
6652
GTTTATATTCTTATCCTA
213
GTTTATATTCTTATCCT
636

CCAGG

ACC

6636
6658
ATTCTTATCCTACCAGG
214
ATTCTTATCCTACCAG
637

CTTCGG

GCTT

6669
6691
CATATTGTAACTTACTA
215
CATATTGTAACTTACT
638

CTCCGG

ACTC

6687
6709
TCCGGAAAAAAAGAAC
216
TCCGGAAAAAAAGAA
639

CATTTGG

CCATT

6696
6718
AAAGAACCATTTGGATA
217
AAAGAACCATTTGGAT
640

CATAGG

ACAT

6701
6723
ACCATTTGGATACATAG
218
ACCATTTGGATACATA
641

GTATGG

GGTA

6723
6745
GTCTGAGCTATGATATC
219
GTCTGAGCTATGATAT
642

AATTGG

CAAT

6732
6754
ATGATATCAATTGGCTT
220
ATGATATCAATTGGCT
643

CCTAGG

TCCT

6713
6755
TGATATCAATTGGCTTC
221
TGATATCAATTGGCTT
644

CTAGGG

CCTA

6768
6790
GCACACCATATATTTAC
222
GCACACCATATATTTrA
645

AGTAGG

CAGT

6831
6853
ATAATCATCGCTATCCC
223
ATAATCATCGCTATCC
646

CACCGG

CCAC

6867
6889
AGCTGACTCGCCACACT
224
AGCTGACTCGCCACAC
647

CCACGG

TCCA

6909
6931
GCTGCAGTGCTCTGAGC
225
GCTGCAGTGCTCTGAG
648

CCTAGG

CCCT

6933
6955
TTCATCTTTCTTTTCACC
226
TTCATCTTTCTTTTCAC
649

GTAGG

CGT

6936
6958
ATCTTTCTTTTCACCGTA
227
ATCTTTCTTTTCACCGT
650

GGTGG

AGG

6945
6967
TTCACCGTAGGTGGCCT
228
TTCACCGTAGGTGGCC
651

GACTGG

TGAC

7032
7054
TTCCACTATGTCCTATC
229
TTCCACTATGTCCTAT
652

AATAGG

CAAT

7053
7075
GGAGCTGTATTTGCCAT
230
GGAGCTGTATTTGCCA
653

CATAGG

TCAT

7056
7078
GCTGTATTTGCCATCAT
231
GCTGTATTTGCCATCA
654

AGGAGG

TAGG

7086
7108
CACTGATTTCCCCTATT
232
CACTGATTTCCCCTAT
655

CTCAGG

TCTC

7140
7162
CATTTCACTATCATATT
233
CATTTCACTATCATAT
656

CATCGG

TCAT

7176
7198
TTCTTCCCACAACACTT
234
TTCTTCCCACAACACT
657

TCTCGG

TTCT

7185
7207
CAACACTTTCTCGGCCT
235
CAACACTTTCTCGGCC
658

ATCCGG

TATC

7205
7227
CGGAATGCCCCGACGTT
236
CGGAATGCCCCGACGT
659

ACTCGG

TACT

7251
7273
TGAAACATCCTATCATC
237
TGAAACATCCTATCAT
660

TGTAGG

CTGT

7358
7380
AGAAGAACCCTCCATAA
238
AGAAGAACCCTCCATA
661

ACCTGG

AACC

7371
7393
ATAAACCTGGAGTGACT
239
ATAAACCTGGAGTGAC
662

ATATGG

TATA

7432
7454
ACATAAAATCTAGACAA
240
ACATAAAATCTAGACA
663

AAAAGG

AAAA

7436
7458
AAAATCTAGACAAAAA
241
AAAATCTAGACAAAA
664

AGGAAGG

AAGGA

7457
7479
GGAATCGAACCCCCCAA
242
GGAATCGAACCCCCCA
665

AGCTGG

AAGC

7476
7498
CTGGTTTCAAGCCAACC
243
CTGGTTTCAAGCCAAC
666

CCATGG

CCCA

7499
7521
CCTCCATGACTTTTTCA
244
CCTCCATGACTTTTTC
667

AAAAGG

AAAA

7544
7566
CTTTGTCAAAGTTAAAT
245
CTTTGTCAAAGTTAAA
668

TATAGG

TTAT

7567
7589
CTAAATCCTATATATCT
246
CTAAATCCTATATATC
669

TAATGG

TTAA

7586
7608
ATGGCACATGCAGCGCA
247
ATGGCACATGCAGCGC
670

AGTAGG

AAGT

7741
7763
TACTAACATCTCAGACG
248
TACTAACATCTCAGAC
671

CTCAGG

GCTC

7831
7853
CATCCTTTACATAACAG
249
CATCCTTTACATAACA
672

ACGAGG

GACG

7865
7887
TCCCTTACCATCAAATC
250
TCCCTTACCATCAAAT
673

AATTGG

CAAT

7875
7897
TCAAATCAATTGGCCAC
251
TCAAATCAATTGGCCA
674

CAATGG

CCAA

7904
7926
ACCTACGAGTACACCGA
252
ACCTACGAGTACACCG
675

CTACGG

ACTA

7907
7929
TACGAGTACACCGACTA
253
TACGAGTACACCGACT
676

CGGCGG

ACGG

7955
7977
CCCCCATTATTCCTAGA
254
CCCCCATTTTCCTAG
677

ACCAGG

AACC

8069
8091
TCATGAGCTGTCCCCAC
255
TCATGAGCTGTCCCCA
678

ATTAGG

CATT

8093
8115
TTAAAAACAGATGCAAT
256
TTAAAAACAGATGCAA
679

TCCCGG

TTCC

8131
8153
CACTTTCACCGCTACAC
257
CACTTTCACCGCTACA
680

GACCGG

CGAC

8132
8154
ACTTTCACCGCTACACG
258
ACTTTCACCGCTACAC
681

ACCGGG

GACC

8133
8155
CTTTCACCGCTACACGA
259
CTTTCACCGCTACACG
682

CCGGGG

ACCG

8134
8156
TTTCACCGCTACACGAC
260
TTTCACCGCTACACGA
683

CGGGGG

CCGG

8144
8166
ACACGACCGGGGGTAT
261
ACACGACCGGGGGTAT
684

ACTACGG

ACTA

8165
8187
GGTCAATGCTCTGAAAT
262
GGTCAATGCTCTGAAA
685

CTGTGG

TCTG

8228
8250
CCCCTAAAAATCTTTGA
263
CCCCTAAAAATCTTTG
686

AATAGG

AAAT

8229
8251
CCCTAAAAATCTTTGAA
264
CCCTAAAAATCTTTGA
687

ATAGGG

AATA

8370
8392
CCCAACTAAATACTACC
265
CCCAACTAAATACTAC
688

GTATGG

CGTA

8551
8573
TTCATTGCCCCCACAAT
266
TTCATTTGCCCCCACAA
689

CCTAGG

TCCT

8698
8720
ATAACCATACACAACAC
267
ATAACCATACACAACA
690

TAAAGG

CTAA

8761
8783
ATTGCCACAACTAACCT
268
ATTGCCACAACTAACC
691

CCTCGG

TCCT

8817
8839
ACTATCTATAAACCTAG
269
ACTATCTATAAACCTA
692

CCATGG

GCCA

8835
8857
CATGGCCATCCCCTTAT
270
CATGGCCATCCCCTTA
693

GAGCGG

TGAG

8836
8858
ATGGCCATCCCCTTATG
271
ATGGCCATCCCCTTAT
694

AGCGGG

GAGC

8851
8873
TGAGCGGGCACAGTGAT
272
TGAGCGGGCACAGTG
695

TATAGG

ATTAT

8899
8921
CTAGCCCACTTCTTACC
273
CTAGCCCACTTCTTAC
696

ACAAGG

CACA

8973
8995
ACTCATTCAACCAATAG
274
ACTCATTCAACCAATA
697

CCCTGG

GCCC

9004
9026
CTAACCGCTAACATTACC
275
CTAACCGCTAACATTA
698

TGCAGG

CTGC

9028
9050
CACCTACTCATGCACCT
276
CACCTACTCATGCACC
699

AATTGG

TAAT

9243
9265
CCCAGCCCATGACCCCT
277
CCCAGCCCATGACCCC
700

AACAGG

TAAC

9244
9266
CCAGCCCATGACCCCTA
278
CCAGCCCATGACCCCT
701

ACAGGG

AACA

9245
9267
CAGCCCATGACCCCTAA
279
CAGCCCATGACCCCTA
702

CAGGGG

ACAG

9273
9295
TCAGCCCTCCTAATGAC
280
TCAGCCCTCCTAATGA
703

CTCCGG

CCTC

9321
9343
TCCATAACGCTCCTCAT
281
TCCATAACGCTCCTCA
704

ACTAGG

TACT

9358
9380
CACTAACCATATACCAA
282
CACTAACCATATACCA
705

TGATGG

ATGA

9390
9412
ACACGAGAAAGCACAT
283
ACACGAGAAAGCACA
706

ACCAAGG

TACCA

9417
9439
CACACACCACCTGTCCA
284
CACACACCACCTGTCC
707

AAAAGG

AAAA

9429
9451
GTCCAAAAAGGCCTTCG
285
GTCCAAAAAGGCCTTC
708

ATACGG

GATA

9430
9452
TCCAAAAAGGCCTTCGA
286
TCCAAAAAGGCCTTCG
709

TACGGG

ATAC

9471
9493
TCAGAAGTTTTTTTCTTC
287
TCAGAAGTTTTTTTCTT
710

GCAGG

CGC

9522
9544
CTAGCCCCTACCCCCCA
288
CTAGCCCCTACCCCCC
711

ATTAGG

AATT

9525
9547
GCCCCTACCCCCCAATT
289
GCCCCTACCCCCCAAT
712

AGGAGG

TAGG

9526
9548
CCCCTACCCCCCAATTA
290
CCCCTACCCCCCAATT
713

GGAGGG

AGGA

9532
9554
CCCCCCAATTAGGAGGG
291
CCCCCCAATTAGGAGG
714

CACTGG

GCAC

9543
9565
GGAGGGCACTGGCCCCC
292
GGAGGGCCACTGGCCCC
715

AACAGG

CAAC

9606
9628
ACATCCGTATTACTCGC
293
ACATCCGTATTACTCG
716

ATCAGG

CATC

9692
9714
ACTGCTTATTACAATTT
294
ACTGCTTATTACAATT
717

TACTGG

TTAC

9693
9715
CTGCTTATTACAATTTT
295
CTGCTTATTACAATTTT
718

ACTGGG

ACT

9756
9778
TCTCCCTTCACCATTTCC
296
TCTCCCTTCACCATTTC
719

GACGG

CGA

9765
9787
ACCATTTCCGACGGCAT
297
ACCATTTCCGACGGCA
720

CTACGG

TCTA

9789
9811
TCAACATTTTTTGTAGC
298
TCAACATTTTTTGTAG
721

CACAGG

CCAC

9798
9820
TTTGTAGCCACAGGCTT
299
TTTGTAGCCACAGGCT
722

CCACGG

TCCA

9816
9838
CACGGACTTCACGTCAT
300
CACGGACTTCACGTCA
723

TATTGG

TTAT

9885
9907
TTTACATCCAAACATCA
301
TTTACATCCAAACATC
724

CTTTGG

ACTT

9910
9932
TCGAAGCCGCCGCCTGA
302
TCGAAGCCGCCGCCTG
725

TACTGG

ATAC

9926
9948
ATACTGGCATTTTGTAG
303
ATACTGGCATTTTGTA
726

ATGTGG

GATG

9963
9985
TATGTCTCCATCTATTG
304
TATGTCTCCATCTATT
727

ATGAGG

GATG

9964
9986
ATGTCTCCATCTATTGA
305
ATGTCTCCATCTATTG
728

TGAGGG

ATGA

10122
10144
TTTTGACTACCACAACT
306
TTTTGACTACCACAAC
729

CAACGG

TCAA

10155
10177
AAATCCACCCCTTACGA
307
AAATCCACCCCTTACG
730

GTGCGG

AGTG

10343
10365
CATCATCCTAGCCCTAA
308
CATCATCCTAGCCCTA
731

GTCTGG

AGTC

10365
10387
GCCTATGAGTGACTACA
309
GCCTATGAGTGACTAC
732

AAAAGG

AAAA

10385
10407
AGGATTAGACTGAACCG
310
AGGATTAGACTGAACC
733

AATTGG

GAAT

10500
10522
GCATTTACCATCTCACT
311
GCATTTACCATCTCAC
734

TCTAGG

TTCT

10551
10573
TCCTCCCTACTATGCCT
312
TCCTCCCTACTATGCC
735

AGAAGG

TAGA

10664
10686
CTTTGCCGCCTGCGAAG
313
CTTTGCCGCCTGCGAA
736

CAGCGG

GCAG

10667
10689
TGCCGCCTGCGAAGCAG
314
TGCCGCCTGCGAAGCA
737

CGGTGG

GCGG

10668
10690
GCCGCCTGCGAAGCAGC
315
GCCGCCTGCGAAGCAG
738

GGTGGG

CGGT

10704
10726
GTCTCAATCTCCAACAC
316
GTCTCAATCTCCAACA
739

ATATGG

CATA

10972
10994
ACTCCTACCCCTCACAA
317
ACTCCTACCCCTCACA
740

TCATGG

ATCA

11128
11150
AACCACACTTATCCCCA
318
AACCACACTTATCCCC
741

CCTTGG

ACCT

11147
11169
TTGGCTATCATCACCCG
319
TTGGCTATCATCACCC
742

ATGAGG

GATG

11174
11196
CAGCCAGAACGCCTGA
320
CAGCCAGAACGCCTGA
743

ACGCAGG

ACGC

11204
11226
TTCCTATTCTACACCCT
321
TTCCTATTCTACACCCT
744

AGTAGG

AGT

11252
11274
ATTTACACTCACAACAC
322
ATTTACACTCACAACA
745

CCTAGG

CCCT

11369
11391
ATAGTAAAGATACCTCT
323
ATAGTAAAGATACCTC
746

TTACGG

TTTA

11417
11439
CATGTCGAAGCCCCCAT
324
CATGTCGAAGCCCCCA
747

CGCTGG

TCGC

11418
11440
ATGTCGAAGCCCCCATC
325
ATGTCGAAGCCCCCAT
748

GCTGGG

CGCT

11453
11475
GCCGCAGTACTCTTAAA
326
GCCGCAGTACTCTTAA
749

ACTAGG

AACT

11456
11478
GCAGTACTCTTAAAACT
327
GCAGTACTCTTAAAAC
750

AGGCGG

TAGG

11462
11484
CTCTTAAAACTAGGCGG
328
CTCTTAAAACTAGGCG
751

CTATGG

GCTA

11540
11562
TTCCTTGTACTATCCCTA
329
TTCCTTGTACTATCCCT
752

TGAGG

ATG

11669
11691
CAAACCCCCTGAAGCTT
330
CAAACCCCCTGAAGCT
753

CACCGG

TCAC

11696
11718
GTCATTCTCATAATCGC
331
GTCATTCTCATAATCG
754

CCACGG

CCCA

11697
11719
TCATTCTCATAATCGCC
332
TCATTCTCATAATCGC
755

CACGGG

CCAC

11777
11799
CGCATCATAATCCTCTC
333
CGCATCATAATCCTCT
756

TCAAGG

CTCA

11866
11888
ACCCCCCACTATTAACC
334
ACCCCCACTATTAAC
757

TACTGG

CTAC

11867
11889
CCCCCCACTATTAACCT
335
CCCCCCACTATTAACC
758

ACTGGG

TACT

11927
11949
AATATCACTCTCCTACT
336
AATATCACTCTCCTAC
759

TACAGG

TTAC

11985
12007
ACATATTTACCACAACA
337
ACATATTTACCACAAC
760

CAATGG

ACAA

11986
12008
CATATTTACCACAACAC
338
CATATTTACCACAACA
761

AATGGG

CAAT

11987
12009
ATATTTACCACAACACA
339
ATATTTACCACAACAC
762

ATGGGG

AATG

12104
12126
CTCAACCCCGACATCAT
340
CTCAACCCCGACATCA
763

TACCGG

TTAC

12105
12127
TCAACCCCGACATCATT
341
TCAACCCCGACATCAT
764

ACCGGG

TACC

12164
12186
GATTGTGAATCTGACAA
342
GATTGTGAATCTGACA
765

CAGAGG

ACAG

12235
12257
TGCCCCCATGTCTAACA
343
TGCCCCCATGTCTAAC
766

ACATGG

AACA

12254
12276
ATGGCTTTCTCAACTTTT
344
ATGGCTTTCTCAACTT
767

AAAGG

TTAA

12272
12294
AAAGGATAACAGCTATC
345
AAAGGATAACAGCTAT
768

CATTGG

CCAT

12279
12301
AACAGCTATCCATTGGT
346
AACAGCTATCCATTGG
769

CTTAGG

TCTT

12294
12316
GTCTTAGGCCCCAAAAA
347
GTCTTAGGCCCCAAAA
770

TTTTGG

ATTT

12608
12630
CTGTAGCATTGTTCGTT
348
CTGTAGCATTGTTCGT
771

ACATGG

TACA

12742
12764
AACCTATTCCAACTGTT
349
AACCTATTCCAACTGT
772

CATCGG

TCAT

12750
12772
CCAACTGTTCATCGGCT
350
CCAACTGTTCATCGGC
773

GAGAGG

TGAG

12751
12773
CAACTGTTCATCGGCTG
351
CAACTGTTCATCGGCT
774

AGAGGG

GAGA

12757
12779
TTCATCGGCTGAGAGGG
352
TTCATCGGCTGAGAGG
775

CGTAGG

GCGT

12847
12869
GCAATCCTATACAACCG
353
GCAATCCTATACAACC
776

TATCGG

GTAT

12856
12878
TACAACCGTATCGGCGA
354
TACAACCGTATCGGCG
777

TATCGG

ATAT

12958
12980
CCAAGCCTCACCCCACT
355
CCAAGCCTCACCCCAC
778

ACTAGG

TACT

12979
13001
GGCCTCCTCCTAGCAGC
356
GGCCTCCTCCTAGCAG
779

AGCAGG

CAGC

12997
13019
GCAGGCAAATCAGCCC
357
GCAGGCAAATCAGCCC
780

AATTAGG

AATT

13030
13052
TGACTCCCCTCAGCCAT
358
TGACTCCCCTCAGCCA
781

AGAAGG

TAGA

13081
13103
TCAAGCACTATAGTTGT
359
TCAAGCACTATAGTTG
782

AGCAGG

TAGC

13156
13178
CAAACTCTAACACTATG
360
CAAACTCTAACACTAT
783

CTTAGG

GCTT

13246
13268
TTCTCCACTTCAAGTCA
361
TTCTCCACTTCAAGTC
784

ACTAGG

AACT

13267
13289
GGACTCATAATAGTTAC
362
GGACTCATAATAGTTA
785

AATCGG

CAAT

13345
13367
GCCATACTATTTATGTG
363
GCCATACTATTTATGT
786

CTCCGG

GCTC

13346
13368
CCATACTATTTATGTGC
364
CCATACTATTTATGTG
787

TCCGGG

CTCC

13393
13415
GAACAAGATATTCGAA
365
GAACAAGATATTCGAA
788

AAATAGG

AAAT

13396
13418
CAAGATATTCGAAAAAT
366
CAAGATATTCGAAAAA
789

AGGAGG

TAGG

13441
13463
ACTTCAACCTCCCTCAC
367
ACTTCAACCTCCCTCA
790

CATTGG

CCAT

13459
13481
ATTGGCAGCCTAGCATT
368
ATTGGCAGCCTAGCAT
791

AGCAGG

TAGC

13477
13499
GCAGGAATACCTTTCCT
369
GCAGGAATACCTTTCC
792

CACAGG

TCAC

13612
13634
ATAATTCTTCTCACCCT
370
ATAATTCTTCTCACCC
793

AACAGG

TAAC

13686
13708
ACTAAACCCCATTAAAC
371
ACTAAACCCCATTAAA
794

GCCTGG

CGCC

13693
13715
CCCATTAAACGCCTGGC
372
CCCATTAAACGCCTGG
795

AGCCGG

CAGC

13708
13730
GCAGCCGGAAGCCTATT
373
GCAGCCGGAAGCCTAT
796

CGCAGG

TCGC

13804
13826
GCCCTCGCTGTCACTTT
374
GCCCTCGCTGTCACTT
797

CCTAGG

TCCT

13894
13916
TTTTATTTCTCCAACATA
375
TTTTATTTCTCCAACAT
798

CTCGG

ACT

13936
13958
CACCGCACAATCCCCTA
376
CACCGCACAATCCCCT
799

TCTAGG

ATCT

14059
14081
ATCATCACCTCAACCCA
377
ATCATCACCTCAACCC
800

AAAAGG

AAAA

14237
14259
TACAAAGCCCCCGCACC
378
TACAAAGCCCCCGCAC
801

AATAGG

CAAT

14417
14439
ACCCCTGACCCCCATGC
379
ACCCCTGACCCCCATG
802

CTCAGG

CCTC

14579
14601
AATACTAAACCCCCATA
380
AATACTAAACCCCCAT
803

AATAGG

AAAT

14585
14607
AAACCCCCATAAATAGG
381
AAACCCCCATAAATAG
804

AGAAGG

GAGA

14664
14686
CATACATCATTATTCTC
382
CATACATCATTATTCT
805

GCACGG

CGCA

14825
14847
ATCTCCGCATGATGAAA
383
ATCTCCGCATGATGAA
806

CTTCGG

ACTT

14837
14859
TGAAACTTCGGCTCACT
384
TGAAACTTCGGCTCAC
807

CCTTGG

TCCT

14867
14889
CTGATCCTCCAAATCAC
385
CTGATCCTCCAAATCA
808

CACAGG

CCAC

14951
14973
ATCACTCGAGACGTAAA
386
ATCACTCGAGACGTAA
809

TTATGG

ATTA

14981
15003
ATCCGCTACCTTCACGC
387
ATCCGCTACCTTCACG
810

CAATGG

CCAA

15020
15042
ATCTGCCTCTTCCTACA
388
ATCTGCCTCTTCCTAC
811

CATCGG

ACAT

15021
15043
TCTGCCTCTTCCTCACA
389
TCTGCCTCTTCCTACA
812

ATCGGG

CATC

15026
15048
CTCTTCCTACACATCGG
390
CTCTTCCTACACATCG
813

GCGAGG

GGCG

15038
15060
ATCGGGCGAGGCCTATA
391
ATCGGGCGAGGCCTAT
814

TTACGG

ATTA

15071
15093
TACTCAGAAACCTGAAA
392
TACTCAGAAACCTGAA
815

CATCGG

ACAT

15113
15135
ACTATAGCAACAGCCTT
393
ACTATAGCAACAGCCT
816

CATAGG

TCAT

15131
15153
ATAGGCTATGTCCTCCC
394
ATAGGCTATGTCCTCC
817

GTGAGG

CGTG

15149
15171
TGAGGCCAAATATCATT
395
TGAGGCCAAATATCAT
818

CTGAGG

TCTG

15150
15172
GAGGCCAAATATCATTC
396
GAGGCCAAATATCATT
819

TGAGGG

CTGA

15151
15173
AGGCCAAATATCATTCT
397
AGGCCAAATATCATTC
820

GAGGGG

TGAG

15194
15216
CTATCCGCCATCCCATA
398
CTATCCGCCATCCCAT
821

CATTGG

ACAT

15195
15217
TATCCGCCATCCCATAC
399
TATCCGCCATCCCATA
822

ATTGGG

CATT

15221
15243
GACCTAGTTCAATGAAT
400
GACCTAGTTCAATGAA
823

CTGAGG

TCTG

15224
15246
CTAGTTCAATGAATCTG
401
CTAGTTCAATGAATCT
824

AGGAGG

GAGG

15334
15356
CCTCCTATTCTTGCACG
402
CCTCCTATTCTTGCAC
825

AAACGG

GAAA

15335
15357
CTCCTATTCTTGCACGA
403
CTCCTATTCTTGCACG
826

AACGGG

AAAC

15353
15375
ACGGGATCAAACAACC
404
ACGGGATCAAACAAC
827

CCCTAGG

CCCCT

15416
15438
TACACAATCAAAGACGC
405
TACACAATCAAAGACG
828

CCTCGG

CCCT

15476
15498
CTATTCTCACCAGACCT
406
CTATTCTCACCAGACC
829

CCTAGG

TCCT

15590
15612
CGATCCGTCCCTAACAA
407
CGATCCGTCCCTAACA
830

ACTAGG

AACT

15593
15615
TCCGTCCCTAACAAACT
408
TCCGTCCCTAACAAAC
831

AGGAGG

TAGG

15740
15762
CTCCTCATTCTAACCTG
409
CTCCTCATTCTAACCT
832

AATCGG

GAAT

15743
15765
CTCATTCTAACCTGAAT
410
CTCATTCTAACCTGAA
833

CGGAGG

TCGG

15776
15798
AGCTACCCTTTTACCAT
411
AGCTACCCTTTTACCA
834

CATTGG

TCAT

15861
15883
TTGAAAACAAAATACTC
412
TTGAAAACAAAATACT
835

AAATGG

CAAA

15862
15884
TGAAAACAAAATACTCA
413
TGAAAACAAAATACTC
836

AATGGG

AAAT

15906
15928
AATACACCAGTCTTGTA
414
AATACACCAGTCTTGT
837

AACCGG

AAAC

15928
15950
GAGATGAAAACCTTTTT
415
GAGATGAAAACCTTTT
838

CCAAGG

TCCA

16012
16034
AACTATTCTCTGTTCTTT
416
AACTTTCTCTGTTCTT
839

CATGG

TCA

16013
16035
ACTATTCTCTGTTCTTTC
417
ACTATTCTCTGTTCTTT
840

ATGGG

CAT

16014
16036
CTATTCTCTGTTCTTTCA
418
CTATTCTCTGTTCTTTC
841

TGGGG

ATG

16026
16048
CTTTCATGGGGAAGCAG
419
CTTTCATGGGGAAGCA
842

ATTTGG

GATT

16027
16049
TTTCATGGGGAAGCAGA
420
TTTCATGGGGAAGCAG
843

TTTGGG

ATTT

16108
16130
CAGCCACCATGAATATT
421
CAGCCACCATGAATAT
844

GTACGG

TGTA

16252
16274
AAAGCCACCCCTCACCC
422
AAAGCCACCCCTCACC
845

ACTAGG

CACT

16348
16370
CAAATCCCTTCTCGTCC
423
CAAATCCCTTCTCGTC
846

CCATGG

CCCA

16367
16389
ATGGATGACCCCCCTCA
424
ATGGATGACCCCCCTC
847

GATAGG

AGAT

16368
16390
TGGATGACCCCCCTCAG
425
TGGATGACCCCCCTCA
848

ATAGGG

GATA

16369
16391
GGATGACCCCCCTCAGA
426
GGATGACCCCCCTCAG
849

TAGGGG

ATAG

16434
16456
GAGTGCTACTCTCCTCG
427
GAGTGCTACTCTCCTC
850

CTCCGG

GCTC

16435
16457
AGTGCTACTCTCCTCGC
428
AGTGCTACTCTCCTCG
851

TCCGGG

CTCC

16449
16471
CGCTCCGGGCCCATAAC
429
CGCTCCGGGCCCATAA
852

ACTTGG

CACT

16450
16472
GCTCCGGGCCCATAACA
430
GCTCCGGGCCCATAAC
853

CTTGGG

ACTT

16451
16473
CTCCGGGCCCATAACAC
431
CTCCGGGCCCATAACA
854

TTGGGG

CTTG

16452
16474
TCCGGGCCCATAACACT
432
TCCGGGCCCATAACAC
855

TGGGGG

TTGG

16482
16504
AGTGAACTGTATCCGAC
433
AGTGAACTGTATCCGA
856

ATCTGG

CATC

16495
16517
CGACATCTGGTTCCTAC
434
CGACATCTGGTTCCTA
857

TTCAGG

CTTC

16496
16518
GACATCTGGTTCCTACT
435
GACATCTGGTTCCTAC
858

TCAGGG

TTCA

TABLE 4

gRNA target sequence for human mtDNA carrying NGG sequence on the (−) strand.

nt sequence on the (+)

strand containing CCN

Chr end
sequence followed by the

20 nt gRNA target

Chr start
position
reverse complementary

sequence

position
(+
sequence of gRNA target
SEQ
(will encode the gRNA
SEQ

(+ strand)
strand)
sequence
ID NO:
targeting sequence)
ID NO:

17
39
CCCTATTAACCACTCAC
859
GCTCCCGTGAGTGGTT
2628

GGGAGC

AATA

18
40
CCTATTAACCACTCACG
860
AGCTCCCGTGAGTGGT
2629

GGAGCT

TAAT

26
48
CCACTCACGGGAGCTCT
861
GCATGGAGAGCTCCCG
2630

CCATGC

TGAG

43
65
CCATGCATTTGGTATTT
862
AGACGAAAATACCAA
2631

TCGTCT

ATGCA

104
126
CCGGAGCACCCTATGTC
863
TACTGCGACATAGGGT
2632

GCAGTA

GCTC

112
134
CCCTATGTCGCAGTATC
864
AAGACAGATACTGCG
2633

TGTCTT

ACATA

113
135
CCTATGTCGCAGTATCT
865
AAAGACAGATACTGC
2634

GTCTTT

GACAT

140
162
CCTGCCTCATCCTATTA
866
GATAAATAATAGGATG
2635

TTTATC

AGGC

144
166
CCTCATCCTATTATTTAT
867
GTGCGATAAATAATAG
2636

CGCAC

GATG

150
172
CCTATTATTTATCGCAC
868
ACGTAGGTGCGATAAA
2637

CTACGT

TAAT

166
188
CCTACGTTCAATATTAC
869
TCGCCTGTAATATTGA
2638

AGGCGA

ACGT

261
283
CCACTTTCCACACAGAC
870
TATGATGTCTGTGTGG
2639

ATCATA

AAAG

268
290
CCACACAGACATCATAA
871
TTTTTGTTATGATGTCT
2640

CAAAAA

GTG

298
320
CCAAACCCCCCCTCCCC
872
GAAGCGGGGGAGGGG
2641

CGCTTC

GGGTT

304
326
CCCCCCTCCCCCGCTTC
873
TGGCCAGAAGCGGGG
2642

TGGCCA

GAGGG

305
327
CCCCCTCCCCCGCTTCT
874
GTGGCCAGAAGCGGG
2643

GGCCAC

GGAGG

306
328
CCCCTCCCCCGCTTCTG
875
TGTGGCCAGAAGCGG
2644

GCCACA

GGGAG

107
329
CCCTCCCCCGCTTCTGG
876
CTGTGGCCAGAAGCGG
2645

CCACAG

GGGA

308
330
CCTCCCCCGCTTCTGGC
877
GCTGTGGCCAGAAGCG
2646

CACAGC

GGGG

311
333
CCCCCGCTTCTGGCCAC
878
AGTGCTGTGGCCAGAA
2647

AGCACT

GCGG

312
334
CCCCGCTTCTGGCCACA
879
AAGTGCTGTGGCCAGA
2648

GCACTT

AGCG

313
335
CCCGCTTCTGGCCACAG
880
TAAGTGCTGTGGCCAG
2649

CACTTA

AAGC

314
336
CCGCTTCTGGCCACAGC
881
TTAAGTGCTGTGGCCA
2650

ACTTAA

GAAG

324
346
CCACAGCACTTAAACAC
882
AGAGATGTGTTTAAGT
2651

ATCTCT

GCTG

348
370
CCAAACCCCAAAAACA
883
GGTTCTTTGTTTTTGGG
2652

AAGAACC

GTT

353
375
CCCCAAAAACAAAGAA
884
GTTAGGGTTCTTTGTTT
2653

CCCTAAC

TTG

354
376
CCCAAAAACAAAGAAC
885
TGTTAGGGTTCTTTGTT
2654

CCTAACA

TTT

355
377
CCAAAAACAAAGAACC
886
GTGTTAGGGTTCTTTG
2655

CTAACAC

TTTT

369
391
CCCTAACACCAGCCTAA
887
ATCTGGTTAGGCTGGT
2656

CCAGAT

GTTA

370
392
CCTAACACCAGCCTAAC
888
AATCTGGTTAGGCTGG
2657

CAGATT

TGTT

377
399
CCAGCCTAACCAGATTT
889
AATTTGAAATCTGGTT
2658

CAAATT

AGGC

381
403
CCTAACCAGATTTCAAA
890
ATAAAATTTGAAATCT
2659

TTTTAT

GGTT

386
408
CCAGATTTCAAATTTTA
891
AAAAGATAAAATTTGA
2660

TCTTTT

AATC

433
455
CCCCCCAACTAACACAT
892
AAAATAATGTGTTAGT
2661

TATTTT

TGGG

434
456
CCCCCAACTAACACATT
893
GAAAATAATGTGTTAG
2662

ATTTTC

TTGG

435
457
CCCCAACTAACACATTA
894
GGAAAATAATGTGTTA
2663

TTTTCC

GTTG

436
458
CCCAACTAACACATTAT
895
GGGAAAATAATGTGTT
2664

TTTCCC

AGTT

437
459
CCAACTAACACATTATT
896
GGGGAAAATAATGTGT
7665

TTCCCC

TAGT

456
478
CCCCTCCCACTCCCATA
897
TAGTAGTATGGGAGTG
2666

CTACTA

GGAG

457
479
CCCTCCCACTCCCATAC
898
TTAGTAGTATGGGAGT
2667

TACTAA

GGGA

458
480
CCTCCCACTCCCATACT
899
ATTAGTAGTATGGGAG
2668

ACTAAT

TGGG

461
483
CCCACTCCCATACTACT
900
GAGATTAGTAGTATGG
2669

AATCTC

GAGT

462
484
CCACTCCCATACTACTA
901
TGAGATTAGTAGTATG
2670

ATCTCA

GGAG

467
489
CCCATACTACTAATCTC
902
ATTGATGAGATTAGTA
2671

ATCAAT

GTAT

468
490
CCATACTACTAATCTCA
903
TATTGATGAGATTAGT
2672

TCAATA

AGTA

494
516
CCCCCGCCCATCCTACC
904
GTGCTGGGTAGGATGG
2673

CAGCAC

GCGG

495
517
CCCCGCCCATCCTACCC
905
TGTGCTGGGTAGGATG
2674

AGCACA

GGCG

496
518
CCCGCCCATCCTACCCA
906
GTGTGCTGGGTAGGAT
2675

GCACAC

GGGC

497
519
CCGCCCATCCTACCCAG
907
TGTGTGCTGGGTAGGA
2676

CACACA

TGGG

500
522
CCCATCCTACCCAGCAC
908
GTGTGTGTGCTGGGTA
2677

ACACAC

GGAT

501
523
CCATCCTACCCAGCACA
909
TGTGTGTGTGCTGGTA
2678

CACACA

AGGA

505
527
CCTACCCAGCACACACA
910
GCGGTGTGTGTGTGCT
2679

CACCGC

GGGT

509
531
CCCAGCACACACACACC
911
AGCAGCGGTGTGTGTG
2680

GCTGCT

TGCT

510
532
CCAGCACACACACACCG
912
TAGCAGCGGTGTGTGT
2681

CTGCTA

GTGC

524
546
CCGCTGCTAACCCCATA
913
TCGGGGTATGGGGTTA
2682

CCCCGA

GCAG

534
556
CCCCATACCCCGAACCA
914
TTTGGTTGGTTCGGGG
2683

ACCAAA

TATG

535
557
CCCATACCCCGAACCAA
915
GTTTGGTTGGTTCGGG
2684

CCAAAC

GTAT

536
558
CCATACCCCGAACCAAC
916
GGTTTGGTTGGTTCGG
2685

CAAACC

GGTA

541
563
CCCCGAACCAACCAAAC
917
TTTGGGGTTTGGTTGG
2686

CCCAAA

TTCG

542
564
CCCGAACCAACCAAACC
918
CTTTGGGGTTTGGTTG
2687

CCAAAG

GTTC

543
565
CCGAACCAACCAAACCC
919
TCTTTGGGGTTTGGTT
2688

CAAAGA

GGTT

548
570
CCAACCAAACCCCAAA
920
GGGTGTCTTTGGGGTT
2689

GACACCC

TGGT

552
574
CCAAACCCCAAAGACA
921
TGGGGGGTGTCTTTGG
2690

CCCCCCA

GGTT

557
579
CCCCAAAGACACCCCCC
922
AACTGTGGGGGGTGTC
2691

ACAGTT

TTTG

558
580
CCCAAAGACACCCCCCA
923
AAACTGTGGGGGGTGT
2692

CAGTTT

CTTT

559
581
CCAAAGACACCCCCCAC
924
TAAACTGTGGGGGGTG
2693

AGTTTA

TCTT

568
590
CCCCCCACAGTTTATGT
925
TAAGCTACATAAACTG
2694

AGCTTA

TGGG

569
591
CCCCCACAGTTTATGTA
926
GTAAGCTACATAAACT
2695

GCTTAC

GTGG

570
592
CCCCACAGTTTATGTAG
927
GGTAAGCTACATAAAC
2696

CTTACC

TGTG

571
593
CCCACAGTTTATGTAGC
928
AGGTAAGCTACATAAA
2697

TTACCT

CTGT

572
594
CCACAGTTTATGTAGCT
929
GAGGTAAGCTACATAA
2698

TACCTC

ACTG

591
613
CCTCCTCAAAGCAATAC
930
TTCAGTGTATTGCTTT
2699

ACTGAA

GAGG

594
616
CCTCAAAGCAATACACT
931
ATTTTCAGTGTATTGC
2700

GAAAAT

TTTG

637
659
CCCCATAAACAAATAGG
932
ACCAAACCTATTTGTT
2701

TTTGGT

TATG

638
660
CCCATAAACAAATAGGT
933
GACCAAACCTATTTGT
2702

TTGGTC

TTAT

639
661
CCATAAACAAATAGGTT
934
GGACCAAACCTATTTG
2703

TGGTCC

TTTA

660
682
CCTAGCCTTTCTATTAG
935
TAAGAGCTAATAGAA
2704

CTCTTA

AGGCT

665
687
CCTTTCTATTAGCTCTTA
936
CTTACTAAGAGCTAAT
2705

GTAAG

AGAA

705
727
CCCCGTTCCAGTGAGTT
937
AGGGTGAACTCACTGG
2706

CACCCT

AACG

706
728
CCCGTTCCAGTGAGTTC
938
GAGGGTGAACTCACTG
2707

ACCCTC

GAAC

707
729
CCGTTCCAGTGAGTTCA
939
AGAGGGTGAACTCACT
2708

CCCTCT

GGAA

712
734
CCAGTGAGTTCACCCTC
940
GATTTAGAGGGTGAAC
2709

TAAATC

TCAC

724
746
CCCTCTAAATCACCACG
941
TTTGATCGTGGTGATT
2710

ATCAAA

TAGA

725
747
CCTCTAAATCACCACGA
942
TTTTGATCGTGGTGAT
2711

TCAAAA

TTAG

736
758
CCACGATCAAAAGGAA
943
ATGCTTGTTCCTTTTGA
2712

CAAGCAT

TCG

792
814
CCTAGCCACACCCCCAC
944
TTTCCCGTGGGGGTGT
2713

GGGAAA

GGCT

797
819
CCACACCCCCACGGGAA
945
TGCTGTTTCCCGTGGG
2714

ACAGCA

GGTG

802
824
CCCCCACGGGAAACAG
946
ATCACTGCTGTTTCCC
2715

CAGTGAT

GTGG

803
825
CCCCACGGGAAACAGC
947
AATCACTGCTGTTTCC
2716

AGTGATT

CGTG

804
826
CCCACGGGAAACAGCA
948
TAATCACTGCTGTTTC
2717

GTGATTA

CCGT

805
827
CCACGGGAAACAGCAG
949
TTAATCACTGCTGTTT
2718

TGATTAA

CCCG

828
850
CCTTTAGCAATAAACGA
950
AAACTTTCGTTTATTG
2719

AAGTTT

CTAA

867
889
CCCCAGGGTTGGTCAAT
951
CACGAAATTGACCAAC
2720

TTCGTG

CCTG

868
890
CCCAGGGTTGGTCAATT
952
GCACGAAATTGACCAA
2721

TCGTGC

CCCT

869
891
CCAGGGTTGGTCAATTT
953
GGCACGAAATTGACCA
2722

CGTGCC

ACCC

890
912
CCAGCCACCGCGGTCAC
954
AATCGTGTGACCGCGG
2723

ACGATT

TGGC

894
916
CCACCGCGGTCACACGA
955
GGTTAATCGTGTGACC
2724

TTAACC

GCGG

897
919
CCGCGGTCACACGATTA
956
TTGGGTTAATCGTGTG
2725

ACCCAA

ACCG

915
937
CCCAAGTCAATAGAAGC
957
ACGCCGGCTTCTATTG
2726

CGGCGT

ACTT

916
938
CCAAGTCAATAGAAGCC
958
TACGCCGGCTTCTATT
2727

GGCGTA

GACT

931
953
CCGGCGTAAAGAGTGTT
959
ATCTAAAACACTCTTT
2728

TTAGAT

ACGC

956
978
CCCCCTCCCCAATAAAG
960
TTTTAGCTTTTTGGG
2729

CTAAAA

GAGG

957
979
CCCCTCCCCAATAAAGC
961
GTTTTAGCTTTATTGG
2730

TAAAAC

GGAG

958
980
CCCTCCCCAATAAAGCT
962
AGTTTTAGCTTTATTG
2731

AAAACT

GGGA

959
981
CCTCCCCAATAAAGCTA
963
GAGTTTTAGCTTTATT
2732

AAACTC

GGGG

962
984
CCCCAATAAAGCTAAAA
964
GGTGAGTTTTAGCTTT
2733

CTCACC

ATTG

963
985
CCCAATAAAGCTAAAAC
965
AGGTGAGTTTTAGCTT
2734

TCACCT

TATT

964
986
CCAATAAAGCTAAAACT
966
CAGGTGAGTTTTAGCT
2735

CACCTG

TTAT

983
1005
CCTGAGTTGTAAAAAAC
967
ACTGGAGTTTTTTACA
2736

TCCAGT

ACTC

1001
1023
CCAGTTGACACAAAATA
968
GTAGTCTATTTTGTGT
2737

GACTAC

CAAC

1064
1086
CCCAAACTGGGATTAGA
969
GGGGTATCTAATCCCA
2738

TACCCC

GTTT

1065
1087
CCAAACTGGGATTAGAT
970
TGGGGTATCTAATCCC
2739

ACCCCA

AGTT

1083
1105
CCCCACTATGCTTAGCC
971
GTTTAGGGCTAAGCAT
2740

CTAAAC

AGTG

1084
1106
CCCACTATGCTTAGCCC
972
GGTTTAGGGCTAAGCA
2741

TAAACC

TAGT

1085
1107
CCACTATGCTTAGCCCT
973
AGGTTTAGGGCTAAGC
2742

AAACCT

ATAG

1098
1120
CCCTAAACCTCAACAGT
974
GATTTAACTGTTGAGG
2743

TAAATC

TTTA

1099
1121
CCTAAACCTCAACAGTT
975
TGATTTAACTGTTGAG
2744

AAATCA

GTTT

1105
1127
CCTCAACAGTTAAATCA
976
TTTTGTTGATTTAACTG
2745

ACAAAA

TTG

1135
1157
CCAGAACACTACGAGCC
977
AGCTGTGGCTCGTAGT
2746

ACAGCT

GTTC

1150
1172
CCACAGCTTAAAACTCA
978
GTCCTTTGAGTTTTAA
2747

AAGGAC

GCTG

1172
1194
CCTGGCGGTGCTTCATA
979
GAGGGATATGAAGCA
2748

TCCCTC

CCGCC

1190
1212
CCCTCTAGAGGAGCCTG
980
ACAGAACAGGCTCCT
2749

TTCTGT

TAGA

1191
1213
CCTCTAGAGGAGCCTGT
981
TACAGAACAGGCTCCT
2750

TCTGTA

CTAG

1203
1225
CCTGTTCTGTAATCGAT
982
GGGTTTATCGATTACA
2751

AAACCC

GAAC

1223
1245
CCCCGATCAACCTCAC
983
AGAGGTGGTGAGGTTG
2752

ACCTCT

ATCG

1224
1246
CCCGATCAACCTCACCA
984
AAGAGGTGGTGAGGTT
2753

CCTCTT

GATC

1225
1247
CCGATCAACCTCACCAC
985
CAAGAGGTGGTGAGG
2754

CTCTTG

TTGAT

1233
1255
CCTCACCACCTCTTGCT
986
AGGCTGAGCAAGAGG
2755

CAGCCT

TGGTG

1238
1260
CCACCTCTTGCTCAGCC
987
TATATAGGCTGAGCAA
2756

TATATA

GAGG

1241
1263
CCTCTTGCTCAGCCTAT
988
CGGTATATAGGCTGAG
2757

ATACCG

CAAG

1253
1275
CCTATATACCGCCATCT
989
TGCTGAAGATGGCGGT
2758

TCAGCA

ATAT

1261
1283
CCGCCATCTTCAGCAAA
990
TCAGGGTTTGCTGAAG
2759

CCCTGA

ATGG

1264
1286
CCATCTTCAGCAAACCC
991
TCATCAGGGTTTGCTG
2760

TGATGA

AAGA

1278
1300
CCCTGATGAAGGCTACA
992
TTACTTTGTAGCCTTC
2761

AAGTAA

ATCA

1279
1301
CCTGATGAAGGCTACAA
993
CTTACTTTGTAGCCTTC
2762

AGTAAG

ATC

1310
1332
CCCACGTAAAGACGTTA
994
TTGACCTAACGTCTTT
2763

GGTCAA

ACGT

1311
1333
CCACGTAAAGACGTTAG
995
CTTGACCTAACGTCTT
2764

GTCAAG

TACG

1340
1362
CCCATGAGGTGGCAAG
996
CCCATTTGTTGCCACC
2765

AAATGGG

TCAT

1341
1363
CCATGAGGTGGCAAGA
997
GCCCATTTCTTGCCAC
2766

AATGGGC

CTCA

1375
1397
CCCCAGAAAACTACGAT
998
AGGGCTATCGTAGTTT
2767

AGCCCT

TCTG

1376
1398
CCCAGAAAACTACGATA
999
AAGGGCTATCGTAGTT
2768

GCCCTT

TTCT

1377
1399
CCAGAAAACTACGATA
1000
TAAGGGCTATCGTAGT
2769

GCCCTTA

TTTC

1394
1416
CCCTTATGAAACTTAAG
1001
TCGACCCTTAAGTTTC
2770

GGTCGA

ATAA

1395
1417
CCTTATGAAACTTAAGG
1002
TTCGACCCTTAAGTTT
2771

GTCGAA

CATA

1465
1487
CCCTGAAGCGCGTACAC
1003
GGCGGTGTGTACGCGC
2772

ACCGCC

TTCA

1466
1488
CCTGAAGCGCGTACACA
1004
GGGCGGTGTGTACGCG
2773

CCGCCC

CTTC

1483
1505
CCGCCCTCACCCTCCT
1005
TACTTGAGGAGGGTGA
2774

CAAGTA

CGGG

1486
1508
CCCGTCACCCTCCTCAA
1006
GTATACTTGAGGAGGG
2775

GTATAC

TGAC

1487
1509
CCGTCACCCTCCTCAAG
1007
AGTATACTTGAGGAGG
7776

TATACT

GTGA

1493
1515
CCCTCCTCAAGTATACT
1008
CTTTGAAGTATACTTG
2777

TCAAAG

AGGA

1494
1516
CCTCCTCAAGTATACTT
1009
CCTTTGAAGTATACTT
2778

CAAAGG

GAGG

1497
1519
CCTCAAGTATACTTCAA
1010
TGTCCTTTGAAGTATA
2779

AGGACA

CTTG

1531
1553
CCCCTACGCATTTATAT
1011
TCCTCTATATAAATGC
2780

AGAGGA

GTAG

1532
1554
CCCTACGCATTTATATA
1012
CTCCTCTATATAAATG
2781

GAGGAG

CGTA

1533
1555
CCTACGCATTTATATAG
1013
TCTCCTCTATATAAAT
2782

AGGAGA

GCGT

1601
1623
CCAGAGTGTAGCTTAAC
1014
CTTTGTGTTAAGCTAC
2783

ACAAAG

ACTC

1626
1648
CCCAACTTACACTTAGG
1015
AAATCTCCTAAGTGTA
2784

AGATTT

AGTTT

162
1649
CCAACTTACACTTAGGA
1016
GAAATCTCCTAAGTGT
2785

GATTTC

AAGT

1662
1684
CCGCTCTGAGCTAAACC
1017
GGGCTAGGTTTAGCTC
2786

TAGCCC

AGAG

1677
1699
CCTAGCCCCAAACCCAC
1018
GGTGGAGTGGGTTTGG
2787

TCCACC

GGCT

1682
1704
CCCCAAACCCACTCCAC
1019
AGTAAGGTGGAGTGG
2788

CTTACT

GTTTG

1683
1705
CCCAAACCCACTCCACC
1020
TAGTAAGGTGGAGTGG
2789

TTACTA

GTTT

1684
1706
CCAAACCCACTCCACCT
1021
GTAGTAAGGTGGAGTG
2790

TACTAC

GGTT

1689
1711
CCCACTCCACCTTACTA
1022
GTCTGGTAGTAAGGTG
2791

CCAGAC

GAGT

1690
1712
CCACTCCACCTTACTAC
1023
TGTCTGGTAGTAAGGT
2792

CAGACA

GGAG

1695
1717
CCACCTTACTACCAGAC
1024
AAGGTTGTCTGGTAGT
2793

AACCTT

AAGG

1698
1720
CCTTACTACCAGACAAC
1025
GCTAAGGTTGTCTGGT
2794

CTTAGC

AGTA

1706
1728
CCAGACAACCTTAGCC
1026
ATGGTTTGGCTAAGGT
2795

AACCAT

TGTC

1714
1736
CCTTAGCCAAACCATTT
1027
TTGGGTAAATGGTTTG
2796

ACCCAA

GCTA

1720
1742
CCAAACCATTTACCCAA
1028
CTTTATTTGGGTAAAT
2797

ATAAAG

GGTT

1725
1747
CCATTTACCCAAATAAA
1029
CTATACTTTATTTGGG
2798

GTATAG

TAAA

1732
1754
CCCAAATAAAGTATAGG
1030
CTATCGCCTATACTTT
2799

CGATAG

ATTT

1733
1755
CCAAATAAAGTATAGGC
1031
TCTATCGCCTATACTTT
2800

GATAGA

ATT

1764
1786
CCTGGCGCAATAGATAT
1032
GGTACTATATCTATTG
2801

AGTACC

CGCC

1785
1807
CCGCAAGGGAAAGATG
1033
AATTTTTCATCTTTCCC
2802

AAAAATT

TTG

1812
1834
CCAAGCATAATATAGCA
1034
AGTCCTTGCTATATTA
2803

AGGACT

TGCT

1837
1859
CCCCTATACCTTCTGCA
1035
TCATTATGCAGAAGGT
2804

TAATGA

ATAG

1838
1860
CCCTATACCTTCTGCAT
1036
TTCATTATGCAGAAGG
2805

AATGAA

TATA

1839
1861
CCTATACCTTCTGCATA
1037
ATTCATTATGCAGAAG
2806

ATGAAT

GTAT

1845
1867
CCTTCTGCATAATGAAT
1038
TAGTTAATTCATTATG
2807

TAACTA

CAGA

1889
1911
CCAAAGCTAAGACCCCC
1039
GGTTTCGGGGGTCTTA
2808

GAAACC

GCTT

1901
1923
CCCCCGAAACCAGACG
1040
GGTAGCTCGTCTGGTT
2809

AGCTACC

TCGG

1902
1924
CCCCGAAACCAGACGA
1041
AGGTAGCTCGTCTGGT
2810

GCTAC

TTCG

1903
1925
CCCGAAACCAGACGAG
1042
TAGGTAGCTCGTCTGG
2811

CTACCTA

TTTC

1904
1926
CCGAAACCAGACGAGC
1043
TTAGGTAGCTCGTCTG
2812

TACCTAA

GTTT

1910
1932
CCAGACGAGCTACCTAA
1044
CTGTTCTTTTGGTAGCT
2813

GAACAG

CGTC

1922
1944
CCTAAGAACAGCTAAA
1045
GTGCTCTTTTAGCTGTT
2814

AGAGCAC

CTT

1946
1968
CCCGTCTATGTAGCAAA
1046
CACTATTTTGCTACAT
2815

ATAGTG

AGAC

1947
1969
CCGTCTATGTAGCAAAA
1047
CCACTATTTTGCTACA
2816

TAGTGG

TAGA

1996
2018
CCTACCGAGCCTGGTGA
1048
CAGCTATCACCAGGCT
2817

TAGCTG

CGGT

2000
2022
CCGAGCCTGGTGATAGC
1049
CAACCAGCTATCACCA
2818

TGGTTG

GGCT

2005
2027
CCTGGTGATAGCTGGTT
1050
TTGGACAACCAGCTAT
2819

GTCCAA

CACC

2024
2046
CCAAGATAGAATCTTAG
1051
GTTGAACTAAGATTCT
2820

TTCAAC

ATCT

2057
2079
CCCACAGAACCCTCTAA
1052
GGGGATTTAGAGGGTT
2821

ATCCCC

CTGT

2058
2080
CCACAGAACCCTCTAAA
1053
AGGGGATTTAGAGGGT
2822

TCCCCT

TCTG

2066
7088
CCCTCTAAATCCCCTTG
1054
AATTTACAAGGGGATT
2823

TAAATT

TAGA

2067
2089
CCTCTAAATCCCCTTGT
1055
AAATTTACAAGGGGAT
2824

AAATTT

TTAG

2076
2098
CCCCTTGTAAATTTAAC
1056
CTAACAGTTAAATTTA
2825

TGTTAG

CAAG

2077
2099
CCCTTGTAAATTTAACT
1057
ACTAACAGTTAAATTT
2826

GTTAGT

ACAA

2078
2100
CCTTGTAAATTTAACTG
1058
GACTAACAGTTAAATT
2827

TTAGTC

TACA

2100
2122
CCAAAGAGGAACAGCT
1059
TCCAAAGAGCTGTTCC
2828

CTTTGGA

TCTT

2136
2158
CCTTGTAGAGAGAGTAA
1060
AATTTTTTACTCTCTCT
2829

AAAATT

ACA

2164
2186
CCCATAGTAGGCCTAAA
1061
GCTGCTTTTAGGCCTA
2830

AGCAGC

CTAT

2165
2187
CCATAGTAGGCCTAAAA
1062
GGCTGCTTTTAGGCCT
2831

GCAGCC

ACTA

2175
2197
CCTAAAAGCAGCCACCA
1063
CTTAATTGGTGGCTGC
2832

ATTAAG

TTTT

2186
2208
CCACCAATTAAGAAAGC
1064
TTGAACGCTTTCTTAA
2833

GTTCAA

TTGG

2189
2211
CCAATTAAGAAAGCGTT
1065
AGCTTGAACGCTTTCT
2834

CAAGCT

AAT

2217
2239
CCCACTACCTAAAAAAT
1066
TTTGGGATTTTTTAGG
2835

CCCAAA

TAGT

2218
2240
CCACTACCTAAAAAATC
1067
GTTTGGGATTTTTTAG
2836

CCAAAC

GTAG

2224
2246
CCTAAAAAATCCCAAAC
1068
TTATATGTTTGGGATT
2837

ATATAA

TTTT

2234
2256
CCCAAACATATAACTGA
1069
AGGAGTTCAGTTATAT
2838

ACTCCT

GTTT

2235
2257
CCAAACATATAACTGAA
1070
GAGGAGTTCAGTTATA
2839

CTCCTC

TGTT

2254
2276
CCTCACACCCAATTGGA
1071
GATTGGTCCAATTGGG
2840

CCAATC

TGTG

2261
2283
CCCAATTGGACCAATCT
1072
GGTGATAGATTGGTCC
2841

ATCACC

AATT

2262
2284
CCAATTGGACCAATCTA
1073
GGGTGATAGATTGGTC
2842

TCACCC

CAAT

2271
2293
CCAATCTATCACCCTAT
1074
TCTTCTATAGGGTGAT
2843

AGAAGA

AGAT

2282
2304
CCCTATAGAAGAACTAA
1075
CTAACATTAGTTCTTC
2844

TGTTAG

TATA

2283
2305
CCTATAGAAGAACTAAT
1076
ACTAACATTAGTTCTT
7845

GTTAGT

CTAT

2328
2350
CCTCCGCATAAGCCTGC
1077
TCTGACGCAGGCTTAT
2846

GTCAGA

GCGG

2331
2353
CCGCATAAGCCTGCGTC
1078
TAATCTGACGCAGGCT
2847

AGATTA

TATG

2340
2362
CCTGCGTCAGATTAAAA
1079
TCAGTGTTTTAATCTG
2848

CACTGA

ACGC

2378
2400
CCCAATATCTACAATCA
1080
GTTGGTTGATTGTAGA
2849

ACCAAC

TATT

2379
2401
CCAATATCTACAATCAA
1081
TGTTGGTTGATTGTAG
2850

CCAACA

ATAT

2396
2418
CCAACAAGTCATTATTA
1082
TGAGGGTAATAATGAC
2851

CCCTCA

TTGT

2413
2435
CCCTCACTGTCAACCCA
1083
CTGTGTTGGGTTGACA
2852

ACACAG

GTGA

2414
2436
CCTCACTGTCAACCCAA
1084
CCTGTGTTGGGTTGAC
2853

CACAGG

AGTG

2426
2448
CCCAACACGGCATGCT
1085
CTTATGAGCATGCCTG
2854

CATAAG

TGTT

2427
2449
CCAACACAGGCATGCTC
1086
CCTTATGAGCATGCCT
2855

ATAAGG

GTGT

2488
2510
CCCCGCCTGTTTACCAA
1087
ATGTTTTTGGTAAACA
2856

AAACAT

GGCG

2489
2511
CCCGCCTGTTTACCAAA
1088
GATGTTTTTGGTAAAC
2857

AACATC

AGGC

2490
2512
CCGCCTGTTTACCAAAA
1089
TGATGTTTTTGGTAAA
2858

ACATCA

CAGG

2493
2515
CCTGTTTACCAAAAACA
1090
AGGTGATGTTTTTGGT
2859

TCACCT

AAAC

2501
2523
CCAAAAACATCACCTCT
1091
GATGCTAGAGGTGATG
2860

AGCATC

TTTT

2513
2535
CCTCTAGCATCACCAGT
1092
TCTAATACTGGTGATG
2861

ATTAGA

CTAG

2525
2547
CCAGTATTAGAGGCACC
1093
GCAGGCGGTGCCTCTA
2862

GCCTGC

ATAC

2540
2562
CCGCCTGCCCAGTGACA
1094
AACATGTGTCACTGGG
2863

CATGTT

CAGG

2543
2565
CCTGCCCAGTGACACAT
1095
TTAAACATGTGTCACT
2864

GTTTAA

GGGC

2547
2569
CCCAGTGACACATGTTT
1096
GCCGTTAAACATGTGT
2865

AACGGC

CACT

2548
2570
CCAGTGACACATGTTTA
1097
GGCCGTTAAACATGTG
2866

ACGGCC

TCAC

2569
2591
CCGCGGTACCCTAACCG
1098
TTTGCACGGTTAGGGT
2867

TGCAAA

ACCG

2577
2599
CCCTAACCGTGCAAAGG
1099
ATGCTACCTTTGCACG
2868

TAGCAT

GTTA

2578
2600
CCTAACCGTGCAAAGGT
1100
TATGCTACCTTTGCAC
2869

AGCATA

GGTT

2583
2605
CCGTGCAAAGGTAGCAT
1101
GTGATTATGTACCT
2870

AATCAC

TGCA

2611
2633
CCTTAAATAGGGACCTG
1101
TTCATACAGGTCCCTA
2871

TATGAA

TTTA

2624
2646
CCTGTATGAATGGCTCC
1103
CCTCGTGGAGCCATTC
2872

ACGAGG

ATAC

2639
2661
CCACGAGGGTTCAGCTG
1104
AAGAGACAGCTGAAC
2873

TCTCTT

CCTCG

2670
2692
CCAGTGAAATTGACCTG
1105
CACGGGCAGGTCAATT
2874

CCCGTG

TCAC

2683
2705
CCTGCCCGTGAAGAGGC
1106
ATGCCCGCCTCTTCAC
7875

GGGCAT

GGGC

2687
2709
CCCGTGAAGAGGCGGG
1107
TGTTATGCCCGCCTCT
2876

CATAACA

TCAC

2688
2710
CCGTGAAGAGGCGGGC
1108
GTGTTATGCCCGCCTC
2877

ATAACAC

TTCA

2726
2748
CCCTATGGAGCTTTAAT
1109
TAATAAATTAAAGC
2878

TTATTA

CATA

2727
2749
CCTATGGAGCTTTAATT
1110
TTAATAAATTAAAGCT
2879

TATTAA

CCAT

2761
2783
CCTAACAAACCCACAGG
1111
TTAGGACCTGTGGGTT
2880

TCCTAA

TGTT

2770
2792
CCCACAGGTCCTAAACT
1112
TTTGGTAGTTTAGGAC
2881

ACCAAA

CTGT

2771
2793
CCACAGGTCCTAAACTA
1113
GTTTGGTAGTTTAGGA
2882

CCAAAC

CCTG

7779
2801
CCTAAACTACCAAACCT
1114
TAATGCAGGTTTGGTA
2883

GCATTA

GTTT

2788
2810
CCAAACCTGCATTAAAA
1115
CGAAATTTTTAATGCA
2884

ATTTCG

GGTT

2793
2815
CCTGCATTAAAAATTTC
1116
CCAACCGAAATTTTTA
2885

GGTTGG

ATGC

2821
2843
CCTCGGAGCAGAACCCA
1117
GGAGGTTGGGTTCTGC
2886

ACCTCC

TCCG

2834
2856
CCCAACCTCCGAGCAGT
1118
GCATGTACTGCTCGGA
2887

ACATGC

GGTT

2835
2857
CCAACCTCCGAGCAGTA
1119
AGCATGTACTGCTCGG
2888

CATGCT

AGGT

2839
2861
CCTCCGAGCAGTACATG
1120
TCTTAGCATGTACTGC
2889

CTAAGA

TCGG

2842
2864
CCGAGCAGTACATGCTA
1121
AAGTCTTAGCATGTAC
2890

AGACTT

TGCT

2867
2889
CCAGTCAAAGCGAACTA
1122
GTATACTTAGTTCGCTT
2891

CTATAC

TGAC

2899
2921
CCAATAACTTGACCAAC
1123
TGTTCCGTTGGTCAACG
2892

GGAACA

TTAT

2911
2933
CCAACGGAACAAGTTAC
1124
CCTAGGGTAACTTGTT
2893

CCTAGG

CCGT

2927
2949
CCCTAGGGATAACAGCG
1125
GGATTGCGCTGTTATC
2894

CAATCC

CCTA

2928
2950
CCTAGGGATAACAGCGC
1126
AGGATTGCGCTGTTAT
2895

AATCCT

CCCT

2948
2970
CCTATTCTAGAGTCCAT
1127
GTTGATATGGACTCTA
2896

ATCAAC

GAAT

2961
2983
CCATATCAACAATAGGG
1128
CGTAAACCCTATTGTT
2897

TTTACG

GATA

2985
3007
CCTCGATGTTGGATCAG
1129
GATGTCCTGATCCAAC
2898

GACATC

ATCG

3007
3029
CCCGATGGTGCAGCCGC
1130
TTAATAGCGGCTGCAC
2899

TATTAA

CATC

3008
3030
CCGATGGTGCAGCCGCT
1131
TTTAATAGCGGCTGCA
2900

ATTAAA

CCAT

3020
3042
CCGCTATTAAAGGTTCG
1132
AACAAACGAACCTTTA
2901

TTTGTT

ATAG

3056
3078
CCTACGTGATCTGAGTT
1133
GGTCTGAACTCAGATC
2902

CAGACC

ACGT

3077
3099
CCGGAGTAATCCAGGTC
1134
GAAACCGACCTGGATT
2903

GGTTTC

ACTC

3087
3109
CCAGGTCGGTTTCTATC
1135
AANGTAGATAGAAAC
2904

TACNTT

CGACC

3116
3138
CCTCCCTGTACGAAAGG
1136
TCTTGTCCTTTCGTACA
2905

ACAAGA

GGG

3119
3141
CCCTGTACGAAAGGACA
1137
TTCTCTTGTCCTTTCGT
2906

AGAGAA

ACA

3120
3142
CCTGTACGAAAGGACA
1138
TTTCTCTTGTCCTTTCG
2907

AGAGAAA

TAC

3148
3170
CCTACTTCACAAAGCGC
1139
GGGAAGGCGCTTTGTG
2908

CTTCCC

AAGT

3164
3186
CCTTCCCCCGTAAATGA
1140
ATGATATCATTTACGG
2909

TATCAT

GGGA

3168
3190
CCCCCGTAAATGATATC
1141
TGAGATGATATCATTT
2910

ATCTCA

ACGG

3169
3191
CCCCGTAAATGATATCA
1142
TTGAGATGATATCATT
2911

TCTCAA

TACG

3170
3192
CCCGTAAATGATATCAT
1143
GTTGAGATGATATCAT
2912

CTCAAC

TTAC

3171
3193
CCGTAAATGATATCATC
1144
AGTTGAGATGATATCA
2913

TCAACT

TTTA

3204
3226
CCCACACCCACCCAAGA
1145
CCCTGTTCTTGGGTGG
2914

ACAGGG

GTGT

3205
3227
CCACACCCACCCAAGAA
1146
ACCCTGTTCTTGGGTG
2915

CAGGGT

GGTG

3210
3232
CCCACCCAAGAACAGG
1147
AACAAACCCTGTTCTT
2916

GTTTGTT

GGGT

3211
3233
CCACCCAAGAACAGGG
1148
TAACAAACCCTGTTCT
2917

TTTGTTA

TGGG

3214
3236
CCCAAGAACAGGGTTTG
1149
TCTTAACAAACCCTGT
2918

TTAAGA

TCTT

3215
3237
CCAAGAACAGGGTTTGT
1150
ATCTTAACAAACCCTG
2919

TAAGAT

TTCT

3245
3267
CCCGGTAATCGCATAAA
1151
TTAAGTTTTATGCGAT
2920

ACTTAA

TACC

3246
3268
CCGGTAATCGCATTAAAA
1152
TTTAAGTTTTATGCGA
2921

CTTAAA

TTAC

3292
3314
CCTCTTCTTAACAACAT
1153
ATGGGTATGTTGTTAA
2922

ACCCAT

GAAG

3310
3332
CCCATGGCCAACCTCCT
1154
AGGAGTAGGAGGTTG
2923

ACTCCT

GCCAT

3311
3333
CCATGGCCAACCTCCTA
1155
GAGGAGTAGGAGGTT
2924

CTCCTC

GGCCA

3317
3339
CCAACCTCCTACTCCTC
1156
TACAATGAGGAGTAG
2925

ATTGTA

GAGGT

3321
3343
CCTCCTACTCCTATTGT
1157
TGGGTACAATGAGGA
2926

ACCCA

GTAGG

3324
3346
CCTACTCCTCATTGTAC
1158
GAATGGGTACAATGA
2927

CCATTC

GGAGT

3330
3352
CCTCATTGTACCCATTC
1159
CGATTAGAATGGGTAC
2928

TAATCG

AATG

3340
3362
CCCATTCTAATCGCAAT
1160
AATGCCATTGCGATTA
2929

GGCATT

GAAT

3341
3363
CCATTCTAATCGCAATG
1161
GAATGCCATTGCGATT
2930

GCATTC

AGAA

3363
3385
CCTAATGCTTACCGAAC
1162
TTTTTCGTTCGGTAAG
2931

GAAAAA

CATT

3374
3396
CCGAACGAAAAATTCTA
1163
ATAGCCTAGAATTTTT
2932

GGCTAT

CGTT

3414
3436
CCCCAACGTTGTAGGCC
1164
CGTAGGGGCCTACAAC
2933

CCTACG

GTTG

3415
3437
CCCAACGTTGTAGGCCC
1165
CCGTAGGGGCCTACAA
2934

CTACGG

CGTT

3416
3438
CCAACGTTGTAGGCCCC
1166
CCCGTAGGGGCCTACA
2935

TACGGG

ACGT

3429
3451
CCCCTACGGGCTACTAC
1167
AGGTTGTAGTAGCCC
2936

AACCCT

GTAG

3430
3452
CCCTACGGGCTACTACA
1168
AAGGGTTGTAGTAGCC
2937

ACCCTT

CGTA

3431
3453
CCTACGGGCTACTACAA
1169
GAAGGGTTGTAGTAGC
2938

CCCTTC

CCGT

3448
3470
CCCTTCGCTGACGCCAT
1170
AGTTTTATGGCGTCAG
2939

AAAACT

CGAA

3449
3471
CCTTCGCTGACGCCATA
1171
GAGTTTTATGGCGTCA
2940

AAACTC

GCGA

3461
3483
CCATAAAACTCTTCACC
1172
CTCTTTGGTGAAGAGT
2941

AAAGAG

TTTA

3476
3498
CCAAAGAGCCCCTAAA
1173
GGCGGGTTTTAGGGGC
2942

ACCCGCC

TCTT

3484
3506
CCCCTAAAACCCGCCAC
1174
GTAGATGTGGCGGGTT
2943

ATCTAC

TTAG

3485
3507
CCCTAAAACCCGCCACA
1175
GGTAGATGTGGCGGGT
2944

TCTACC

TTTA

3486
3508
CCTAAAACCCGCCACAT
1176
TGGTAGATGTGGCGGG
2945

CTACCA

TTTT

3493
3515
CCCGCCACATCTACCAT
1177
AGGGTGATGGTAGATG
2946

CACCCT

TGGC

3494
3516
CCGCCACATCTACCATC
1178
GAGGGTGATGGTAGAT
2947

ACCCTC

GTGG

3497
3519
CCACATCTACCATCACC
1179
GTAGAGGGTGATGGTA
2948

CTCTAC

GATG

3506
3528
CCATCACCCTCTACATC
1180
GGCGGTGATGTAGAG
2949

ACCGCC

GGTGA

3512
3534
CCCTCTACATCACCGCC
1181
GGTCGGGGCGGTGATG
2950

CCGACC

TAGA

3513
3535
CCTCTACATCACCGCCC
1182
AGGTCGGGGCGGTGAT
2951

CGACCT

GTAG

3524
3546
CCGCCCCGACCTTAGCT
1183
GGTGAGAGCTAAGGTC
2952

CTCACC

GGGG

3527
3549
CCCCGACCTTAGCTCTC
1184
GATGGTGAGAGCTAA
2953

ACCATC

GGTCG

3528
3550
CCCGACCTTAGCTCTCA
1185
CGATGGTGAGAGCTAA
2954

CCATCG

GGTC

3529
3551
CCGACCTTAGCTCTCAC
1186
GCGATGGTGAGAGCTA
2955

CATCGC

AGGT

3533
3555
CCTTAGCTCTCACCATC
1187
AAGAGCGATGGTGAG
2956

GCTCTT

AGCTA

3545
3567
CCATCGCTCTTCTACTA
1188
GGTTCATAGTAGAAGA
2957

TGAACC

GCGA

3566
3588
CCCCCCTCCCCATACCC
1189
GGGGTTGGGTATGGGG
2958

AACCCC

AGGG

3567
3589
CCCCCTCCCCATACCA
1190
GGGGGTTGGGTATGGG
2959

ACCCCC

GAGG

3568
3590
CCCCTCCCCATACCCAA
1191
AGGGGGTTGGGTATGG
2960

CCCCCT

GGAG

3569
3591
CCCTCCCCATACCCAAC
1192
CAGGGGGTTGGGTATG
2961

CCCCTG

GGGA

3570
3592
CCTCCCCATACCCAACC
1193
CCAGGGGGTTGGGTAT
2962

CCCTGG

GGGG

3573
3595
CCCCATACCCAACCCCC
1194
TGACCAGGGGGTTGGG
2963

TGGTCA

TATG

3574
3596
CCCATACCCAACCCCCT
1195
TTGACCAGGGGGTTGG
2964

GGTCAA

GTAT

3575
3597
CCATACCCAACCCCCTG
1196
GTTGACCAGGGGGTTG
2965

GTCAAC

GGTA

3580
3602
CCCAACCCCCTGGTCAA
1197
TTGAGGTTGACCAGGG
2966

CCTCAA

GGTT

3581
3603
CCAACCCCCTGGTCAAC
1198
GTTGAGGTTGACCAGG
2967

CTCAAC

GGGT

3585
3607
CCCCCTGGTCAACCTCA
1199
CTAGGTTGAGGTTGAC
2968

ACCTAG

CAGG

3586
3608
CCCCTGGTCAACCTCAA
1200
CCTAGGTTGAGGTTGA
2969

CCTAGG

CCAG

3587
3609
CCCTGGTCAACCTCAAC
1201
GCCTAGGTTGAGGTTG
2970

CTAGGC

ACCA

3588
3610
CCTGGTCAACCTCAACC
1202
GGCCTAGGTTGAGGTT
2971

TAGGCC

GACC

3597
3619
CCTCAACCTAGGCCTCC
1203
TAAATAGGAGGCCTAG
2972

TATTTA

GTTG

3603
3625
CCTAGGCCTCCTATTTA
1204
CTAGAATAAATAGGA
2973

TTCTAG

GGCCT

3609
3631
CCTCCTATTTATTCTAGC
1205
AGGTGGCTAGAATAA
2974

CACCT

ATAGG

3612
3634
CCTATTTATTTAGCCA
1206
TAGAGGTGGCTAGAAT
2975

CCTCTA

AAAT

3626
3648
CCACCTCTAGCCTAGCC
1207
GTAAACGGCTAGGCTA
2976

GTTTAC

GAGG

3629
3651
CCTCTAGCCTAGCCGTT
1208
TGAGTAAACGGCTAGG
2977

TACTCA

CTAG

3636
3658
CCTAGCCGTTTACTCAA
1209
AGAGGATTGAGTAAA
2978

TCCTCT

CGGCT

3641
3663
CCGTTTACTCAATCCTC
1210
TGATCAGAGGATTGAG
2979

TGATCA

TAAA

3654
3676
CCTCTGATCAGGGTGAG
1211
TTGATGCTCACCCTGA
2980

CATCAA

TCAG

3689
3711
CCCTGATCGGCGCCTG
1212
TGCTCGCAGTGCGCCG
2981

CGAGCA

ATCA

3690
3712
CCTGATCGGCACTGC
1213
CTGCTCGCAGTGCGCC
2982

GAGCAG

GATC

3716
3738
CCCAAACAATCTCATAT
1214
GACTTCATATGAGATT
2983

GAAGTC

GTTT

3717
3739
CCAAACAATCTCATATG
1215
TGACTTCATATGAGAT
2984

AAGTCA

TGTT

3740
3762
CCCTAGCCATCATTCTA
1216
TGATAGTAGAATGATG
2985

CTATCA

GCTA

3741
3763
CCTAGCCATCATTCTAC
1217
TTGATAGTAGAATGAT
2986

TATCAA

GGCT

3746
3768
CCATCATTCTACTATCA
1218
TAATGTTGATAGTAGA
2987

ACATTA

ATGA

3782
3804
CCTTTAACCTCTCCACC
1219
GATAAGGGTGGAGAG
2988

CTTATC

GTTAA

3789
3811
CCTCTCCACCCTTATCA
1220
GTGTTGTGATAAGGGT
2989

CAACAC

GGAG

3794
3816
CCACCCTTATCACAACA
1221
TTCTTGTGTTGTGATA
2990

CAAGAA

AGGG

3797
3819
CCCTTATCACAACACAA
1222
GTGTTCTTGTGTTGTG
2991

GAACAC

ATAA

3798
3820
CCTTATCACAACACAAG
1223
GGTGTTCTTGTGTTGT
2992

AACACC

GATA

3819
3841
CCTCTGATTACTCCTGC
1224
ATGATGGCAGGAGTA
2993

CATCAT

ATCAG

3831
3853
CCTGCCATCATGACCCT
1225
TGGCCAAGGGTCATGA
2994

TGGCCA

GGC

3835
3857
CCATCATGACCCTTGGC
1226
ATTATGGCCAAGGGTC
2995

CATAAT

ATGA

3844
3866
CCCTTGGCCATAATATG
1227
ATAAATCATATTATGG
2996

ATTTAT

CCAA

3845
3867
CCTTGGCCATAATATGA
1228
GATAAATCATATTATG
2997

TTTATC

GCCA

3851
3873
CCATAATATGATTTATC
1229
TGTGGAGATAAATCAT
2998

TCCACA

ATTA

3869
3891
CCACACTAGCAGAGACC
1230
TCGGTTGGTCTCTGCT
2999

AACCGA

AGTG

3884
3906
CCAACCGAACCCCCTTC
1231
AAGGTCGAAGGGGGT
3000

GACCTT

TCGGT

3888
3910
CCGAACCCCCTTCGACC
1232
CGGCAAGGTCGAAGG
3001

TTGCCG

GGGTT

3893
3915
CCCCCTTCGACCTTGCC
1233
CCCTTCGGCAAGGTCG
3002

GAAGGG

AAGG

3894
3916
CCCCTTCGACCTTGCCG
1234
CCCCTTCGGCAAGGTC
3003

AAGGGG

GAAG

3895
3917
CCCTTCGACCTTGCCGA
1235
TCCCCTTCGGCAAGGT
3004

AGGGGA

CGAA

3896
3918
CCTTCGACCTTGCCGAA
1236
CTCCCCTTCGGCAAGG
3005

GGGGAG

TCGA

3903
3925
CCTTGCCGAAGGGGAGT
1237
GTTCGGACTCCCCTTC
3006

CCGAAC

GGCA

3908
3930
CCGAAGGGGAGTCCGA
1238
GACTAGTTCGGACTCC
3007

ACTAGTC

CCTT

3920
3942
CCGAACTAGTCTCAGGC
1239
GTTGAAGCCTGAGACT
3008

TTCAAC

AGTT

3953
3975
CCGCAGGCCCCTTCGCC
1240
GAATAGGGCGAAGGG
3009

CTATTC

GCCTG

3960
3982
CCCCTTCGCCCTATTCTT
1241
CTATGAAGAATAGGGC
3010

CATAG

GAAG

3961
3983
CCCTTCGCCCTATTCTTC
1242
GCTATGAAGAATAGG
3011

ATAGC

GCGAA

3962
3984
CCTTCGCCCTATTCTTCA
1243
GGCTATGAAGAATAG
3012

TAGCC

GGCGA

3968
3990
CCCTATTCTTCATAGCCG
1244
GTATTCGGCTATGAAG
3013

GAATAC

AATA

3969
3991
CCTATTCTTCATAGCCG
1245
TGTATTCGGCTATGAA
3014

AATACA

GAAT

3983
4005
CCGAATACACAAACATT
1246
TATAATAATGTTTGTG
3015

ATTATA

TATT

4013
4035
CCCTCACCACTACAATC
1247
TAGGAAGATTGTAGTG
3016

TTCCTA

GTGA

4014
4036
CCTCACCACTACAATCT
1248
CTAGGAAGATTGTAGT
3017

TCCTAG

GGTG

4019
4041
CCACTACAATCTTCCTA
1249
TGTTCCTAGGAAGATT
3018

GGAACA

CTTAG

4032
4054
CCTAGGAACAACATATG
1250
GTGCGTCATATGTTGT
3019

ACGCAC

TCCT

4058
4080
CCCCTGAACTCTACACA
1251
ATATGTTGTGTAGAGT
3020

ACATAT

TCAG

4059
4081
CCCTGAACTCTACACAA
1252
AATATGTTGTGTAGAG
3021

CATATT

TTCA

4060
4082
CCTGAACTCTACCAAC
1253
AAATATGTTGTGTAGA
3022

ATATTT

GTTC

4088
4110
CCAAGACCCTACTTCTA
1254
GGAGGTTAGAAGTAG
3023

ACCTCC

GGTCT

4094
4116
CCCTACTTCTAACCTCC
1255
GAACAGGGAGGTTAG
3024

CTGTTC

AAGTA

4095
4117
CCTACTTCTAACTCCC
1256
AGAACAGGGAGGTTA
3025

TGTTCT

GAAGT

4106
4128
CCTCCCTGTTCTTATGA
1257
TCGAATTCATAAGAAC
3026

ATTCGA

AGGG

4109
4131
CCCTGTTCTTATGAATT
1258
TGTTCGAATTCATAAG
3027

CGAACA

AACA

4110
4132
CCTGTTCTTATGAATTC
1259
CTGTTCGAATTCATAA
3028

GAACAG

GAAC

4137
4159
CCCCCGATTCCGCTACG
1260
GTTGGTCGTAGCGGAA
3029

ACCAAC

TCGG

4138
4160
CCCCGATTCCGCTACGA
1261
AGTTGGTCGTAGCGGA
3030

CCAACT

ATCG

4139
4161
CCCGATTCCGCTACGAC
1262
GAGTTGGTCGTAGCGG
3031

CAACTC

AATC

4140
4162
CCGATTCCGCTACGACC
1263
TGAGTTGGTCGTAGCG
3032

AACTCA

GAAT

4146
4168
CCGCTACGACCAACTCA
1264
GGTGTATGAGTTGGTC
3033

TACACC

GTAG

4155
4177
CCAACTCATACACCTCC
1265
TTCATAGGAGGTGTAT
3034

TATGAA

GAGT

4167
4189
CCTCCTATGAAAAAACT
1266
GTAGGAAGTTTTTTCA
3035

TCCTAC

TAGG

4170
4192
CCTATGAAAAAACTTCC
1267
GTGGTAGGAAGTTTTT
3036

TACCAC

TCAT

4185
4207
CCTACCACTCACCCTAG
1268
GTAATGCTAGGGTGAG
3037

CATTAC

TGGT

4189
4211
CCACTCACCCTAGCATT
1269
ATAAGTAATGCTAGGG
3038

ACTTAT

TGAG

4196
4218
CCCTAGCATTACTTATA
1270
ATATCATATAAGTAAT
3039

TGATAT

GCTA

4197
4219
CCTAGCATTACTTATAT
1271
CATATCATATAAGTAA
3040

GATATG

TGCT

4223
4245
CCATACCCATTACAATC
1272
GCTGGAGATTGTAATG
3041

TCCAGC

GGTA

4228
4250
CCCATTACAATCTCCAG
1273
GGAATGCTGGAGATTG
3042

CATTCC

TAAT

4229
4251
CCATTACAATCTCCAGC
1274
GGGAATGCTGGAGATT
3043

ATTCCC

GTAA

4241
4263
CCAGCATTCCCCCTCAA
1275
TTAGGTTTGAGGGGGA
3044

ACCTAA

ATGC

4249
4271
CCCCCTCAAACCTAAGA
1276
CATATTTCTTAGGTTT
3045

AATATG

GAGG

4250
4272
CCCCTCAAACCTAAGAA
1277
ACATATTTCTTAGGTT
3046

ATATGT

TGAG

4251
4273
CCCTCAAACCTAAGAAA
1278
GACATATTTCTTAGGT
3047

TATGTC

TTGA

4252
4274
CCTCAAACCTAAGAAAT
1279
AGACATATTTCTTAGG
3048

ATGTCT

TTTG

4259
4281
CCTAAGAAATATGTCTG
1280
TTTTATCAGACATATT
3049

ATAAAA

TCTT

4318
4340
CCCCCTTATTTCTAGGA
1281
TCATAGTCCTAGAAAT
3050

CTATGA

AAGG

4319
4341
CCCCTTATTTCTAGGAC
1282
CTCATAGTCCTAGAAA
3051

TATGAG

TAAG

4320
4342
CCCTTATTTCTAGGACT
1283
TCTCATAGTCCTAGAA
3052

ATGAGA

ATAA

4321
4343
CCTTATTTCTAGGACTA
1284
TTCTCATAGTCCTAGA
3053

TGAGAA

AATA

4349
4371
CCATCCCTGAGAATCC
1285
AATTTTGGATTCTCAG
3054

AAAATT

GGAT

4350
4372
CCATCCCTGAGAATCCA
1286
GAATTTTGGATTCTCA
3055

AAATTC

GGGA

4354
4376
CCCTGAGAATCCAAAAT
1287
CGGAGAATTTTGGATT
3056

TCTCCG

CTCA

4355
4377
CCTGAGAATCCAAAATT
1288
ACGGAGAATTTTGGAT
3057

CTCCGT

TCTC

4364
4386
CCAAAATTCTCCGTGCC
1289
ATAGGTGGCACGGAG
3058

ACCTAT

AATTT

4374
4396
CCGTGCCACCTATCACA
1290
ATGGGGTGTGATAGGT
3059

CCCCAT

GGCA

4379
4401
CCACCTATCACACCCCA
1291
TTAGGATGGGGTGTGA
3060

TCCTAA

TAGG

4382
4404
CCTATCACACCCCATCC
1292
ACTTTAGGATGGGGTG
3061

TAAAGT

TGAT

4391
4413
CCCCATCCTAAAGTAAG
1293
GCTGACCTTACTTTAG
3062

GTCAGC

GATG

4392
4414
CCCATCCTAAAGTAAGG
1294
AGCTGACCTTACTTTA
3063

TCAGCT

GGAT

4393
4415
CCATCCTAAAGTAAGGT
1295
TAGCTGACCTTACTTT
3064

CAGCTA

AGGA

4397
4419
CCTAAAGTAAGGTCAGC
1296
TATTTAGCTGACCTTA
3065

TAAATA

CTTT

4430
4452
CCCATACCCCGAAAATG
1297
AACCAACATTTTCGGG
3066

TTGGTT

GTAT

4431
4453
CCATACCCCGAAAATGT
1298
AACCAACATTTTCGGG
3067

TGGTTA

GGTA

4436
4458
CCCCGAAAATGTTGGTT
1299
GGGTATAACCAACATT
3068

ATACCC

TTCG

4437
4459
CCCGAAAATGTTGGTTA
1300
AGGGTATAACCAACAT
3069

TACCCT

TTTC

4438
4460
CCGAAAATGTTGGTTAT
1301
AAGGGTATAACCAAC
3070

ACCCTT

ATTTT

4456
4478
CCCTTCCCGTACTAATT
1302
GGGATTAATTAGTACG
3071

AATCCC

GGAA

4457
4479
CCTTCCCGTACTAATTA
1303
GGGGATTAATTAGTAC
3072

ATCCCC

GGGA

4461
4483
CCCGTACTAATTAATCC
1304
GCCAGGGGATTAATTA
3073

CCTGGC

GTAC

4462
4484
CCGTACTAATTAATCCC
1305
GGCCAGGGGATTAATT
3074

CTGGCC

AGTA

4476
4498
CCCCTGGCCCAACCCGT
1306
TAGATGACGGGTTGGG
3075

CATCTA

CCAG

4477
4499
CCCTGGCCCAACCCGTC
1307
GTAGATGACGGGTTGG
3076

ATCTAC

GCCA

4478
4500
CCTGGCCCAACCCGTCA
1308
AGTAGATGACGGGTTG
3077

TCTACT

GGCC

4483
4505
CCCAACCCGTCATCTAC
1309
GGTAGAGTAGATGAC
3078

TCTACC

GGGTT

4484
4506
CCAACCCGTCATCTACT
1310
TGGTAGAGTAGATGAC
3079

CTACCA

GGGT

4488
4510
CCCGTCATCTACTCTAC
1311
AAGATGGTAGAGTAG
3080

CATCTT

ATGAC

4489
4511
CCGTCATCTACTCTACC
1312
AAAGATGGTAGAGTA
3081

ATCTTT

GATGA

4504
4526
CCATCTTTGCAGGCACA
1313
GATGAGTGTGCCTGCA
3082

CTCATC

AAGA

4555
4577
CCTGAGTAGGCCTA
1314
GTTTATTTCTAGGCCT
3083

ATAAAC

ACTC

4565
4587
CCTAGAAATAAACATGC
1315
AAGCTAGCATGTTTAT
3084

TAGCTT

TTCT

4593
4615
CCAGTTCTAACCAAAAA
1316
TTTATTTTTTTGGTTAG
3085

AATAAA

AAC

4603
4625
CCAAAAAAATAAACCCT
1317
GGAACGAGGGTTTATT
3086

CGTTCC

TTTT

4616
4638
CCCTCGTTCCACAGAAG
1318
TGGCAGCTTCTGTGGA
3087

CTGCCA

ACGA

4617
4639
CCTCGTTCCACAGAAGC
1319
ATGGCAGCTTCTGTGG
3088

TGCCAT

AACG

4624
4646
CCACAGAAGCTGCCATC
1320
ATACTTGATGGCAGCT
3089

AAGTAT

TCTG

4636
4658
CCATCAAGTATTTCCTC
1321
TTGCGTGAGGAAATAC
3090

ACGCAA

TTGA

4649
4671
CCTCACGCAAGCAACCG
1322
TGGATGCGGTTGCTTG
3091

CATCCA

CGTG

4663
4685
CCGCATCCATAATCCTT
1323
TATTAGAAGGATTATG
3097

CTAATA

GATG

4669
4691
CCATAATCCTTCTAATA
1324
GATAGCTATTAGAAGG
3093

GCTATC

ATTA

4676
4698
CCTTCTAATAGCTATCC
1325
TGAAGAGGATAGCTAT
3094

TCTTCA

TAGA

4691
4713
CCTCTTCAACAATATAC
1326
CGGAGAGTATATTGTT
3095

TCTCCG

GAAG

4711
4733
CCGGACAATGAACCATA
1327
ATTGGTTATGGTTCAT
3096

ACCAAT

TGTC

4723
4745
CCATAACCAATACTACC
1328
TTGATTGGTAGTATTG
3097

AATCAA

GTTA

4729
4751
CCAATACTACCAATCAA
1329
TGAGTATTGATTGGTA
3098

TACTCA

GTAT

4738
4760
CCAATCAATACTCATCA
1330
TATTAATGATGAGTAT
3099

TTAATA

TGAT

4795
4817
CCCCCTTTCACTTCTGA
1331
TGGGACTCAGAAGTGA
3100

GTCCCA

AAGG

4796
4818
CCCCTTTCACTTCTGAG
1332
CTGGGACTCAGAAGTG
3101

TCCCAG

AAAG

4797
4819
CCCTTTCACTTCTGAGT
1333
TCTGGGACTCAGAAGT
3102

CCCAGA

GAAA

4798
4820
CCTTTCACTTCTGAGTC
1334
CTCTGGGACTCAGAAG
3103

CCAGAG

TGAA

4814
4836
CCCAGAGGTTACCCAAG
1335
GGGTGCCTTGGGTAAC
3104

GCACCC

CTCT

4815
4837
CCAGAGGTTACCCAAGG
1336
GGGGTGCCTTGGGTAA
3105

CACCCC

CCTC

4825
4847
CCCAAGGCACCCCTCTG
1337
GGATGTCAGAGGGGT
3106

ACATCC

GCCTT

4826
4848
CCAAGGCACCCCTCTGA
1338
CGGATGTCAGAGGGGT
3107

CATCCG

GCCT

4834
4856
CCCCTCTGACATCCGGC
1339
AAGCAGGCCGGATGTC
3108

CTGCTT

AGAG

4835
4857
CCCTCTGACATCCGGCC
1340
GAAGCAGGCCGGATG
3109

TGCTTC

TCAGA

4836
4858
CCTCTGACATCCGGCCT
1341
AGAAGCAGGCCGGAT
3110

GCTTCT

GTCAG

4846
4868
CCGGCCTGCTTCTTCTC
1342
TCATGTGAGAAGAAGC
3111

ACATGA

AGGC

4850
4872
CCTGCTTCTTCTCACAT
1343
TTTGTCATGTGAGAAG
3112

GACAAA

AAGC

4879
4901
CCCCCATCTCAATCATA
1344
TTGGTATATGATTGAG
3113

TACCAA

ATGG

4880
4902
CCCCATCTCAATCATAT
1345
TTTGGTATATGATTGA
3114

ACCAAA

GATG

4881
4903
CCCATCTCAATCATATA
1346
ATTTGGTATATGATTG
3115

CCAAAT

AGAT

4882
4904
CCATCTCAATCATATAC
1347
GATTTGGTATATGATT
3116

CAAATC

GAGA

4898
4920
CCAAATCTCTCCCTCAC
1348
CGTTTAGTGAGGGAGA
3117

TAAACG

GATT

4908
4930
CCCTCACTAAACGTAAG
1349
AGAAGGCTTACGTTTA
3118

CCTTCT

GTGA

4909
4931
CCTCACTAAACGTAAGC
1350
GAGAAGGCTTACGTTT
3119

CTTCTC

AGTG

4925
4947
CCTTCTCCTCACTCTCTC
1351
AGATTGAGAGAGTGA
3120

AATCT

GGAGA

4931
4953
CCTCACTCTCTCAATCTT
1352
TGGATAAGATTGAGAG
3121

ATCCA

AGTG

4951
4973
CCATCATAGCAGGCAGT
1353
ACCTCAACTGCCTGCT
3122

TGAGGT

ATGA

4982
5004
CCAAACCCAGCTACGCA
1354
AGATTTTGCGTAGCTG
3123

AAATCT

GGTT

4987
5009
CCCAGCTACGCAAAATC
1355
TGCTAAGATTTTGCGT
3124

TTAGCA

AGCT

4988
5010
CCAGCTACGCAAAATCT
1356
ATGCTAAGATTTTGCG
3125

TAGCAT

TAGC

5014
5036
CCTCAATTACCCACATA
1357
TCATCCTATGTGGGTA
3126

GGATGA

ATTG

5023
5045
CCCACATAGGATGAATA
1358
TGCTATTATTCATCCT
3127

ATAGCA

ATGT

5024
5046
CCACATAGGATGAATAA
1359
CTGCTATTATTCATCCT
3128

TAGCAG

ATG

5052
5074
CCGTACAACCCTAACAT
1360
ATGGTTATGTTAGGGT
3129

AACCAT

TGTA

5060
5082
CCCTAACATAACCATTC
1361
AATTAAGAATGGTTAT
3130

TTAATT

GTTA

5061
5083
CCTAACATAACCATTCT
1362
AAATTAAGAATGGTTA
3131

TAATTT

TGTT

5071
5093
CCATTCTTAATTTAACT
1363
ATAAATAGTTAAATTA
3132

ATTTAT

AGAA

5099
5121
CCTAACTACTACCGCAT
1364
GTAGGAATGCGGTAGT
3133

TCCTAC

AGTT

5110
5132
CCGCATTCCTACTACTC
1365
TAAGTTGAGTAGTAGG
3134

AACTTA

AATG

5117
5139
CCTACTACTCAACTTAA
1366
TGGAGTTTAAGTTGAG
3135

ACTCCA

TAGT

5137
5159
CCAGCACCACGACCCTA
1367
TAGTAGTAGGGTCGTG
3136

CTACTA

GTGC

5143
5165
CCACGACCCTACTACTA
1368
GCGAGATAGTAGTAG
3137

TCTCGC

GGTCG

5149
5171
CCCTACTACTATCTCGC
1369
TCAGGTGCGAGATAGT
3138

ACCTGA

AGTA

5150
5172
CCTACTACTATCTCGCA
1370
TTCAGGTGCGAGATAG
3139

CCTGAA

TAGT

5167
5189
CCTGAAACAAGCTAACA
1371
TAGTCATGTTAGCTTG
3140

TGACTA

TTTC

5193
5215
CCCTTAATTCCATCCAC
1372
AGGAGGGTGGATGGA
3141

CCTCCT

ATTAA

5194
5216
CCTTAATTCCATCCACC
1373
GAGGAGGGTGGATGG
3142

CTCCTC

AATTA

5202
5224
CCATCCACCCTCCTC
1374
CCTAGGGAGAGGAGG
3143

CCTAGG

GTGGA

5206
5228
CCACCCTCCTCTCCCTA
1375
GCCTCCTAGGGAGAGG
3144

GGAGGC

AGGG

5209
5231
CCCTCCTCTCCCTAGGA
1376
CAGGCCTCCTAGGGAG
3145

GGCCTG

AGGA

5210
5232
GCTCCTCTCCCTAGGAG
1377
CCAGGCCTCCTAGGGA
3146

GCCTGC

GAGG

5213
5235
CCTCTCCCTAGGAGGCC
1378
GGGGCAGGCCTCCTAG
3147

TGCCCC

GGAG

5218
5240
CCCTAGGAGGCCTGCCC
1379
TAGCGGGGGCAGGCCT
3148

CCGCTA

CCTA

5219
5241
CCTAGGAGGCCTGCCCC
1380
TTAGCGGGGGCAGGCC
3149

CGCTAA

TCCT

5228
5250
CCTGCCCCCGCTAACCG
1381
AAAAGCCGGTTAGCG
3150

GCTTTT

GGGGC

5232
5254
CCCCCGCTAACCGGCTT
1382
GGCAAAAAGCCGGTT
3151

TTTGCC

AGCGG

5213
5255
CCCCGCTAACCGGCTTT
1383
GGGCAAAAAGCCGGT
3152

TTGCCC

TAGCG

5234
5256
CCCGCTAACCGGCTTTT
1384
TGGGCAAAAAGCCGG
3153

TGCCCA

TTAGC

5235
5257
CCGCTAACCGGCTTTTT
1385
TTGGGCAAAAAGCCG
3154

GCCCAA

GTTAG

5242
5264
CCGGCTTTTTGCCCAAA
1386
GGCCCATTTGGGCAAA
3155

TGGGCC

AAGC

5253
5275
CCCAAATGGGCCATTAT
1387
TCTTCGATAATGGCCC
3156

CGAAGA

ATTT

5254
5276
CCAAATGGGCCATTATC
1388
TTCTTCGATAATGGCC
3157

GAAGAA

CATT

5263
5285
CCATTATCGAAGAATTC
1389
TTTTGTGAATTCTTCG
3158

ACAAAA

ATAA

5294
5316
CCTCATCATCCCCACCA
1390
CTATGATGGTGGGGAT
3159

TCATAG

GATG

5303
5325
CCCCACCATCATAGCCA
1391
TGATGGTGGCTATGAT
3160

CCATCA

GGTG

5304
5326
CCCACCATCATAGCCAC
1392
GTGATGGTGGCTATGA
3161

CATCAC

TGGT

5305
5327
CCACCATCATAGCCACC
1393
GGTGATGGTGGCTATG
3162

ATCACC

ATGG

5308
5330
CCATCATAGCCACCATC
1394
GAGGGTGATGGTGGCT
3163

ACCCTC

ATGA

5317
5339
CCACCATCACCCTCCTT
1395
GAGGTTAAGGAGGGT
3164

AACCTC

GATGG

5320
5342
CCATCACCCTCCTTAAC
1396
GTAGAGGTTAAGGAG
3165

CTCTAC

GGTGA

5326
5348
CCCTCCTTAACCTCTAC
1397
GTAGAAGTAGAGGTTA
3166

TTCTAC

AGGA

5327
5349
CCTCCTTAACCTCTACTT
1398
GGTAGAAGTAGAGGTT
3167

CTACC

AAGG

5330
5352
CCTTAACCTCTACTTCT
1399
GTAGGTAGAAGTAGA
3168

ACCTAC

GGTTA

5336
5358
CCTCTACTTCTACCTAC
1400
TTAGGCGTAGGTAGAA
3169

GCCTAA

GTAG

5348
5370
CCTACGCCTAATCTACT
1401
AGGTGGAGTAGATTAG
3170

CCACCT

GCGT

5354
5376
CCTAATCTACTCCACCT
1402
TGATTGAGGTGGAGTA
3171

CAATCA

GATT

5365
5387
CCACCTCAATCACACTA
1403
GGGGAGTAGTGTGATT
3172

CTCCCC

GAGG

5368
5390
CCTCAATCACACTACTC
1404
TATGGGGAGTAGTGTG
3173

CCCATA

ATTG

5384
5406
CCCCATATCTAACAACG
1405
TTTTTACGTTGTTAGAT
3174

TAAAAA

ATG

5385
5407
CCCATATCTAACAACGT
1406
ATTTTTACGTTGTTAG
3175

AAAAAT

ATAT

5386
5408
CCATATCTAACAACGT
1407
TATTTTTACGTTGTTAG
3176

AAAATA

ATA

5433
5455
CCCACCCCATTCCTCCC
1408
AGTGTGGGGAGGAAT
3177

CACACT

GGGGT

5434
5456
CCACCCCATTCCTCCCC
1409
GAGTGTGGGGAGGAA
3178

ACACTC

TGGGG

5417
5459
CCCCATTCCTCCCCACA
1410
GATGAGTGTGGGGAG
3179

CTCATC

GAATG

5438
5460
CCCATTCCTCCCCACAC
1411
CGATGAGTGTGGGGA
3180

TCATCG

GGAAT

5439
5461
CCATTCCTCCCCACACT
1412
GCGATGAGTGTGGGG
3181

CATCGC

AGGAA

5444
5466
CCTCCCCACACTCATCG
1413
TAAGGGCGATGAGTGT
3182

CCCTTA

GGGG

5447
5469
CCCCACACTCATCGCCC
1414
TGGTAAGGGCGATGA
3183

TTACCA

GTGTG

5448
5470
CCCACACTCATCGCCCT
1415
GTGGTAAGGGCGATG
3184

TACCAC

AGTGT

5449
5471
CCACACTCATCGCCCTT
1416
CGTGGTAAGGGCGATG
3185

ACCACG

AGTG

5461
5483
CCCTTACCACGCTACTC
1417
AGGTAGGAGTAGCGT
3186

CTACCT

GGTAA

5462
5484
CCTTACCACGCTACTCC
1418
TAGGTAGGAGTAGCGT
3187

TACCTA

GGTA

5467
5489
CCACGCTACTCCTACCT
1419
GGAGATAGGTAGGAG
3188

ATCTCC

TAGCG

5477
5499
CCTACCTATCTCCCCTTT
1420
GTATAAAAGGGGAGA
3189

TATAC

TAGGT

5481
5503
CCTATCTCCCCTTTATA
1421
ATTAGTATAAAAGGGG
3190

CTAAT

AGAT

5488
5510
CCCCTTTTATACTAATA
1422
TAAGATTATTAGTATA
3191

ATCTTA

AAAG

5489
5511
CCCTTTTATACTAATAA
1423
ATAAGATTATTAGTAT
3192

TCTTAT

AAAA

5490
5512
CCTTTTATACTAATAAT
1424
TATAAGATTATTAGTA
3193

CTTATA

TAAA

5534
5556
CCAAGAGCCTTCAAAGC
1425
CTGAGGGCTTTGAAGG
3194

CCTCAG

CTCT

5541
5563
CCTTCAAAGCCCTCAGT
1426
CAACTTACTGAGGGCT
3195

AAGTTG

TTGA

5550
5572
CCCTCAGTAAGTTGCAA
1427
TAAGTATTGCAACTTA
3196

TACTTA

CTGA

5551
5573
CCTCAGTAAGTTGCAAT
1428
TTAAGTATTGCAACTT
3197

ACTTAA

ACTG

5601
5623
CCCCACTCTGCATCAAC
1429
CGTTCAGTTGATGCAG
3198

TGAACG

AGTG

5602
5624
CCCACTCTGCATCAACT
1430
GCGTTCAGTTGATGCA
3199

GAACGC

GAGT

5603
5625
CCACTCTGCATCAACTG
1431
TGCGTTCAGTTGATGC
3200

AACGCA

AGAG

5632
5654
CCACTTTAATTAAGCTA
1432
AGGGCTTAGCTTAATT
3201

AGCCCT

AAAG

5651
5673
CCCTTACTAGACCAATG
1433
AAGTCCCATTGGTCTA
3202

GGACTT

GTAA

5652
5674
CCTTACTAGACCAATGG
1434
TAAGTCCCATTGGTCT
3203

GACTTA

AGTA

5667
5684
CCAATGGGACTTAAACC
1435
TTTGTGGGTTTAAGTC
3204

CACAAA

CCAT

5677
5699
CCCACAAACACTTAGTT
1436
GCTGTTAACTAAGTGT
3205

AACAGC

TTGT

5678
5700
CCACAAACACTTAGTTA
1437
AGCTGTTAACTAAGTG
3206

ACAGCT

TTTG

5706
5728
CCCTAATCAACTGGCTT
1438
AGATTGAAGCCAGTTG
3207

CAATCT

ATTA

5707
5729
CCTAATCAACTGGCTTC
1439
TAGATTGAAGCCAGTT
3208

AATCTA

GATT

5735
5757
CCCGCCGCCGGGAAAA
1440
CCGCCTTTTTTCCCGG
3209

AAGGCGG

CGGC

5736
5758
CCGCCGCCGGGAAAAA
1441
CCCGCCTTTTTTCCCG
3210

AGGCGGG

GCGG

5739
5761
CCGCCGGGAAAAAAGG
1442
TCTCCCGCCTTTTTTCC
3211

CGGGAGA

CGG

5742
5764
CCGGGAAAAAAGGCGG
1443
GCTTCTCCCGCCTTTTT
3212

GAGAAGC

TCC

5764
5786
CCCCGGCAGGTTTGAAG
1444
AACCAGCTTCAAACCT
3213

CTGCTT

GCCG

5765
5787
CCCGGCAGGTTTGAAGC
1445
GAAGCAGCTTCAAACC
3214

TGCTTC

TGCC

5766
5788
CCGGCAGGTTTGAAGCT
1446
AGAAGCAGCTTCAAAC
3215

GCTTCT

CTGC

5817
5839
CCTCGGAGCTGGTAAAA
1447
GCCTCTTTTTACCAGC
3216

AGAGGC

TCCG

5839
5861
CCTAACCCCTGTCTTTA
1448
TAAATCTAAAGACAGG
3217

GATTTA

GGTT

5844
5866
CCCCTGTCTTTAGATTT
1449
GACTGTAAATCTAAAG
3218

ACAGTC

ACAG

5845
5867
CCCTGTCTTTAGATTTA
1450
GGACTGTAAATCTAAA
3219

CAGTCC

GACA

5846
5868
CCTGTCTTTAGATTTAC
1451
TGGACTGTAAATCTAA
3220

AGTCCA

AGAC

5866
5888
CCAATGCTTCACTCAGC
1452
AAAATGGCTGAGTGA
3221

CATTTT

AGCAT

5882
5904
CCATTTTACCTCACCCC
1453
TCAGTGGGGGTGAGGT
3222

CACTGA

AAAA

5890
5912
CCTCACCCCCACTGATG
1454
GGCGAACATCAGTGG
3223

TTCGCC

GGGTG

5895
5917
CCCCCACTGATGTTCGC
1455
CGGTCGGCGAACATCA
3224

CGACCG

GTGG

5896
5918
CCCCACTGATGTTCGCC
1456
ACGGTCGGCGAACATC
3225

GACCGT

AGTG

5897
5919
CCCACTGATGTTCGCCG
1457
AACGGTCGGCGAACAT
3226

ACCGTT

CAGT

5898
5920
CCACTGATGTTCGCCGA
1458
CAACGGTCGGCGAAC
3227

CCGTTG

ATCAG

5911
5933
CCGACCGTTGACTATTC
1459
TGTAGAGAATAGTCAA
3228

TCTACA

CGGT

5915
5937
CCGTTGACTATTCTCTA
1460
GGTTTGTAGAGAATAG
3229

CAAACC

TCAA

5936
5958
CCACAAAGACATTGGA
1461
ATAGTGTTCCAATGTC
3230

ACACTAT

TTTG

5960
5982
CCTATTATTCGGCGCAT
1462
CAGCTCATGCGCCGAA
3231

GAGCTG

TAAT

5987
6009
CCTAGGCACAGCTCTAA
1463
GGAGGCTTAGAGCTGT
3232

GCCTCC

GCCT

6005
6027
CCTCCTTATTCGAGCCG
1464
CCAGCTCGGCTCGAAT
3233

AGCTGG

AAGG

6008
6030
CCTTATTCGAGCCGAGC
1465
GGCCCAGCTCGGCTCG
3234

TGGGCC

AATA

6019
6041
CCGAGCTGGGCCAGCCA
1466
GTTGCCTGGCTGGCCC
3235

GGCAAC

AGCT

6029
6051
CCAGCCAGGCAACCTTC
1467
TACCTAGAAGGTTGCC
3236

TAGGTA

TGGC

6033
6055
CCAGGCAACCTTCTAGG
1468
TCGTTACCTAGAAGGT
3237

TAACGA

TGCC

6041
6063
CCTTCTAGGTAACGACC
1469
AGATGTGGTCGTTACC
3238

ACATCT

TAGA

6056
6078
CCACATCTACAACGTTA
1470
TGACGATAACGTTGTA
3239

TCGTCA

GATG

6082
6104
CCCATGCATTTGTAATA
1471
GAAGATTATTACAAAT
3240

ATCTTC

GCAT

6083
6105
CCATGCATTTGTAATAA
1472
AGAAGATTATTACAAA
3241

TCTTCT

TGCA

6117
6139
CCCATCATAATCGGAGG
1473
CCAAAGCCTCCGATTA
3242

CTTTGG

TGAT

6118
6140
CCATCATAATCGGAGGC
1474
GCCAAAGCCTCCGATT
3243

TTTGGC

ATGA

6153
6175
CCCCTAATAATCGGTGC
1475
TCGGGGGCACCGATTA
3244

CCCCGA

TTAG

6154
6176
CCCTAATAATCGGTGCC
1476
ATCGGGGGCACCGATT
3245

CCCGAT

ATTA

6155
6177
CCTAATAATCGGTGCCC
1477
TATCGGGGGCACCGAT
3246

CCGATA

TATT

6169
6191
CCCCCGATATGGCGTTT
1478
GCGGGGAAACGCCAT
3247

CCCCGC

ATCGG

6170
6192
CCCCGATATGGCGTTTC
1479
TGCGGGGAAACGCCAT
3248

CCCGCA

ATCG

6171
6193
CCCGATATGGCGTTTCC
1480
ATGCGGGGAAACGCC
3249

CCGCAT

ATATC

6172
6194
CCGATATGGCGTTTCCC
1481
TATGCGGGGAAACGCC
3250

CGCATA

ATAT

6186
6208
CCCCGCATAAACAACAT
1482
AAGCTTATGTTGTTTA
3251

AAGCTT

TGCG

6187
6209
CCCGCATAAACAACATA
1483
GAAGCTTATGTTGTTT
3252

AGCTTC

ATGC

6188
6210
CCGCATAAACAACATAA
1484
AGAAGCTTATGTTGTT
3253

GCTTCT

TATG

6219
6241
CCTCCCTCTCTCCTACTC
1485
AGCAGGAGTAGGAGA
3254

CTGCT

GAGGG

6222
6244
CCCTCTCTCCTACTCCTG
1486
GCGAGCAGGAGTAGG
3255

CTCGC

AGAGA

6223
6245
CCTCTCTCCTACTCCTGC
1487
TGCGAGCAGGAGTAG
3256

TCGCA

GAGAG

6210
6252
CCTACTCCTGCTCGCAT
1488
TAGCAGATGCGAGCA
3257

CTGCTA

GGAGT

6236
6258
CCTGCTCGCATCTGCTA
1489
CCACTATAGCAGATGC
3258

TAGTGG

GAGC

6262
6284
CCGGAGCAGGAACAGG
1490
TGTTCAACCTGTTCCT
3259

TTGAACA

GCTC

6290
6312
CCCTCCCTTAGCAGGGA
1491
AGTAGTTCCCTGCTAA
3260

ACTACT

GGGA

6291
6313
CCTCCCTTAGCAGGGAA
1492
GAGTAGTTCCCTGCTA
3261

CTACTC

AGGG

6294
6316
CCCTTAGCAGGGAACTAC
1493
TGGGAGTAGTTCCCTG
3262

CTCCCA

CTAA

6295
6317
CCTTAGCAGGGAACTAC
1494
GTGGGAGTAGTTCCCT
3263

TCCCAC

GCTA

6313
6335
CCCACCCTGGAGCCTCC
1495
GTCTACGGTGGCTCCA
3264

GTAGAC

GGGT

6314
6336
CCACCCTGGAGCCTCCG
1496
GGTCTACGGAGGCTCC
3265

TAGACC

AGGG

6317
6339
CCCTGGAGCCTCCGTAG
1497
TTAGGTCTACGGAGGC
3266

ACCTAA

TCCA

6318
6340
CCTGGAGCCTCCGTAGA
1498
GTTAGGTCTACGGAGG
3267

CCTAAC

CTCC

6325
6347
CCTCCGTAGACCTAACC
1499
GAAGATGGTTAGGTCT
3268

ATCTTC

ACGG

6328
6350
CCGTAGACCTAACCATC
1500
GGAGAAGATGGTTAG
3269

TTCTCC

GTCTA

6335
6357
CCTAACCATCTTCTCCTT
1501
GGTGTAAGGAGAAGA
3270

ACACC

TGGTT

6340
6362
CCATCTTCTCCTTACAC
1502
TGCTAGGTGTAAGGAG
3271

CTAGCA

AAGA

6349
6371
CTTACACCTAGCAGGT
1503
GGAGACACCTGCTAGG
3272

GTCTCC

TGTA

6356
6378
CCTAGCAGGTGTCTCCT
1504
AGATAGAGGAGACAC
3273

CTATCT

CTGCT

6370
6392
CCTCTATCTTAGGGGCC
1505
ATTGATGGCCCCTAAG
3274

ATCAAT

ATAG

6385
6407
CCATCAATTTCATCACA
1506
AATTGTTGTGATGAAA
3275

ACAATT

TTGA

6420
6442
CCCCCTGCCATAACCCA
1507
TGGTATTGGGTTATGG
3276

ATACCA

CAGG

6421
6443
CCCCTGCCATAACCCAA
1508
TTGGTATTGGGTTATGG
3277

TACCAA

GCAG

6422
6444
CCCTGCCATAACCCAAT
1509
TTTGGTATTGGGTTAT
3278

ACCAAA

GGCA

6423
6445
CCTGCCATAACCCAATA
1510
GTTTGGTATTGGGTTA
3279

CCAAAC

TGGC

6427
6449
CCATAACCCAATACCAA
1511
GGGCGTTTGGTATTGG
3280

ACGCCC

GTTA

6433
6455
CCCAATACCAAACGCCC
1512
GAAGAGGGGCGTTTG
3281

CTCTTC

GTATT

6434
6456
CCAATACCAAACGCCCC
1513
CGAAGAGGGGCGTTTG
3282

TCTTCG

GTAT

6440
6462
CCAAACGCCCCTCTTCG
1514
ATCAGACGAAGAGGG
3283

TCTGAT

GCGTT

6447
6469
CCCCTCTTCGTCTGATC
1515
AGGACGGATCAGACG
3284

CGTCCT

AAGAG

6448
6470
CCCTCTTCGTCTGATCC
1516
TAGGACGGATCAGAC
3285

GTCCTA

GAAGA

6449
6471
CCTCTTCGTCTGATCCG
1517
TTAGGACGGATCAGAC
3286

TCCTAA

GAAG

6463
6485
CCGTCCTAATCACAGCA
1518
TAGGACTGCTGTGATT
3287

GTCCTA

AGGA

6467
6489
CCTAATCACAGCAGTCC
1519
GAAGTAGGACTGCTGT
3288

TACTTC

GATT

6482
6504
CCTACTTCTCCTATCTCT
1520
CTGGGAGAGATAGGA
3289

CCCAG

GAAGT

6491
6513
CCTATCTCTCCCAGTCC
1521
CAGCTAGGACTGGGA
3290

TAGCTG

GAGAT

6500
6522
CCCAGTCCTAGCTGCTG
1522
TGATGCCAGCAGCTAG
3291

GCATCA

GACT

6501
6523
CCAGTCCTAGCTGCTGG
1523
GTGATGCCAGCAGCTA
3292

CATCAC

GGAC

6506
6528
CCTAGCTGCTGGCATCA
1524
GTATAGTGATGCCAGC
3293

CTATAC

AGCT

6539
6561
CCGCAACCTCAACACCA
1525
AGAAGGTGGTGTTGAG
3294

CCTTCT

GTTG

6545
6567
CCTCAACACCCTTCT
1526
GGTCGAAGAAGGTGG
3295

TCGACC

TGTTG

6553
6575
CCACCTTCTTCGACCCC
1527
TCCGGCGGGGTCGAAG
3296

GCCGGA

AAGG

6556
6578
CCTTCTTCGACCCCGCC
1528
TCCTCCGGCGGGGTCG
3297

GGAGGA

AAGA

6566
6588
CCCCGCCGGAGGAGGA
1529
TGGGGTCTCCTCCTCC
3298

GACCCCA

GGCG

6567
6589
CCCGCCGGAGGAGGAG
1530
ATGGGGTCTCCTCCTC
3299

ACCCCAT

CGGC

6568
6590
CCGCCGGAGGAGGAGA
1531
AATGGGGTCTCCTCCT
3300

CCCCATT

CCGG

6571
6593
CCGGAGGAGGAGACCC
1532
TAGAATGGGGTCTCCT
3301

CATTCTA

CCTC

6584
6606
CCCCATTCTATACCAAC
1533
ATAGGTGTTGGTATAG
3302

ACCTAT

AATG

6585
6607
CCCATTCTATACCAACA
1534
AATAGGTGTTGGTATA
3303

CCTATT

GAAT

6586
6608
CCATTCTATACCAACAC
1535
GAATAGGTGTTGGTAT
3304

CTATTC

AGAA

6596
6618
CCAACACCTATTCTGAT
1536
CGAAAAATCAGAATA
3305

TTTTCG

GGTGT

6602
6624
CCTATTCTGATTTTTCGG
1537
GGTGACCGAAAAATC
3306

TCACC

AGAAT

6623
6645
CCCTGAAGTTTATATTC
1538
GGATAAGAATATAAA
3307

TTATCC

CTTCA

6624
6646
CCTGAAGTTTATATTCT
1539
AGGATAAGAATATAA
3308

TATCCT

ACTTC

6644
6666
CCTACCAGGCTTCGGAA
1540
AGATTATTCCGAAGCC
3309

TAATCT

TGGT

6648
6670
CCAGGCTTCGGAATAAT
1541
TGGGAGATTATTCCGA
3310

CTCCCA

AGCC

6667
6689
CCCATATTGTAACTAC
1542
GGAGTAGTAAGTTACA
3311

TACTCC

ATAT

6668
6690
CCATATTGTAACTTACT
1543
CGGAGTAGTAAGTTAC
3312

ACTCCG

AATA

6688
6710
CCGGAAAAAAAGAACC
1544
TCCAAATGGTTCTTTTT
3313

ATTTGGA

TTC

6702
6724
CCATTTGGATACATAGG
1545
ACCATACCTATGTATC
3314

TATGGT

CAAA

6749
6771
CCTAGGGTTTATCGTGT
1546
GTGCTCACACGATAAA
3315

GAGCAC

CCCT

6773
6795
CCATATATTTACAGTAG
1547
CTATTCCTACTGTAAA
3316

GAATAG

TATA

6820
6842
CCTCCGCTACCATAATC
1548
AGCGATGATTATGGTA
3317

ATCGCTGCGG

GCGG

6823
6845
CCGCTACCATAATCATC
1549
GATAGCGATGATTATG
3318

GCTATC

GTAG

6829
6851
CCATAATCATCGCTATC
1550
GGTGGGGATAGCGAT
3319

CCCACC

GATTA

6845
6867
CCCCACCGGCGTCAAAG
1551
TAAATACTTTGACGCC
3320

TATTTA

GGTG

6846
6868
CCCACCGGCGTCAAAGT
1552
CTAAATACTTTGACGC
3321

ATTTAG

CGGT

6847
6869
CCACCGGCGTCAAAGTA
1553
GCTAAATACTTTGACG
3322

TTTAGC

CCGG

6850
6872
CCGGCGTCAAAGTATTT
1554
TCAGCTAAATACTTTG
3323

AGCTGA

ACGC

6877
6899
CCACACTCCACGGAAGC
1555
CATATTGCTTCCGTGG
3324

AATATG

AGTG

6884
6906
CCACGGAAGCAATATG
1556
ATCATTTCATATTGCTT
3325

AAATGAT

CCG

6925
6947
CCCTAGATTCATCTTT
1557
GAAAAGAAAGATGAA
3326

CTTTTC

TCCTA

6926
6948
CCTAGGATTCATCTTTC
1558
TGAAAAGAAAGATGA
3327

TTTTCA

ATCCT

6949
6971
CCGTAGGTGGCCTGACT
1559
AATGCCAGTCAGGCCA
3328

GGCATT

CCTA

6959
6981
CCTGACTGGCATTGTAT
1560
TTGCTAATACAATGCC
3329

TAGCAA

AGTC

7027
7049
CCCACTTCCACTATGTC
1561
TGATAGGACATAGTGG
3330

CTATCA

AAGT

7028
7050
CCACTTCCACTATGTCC
1562
TTGATAGGACATAGTG
3331

TATCAA

GAAG

7034
7056
CCACTATGTCCTATCAA
1563
CTCCTATTGATAGGAC
3332

TAGGAG

ATAG

7043
7065
CCTATCAATAGGAGCTG
1564
CAAATACAGCTCCTAT
3333

TATTTG

TGAT

7066
7088
CCATCATAGGAGGCTTC
1565
GTGAATGAAGCCTCCT
3334

ATTCAC

ATGA

7095
7117
CCCCTATTCTCAGGCTA
1566
AGGGTGTAGCCTGAGA
3335

CACCCT

ATAG

7096
7118
CCCTATTCTCAGGCTAC
1567
TAGGGTGTAGCCTGAG
3336

ACCCTA

AATA

7097
7119
CCTATTCFCAGGCTACA
1568
CTAGGGTGTAGCCTGA
3337

CCCTAG

GAAT

7114
7136
CCCTAGACCAAACCTAC
1569
TTTGGCGTAGGTTTGG
3338

GCCAAA

TCTA

7115
7137
CCTAGACCAAACCTACG
1570
TTTTGGCGTAGGTTTG
3339

CCAAAA

GTCT

7121
7143
CCAAACCTACGCCAAAA
1571
AATGGATTTTGGCGTA
3340

TCCATT

GGTT

7126
7148
CCTACGCCAAAATCCAT
1572
AGTGAAATGGATTTTG
3341

TTCACT

GCGT

7132
7154
CCAAAATCCATTTCACT
1573
TATGATAGTGAAATGG
3342

ATCATA

ATTT

7139
7161
CCATTTCACTATCATAT
1574
CGATGAATATGATAGT
3343

TCATCG

GAAA

7181
7203
CCCACAACACTTTCTCG
1575
ATAGGCCGAGAAAGT
3344

GCCTAT

GTTGT

7182
7204
CCACAACACTTTCTCGG
1576
GATAGGCCGAGAAAG
3345

CCTATC

TGTTG

7199
7221
CCTATCCGGAATGCCCC
1577
AACGTCGGGGCATTCC
3346

GACGTT

GGAT

7204
7226
CCGGAATGCCCCGACGT
1578
CGAGTAACGTCGGGGC
3347

TACTCG

ATTC

7212
7234
CCCCGACGTTACTCGGA
1579
GGGTAGTCCGAGTAAC
3348

CTACCC

GTCG

7213
7235
CCCGACGTTACTCGGAC
1580
GGGGTAGTCCGAGTAA
3349

TACCCC

CGTC

7214
7236
CCGACGTTACTCGGACT
1581
CGGGGTAGTCCGAGTA
3350

ACCCCG

ACGT

7232
7254
CCCCGATGCATACACCA
1582
TTCATGTGGTGTATGC
3351

CATGAA

ATCG

7233
7255
CCCGATGCATACACCAC
1583
TTTCATGTGGTGTATG
3352

ATGAAA

CATC

7234
7256
CCGATGCATACACCACA
1584
GTTTCATGTGGTGTAT
3353

TGAAAC

GCAT

7246
7268
CCACATGAAACATCCTA
1585
AGATGATAGGATGTTT
3354

TCATCT

CATG

7259
7281
CCTATCATCTGTAGGCT
1586
TGAATGAGCCTACAGA
3355

CATTCA

TGAT

7327
7349
CCTTCGCTTCGAAGCGA
1587
GACTTTTCGCTTCGAA
3356

AAAGTC

GCGA

7349
7371
CCTAATAGTAGAAGAAC
1588
TGGAGGGTTCTTCTAC
3357

CCTCCA

TATT

7365
7387
CCCTCCATAAACCTGGA
1589
AGTCACTCCAGGTTTA
3358

GTGACT

TGGA

7366
7388
CCTCCATAAACCTGGAG
1590
TAGTCACTCCAGGTTT
3359

TGACTA

ATGG

7369
7391
CCATAAACCTGGAGTGA
1591
ATATAGTCACTCCAGG
3360

CTATAT

TTTA

7376
7398
CCTGGAGTGACTATATG
1592
GGCATCCATATAGTCA
3361

GATGCC

CTCC

7397
7419
CCCCCCACCCTACCACA
1593
CGAATGTGTGGTAGGG
3362

CATTCG

TGGG

7398
7420
CCCCCACCCTACCACAC
1594
TCGAATGTGTGGTAGG
3363

ATTCGA

GTGG

7399
7421
CCCCACCCTACCACACA
1595
TTCGAATGTGTGGTAG
3364

TTCGAA

GGTG

7400
7422
CCCACCCTACCACACAT
1596
CTTCGAATGTGTGGTA
3365

TCGAAG

GGGT

7401
7423
CCACCCTACCACACATT
1597
TCTTCGAATGTGTGGT
3366

CGAAGA

AGGG

7404
7426
CCCTACCACACATTCGA
1598
GGTTCTTCGAATGTGT
3367

AGAACC

GGTA

7405
7427
CCTACCACACATTCGAA
1599
GGGTTCTTCGAATGTG
3368

GAACCC

TGGT

7409
7431
CCACACATTCGAAGAAC
1600
ATACGGGTTCTTCGAA
3369

CCGTAT

TGTG

7425
7447
CCCGTATACATAAAATC
1601
TGTCTAGATTTTATGT
3370

TAGACA

ATAC

7426
7448
CCGTATACATAAAATCT
1602
TTGTCTAGATTTTATGT
3371

AGACAA

ATA

7466
7488
CCCCCCAAAGCTGGTTT
1603
GGCTTGAAACCAGCTT
3372

CAAGCC

TGGG

7467
7489
CCCCCAAAGCTGGTTTC
1604
TGGCTTGAAACCAGCT
3373

AAGCCA

TTGG

7468
7490
CCCCAAAGTGGTTTCA
1605
TTGGCTTGAAACCAGC
3374

AGCCAA

TTTG

7469
7491
CCCAAAGCTGGTTTCAA
1606
GTTGGCTTGAAACCAG
3375

GCCAAC

CTTT

7470
7492
CCAAAGCTGGTTTCAAG
1607
GGTTGGCTTGAAACCA
3376

CCAACC

GCTT

7487
7509
CCAACCCCATGGCCTCC
1608
AGTCATGGAGGCCATG
3377

ATGACT

GGGT

7491
7513
CCCCATGGCCTCCATGA
1609
AAAAAGTCATGGAGG
3378

CTTTTT

CCATG

7492
7514
CCCATGGCCTCCATGAC
1610
GAAAAAGTCATGGAG
3379

TTTTTC

GCCAT

7493
7515
CCATGGCCTCCATGACT
1611
TGAAAAAGTCATGGA
3380

TTTTCA

GGCCA

7499
7521
CCTCCATGACTTTTTCA
1612
CCTTTTTGAAAAAGTC
3381

AAAAGG

ATGG

7502
7524
CCATGACTTTTTCAAAA
1613
ATACCTTTTTGAAAAA
3382

AGGTAT

GTCA

7533
7555
CCATTTCATAACTTTGT
1614
ACTTTGACAAAGTTAT
3383

CAAAGT

GAAA

7573
7595
CCTATATATCTTAATGG
1615
CATGTGCCATTAAGAT
3384

CACATG

ATAT

7626
7648
CCCCTATCATAGAAGAG
1616
GATAAGCTCTTCTATG
3385

CTTATC

ATAG

7627
7649
CCCTATCATAGAAGAGC
1617
TGATAAGCTCTTCTAT
3386

TTATCA

GATA

7628
7650
CCTATCATAGAAGAGCT
1618
GTGATAAGCTCTTCTA
3387

TATCAC

TGAT

7650
7672
CCTTTCATGATCACGCC
1619
TATGAGGGCGTGATCA
3388

CTCATA

TGAA

7665
7687
CCCTCATAATCATTTTC
1620
GATAAGGAAAATGATT
3389

CTTATC

ATGA

7666
7688
CCTCATAATCATTTTCCT
1621
AGATAAGGAAAATGA
3390

TATCT

TTATG

7681
7703
CCTTATCTGCTTCCTAGT
1622
ACAGGACTAGGAAGC
3391

CCTGT

AGATA

7693
7715
CCTAGTCCTGTATGCCC
1623
GGAAAAGGGCATACA
3392

TTTTCC

GGACT

7699
7721
CCTGTATGCCCTTTTCCT
1624
GTGTTAGGAAAAGGG
3393

AACAC

CATAC

7707
7729
CCCTTTTCCTAACACTC
1625
TGTTGTGAGTGTTAGG
3394

ACAACA

AAAA

7708
7730
CCTTTTCTAACACTCA
1626
TTGTTGTGAGTGTTAG
3395

CAACAA

GAAA

7714
7736
CCTAACACTCACAACAA
1627
TTAGTTTTGTTGTGAG
3396

AACTAA

TGTT

7773
7795
CCGTCTGAACTATCCTG
1628
GGCGGGCAGGATAGTT
3397

CCCGCC

CAGA

7786
7808
CCTGCCCGCCATCATCC
1629
GGACTAGGATGATGGC
3398

TAGTCC

GGGC

7790
7812
CCCGCCATCATCCTAGT
1630
ATGAGGACTAGGATG
3399

CCTCAT

ATGGC

7791
7813
CCGCCATCATCCTAGTC
1631
GATGAGGACTAGGAT
3400

CTCATC

GATGG

7794
7816
CCATCATCCTAGTCCTC
1632
GGCGATGAGGACTAG
3401

ATCGCC

GATGA

7801
7823
CCTAGTCCTCATCGCCC
1633
ATGGGAGGGCGATGA
3402

TCCCAT

GGACT

7807
7829
CCTCATCGCCCTCCCAT
1634
GTAGGGATGGGAGGG
3403

CCCTAC

CGATG

7815
7837
CCCTCCCATCCCTACGC
1635
AAGGATGCGTAGGGA
3404

ATCCTT

TGG

7816
7838
CCTCCCATCCCTACGCA
1636
AAAGGATGCGTAGGG
3405

TCCTTT

ATGGG

7819
7841
CCCATCCCTACGCATCC
1637
TGTAAAGGATGCGTAG
3406

TTTACA

GGAT

7820
7842
CCATCCCTACGCATCCT
1638
ATGTAAAGGATGCGTA
3407

TTACAT

GGGA

7824
7846
CCCTACGCATCCTTTAC
1639
TGTTATGTAAAGGATG
3408

ATAACA

CGTA

7825
7847
CCTACGCATCCTTTACA
1640
CTGTTATGTAAAGGAT
3409

TAACAG

GCGT

7834
7856
CCTTTACATAACAGACG
1641
TGACCTCGTCTGTTAT
3410

AGGTCA

GTAA

7862
7884
CCCTCCCTTACCATCAA
1642
ATTGATTTGATGGTAA
3411

ATCAAT

GGGA

7863
7885
CCTCCCTTACCATCAAA
1643
AATTGATTTGATGGTA
3412

TCAATT

AGGG

7866
7888
CCCTTACCATCAAATCA
1644
GCCAATTGATTTGATG
3413

ATTGGC

GTAA

7867
7889
CCTTACCATCAAATCAA
1645
GGCCAATTGATTTGAT
3414

TTGGCC

GGTA

7872
7894
CCATCAAATCAATTGGC
1646
TTGGTGGCCAATTGAT
3415

CACCAA

TTGA

7888
7910
CCACCAATGGTACTGAA
1647
CGTAGGTTCAGTACCA
3416

CCTACG

TTGG

7891
7913
CCAATGGTACTGAACCT
1648
ACTCGTAGGTTCAGTA
3417

ACGAGT

CCAT

7905
7927
CCTACGAGTACACCGAC
1649
GCCGTAGTCGGTGTAC
3418

TACGGC

TCGT

7917
7939
CCGACTACGGCGGACTA
1650
GAAGATTAGTCCGCCG
3419

ATCTTC

TAGT

7944
7966
CCTACATACTTCCCCCA
1651
GAATAATGGGGGAAG
3420

TTATTC

TATGT

7955
7977
CCCCCATTATTCCTAGA
1652
CCTGGTTCTAGGAATA
3421

ACCAGG

ATGG

7956
7978
CCCCATTTTCCTAGAA
1653
GCCTGGTTCTAGGAAT
3422

CCAGGC

AATG

7957
7979
CCCATTATTCCTAGAAC
1654
CGCCTGGTTCTAGGAA
3423

CAGGCG

TAAT

7958
7980
CCATTATTCCTAGAACC
1655
TCGCCTGGTTCTAGGA
3424

AGGCGA

ATAA

7966
7988
CCTAGAACCAGGCGACC
1656
GTCGCAGGTCGCCTGG
3425

TGCGAC

TTCT

7973
7995
CCAGGCGACCTGCGACT
1657
TCAAGGACTCGCAGGT
3426

CCTTGA

CGCC

7981
8003
CCTGCGACTCCTTGACG
1658
TGTCAACGTCAAGGAG
3427

TTGACA

TCGC

7990
8012
CCTTGACGTTGACAATC
1659
CTACTCGATTGTCAAC
3428

GAGTAG

GTCA

8017
8039
CCCGATTGAAGCCCCCA
1660
TACGAATGGGGGCTTC
3429

TTCCTTA

AATC

8018
8040
CCGATTGAAGCCCCCAT
1661
ATACGAATGGGGGCTT
3430

TCGTAT

CAAT

8028
8050
CCCCCATTCGTATAATA
1662
TGTAATTATTATACGA
3431

ATTACA

ATGG

8029
8051
CCCCATTCGTATAATAA
1663
ATGTAATTATTATACG
3432

TTACAT

AATG

8030
8052
CCCATTCGTATAATAAT
1664
GATGTAATTATTATAC
3433

TACATC

GAAT

8031
8053
CCATTCGTATAATAATT
1665
TGATGTAATTATTATA
3434

ACATCA

CGAA

8080
8102
CCCCACATTAGGCTTAA
1666
CTGTTTTTAAGCCTAA
3435

AAACAG

TGTG

8081
8103
CCCACATTAGGCTTAAA
1667
TCTGTTTTTAAGCCTA
3436

AACAGA

ATGT

8082
8104
CCACATTAGGCTTAAAA
1668
ATCTGTTTTTAAGCCT
3437

ACAGAT

AATG

8111
8133
CCCGGACGTCTAAACCA
1669
GTGGTTTGGTTTAGAC
3438

AACCAC

GTCC

8112
8134
CCGGACGTCTAAACCAA
1670
AGTGGTTTGGTTTAGA
3439

ACCACT

CGTC

8125
8147
CCAAACCACTTTCACCG
1671
GTGTAGCGGTGAAAGT
3440

CTACAC

GGTT

8130
8152
CCACTTTCACCGCTACA
1672
CGGTCGTGTAGCGGTG
3441

CGACCG

AAAG

8139
8161
CCGCTACACGACCGGGG
1673
GTATACCCCCGGTCGT
3442

GTATAC

GTAG

8150
8172
CCGGGGGTATACTACGG
1674
CATTGACCGTAGTATA
3443

TCAATG

CCCC

8194
8216
CCACAGTTTCATGCCCA
1675
GGACGATGGGCATGA
3444

TCGTCC

AACTG

8207
8229
CCCATCGTCCTAGAATT
1676
GGAATTAATTCTAGGA
3445

AATTCC

CGAT

8208
8230
CCATCGTCCTAGAATTA
1677
GGGAATTAATTCTAG
3446

ATTCCC

ACGA

8215
8237
CCTAGAATTAATTCCCC
1678
TTTTTAGGGGAATTAA
3447

TAAAAA

TTCT

8228
8250
CCCCTAAAAATCTTTGA
1679
CCTATTTCAAAGATTT
3448

AATAGG

TTAG

8229
8251
CCCTAAAAATCTTTGAA
1680
CCCTATTTCAAAGATT
3449

ATAGGG

TTTA

8230
8252
CCTAAAAATCTTTGAAA
1681
GCCCTATTTCAAAGAT
3450

TAGGGC

TTTT

8252
8274
CCCGTATTTACCCTATA
1682
GGGTGCTATAGGGTAA
3451

GCACCC

ATAC

8253
8275
CCGTATTTACCCTATAG
1683
GGGGTGCTATAGGGTA
3452

CACCCC

AATA

8262
8284
CCCTATAGCACCCCCTC
1684
GGGGTAGAGGGGGTG
3453

TACCCC

CTATA

8263
8285
CCTATAGCACCCCCTCT
1685
GGGGGTAGAGGGGGT
3454

ACCCCC

GCTAT

8272
8294
CCCCCTCTACCCCCTCT
1686
GGCTCTAGAGGGGGTA
3455

AGAGCC

GAGG

8273
8295
CCCCTCTACCCCCTCTA
1687
GGGCTCTAGAGGGGGT
3456

GAGCCC

AGAG

8274
8296
CCCTCTACCCCCTCTAG
1688
TGGGCTCTAGAGGGGG
3457

AGCCCA

TAGA

8275
8297
CCTCTACCCCCTCTAGA
1689
GTGGGCTCTAGAGGCG
3458

GCCCAC

GTAG

8281
8303
CCCCCTCTAGAGCCCAC
1690
TTTACAGTGGGCTCTA
3459

TGTAAA

GAGG

8282
8304
CCCCTCTAGAGCCCACT
1691
CTTTACAGTGGGCTCT
3460

GTAAAG

AGAG

8283
8305
CCCTCTAGAGCCCACTG
1692
GCTTTACAGTGGGCTC
3461

TAAAGC

TAGA

8284
8306
CCTCTAGAGCCCACTGT
1693
AGCTTTACAGTGGGCT
3462

AAAGCT

CTAG

8293
8315
CCCACTGTAAAGCTAAC
1694
TGCTAAGTTAGCTTTA
3463

TTAGCA

CAGT

8294
8316
CCACTGTAAAGCTAACT
1695
ATGCTAAGTTAGCTTT
3464

TAGCAT

ACAG

8320
8342
CCTTTTAAGTTAAAGAT
1696
CTCTTAATCTTTAACTT
3465

TAAGAG

AAA

8345
8367
CCAACACCTCTTTACAG
1697
ATTTCACTGTAAAGAG
3466

TGAAAT

GTGT

8351
8373
CCTCTTTACAGTGAAAT
1698
TGGGGCATTTCACTGT
3467

GCCCCA

AAAG

8369
8391
CCCCAACTAAATACTAC
1699
CATACGGTAGTATTTA
3468

CGTATG

GTTG

8370
8392
CCCAACTAAATACTACC
1700
CCATACGGTAGTATTT
3469

GTATGG

AGTT

8371
8393
CCAACTAAATACTACCG
1701
GCCATACGGTAGTATT
3470

TATGGC

TAGT

8385
8407
CCGTATGGCCCACCATA
1702
GGTAATTATGGTGGGC
3471

ATTACC

CATA

8393
8415
CCCACCATAATTACCCC
1703
AGTATGGGGGTAATTA
3472

CATACT

TGGT

8394
8416
CCACCATAATTACCCCC
1704
GAGTATGGGGGTAATT
3473

ATACTC

ATGG

8397
8419
CCATAATTACCCCCATA
1705
AAGGAGTATGGGGGT
3474

CTCCTT

AATTA

8406
8428
CCCCCATACTCCTTACA
1706
GAATAGTGTAAGGAGT
3475

CTATTC

ATGG

8407
8429
CCCCATACTCCTTACAC
1707
GGAATAGTGTAAGGA
3476

TATTCC

GTATG

8408
8430
CCCATACTCCTTACACT
1708
AGGAATAGTGTAAGG
3477

ATTCCT

AGTAT

8409
8431
CCATACTCCTTACACTTA
1709
GAGGAATAGTGTAAG
3478

TTCCTC

GAGTA

8416
8438
CCTTACACTATTCCTCA
1710
GGGTGATGAGGAATA
3479

TCACCC

GTGTA

8428
8450
CCTCATCACCCAACTAA
1711
ATATTTTTAGTTGGGT
3480

AAATAT

GATG

8436
8458
CCCAACTAAAAATATTA
1712
TGTGTTTAATATTTTTA
3481

AACACA

GTT

8437
8459
CCAACTAAAAATATTAA
1713
TTGTGTTTAATATTTTT
3482

ACACAA

AGT

8464
8486
CCACCTACCTCCCTCAC
1714
GCTTTGGTGAGGGAGG
3483

CAAAGC

GAGG

8467
8489
CCTACCTCCCTCACCAA
1715
TGGGCTTTGGTGAGGG
3484

AGCCCA

AGGT

8471
8493
CCTCCCTCACCAAAGCC
1716
TTTATGGGCTTTGGTG
3485

CATAAA

AGGG

8474
8496
CCCTCACCAAAGCCCAT
1717
ATTTTTATGGGCTTTG
3486

AAAAAT

GTGA

8475
8497
CCTCACCAAAGCCCATA
1718
TATTTTTATGGGCTTTG
3487

AAAATA

GTG

8480
8502
CCAAAGCCCATAAAAAT
1719
TTTTTTATTTTTATGG
3488

AAAAAA

CTT

8486
8508
CCCATAAAAATAAAAA
1720
TTATAATTTTTTATTTT
3489

ATTATAA

TAT

8487
8509
CCATAAAAATAAAAAA
1721
GTTATAATTTTTTATTT
3490

TTATAAC

TTA

8513
8535
CCCTGAGAACCAAAATG
1722
TTCGTTCATTTTGGTTC
3491

AACGAA

TCA

8514
8536
CCTGAGAACCAAAATG
17231
TTTCGTTCATTTTGGTT
3492

AACGAAA

CTC

8522
8544
CCAAAATGAACGAAAA
1724
GAACAGATTTTCGTTC
3493

TCTGTTC

ATTT

8558
8580
CCCCCACAATCCTAGGC
1725
GGGTAGGCCTAGGATT
3494

CTACCC

GTGG

8559
8581
CCCCACAATCCTAGGCC
1726
CGGGTAGGCCTAGGAT
3495

TACCCG

TGTG

8560
8582
CCCACAATCCTAGGCCT
1727
GCGGGTAGGCCTTAGG
3496

ACCCGC

ATTGT

8561
8583
CCACAATCCTAGGCCTA
1728
GGCGGGTAGGCCTAG
3497

CCCGCC

GATTG

8568
8590
CCTAGGCCTACCCGCCG
1729
GTACTGCGGCGGGTAG
3498

CAGTAC

GCCT

8574
8596
CCTACCCGCCGCAGTAC
1730
TGATCAGTACTGCGGC
3499

TGATCA

GGGT

8578
8600
CCCGCCGCAGTACTGAT
1731
AGAATGATCAGTACTG
3500

CATTCT

CGGC

8579
8601
CCGCCGCAGTACTGATC
1732
TAGAATGATCAGTACT
3501

ATTCTA

GCGG

8582
8604
CCGCAGTACTGATCATT
1733
AAATAGAATGATCAGT
3502

CTATTT

ACTG

8605
8627
CCCCCTCTATTGATCCC
1734
GAGGTGGGGATCAAT
3503

CACCTC

AGAGG

8606
8628
CCCCTCTATTGATCCCC
1735
GGAGGTGGGGATCAA
3504

ACCTCC

TAGAG

8607
8629
CCCTCTATTGATCCCCA
1736
TGGAGGTGGGGATCA
3505

CCTCCA

ATAGA

8608
8630
CCTCTATTGATCCCCAC
1737
TTGGAGGTGGGGATCA
3506

CTCCAA

ATAG

8619
8641
CCCCACCTCCAAATATC
1738
TGATGAGATATTTGGA
3507

TCATCA

GGTG

8620
8642
CCCACCTCCAAATATCT
1739
TTGATGAGATATTTGG
3508

CATCAA

AGGT

8621
8643
CCACCTCCAAATATCTC
1740
GTTGATGAGATATTTG
3509

ATCAAC

GAGG

8624
8646
CCTCCAAATATCTCATC
1741
GTTGTTGATGAGATAT
3510

AACAAC

TTGG

8627
8649
CCAAATATCTCATCAAC
1742
TCGGTTGTTGATGAGA
3511

AACCGA

TATT

8646
8668
CCGACTAATCACCACCC
1743
ATTGTTGGGTGGTGAT
3512

AACAAT

TAGT

8657
8679
CCACCCAACAATGACTA
1744
TTTGATTAGTCATTGTT
3513

ATCAAA

GGG

8660
8682
CCCAACAATGACTAATC
1745
TAGTTTGATTAGTCAT
3514

AAACTA

TGTT

8661
8683
CCAACAATGACTAATCA
1746
TTAGTTTGATTAGTCA
3515

AACTAA

TTGT

8684
8706
CCTCAAAACAAATGATA
1747
TATGGTTATCATTTGTT
3516

ACCTA

TTG

8702
8724
CCATACACAACACTAAA
1748
TCGTCCTTTAGTGTTGT
3517

GGACGA

GTA

8726
8748
CCTGATCTCTTATACTA
1749
GGATACTAGTATAAGA
3518

GTATCC

GATC

8747
8769
CCTTAATCATTTTTATTG
1750
TGTGGCAATAAAAATG
3519

CCACA

ATTA

8765
8787
CCACAACTAACCTCCTC
1751
GAGTCCGAGGAGGTTA
3570

GGACTC

GTTG

8775
8797
CCTCCTCGGACTCCTGC
1752
AGTGAGGCAGGAGTC
3521

CTCACT

CGAGG

8778
8800
CCTCGGACTCCTGCCTC
1753
ATGAGTGAGGCAGGA
3522

ACTCAT

GTCCG

8787
8809
CCTGCCTCACTCATTTA
1754
TTGGTGTAAATGAGTG
3523

CACCAA

AGGC

8791
8813
CCTCACTCATTTACACC
1755
GTGGTTGGTGTAAATG
3524

AACCAC

AGTG

8806
8828
CCAACCACCCAACTATC
1756
TTTATAGATAGTTGGG
3525

TATAAA

TGGT

8810
8832
CCACCCAACTATCTATA
1757
TAGGTTTATAGATAGT
3526

AACCTA

TGGG

8813
8835
CCCAACTATCTATAAAC
1758
GGCTAGGTTTATAGAT
3527

CTAGCC

AGTT

8814
8836
GCCAACTATCTATAAACC
1759
TGGCTAGGTTTATAGA
3528

TAGCCA

TAGT

8829
8851
CCTAGCCATGGCCATCC
1760
ATAAGGGGATGGCCAT
3529

CCTTAT

GGCT

8834
8856
CCATGGCCATCCCCTTA
1761
CGCTCATAAGGGGATG
3530

TGAGCG

GCCA

8840
8862
CCATCCCCTTATGAGCG
1762
TGTGCCCGCTCATAAG
3531

GGCACA

GGGA

8844
8866
CCCCTTATGAGCGGGCA
1763
TCACTGTGCCCGCTCA
3532

CAGTGA

TAAG

8845
8867
CCCTTATGAGCGGGCAC
1764
ATCACTGTGCCCGCTC
3533

AGTGAT

ATAA

8846
8868
CCTTATGAGCGGGCACA
1765
AATCACTGTGCCCGCT
3534

GTGATT

CATA

8897
8919
CCCTAGCCCACTTCTTA
1766
TTGTGGTAAGAAGTGG
3535

CCACAA

GCTA

8898
8920
CCTAGCCCACTTCTTAC
1767
CTTGTGGTAAGAAGTG
3536

CACAAG

GGCT

8903
8925
CCCACTTCTTACCACAA
1768
TGTGCCTTGTGGTAAG
3537

GGCACA

AAGT

8904
8926
CCACTTCTTACCACAAG
1769
GTGTGCCTTGTGGTAA
3538

GCACAC

GAAG

8914
8936
CCACAAGGCACACCTAC
1770
AGGGGTGTAGGTGTGC
3539

ACCCCT

CTTG

8926
8948
CCTACACCCCTTATCCC
1771
AGTATGGGGATAAGG
3540

CATACT

GGTGT

8932
8954
CCCCTTATCCCCATACT
1772
ATAACTAGTATGGGGA
3541

AGTTAT

TAAG

8933
8955
CCCTTATCCCCATACTA
1773
AATAACTAGTATGGGG
3542

GTTATT

ATAA

8934
8956
CCTTATCCCCATACTAG
1774
TAATAACTAGTATGGG
3543

TTATTA

GATA

8940
8962
CCCCATACTAGTTATTA
1775
TTTCGATAATAACTAC
3544

TCGAAA

TATG

8941
8963
CCCATACTAGTTATTAT
1776
GTTTCGATAATAACTA
3545

CGAAAC

GTAT

8942
8964
CCATACTAGTTATTATC
1777
GGTTTCGATAATAACT
3546

GAAACC

AGTA

8963
8985
CCATCAGCCTACTCATT
1778
TGGTTGAATGAGTAGG
3547

CAACCA

CTGA

8970
8992
CCTACTCATTCAACCAA
1779
GGGCTATTGGTTGAAT
3548

TAGCCC

GAGT

8983
9005
CCAATAGCCCTGGCCGT
1780
AGGCGTACGGCCAGG
3549

ACGCCT

GCTAT

8990
9012
CCCTGGCCGTACGCCTA
1781
AGCGGTTAGGCGTACG
3550

ACCGCT

GCCA

8991
9013
CCTGGCCGTACGCCTAA
1782
TAGCGGTTAGGCGTAC
3551

CCGCTA

GGCC

8996
9018
CCGTACGCCTAACCGCT
1783
AATGTTAGCGGTTAGG
3552

AACATT

CGTA

9003
9025
CCTAACCGCTAACATTA
1784
CTGCAGTAATGTTAGC
3553

CTGCAG

GGTT

9008
9030
CCGCTAACATTACTGCA
1785
GTGGCCTGCAGTAATG
3554

GGCCAC

TTAG

9027
9049
CCACCTACTCATGCACC
1786
CAATTAGGTGCATGAG
3555

TAATTG

TAGG

9030
9052
CCTACTCATGCACCTAA
1787
TTCCAATTAGGTGCAT
3556

TTGGAA

GAGT

9042
9064
CCTAATTGGAAGCGCCA
1788
CTAGGGTGGCGCTTCC
3557

CCCTAG

AATT

9056
9078
CCACCCTAGCAATATCA
1789
AATGGTTGATATTGCT
3558

ACCATT

AGGG

9059
9081
CCCTAGCAATATCAACC
1790
GTTAATGGTTGATATT
3559

ATTAAC

GCTA

9060
9082
CCTAGCAATATCAACCA
1791
GGTTAATGGTTGATAT
3560

TTAACC

TGCT

9074
9096
CCATTAACCTTCCCTCT
1792
AAGTGTAGAGGGAAG
3561

ACACTT

GTTAA

9081
9103
CCTTCCCTCTACACTTAT
1793
AGATGATAAGTGTAGA
3562

CATCT

GGGA

9085
9107
CCCTCTACACTTATCAT
1794
GTGAAGATGATAAGTG
3563

CTTCAC

TAGA

9086
9108
CCTCTACACTTATCATC
1795
TGTGAAGATGATAAGT
3564

TTCACA

GTAG

9129
9151
CCTAGAAATCGCTGTCG
1796
TAAGGCGACAGCGAT
3565

CCTTAA

TTCT

9146
9168
CCTTAATCCAAGCCTAC
1797
GAAAACGTAGGCTTGG
3566

GTTTTC

ATTA

9153
9175
CCAAGCCTACGTTTTCA
1798
GAAGTGTGAAAACGT
3567

CACTTTC

AGGCT

9158
9180
CCTACGTTTTCACACTT
1799
TACTAGAAGTGTGAAA
3568

CTAGTA

ACGT

9183
9205
CCTCTACCTGCACGACA
1800
ATGTGTTGTCGTGCAG
3569

ACACAT

GTAG

9189
9211
CCTGCACGACAACACAT
1801
GTCATTATGTGTTGTC
3570

AATGAC

GTGC

9211
9233
CCCACCAATCACATGCC
1802
ATGATAGGCATGTGAT
3571

TATCAT

TGGT

9212
9234
CCACCAATCACATGCCT
1803
TATGATAGGCATGTGA
3572

ATCATA

TTGG

9215
9237
CCAATCACATGCCTATC
1804
CTATATGATAGGCATG
3573

ATATAG

TGAT

9226
9248
CCTATCATATAGTAAAA
1805
GCTGGGTTTTACTATA
3574

CCCAGC

TGAT

9243
9265
CCCAGCCCATGACCCCT
1806
CCTGTTAGGGGTCATG
3575

AACAGG

GGCT

9244
9266
CCAGCCCATGACCCCTA
1807
CCCTGTTAGGGGTCAT
3576

ACAGGG

GGGC

9248
9270
CCCATGACCCCTAACAG
1808
GGGCCCCTGTTAGGGG
3577

GGGCCC

TCAT

9249
9271
CCATGACCCCTAACAGG
1809
AGGGCCCCTGTTAGGG
3578

GGCCCT

GTCA

9255
9277
CCCCTAACAGGGGCCCT
1810
GCTGAGAGGGCCCCTG
3579

CTCAGC

TTAG

9256
9278
CCCTAACAGGGGCCCTC
1811
GGCTGAGAGGGCCCCT
3580

TCAGCC

GTTA

9257
9279
CCTAACAGGGGCCCTCT
1812
GGGCTGAGAGGGCCC
3581

CAGCCC

CTGTT

9268
9290
CCCTCTCAGCCCTCCTA
1813
GGTCATTAGGAGGGCT
3582

ATGACC

GAGA

9269
9291
CCTCTCAGCCCTCCTAA
1814
AGGTCATTAGGAGGGC
3583

TGACCT

TGAG

9277
9299
CCCTCCTAATGACCTCC
1815
TAGGCCGGAGGTCATT
3584

GGCCTA

AGGA

9278
9300
CCTCCTAATGACCTCCG
1816
CTAGGCCGGAGGTCAT
3585

GCCTAG

TAGG

9281
9303
CCTAATGACCTCCGGCC
1817
TGGCTAGGCCGGAGGT
3586

TAGCCA

CATT

9289
9311
CCTCCGGCCTAGCCATG
1818
AAATCACATGGCTAGG
3587

TGATTT

CCGG

9292
9314
CCGGCCTAGCCATGTGA
1819
GTGAAATCACATGGCT
3588

TTTCAC

AGGC

9296
9318
CCTAGCCATGTGATTTC
1820
GGAAGTGAAATCACAT
3589

ACTTCC

GGCT

9301
9323
CCATGTGATTTCACTTC
1821
GGAGTGGAAGTGAAA
3590

CACTCC

TCACA

9317
9339
CCACTCCATAACGCTCC
1822
GTATGAGGAGCGTTAT
3591

TCATAC

GGAG

9322
9344
CCATAACGCTCCTCATA
1823
GCCTAGTATGAGGAGC
3592

CTAGGC

GTTA

9332
9354
CCTCATACTAGGCCTAC
1824
TGGTTAGTAGGCCTAG
3593

TAACCA

TATG

9344
9366
CCTACTAACCAACACAC
1825
TGGTTAGTGTGTTGGT
3594

TAACCA

TAGT

9352
9374
CCAACACACTAACCATA
1826
TTGGTATATGGTFAGT
3595

TACCAA

GTGT

9364
9386
CCATATACCAATGATGG
1827
ATCGCGCCATCATTGG
3596

CGCGAT

TATA

9371
9393
CCAATGATGGCGCGATG
1828
GTGTTACATCGCGCCA
3597

TAACAC

TCAT

9407
9429
CCAAGGCCACCACACAC
1829
CAGGTGGTGTGTGGTG
3598

CACCTG

GCCT

9413
9435
CCACCACACACCACCTG
1830
TTTGGACAGGTGGTGT
3599

TCCAAA

GTGG

9416
9438
CCACACACCACCTGTCC
1831
CTTTTTGGACAGGTGG
3600

AAAAAG

TGTG

9423
9445
CCACCTGTCCAAAAAGG
1832
CGAAGGCCTTTTTGGA
3601

CCTTCG

CAGG

9426
9448
CCTGTCCAAAAAGGCCT
1833
TATCGAAGGCCTTTTT
3602

TCGATA

GGAC

9431
9453
CCAAAAAGGCCTTCGAT
1834
TCCCGTATCGAAGGCC
3603

ACGGGA

TTTT

9440
9462
CCTTCGATACGGGATAA
1835
ATAGGATTATCCCGTA
3604

TCCTAT

TCGA

9458
9480
CCTATTTATTACCTCAG
1836
AAACTTCTGAGGTAAT
3605

AAGTTT

AAAT

9469
9491
CCTCAGAAGTTTTTTTCT
1837
TGCGAAGAAAAAAAC
3606

TCGCA

TTCTG

9505
9527
CCTTTTACCACTCCAGC
1838
GGCTAGGCTGGAGTGG
3607

CTAGCC

TAAA

9512
9534
CCACTCCAGCCTAGCCC
1839
GGGTAGGGGCTAGGCT
3608

CTACCC

GGAG

9517
9539
CCAGCCTAGCCCCTACC
1840
TTGGGGGGTAGGGGCT
3609

CCCCAA

AGGC

9521
9543
CCTAGCCCCTACCCCCC
1841
CTAATTGGGGGGTAGG
3610

AATTAG

GGCT

9526
9548
CCCCTACCCCCCAATTA
1842
CCCTCCTAATTGGGGG
3611

GGAGGG

GTAG

9527
9549
CCCTACCCCCCAATTAG
1843
GCCCTCCTAATTGGGG
3612

GAGGGC

GGTA

9528
9550
CCTACCCCCCAATTAGG
1844
TGCCCTCCTAATTGGG
3613

AGGGCA

GGGT

9532
9554
CCCCCCAATTAGGAGGG
1845
CCAGTGCCCTCCTAAT
3614

CACTGG

TGGG

9533
9555
CCCCCAATTAGGAGGGC
1846
GCCAGTGCCCTCCTAA
3615

ACTGGC

TTGG

9534
9556
CCCCAATTAGGAGGGCA
1847
GGCCAGTGCCCTCCTA
3616

CTGGCC

ATTG

9535
9557
CCCAATTAGGAGGGCAC
1848
GGGCCAGTGCCCTCCT
3617

TGGCCC

AATT

9536
9558
CCAATTAGGAGGGCACT
1849
GGGGCCAGTGCCCTCC
3618

GGCCCC

TAAT

9555
9577
CCCCCAACAGGCATCAC
1850
AGCGGGGTGATGCCTG
3619

CCCGCT

TTGG

9556
9578
CCCCAACAGGCATCACC
1851
TAGCGGGGTGATGCCT
3620

CCGCTA

GTTG

9557
9579
CCCAACAGGCATCACCC
1852
TTAGCGGGGTGATGCC
3621

CGCTAA

TGTT

9558
9580
CCAACAGGCATCACCCC
1853
TTTAGCGGGGTGATGC
3622

GCTAAA

CTGT

9571
9593
CCCCGCTAAATCCCCTA
1854
GACTTCTAGGGGATTT
3623

GAAGTC

AGCG

9572
9594
CCCGCTAAATCCCCTAG
1855
GGACTTCTAGGGGATT
3624

AAGTCC

TAGC

9573
9595
CCGCTAAATCCCCTAGA
1856
GGGACTTCTAGGGGAT
3625

AGTCCC

TTAG

9582
9604
CCCCTAGAAGTCCCACT
1857
TTTAGGAGTGGGACTT
3626

CCTAAA

CTAG

9583
9605
CCCTAGAAGTCCCACTC
1858
GTTTAGGAGTGGGACT
3627

CTAAAC

TCTA

9584
9606
CCTAGAAGTCCCACTCC
1859
TGTTTAGGAGTGGGAC
3628

TAAACA

TTCT

9593
9615
CCCACTCCTAAACACAT
1860
ATACGGATGTGTTTAG
3629

CCGTAT

GAGT

9594
9616
CCACTCCTAAACACATC
1861
AATACGGATGTGTTTA
3630

CGTATT

GGAG

9599
9621
CCTAAACACATCCGTAT
1862
CGAGTAATACGGATGT
3631

TACTCG

GTTT

9610
9632
CCGTATTACTCGCATCA
1863
TACTCCTGATGCGAGT
3632

GGAGTA

AATA

9640
9662
CCTGAGCTCACCATAGT
1864
TATTAGACTATGGTGA
3633

CTAATA

GCTC

9650
9672
CCATAGTCTAATAGAAA
1865
GGTTGTTTTCTATTAG
3634

ACAACC

ACTA

9671
9693
CCGAAACCAAATAATTC
1866
GTGCTTGAATTATTTG
3635

AAGCAC

GTTT

9677
9699
CCAAATAATTCAAGCAC
1867
TAAGCAGTGCTTGAAT
3636

TGCTTA

TATT

9727
9749
CCCTCCTACAAGCCTCA
1868
GTACTCTGAGGCTTGT
3637

GAGTAC

AGGA

9728
9750
CCTCCTACAAGCCTCAG
1869
AGTACTCTGAGGCTTG
3638

AGTACT

TAGG

9731
9753
CCTACAAGCCTCAGAGT
1870
CGAAGTACTCTGAGGC
3639

ACTTCG

TTGT

9739
9761
CCTCAGAGTACTTCGAG
1871
CGAAGTACTCTGAGGC
3640

TCTCCC

CTCTG

9759
9781
CCCTTCACCATTTCCGA
1872
ATGCCGTCGGAAATGG
3641

CGGCAT

TGAA

9760
9782
CCTTCACCATTTCCGAC
1873
GATGCCGTCGGAAATG
3642

GGCATC

GTGA

9766
9788
CCATTTCCGACGGCATC
1874
GCCGTAGATGCCGTCG
3643

TACGGC

GAAA

9772
9794
CCGACGGCATCTACGGC
1875
TGTTGAGCCGTAGATG
3644

TCAACA

CCGT

9805
9827
CCACAGGCTTCCACGGA
1876
GTGAAGTCCGTGGAAG
3645

CTTCAC

CCTG

9815
9837
CCACGGACTTCACGTCA
1877
CAATAATGACGTGAAG
3646

TTATTG

TCCG

9848
9870
CCTCACTATCTGCTTCA
1878
GGCGGATGAAGCAGA
3647

TCCGCC

TAGTG

9866
9888
CCGCCAACTAATATTTC
1879
TAAAGTGAAATATTAG
3648

ACTTTA

TTGG

9869
9891
CCAACTAATATTTCACT
1880
ATGTAAAGTGAAATAT
3649

TTACAT

TAGT

9892
9914
CCAAACATCACTTTGGC
1881
TTCGAAGCCAAAGTGA
3650

TTCGAA

TGTT

9916
9938
CCGCCGCCTGATACTGG
1882
AAAATGCCAGTATCAG
3651

CATTTT

GCGG

9919
9941
CCGCCTGATACTGGCAT
1883
TACAAAATGCCAGTAT
3652

TTTGTA

CAGG

9922
9944
CCTGATACTGGCATTTT
1884
ATCTACAAAATGCCAG
3653

GTAGAT

TATC

9970
9992
CCATCTATTGATGAGGG
1885
GTAAGACCCTCATCAA
3654

TCTTAC

TAGA

10012
10034
CCGTTAACTTCCAATTA
1886
ACTAGTTAATTGGAG
3655

ACTAGT

TTAA

10022
10044
CCAATTAACTAGTTTTG
1887
TGTTGTCAAAACTAGT
3656

ACAACA

TAAT

10069
10091
CCTTAATTTTAATAATC
1888
GGTGTTGATTATTAAA
3657

AACACC

ATTA

10090
10112
CCCTCCTAGCCTTACTA
1889
TATTAGTAGTAAGGCT
3658

CTAATA

AGGA

10091
10113
CCTCCTAGCCTTACTAC
1890
TTATTAGTAGTAAGGC
3659

TAATAA

TAGG

10094
10116
CCTAGCCTTACTACTAA
1891
TAATTATTAGTAGTAA
3660

TAATTA

GGCT

10099
10121
CCTTACTACTAATAATT
1892
TGTAATAATTATTAGT
3661

ATTACA

AGTA

10131
10153
CCACAACTCAACGGCT
1893
TCTATGTAGCCGTTGA
3662

CATAGA

GTTG

10159
10181
CCACCCCTTACGAGTGC
1894
GAAGCCGCACTCGTAA
3663

GGCTTC

GGGG

10162
10184
CCCCTTACGAGTGCGGC
1895
GTCGAAGCCGCACTCG
3664

TTCGAC

TAAG

10163
10185
CCCTTACGAGTGCGGCT
1896
GGTCGAAGCCGCACTC
3665

TCGACC

GTAA

10164
10186
CCTTACGAGTGCGGCTT
1897
GGGTCGAAGCCGCACT
3666

CGACCC

CGTA

10184
10206
CCCTATATCCCCCGCCC
1898
GGACGCGGGCGGGGG
3667

GCGTCC

ATATA

10185
10207
CCTATATCCCCCGCCCG
1899
GGGACGCGGGCGGGG
3668

CGTCCC

GATAT

10192
10214
CCCCCGCCCGCGTCCCT
1900
GGAGAAAGGGACGCG
3669

TTCTCC

GGCGG

10193
10215
CCCCGCCCGCGTCCCTT
1901
TGGAGAAAGGGACGC
3670

TCTCCA

GGGCG

10194
10216
CCCGCCCGCGTCCCTTT
1902
ATGGAGAAAGGGACG
3671

CTCCAT

CGGGC

10195
10217
CCGCCCGCGTCCCTTTC
1903
TATGGAGAAAGGGAC
3672

TCCATA

GCGGG

10198
10220
CCCGCGTCCCTTTCTCC
1904
TTTTATGGAGAAAGGG
3673

ATAAAA

ACGC

10199
10221
CCGCGTCCCTTTCTCCA
1905
ATTTTATGGAGAAAGG
3674

TAAAAT

GACG

10205
10227
CCCTTTCTCCATAAAAT
1906
AGAAGAATTTTATGGA
3675

TCTTCT

GAAA

10206
10228
CCTTTCTCCATAAAATT
1907
AAGAAGAATTTTATGG
3676

CTTCTT

AGAA

10213
10235
CCATAAAATTCTTCTTA
1908
AGCTACTAAGAAGAAT
3677

GTAGCT

TTTA

10240
10262
CCTTCTTATTATTTGATC
1909
TTCTAGATCAAATAAT
3678

TAGAA

AAGA

10267
10289
CCCTCCTTTTACCCCTAC
1910
TCATGGTAGGGGTAAA
3679

CATGA

AGGA

10268
10290
CCTCCTTTTACCCCTACC
1911
CTCATGGTAGGGGTAA
3680

ATGAG

AAGG

10271
10293
CCTTTTACCCCTACCAT
1912
GGGCTCATGGTAGGGG
3681

GAGCCC

TAAA

10278
10300
CCCCTACCATGAGCCCT
1913
GTTTGTAGGGCTCATG
3682

ACAAAC

GTAG

10279
10301
CCCTACCATGAGCCCTA
1914
TGTTTGTAGGGCTCAT
3683

CAAACA

GGTA

10280
10302
CCTACCATGAGCCCTAC
1915
TTGTTTGTAGGGCTCA
3684

AAACAA

TGGT

10284
10306
CCATGAGCCCTACAAAC
1916
TTAGTTGTTTGTAGGG
3685

AACTAA

CTCA

10291
10313
CCCTACAAACAACTAAC
1917
TGGCAGGTTAGTTGTT
3686

CTGCCA

TGTA

10292
10314
CCTACAAACAACTAACC
1918
GTGGCAGGTTAGTTGT
3687

TGCCAC

TTGT

10307
10329
CCTGCCACTAATAGTTA
1919
ATGACATAACTATTAG
3688

TGTCAT

TGGC

10311
10333
CCACTAATAGTTATGTC
1920
AGGGATGACATAACTA
3689

ATCCCT

TTAG

10330
10352
CCCTCTTATTAATCATC
1921
TAGGATGATGATTAAT
3690

ATCCTA

AAGA

10331
10353
CCTCTTATTAATCATCA
1922
CTAGGATGATGATTAA
3691

TCCTAG

TAAG

10349
10371
CCTAGCCCTAAGTCTGG
1923
CATAGCCAGACTTAG
3692

CCTATG

GGCT

10354
10376
CCCTAAGTCTGGCCTAT
1924
TCACTCATAGGCCAGA
3693

GAGTGA

CTTA

10355
10377
CCTAAGTCTGGCCTATG
1925
GTCACTCATAGGCCAG
3694

AGTGAC

ACTT

10366
10388
CCTATGAGTGACTACAA
1926
TCCTTTTTGTAGTCACT
3695

AAAGGA

CAT

10399
10421
CCGAATTGGTATATAGT
1927
GTTTAAACTATATACC
3696

TTAAAC

AATT

10466
10488
CCAAATGCCCCTCATTT
1928
TTATGTAAATGAGGGG
3697

ACATAA

CATT

10473
10495
CCCCTCATTTACATAAA
1929
ATAATATTTATGTAAA
3698

TATTAT

TGAG

10474
10496
CCCTCATTTACATAAAT
1930
TATAATATTTATGTAA
3699

ATTATA

ATGA

10475
10497
CCTCATTTACATAAATA
1931
GTATAATATTTATGTA
3700

TTATAC

AATG

10507
10529
CCATCTCACTTCTAGGA
1932
TAGTATTCCTAGAAGT
3701

ATACTA

GAGA

10544
10566
CCTCATATCCTCCCTAC
1933
GGCATAGTAGGGAGG
3702

TATGCC

ATATG

10552
10574
CCTCCCTACTATGCCTA
1934
TCCTTCTAGGCATAGT
3703

GAAGGA

AGGG

10555
10577
CCCTACTATGCCTAGAA
1935
TATTCCTTCTAGGCAT
3704

GGAATA

AGTA

10556
10578
CCTACTATGCCTAGAAG
1936
TTATTCCTTCTAGCTCA
3705

GAATAA

TAGT

10565
10587
CCTAGAAGGAATAATAC
1937
GCGATAGTATTATTCC
3706

TATCGC

TTCT

10612
10634
CCCTCAACACCCACTCC
1938
TAAGAGGGAGTGGGT
3707

CTCTTA

GTTGA

10613
10635
CCTCAACACCCACTCCC
1939
CTAAGAGGGAGTGGG
3708

TCTTAG

TGTTG

10621
10643
CCCACTCCCTCTTAGCC
1940
AATATTGGCTAAGAGG
3709

AATATT

GAGT

10622
10644
CCACTCCCTCTTAGCCA
1941
CAATATTGGCTAAGAG
3710

ATATTG

GGAG

10627
10649
CCCTCTTAGCCAATATT
1942
AGGCACAATATTGGCT
3711

GTGCCT

AAGA

10628
10650
CCTCTTAGCCAATATTG
1943
TAGGCACAATATTGGC
3712

TGCCTA

TAAG

10636
10658
CCAATATTGTGCCTATT
1944
TATGGCAATAGGCACA
3713

GCCATA

ATAT

10647
10669
CCTATTGCCATACTAGT
1945
GCAAAGACTAGTATGG
3714

CTTTGC

CAAT

10654
10676
CCATACTAGTCTTTGCC
1946
GCAGGCGGCAAAGAC
3715

GCCTGC

TAGTA

10669
10691
CCGCCTGCGAAGCAGCG
1947
GCCCACCGCTGCTTCG
3716

GTGGGC

CAGG

10672
10694
CCTGCGAAGCAGCGGTG
1948
TAGGCCCACCGCTGCT
3717

GGCCTA

TCGC

10691
10713
CCTAGCCCTACTAGTCT
1949
AGATTGAGACTAGTAG
3718

CAATCT

GGCT

10696
10718
CCCTACTAGTCTCAATC
1950
GTTGGAGATTGAGACT
3719

TCCAAC

AGTA

10697
10719
CCTACTAGTCTCAATCT
1951
TGTTGGAGATTGAGAC
3720

CCAACA

TAGT

10714
10736
CCAACACATATGGCCTA
1952
GTAGTCTAGGCCATAT
3721

GACTAC

GTGT

10727
10749
CCTAGACTACGTACATA
1953
TTAGGTTATGTACGTA
3722

ACCTAA

GTCT

10745
10767
CCTAAACCTACTCCAAT
1954
TTTAGCATTGGAGTAG
3723

GCTAAA

GTTT

10751
10773
CCTACTCCAATGCTAAA
1955
ATTAGTTTTAGCATTG
3724

ACTAAT

GAGT

10757
10779
CCAATGCTAAAACTAAT
1956
GGGACGATTAGTTTTA
3725

CGTCCC

GCAT

10777
10799
CCCAACAATTATATTAC
1957
GTGGTAGTAATATAAT
3726

TACCAC

TGTT

10778
10800
CCAACAATTATATTACT
1958
AGTGGTAGTAATATAA
3727

ACCACT

TTGT

10796
10818
CCACTGACATGACTTTC
1959
TTTTTGGAAAGTCATG
3728

CAAAAA

TCAG

10812
10834
CCAAAAAACACATAATT
1960
GATTCAAATTATGTGT
3729

TGAATC

TTTT

10842
10864
CCACCCACAGCCTAATT
1961
GCTAATAATTAGGCTG
3730

ATTAGC

TGGG

10845
10867
CCCACAGCCTAATTATT
1962
GATGCTAATAATTAGG
3731

AGCATC

CTGT

10846
10868
CCACAGCCTAATTATTA
1963
TGATGCTAATAATTAG
3732

GCATCA

GCTG

10852
10874
CCTAATTATTAGCATCA
1964
GAGGGATGATGCTAAT
3733

TCCCTC

AATT

10870
10892
CCCTCTACTATTTTTTAA
1965
TTTGGTTAAAAAATAG
3734

CCAAA

TAGA

10871
10893
CCTCTACTATTTTTTAAC
1966
ATTTGGTTAAAAAATA
3735

CAAAT

GTAG

10888
10910
CCAAATCAACAACAACC
1967
TAAATAGGTTGTTGTT
3736

TATTTA

GATT

10903
10925
CCTATTTAGCTGTTCCC
1968
AGGTTGGGGAACAGCT
3737

CAACCT

AAAT

10917
10939
CCCCAACCTTTTCCTCC
1969
GGGGTCGGAGGAAAA
3738

GACCCC

GGTTG

10918
10940
CCCAACCTTTTCCTCCG
1970
GGGGGTCGGAGGAAA
3739

ACCCCC

AGGTT

10919
10941
CCAACCTTTTCCTCCGA
1971
AGGGGGTCGGAGGAA
3740

CCCCCT

AAGGT

10923
10945
CCTTTTCCTCCGACCCC
1972
TGTTAGGGGGTCGGAG
3741

CTAACA

GAAA

10929
10951
CCTCCGACCCCCTAACA
1973
GGGGGTTGTTAGGGGG
3742

ACCCCC

TCGG

10932
10954
CCGACCCCCTAACAACC
1974
GAGGGGGGTTGTTAGG
3743

CCCCTC

GGGT

10936
10958
CCCCCTAACAACCCCCC
1975
TTAGGAGGGGGGTTGT
3744

TCCTAA

TAGG

10937
10959
CCCCTAACAACCCCCCT
1976
ATTAGGAGGGGGGTTG
3745

CCTAAT

TTAG

10938
10960
CCCTAACAACCCCCCTC
1977
TATTAGGAGGGGGGTT
3746

CTAATA

GTTA

10939
10961
CCTAACAACCCCCCTCC
1978
GTATTAGGAGGGGGGT
3747

TAATAC

TGTT

10947
10969
CCCCCCTCCTAATACTA
1979
GGTAGTTAGTATTAGG
3748

ACTACC

AGGG

10948
10970
CCCCCTCCTAATACTAA
1980
AGGTAGTTAGTATTAG
3749

CTACCT

GAGG

10949
10971
CCCCTCCTAATACTAAC
1981
CAGGTAGTTAGTATTA
3750

TACCTG

GGAG

10950
10972
CCCTCCTAATACTAAC
1982
TCAGGTAGTTAGTATT
3751

ACCTGA

AGGA

10951
10973
CCTCCTAATACTAACTA
1983
GTCAGGTAGTTAGTAT
3752

CCTGAC

TAGG

10954
10976
CCTAATACTAACTACCT
1984
GGAGTCAGGTAGTTAG
3753

GACTCC

TATT

10968
10990
CCTGACTCCTACCCCTC
1985
GATTGTGAGGGGTAGG
3754

ACAATC

AGTC

10975
10997
CCTACCCCTCACAATCA
1986
TTGCCATGATTGTGAG
3755

TGGCAA

GGGT

10979
11001
CCCCTCACAATCATGGC
1987
TGGCTTGCCATGATTG
3756

AAGCCA

TGAG

10980
11002
CCCTCACAATCATGGCA
1988
TTGGCTTGCCATGATT
3757

AGCCAA

GTGA

10981
11003
CCTCACAATCATGGCAA
1989
GTTGGCTTGCCATGAT
3758

GCCAAC

GTG

10999
11021
CCAACGCCACTTATCCA
1990
GTTCACTGGATAAGTG
3759

GTGAAC

GCGT

11005
11027
CCACTTATCCAGTGAAC
1991
ATAGTGGTTCACTGGA
3760

CACTAT

TAAG

11013
11035
CCAGTGAACCACTATCA
1992
TTTTCGTGATAGTGGT
3761

CGAAAA

TCAC

11021
11043
CCACTATCACGAAAAAA
1993
TAGAGTTTTTTTCGTG
3762

ACTCTA

ATAG

11044
11066
CCTCTCTATACTAATCT
1994
GTAGGGAGATTAGTAT
3763

CCCTAC

AGAG

11061
11083
CCCTACAAATCTCCTTA
1995
TATAATTAAGGAGATT
3764

ATTATA

TGTA

11062
11084
CCTACAAATCTCCTTAA
1996
TTATAATTAAGGAGAT
3765

TTATAA

TTGT

11073
11095
CCTTAATTATAACATTC
1997
GGCTGTGAATGTTATA
3766

ACAGCC

ATTA

11094
11116
CCACAGAACTAATCATA
1998
ATAAAATATGATTAGT
3767

TTTTAT

TCTG

11130
11152
CCACACTTATCCCCACC
1999
AGCCAAGGTGGGGAT
3768

TTGGCT

AAGTG

11140
11162
CCCCACCTTGGCTATCA
2000
GGGTGATGATAGCCAA
3769

TCACCC

GGTG

11141
11163
CCCACCTTGGCTATCAT
2001
CGGGTGATGATAGCCA
3770

CACCCG

AGGT

11142
11164
CCACCTTGGCTATCATC
2002
TCGGGTGATGATAGCC
3771

ACCCGA

AAGG

11145
11167
CCTTGGCTATCATCACC
2003
TCATCGGGTGATGATA
3772

CGATGA

GCCA

11160
11182
CCCGATGAGGCAACCA
2004
TTCTGGCTGGTTGCCT
3773

GCCAGAA

CATC

11161
11183
CCGATGAGGCAACCAG
2005
GTTCTGGCTGGTTGCC
3774

CCAGAAC

TCAT

11173
11195
CCAGCCAGAACGCCTGA
2006
CTGCGTTCAGGCGTTC
3775

ACGCAG

TGGC

11177
11199
CCAGAACGCCTGAACGC
2007
GTGCCTGCGTTCAGGC
3776

AGGCAC

GTTC

11185
11207
CCTGAACGCAGGCACAT
2008
GGAAGTATGTGCCTGC
3777

ACTTCC

GTTC

11206
11228
CCTATTCTACACCCTAG
2009
AGCCTACTAGGGTGTA
3778

TAGGCT

GAAT

11217
11239
CCCTAGTAGGCTCCCTT
2010
TAGGGGAAGGGAGCC
3779

CCCCTA

TACTA

11218
11240
CCTAGTAGGCTCCCTTC
2011
GTAGGGGAAGGGAGC
3780

CCCTAC

CTACT

11229
11251
CCCTTCCCCTACTCATC
2012
TAGTGCGATGAGTAGG
3781

GCACTA

GGAA

11230
11252
CCTTCCCCTACTCATCG
2013
TTAGTGCGATGAGTAG
3782

CACTAA

GGGA

11234
11256
CCCCTACTCATCGCACT
2014
TAAATTAGTGCGATGA
3783

AATTTA

GTAG

11235
11257
CCCTACTCATCGCACTA
2015
GTAAATTAGTGCGATG
3784

ATTTAC

AGTA

11236
11258
CCTACTCATCGCACTAA
2016
TGTAAATTAGTGCGAT
3785

TTTACA

GAGT

11268
11290
CCCTAGGCTCACTAAAC
2017
TAGAATGTTTAGTGAG
3786

ATTCTA

CCTA

11269
11291
CCTAGGCTCACTAAACA
2018
GTAGAATGTTTAGTGA
3787

TTCTAC

GCCT

11307
11329
CCCAAGAACTATCAAAC
2019
TCAGGAGTTTGATAGT
3788

TCCTGA

TCTT

11308
11330
CCAAGAACTATCAAACT
2020
CTCAGGAGTTTGATAG
3789

CCTGAG

TTCT

11325
11347
CCTGAGCCAACAACTTA
2021
TCATATTAAGTTGTTG
3790

ATATGA

GCTC

11331
11353
CCAACAACTTAATATGA
2022
AGCTAGTCATATTAAG
3791

CTAGCT

TTGT

11381
11403
CCTCTTTACGGACTCCA
2023
CATAAGTGGAGTCCGT
3792

CTTTATG

AAAG

11395
11417
CCACTTATGACTCCCTA
2024
GGGCTTTAGGGAGTCA
3793

AAGCCC

TAAG

11407
11429
CCCTAAAGCCCATGTCG
2025
GGGCTTCGACATGGGC
3794

AAGCCC

TTTA

11408
11430
CCTAAAGCCCATGTCGA
2026
GGGGCTTCGACATGGG
3795

AGCCCC

CTTT

11415
11437
CCCATGTCGAAGCCCCC
2027
AGCGATGGGGGCTTCG
3796

ATCGCT

ACAT

11416
11438
CCATGTCGAAGCCCCCA
2028
CAGCGATGGGGGCTTC
3797

TCGCTG

GACA

11427
11449
CCCCCATCGCTGGGTCA
2029
TACTATTGACCCAGCG
3798

ATAGTA

ATGG

11428
11450
CCCCATCGCTGGGTCAA
2030
GTACTATTGACCCAGC
3799

TAGTAC

GATG

11429
11451
CCCATCGCTGGGTCAAT
2031
AGTACTATTGACCCAG
3800

AGTACT

CGAT

11430
11452
CCATCGCTGGGTCAATA
2032
AAGTACTATTGACCCA
3801

GTACTT

GCGA

11454
11476
CCGCAGTACTCTTAAAA
2033
GCCTAGTTTTAAGAGT
3802

CTAGGC

ACTG

11494
11516
CCTCACACTCATTCTCA
2034
GGGGGTTGAGAATGA
3803

ACCCCC

GTGTG

11512
11534
CCCCCTGACAAAACACA
2035
AGGCTATGTGTTTTGT
3804

TAGCCT

CAGG

11513
11535
CCCCTGACAAAACACAT
2036
TAGGCTATGTGTTTTG
3805

AGCCTA

TCAG

11514
11536
CCCTGACAAAACACATA
2037
GTAGGCTATGTGTTTT
3806

GCCTAC

GTCA

11515
11537
CCTGACAAAACACATAG
2038
GGTAGGCTATGTGTTT
3807

CCTACC

TGTC

11532
11554
CCTACCCCTTTCCTGTA
2039
GGATAGTACAAGGAA
3808

CTATCC

GGGGT

11536
11558
CCCCTTCCTTGTACTATC
2040
ATAGGGATAGTACAA
3809

CCTAT

GGAAG

11537
11559
CCCTTCCTTGTACTATCC
2041
CATAGGGATAGTACAA
3810

CTATG

GGAA

11538
11560
CCTTCCTTGTACTATCCC
2042
TCATAGGGATAGTACA
3811

TATGA

AGGA

11542
11564
CCTTGTACTATCCCTAT
2043
TGCCTCATAGGGATAG
3812

GAGGCA

TACA

11553
11575
CCCTATGAGGCATAATT
2044
TGTTATAATTATGCCT
3813

ATAACA

CATA

11554
11576
CCTATGAGGCATAATTA
2045
TTGTTATAATTATGCC
3814

TAACAA

TCAT

11580
11602
CCATCTGCCTACGACAA
2046
GTCTGTTTGTCGTAGG
3815

ACAGAC

CAGA

11587
11609
CCTACGACAAACAGACC
2047
ATTTTAGGTCTGTTTGT
3816

TAAAAT

CGT

11602
11624
CCTAAAATCGCTCATTG
2048
AGTATGCAATGAGCGA
3817

CATACT

TTTT

11635
11657
CCACATAGCCCTCGTAG
2049
CTGTTACTACGAGGGC
3818

TAACAG

TATG

11643
11665
CCCTCGTAGTAACAGCC
2050
GAGAATGGCTGTTACT
3819

ATTCTC

ACGA

11644
11666
CCTCGTAGTAACAGCCA
2051
TGAGAATGGCTGTTAC
3820

TTCTCA

TACG

11658
11680
CCATTCTCATCCAAACC
2052
TCAGGGGGTTTGGATG
3821

CCCTGA

AGAA

11668
11690
CCAAACCCCCTGAAGCT
2053
CGGTGAAGCTTCAGGG
3822

TCACCG

GGTT

116173
11695
CCCCCTGAAGCTTCACC
2054
TGCGCCGGTGAAGCTT
3823

GGCGCA

CAGG

11674
11696
CCCCTGAAGCTTCACCG
2055
CTGCGCCGGTGAAGCT
3824

GCGCAG

TCAG

11675
11697
CCCTGAAGCTTCACCGG
2056
ACTGCGCCGGTGAAGC
3825

CGCAGT

TTCA

11676
11698
CCTGAAGCTTCACCGGC
2057
GACTGCGCCGGTGAAG
3826

GCAGTC

CTTC

11688
11710
CCGGCGCAGTCATTCTC
2058
GATTATGAGAATGACT
3827

ATAATC

GCGC

11712
11734
CCCACGGGCTTACATCC
2059
TAATGAGGATGTAAGC
3828

TCATTA

CCGT

11713
11735
CCACGGGCTTACATCCT
2060
GTAATGAGGATGTAAG
3829

CATTAC

CCCG

11727
11749
CCTCATTACTATTCTGC
2061
TGCTAGGCAGAATAGT
3830

CTAGCA

AATG

11743
11765
CCTAGCAAACTCAAACT
2062
GTTCGTAGTTTGAGTT
3831

ACGAAC

TGCT

11788
11810
CCTCTCTCAAGGACTTC
2063
GAGTTTGAAGTCCTTG
3832

AAACTC

AGAG

11815
11837
CCCACTAATAGCTTTTT
2064
GTCATCAAAAAGCTAT
3833

GATGAC

TAGT

11816
11838
CCACTAATAGCTTTTTG
2065
AGTCATCAAAAAGCTA
3834

ATGACT

TTAG

11870
11848
CCTCGCTAACCTCGCCT
2066
GGGGTAAGGCGAGGT
3835

TACCCC

TAGCG

11857
11879
CCTCGCCTTACCCCCCA
2067
TAATAGTGGGGGGTAA
3836

CTATTA

GGCG

11862
11884
CCTTACCCCCCACTATT
2068
TAGGTTAATAGTGGGG
3837

AACCTA

GGTA

11867
11889
CCCCCCACTATTAACCT
2069
CCCAGTAGGTTAATAG
3838

ACTGGG

TGGG

11868
11890
CCCCCACTATTAACCTA
2070
TCCCAGTAGGTTAATA
3839

CTGGGA

GTGG

11869
11891
CCCCACTATTAACCTAC
2071
CTCCCAGTAGGTTAAT
3840

TGGGAG

AGTG

11870
11892
CCCACTATTAACCTACT
2072
TCTCCCAGTAGGTTAA
3841

GGGAGA

TAGT

11871
11893
CCACTATTAACCTACTG
2073
TTCTCCCAGTAGGTTA
3842

GGAGAA

ATAG

11881
11903
CCTACTGGGAGAACTCT
2074
GCACAGAGAGTTCTCC
3843

CTGTGC

CAGT

11910
11932
CCACGTTCTCCTGATCA
2075
GATATTTGATCAGGAG
3844

AATATC

AACG

11919
11941
CCTGATCAAATATCACT
2076
TAGGAGAGTGATATTT
3845

CTCCTA

GATC

11938
11960
CCTACTTACAGGACTCA
2077
GTATGTTGAGTCCTGT
3846

ACATAC

AAGT

11970
11992
CCCTATACTCCCTCTAC
2078
AAATATGTAGAGGGA
3847

ATATTT

GTATA

11971
11993
CCTATACTCCCTCTACA
2079
TAAATATGTAGAGGGA
3848

TATTTA

GTAT

11979
12001
CCCTCTACATATTTACC
2080
TGTTGTGGTAAATATG
3849

ACAACA

TAGA

11980
12002
CCTCTACATATTTACCA
2081
GTGTTGTGGTAAATAT
3850

CAACAC

GTAG

11994
12016
CCACAACACAATGGGG
2082
GAGTGAGCCCCATTGT
3851

CTCACTC

GTTG

12018
12040
CCCACCACATTAACAAC
2083
TTTTATGTTGTTAATGT
3852

ATAAAA

GGT

12019
12041
CCACCACATTAACAACA
2084
GTTTTATGTTGTTAAT
3853

TAAAAC

GTGG

12022
12044
CCACATTAACAACATAA
2085
AGGGTTTTATGTTGTT
3854

AACCCT

AATG

12041
12063
CCCTCATTCACACGAGA
2086
GTGTTTTCTCGTGTGA
3855

AAACAC

ATGA

12042
12064
CCTCATTCACACGAGAA
2087
GGTGTTTTTTCGTGTG
3856

AACACC

AATG

12063
12085
CCCTCATGTTCATACAC
2088
GGATAGGTGTATGAAC
3857

CTATCC

ATGA

12064
12086
CCTCATGTTCATACACC
2089
GGGATAGGTGTATGAA
3858

TATCCC

CATG

12079
12101
CCTATCCCCCATTCTCCT
2090
ATAGGAGGAGAATGG
3859

CCTAT

GGGAT

12084
12106
CCCCCATTCTCCTCCTAT
2091
GAGGGATAGGAGGAG
3860

CCCTC

AATGG

12085
12107
CCCCATTCTCCTCCTATC
2092
TGAGGGATAGGAGGA
3861

CCTCA

GAATG

12086
12108
CCCATTCTCCTCCTATCC
2093
TTGAGGGATAGGAGG
3862

CTCAA

AGAAT

12087
12109
CCATTCTCCTCCTATCCC
2094
GTTGAGGGATAGGAG
3863

TCAAC

GAGAA

12094
12116
CCTCCTATCCCTCAACC
2095
TGTCGGGGTTGAGGGA
3864

CCGACA

TAGG

12097
12119
CCTATCCCTCAACCCCG
2096
TGATGTCGGGGTTGAG
3865

ACATCA

GGAT

12102
12124
CCCTCAACCCCGACATC
2097
GGTAATGATGTCGGGG
3866

ATTACC

TTGA

12103
12125
CCTCAACCCCGACATCA
2098
CGGTAATGATGTCGGG
3867

TTACCG

GTTG

12109
12131
CCCCGACATCATTACCG
2099
AAAACCCGGTAATGAT
3868

GGTTTT

GTCG

12110
12132
CCCGACATCATTACCGG
2100
GAAAACCCGGTAATG
3869

GTTTTC

ATGTC

12111
12133
CCGACATCATTACCGGG
2101
GGAAAACCCGGTAAT
3870

TTTTCC

GATGT

12123
12145
CCGGGTTTTCCTCTTGT
2102
ATATTTACAAGAGGAA
3871

AAATAT

AACC

12132
12154
CCTCTTGTAAATATAGT
2103
GGTTAAACTATATTTA
3872

TTAACC

CAAG

12153
12175
CCAAAACATCAGATTGT
2104
AGATTCACAATCTGAT
3873

GAATCT

GTTT

12194
12216
CCCCTTATTTACCGAGA
2105
GAGCTTTCTCGGTAAA
3874

AAGCTC

TAAG

12195
12217
CCCTTATTTACCGAGAA
2106
TGAGCTTTCTCGGTAA
3875

AGCTCA

ATAA

12196
12218
CCTTATTTACCGAGAAA
2107
GTGAGCTTTCTCGGTA
3876

GCTCAC

AATA

12205
12227
CCGAGAAAGCTCACAA
2108
GCAGTTCTTGTGAGCT
3877

GAACTGC

TTCT

12237
12259
CCCCCATGTCTAACAAC
2109
AGCCATGTTGTTAGAC
3878

ATGGCT

ATGG

12238
12260
CCCCATGTCTAACAACA
2110
AAGCCATGTTGTTAGA
3879

TGGCTT

CATG

12239
12261
CCCATGTCTAACAACAT
2111
AAAGCCATGTTGTTAG
3880

GGCTTT

ACAT

12240
12262
CCATGTCTAACAACATG
2112
GAAAGCCATGTTGTTA
3881

GCTTTC

GACA

12288
12310
CCATTGGTCTTAGGCCC
2113
TTTTTGGGGCCTAAGA
3882

CAAAAA

CCAA

12302
12324
CCCCAAAAATTTTGGTG
2114
GAGTTGCACCAAAATT
3883

CAACTC

TTTG

12303
12325
CCCAAAAATTTTGGTGC
2115
GGAGTTGCACCAAAAT
3884

AACTCC

TTTT

12304
12326
CCAAAAATTTTGGTGCA
2116
TGGAGTTGCACCAAAA
3885

ACTCCA

TTTT

12324
12346
CCAAATAAAAGTAATA
2117
GCATGGTTATTACTTT
3886

ACCATGC

TATT

12341
12363
CCATGCACACTACTATA
2118
GGTGGTTATAGTAGTG
3887

ACCACC

TGCA

12359
12381
CCACCCTAACCCTGACT
2119
TAGGGAAGTCAGGGTT
3888

TCCCTA

AGGG

12362
12384
CCCTAACCCTGACTTCC
2120
AATTAGGGAAGTCAG
3889

CTAATT

GGTTA

12363
12385
CCTAACCCTGACTTCCC
2121
GAATTAGGGAAGTCA
3890

TAATTC

GGGTT

12368
12390
CCCTGACTTCCCTAATT
2122
GGGGGGAATTAGGGA
3891

CCCCCC

AGTCA

12369
12391
CCTGACTTCCCTAATTC
2123
TGGGGGGAATTAGGG
3892

CCCCCA

AAGTC

12377
12399
CCCTAATTCCCCCCATC
2124
CTGTAAGGATGGGGGG
3893

CTTACC

AATTA

12378
12400
CCTAATTCCCCCCATCC
2125
TGGTAAGGATGGGGG
3894

TTACCA

GAATT

12385
12407
CCCCCCATCCTTACCAC
2126
ACGAGGGTGGTAAGG
3895

CCTCGT

ATGGG

12386
12408
CCCCCATCCTTACCACC
2127
AACGAGGGTGGTAAG
3896

CTCGTT

GATGG

12387
12409
CCCCATCCTTACCACCC
2128
TAACGAGGGTGGTAA
3897

TCGTTA

GGATG

12388
12410
CCCATCCTTACCACCCT
2129
TTAACGAGGGTGGTAA
3898

CGTTAA

GGAT

12389
12411
CCATCCTTACCACCCTC
2130
GTTAACGAGGGTGGTA
3899

GTTAAC

AGGA

12393
12415
CCTTACCACCCTCGTTA
2131
TAGGGTTAACGAGGGT
3900

ACCCTA

GGTA

12398
12420
CCACCCTCGTTAACCCT
2132
TTTGTTAGGGTTAACG
3901

AACAAA

AGGG

12401
12423
CCCTCGTTAACCCTAAC
2133
TTTTTTGTTAGGGTTA
3902

AAAAAA

ACGA

12402
12424
CCTCGTTAACCCTAACA
2134
TTTTTTTGTTAGGGTTA
3903

AAAAAA

ACG

12411
12433
CCCTAACAAAAAAAACT
2135
GGTATGAGTTTTTTTT
3904

CATACC

GTTA

12412
12434
CCTAACAAAAAAAACTC
2136
GGGTATGAGTTTTTTT
3905

ATACCC

TGTT

12432
12454
CCCCCATTATGTAAAAT
2137
CAATGGATTTTACATA
3906

CCATTG

ATGG

12433
12455
CCCCATTATGTAAAATC
2138
ACAATGGATTTTACAT
3907

CATTGT

AATG

12434
12456
CCCATTATGTAAAATCC
2139
GACATGGATTTTACA
3908

ATTGTC

TAAT

12435
12457
CCATTATGTAAAATCCA
2140
CGACAATGGATTTTAC
3909

TTGTCG

ATAA

12449
12471
CCATTGTCGCATCCACC
2141
AATAAAGGTGGATGC
3910

TTTATT

GACAA

12461
12483
CCACCTTTATTATCAGT
2142
GAAGAGACTGATAAT
3911

CTCTTC

AAAGG

12464
12486
CCTTTATTATCAGTCTCT
2143
GGGGAAGAGACTGAT
3912

TCCCC

AATAA

12483
12505
CCCCACAACAATATTCA
2144
GGCACATGAATATTGT
3913

TGTGCC

TGTG

12484
12506
CCCACAACAATATTCAT
2145
AGGCACATGAATATTG
3914

GTGCCT

TTGT

12485
12507
CCACAACAATATTCATG
2146
TAGGCACATGAATATT
3915

TGCCTA

GTTG

12504
12526
CCTAGACCAAGAAGTTA
2147
AGATAATAACTTCTTG
3916

TTATCT

GTCT

12510
12532
CCAAGAAGTTATTATCT
2148
AGTTCGAGATAATAAC
3917

CGAACT

TTCT

12542
12564
CCACAACCCAAACAACC
2149
GAGCTGGGTTGTTTGG
3918

CAGCTC

GTTG

12548
12570
CCCAAACAACCCAGCTC
2150
TAGGGAGAGCTGGGTT
3919

TCCCTA

GTTT

12549
12571
CCAAACAACCCAGCTCT
2151
TTAGGGAGAGCTGGGT
3920

CCCTAA

TGTT

12557
12579
CCCAGCTCTCCCTAAGC
2152
TTTGAAGCTTAGGGAG
3921

TTCAAA

AGCT

12558
12580
CCAGCTCTCCCTAAGCT
2153
GTTTGAAGCTTAGGGA
3922

TCAAAC

GAGC

12566
12588
CCCTAACTTCAAACTA
2154
GTAGTCTAGTTTGAAG
3923

GACTAC

CTTA

12567
12589
CCTAAGCTTCAAACTAG
2155
AGTAGTCTAGTTTGAA
3924

ACTACT

GCTT

12593
12615
CCATAATATTCATCCCT
2156
TGCTACAGGGATGAAT
3925

GTAGCA

ATTA

12606
12628
CCCTGTAGCATTGTTCG
2157
ATGTAACGAACAATGC
3926

TTACAT

ACA

12607
12629
CCTGTAGCATTGTTCGT
2158
CATGTAACGAACAATG
3927

TACATG

CTAC

12632
12654
CCATCATAGAATTCTCA
2159
TCACAGTGAGAATTCT
3928

CTGTGA

ATGA

12669
12691
CCCAAACATTAATCAGT
2160
TGAAGAACTGATTAAT
3929

TCTTCA

GTTT

12670
12692
CCAAACATTAATCAGTT
2161
TTGAAGAACTGATTAA
3930

CTTCAA

TGTT

12708
12730
CCTAATTACCATACTAA
2162
CTAAGATTAGTATGGT
3931

TCTTAG

AATT

12716
12738
CCATACTAATCTTAGTT
2163
AGCGGTAACTAAGATT
3932

ACCGCT

AGTA

12734
12756
CCGCTAACAACCTATTC
2164
CAGTTGGAATAGGTTG
3933

CAACTG

TTAG

12744
12766
CCTATTCCAACTGTTCA
2165
AGCCGATGAACAGTTG
3934

TCGGCT

GAAT

12750
12772
CCAACTGTTCATCGGCT
2166
CCTTTCAGCCGATGAA
3935

GAGAGG

CAGT

12788
12810
CCTTCTTGCTCATCAGTT
2167
TCATCAACTGATGAGC
3936

GATGA

AAGA

12815
12837
CCCGAGCAGATGCCAAC
2168
TGCTGTGTTGGCATCT
3937

ACAGCA

GCTC

12816
12838
CCGAGCAGATGCCAAC
2169
CTGCTGTGTTGGCATC
3938

ACAGCAG

TGCT

12827
12849
CCAACACAGCAGCCATT
2170
TGCTTGAATGGCTGCT
3939

CAAGCA

GTGT

12839
12861
CCATTCAAGCAATCCTA
2171
GTTGTATAGGATTGCT
3940

TACAAC

TGAA

12852
12874
CCTATACAACCGTATCG
2172
TATCGCCGATACGGTT
3941

GCGATA

GTAT

12861
12883
CCGTATCGGCGATATCG
2173
TGAAAACCGATATCGCC
3942

GTTTCA

GATA

12885
12907
CCTCGCCTTAGCATGAT
2174
GGATAAATCATGCTAA
3943

TTATCC

GGCG

12890
12912
CCTTAGCATGATTTATC
2175
GTGTAGGATAAATCAT
3944

CTACAC

GCTA

12906
12928
CCTACACTCCAACTCAT
2176
GGTCTCATGAGTTGGA
3945

GAGACC

GTGT

12914
12936
CCAACTCATGAGACCCA
2177
TTGTTGTGGGTCTCAT
3946

CAACAA

GAGT

12927
12949
CCCACAACAAATAGCCC
2178
TTAGAAGGGCTATTTG
3947

TTCTAA

TTGT

12928
12950
CCACAACAAATAGCCCT
2179
TTTAGAAGGGCTATTT
3948

TCTAAA

GTTG

12941
12963
CCCTTCTAAACGCTAAT
2180
GCTTGGATTAGCGTTT
3949

CCAAGC

AGAA

12942
12964
CCTTCTAAACGCTAATC
2181
GGCTTGGATTAGCGTT
3950

CAAGCC

TAGA

12958
12980
CCAAGCCTCACCCCACT
2182
CCTAGTAGTGGGGTGA
3951

ACTAGG

GGCT

12963
12985
CCTCACCCCACTACTAG
2183
GGAGGCCTAGTAGTGG
3952

GCCTCC

GGTG

12968
12990
CCCCACTACTAGGCCTC
2184
TAGGAGGAGGCCTAGT
3953

CTCCTA

AGTG

12969
12991
CCCACTACTAGGCCTCC
2185
CTAGGAGGAGGCCTA
3954

TCCTAG

GTAGT

12970
12992
CCACTACTAGGCCTCCT
2186
GCTAGGAGGAGGCCT
3955

CCTAGC

AGTAG

12981
13003
CCTCCTCCTAGCAGCAG
2187
TGCCTGCTGCTGCTAG
3956

CAGGCA

GAGG

12984
13006
CCTCCTAGCAGCAGCAG
2188
ATTTGCCTGCTGCTGC
3957

GCAAAT

TAGG

12987
13009
CCTAGCAGCAGCAGGC
2189
CTGATTTGCCTGCTGC
3958

AAATCAG

TGCT

13010
13032
CCCAATTAGGTCTCCAC
2190
TCAGGGGTGGAGACCT
3959

CCCTGA

AATT

13011
13033
CCAATTAGGTCTCCACC
2191
GTCAGGGGTGGAGAC
3960

CCTGAC

CTAAT

13023
13045
CCACCCCTGACTCCCCT
2192
TGGCTGAGGGGAGTCA
3961

CAGCCA

GGGG

13026
13048
CCCCTGACTCCCCTCAG
2193
CTATGGCTGAGGGGAG
3962

CCATAG

TCAG

13027
13049
CCCTGACTCCCCTCAGC
2194
TCTATGGCTGAGGGGA
3963

CATAGA

GTCA

13028
13050
CCTGACTCCCCTCAGCC
2195
TTCTATGGCTGAGGGG
3964

ATAGAA

AGTC

13035
13057
CCCCTCAGCCATAGAAG
2196
TGGGGCCTTCTATGGC
3965

GCCCCA

TGAG

13036
13058
CCCTCAGCCATAGAAGG
2197
GTGGGGCCTTCTATGG
3966

CCCCAC

CTGA

13037
13059
CCTCAGCCATAGAAGGC
2198
GGTGGGGCCTTCTATG
3967

CCCACC

GCTG

13043
13065
CCATAGAAGGCCCCACC
2199
GACTGGGGTGGGGCCT
3968

CCAGTC

TCTA

13053
13075
CCCCACCCCAGTCTCAG
2200
GTAGGGCTGAGACTGG
3969

CCCTAC

GGTG

13054
13076
CCCACCCCAGTCTCAGC
2201
AGTAGGGCTGAGACTG
3970

CCTACT

GGGT

13055
13077
CCACCCCAGTCTCAGCC
2202
GAGTAGGGCTGAGACT
3971

CTACTC

GGGG

13058
13080
CCCCAGTCTCAGCCCTA
2203
GTGGAGTAGGGCTGA
3972

CTCCAC

GACTG

13059
13081
CCCAGTCTCAGCCCTAC
2204
AGTGGAGTAGGGCTG
3973

TCCACT

AGACT

13060
13082
CCAGTCTCAGCCCTACT
2205
GAGTGGAGTAGGGCT
3974

CCACTC

GAGAC

13070
13092
CCCTACTCCACTCAAGC
2206
TATAGTGCTTGAGTGG
3975

ACTATA

AGTA

13071
13093
CCTACTCCACTCAAGCA
2207
CTATAGTGCTTGAGTG
3976

CTATAG

GAGT

13077
13099
CCACTCAAGCACTATAG
2208
CTACAACTATAGTGCT
3977

TTGTAG

TGAG

13119
13141
CCGCTTCCACCCCCTAG
2209
TTTCTGCTAGGGGGTG
3978

CAGAAA

GAAG

13125
13147
CCACCCCCTAGCAGAAA
2210
GGCTATTTTCTGCTAG
3979

ATAGCC

GGGG

13128
13150
CCCCCTAGCAGAAAATA
2211
GTGGGCTATTTTCTGC
3980

GCCCAC

TAGG

13129
13151
CCCCTAGCAGAAAATAG
2212
AGTGGGCTATTTTCTG
3981

CCCACT

CTAG

13130
13152
CCCTAGCAGAAAATAGC
2213
TAGTGGGCTATTTTCT
3982

CCACTA

GCTA

13131
13153
CCTAGCAGAAAATAGCC
2214
TAGTGGCCTATTTTC
3983

CACTAA

TGCT

13146
13168
CCCACTAATCCAAACTC
2215
GTGTTAGAGTTTGGAT
3984

TAACAC

TAGT

13147
13169
CCACTAATCCAAACTCT
2216
AGTGTTAGAGTTTGGA
3985

AACACT

TTAG

13155
13177
CCAAACTCTAACACTAT
2217
CTAAGCATAGTGTTAG
3986

GCTTAG

AGTT

13187
13209
CCACTCTGTTCGCAGCA
2218
GCAGACTGCTGCGAAC
3987

GTCTGC

AGAG

13211
13233
CCCTTACACAAAATGAC
2219
TTTGATGTCATTTTGTG
3988

ATCAAA

TAA

13212
13234
CCTTACACAAAATGACA
2220
TTTTGATGTCATTTTGT
3989

TCAAAA

GTA

13244
13266
CCTTCTCCACTTCAAGT
2221
TAGTTGACTTGAAGTG
3990

CAACTA

GAGA

13250
13272
CCACTTCAAGTCAACTA
2222
GAGTCCTAGTTGACTT
3991

GGACTC

GAAG

13296
13318
CCAACCACACCTAGCAT
2223
GCAGGAATGCTAGGTG
3992

TCCTGC

TGGT

13300
13322
CCACACCTAGCATTCCT
2224
ATGTGCAGGAATGCTA
3993

GCACAT

GGTG

13305
13327
CCTAGCATTCCTGCACA
2225
TACAGATGTGCAGGAA
3994

TCTGTA

TGCT

13314
13336
CCTGCACATCTGTACCC
2226
AGGCGTGGGTACAGAT
3995

ACGCCT

GTGC

13328
13350
CCCACGCCTTCTTCAAA
2227
TATGGCTTTGAAGAAG
3996

GCCATA

GCGT

13329
13351
CCACGCCTTCTTCAAAG
2228
GTATGGCTTTGAAGAA
3997

CCATAC

GGCG

13334
13356
CCTTCTTCAAAGCCATA
2229
AAATAGTATGGCTTTG
3998

CTATTT

AAGA

13346
13368
CCATACTATTTATGTGC
2230
CCCGGAGCACATAAAT
3999

TCCGGG

AGTA

13364
13386
CCGGGTCCATCATCCAC
2231
AAGGTTGTGGATGATG
4000

AACCTT

GACC

13370
13392
CCATCATCCACAACCTT
2232
ATTGTTAAGGTTGTGG
4001

AACAAT

ATGA

13377
13399
CCACAACCTTAACAATG
2233
CTTGTTCATTGTTAAG
4002

AACAAG

GTTG

13383
13405
CCTTAACAATGAACAAG
2234
GAATATCTTGTTCATT
4003

ATATTC

GTTA

13430
13452
CCATACCTCTCACTTCA
2235
GGAGGTTGAAGTGAG
4004

ACCTCC

AGGTA

13435
13457
CCTCTCACTTCAACCTC
2236
GTGAGGGAGGTTGAA
4005

CCTCAC

GTGAG

13448
13470
CCTCCCTCACCATTGGC
2237
TAGGCTGCCAATGGTG
4006

AGCCTA

AGGG

13451
13473
CCCTCACCATTGGCAGC
2238
TGCTAGGCTGCCAATG
4007

CTAGCA

GTGA

13452
13474
CCTCACCATTGGCAGCC
2239
ATGCTAGGCTGCCAAT
4008

TAGCAT

GGTG

13457
13479
CCATTGGCAGCCTAGCA
2240
TGCTAATGCTAGGCTG
4009

TTAGCA

CCAA

13467
13489
CCTAGCATTAGCAGGAA
2241
AAGGTATTCCTGCTAA
4010

TACCTT

TGCT

13486
13508
CCTTTCCTCACAGGTTT
2242
GAGTAGAAACCTGTGA
4011

CTACTC

GGAA

13491
13513
CCTCACAGGTTTCTACT
2243
CTTTGGAGTAGAAACC
4012

CCAAAG

TGTG

13508
13530
CCAAAGACCACATCATC
2244
GGTTTCGATGATGTGG
4013

GAAACC

TCTT

13515
13537
CCACATCATCGAAACCG
2245
TGTTTGCGGTTTCGAT
4014

CAAACA

GATG

13529
13551
CCGCAAACATATCATAC
2246
GTTTGTGTATGATATG
4015

ACAAAC

TTTG

13553
13575
CCTGAGCCCTATCTATT
2247
GAGAGTAATAGATAG
4016

ACTCTC

GGCTC

13559
13581
CCCTATCTATTACTCTC
2248
AGCGATGAGAGTAAT
4017

ATCGCT

AGATA

13560
13582
CCTATCTATTACTCTCAT
2249
TAGCGATGAGAGTAAT
4018

CGCTA

AGAT

13583
13605
CCTCCCTGACAAGCGCC
2250
GCTATAGGCGCTTGTC
4019

TATAGC

AGGG

13586
13608
CCCTGACAAGCGCCTAT
2251
AGTGCTATAGGCGCTT
4020

AGCACT

GTCA

13587
13609
CCTGACAAGCGCCTATA
2252
GAGTGCTATAGGCGCT
4021

GCACTC

TGTC

13598
13620
CCTATAGCACTCGAATA
2253
AAGAATTATTCGAGTG
4022

ATTCTT

CTAT

13625
13647
CCCTAACAGGTCAACCT
2254
GAAGCGAGGTTGACCT
4023

CGCTTC

GTTA

13626
13648
CCTAACAGGTCAACCTC
2255
GGAAGCGAGGTTGAC
4024

GCTTCC

CTGTT

13639
13661
CCTCGCTTCCCCACC
2256
TAGTAAGGGTGGGGA
4025

TACTAA

AGCG

13647
13669
CCCCACCCTTACTAACA
2257
CGTTAATGTTAGTAAG
4026

TTAACG

GGTG

13648
13670
CCCACCCTTACTAACAT
2258
TCGTTAATGTTAGTAA
4027

TAACGA

GGGT

13649
13671
CCACCCTTACTAACATT
2259
TTCGTTAATGTTAGTA
4028

AACGAA

AGGG

13652
13674
CCCTTACTAACATTAAC
2260
ATTTTCGTTAATGTTA
4029

GAAAAT

GTAA

13653
13675
CCTTACTAACATTAACG
2261
TATTTTCGTTAATGTTA
4030

AAAATA

GTA

13677
13699
CCCCACCCTACTATACC
2262
TAATGGGGTTTAGTAG
4031

CCATTA

GGTG

13678
13700
CCCACCCTACTAAACCC
2263
TTAATGGGGTTTAGTA
4032

CATTAA

GGGT

13679
13701
CCACCCTACTAAACCCC
2264
TTTAATGGGGTTTAGT
4033

ATTAAA

AGGG

13682
13704
CCCTACTAAACCCCATT
2265
GCGTTTAATGGGGTTT
4034

AAACGC

AGTA

13683
13705
CCTACTAAACCCCATTA
2266
GGCGTTTAATGGGGTT
4035

AACGCC

TAGT

13692
13714
CCCCATTAAACGCCTGG
2267
CGGCTGCCAGGCGTTT
4036

CAGCCG

AATG

13693
13715
CCCATTAAACGCCTGGC
2268
CCGGCTGCCAGGCGTT
4037

AGCCGG

TAAT

13694
13716
CCATTAAACGCCTGGCA
2269
TCCGGCTGCCAGGCGT
4038

GCCGGA

TTAA

13704
13726
CCTGGCAGCCGGAAGCC
2270
CGAATAGGCTTCCGGC
4039

TATTCG

TGCC

13712
13734
CCGGAAGCCTATTCGCA
2271
AAATCCTGCGAATAGG
4040

GGATTT

CTTC

13719
13741
CCTATTCGCAGGATTTC
2272
TAATGAGAAATCCTGC
4041

TCATTA

GAAT

13754
13776
CCCCCGCATCCCCCTTC
2773
TGTTTGGAAGGGGGAT
4042

CAAACA

GCGG

13755
13777
CCCCGCATCCCCCTTCC
2274
TTGTTTGGAAGGGGGA
4043

AAACAA

TGCG

13756
13778
CCCGCATCCCCCTTCCA
7275
GTTGTTTGGAAGGGGG
4044

AACAAC

ATGC

13757
13779
CCGCATCCCCCTTCCAA
2276
TGTTGTTTGGAAGGGG
4045

ACAACA

GATG

13763
13785
CCCCCTTCCAAACAACA
2277
GGGGATTGTTGTTTGG
4046

ATCCCC

AAGG

13764
13786
CCCCTTCCAAACAACAA
2278
GGGGGATTGTTGTTTG
4047

TCCCCC

GAAG

13765
13787
CCCTTCCAAACAACAAT
2279
AGGGGGATTGTTGTTT
4048

CCCCCT

GGAA

13766
13788
CCTTCCAAACAACAATC
2280
GAGGGGGATTGTTGTT
4049

CCCCTC

TGGA

13770
13792
CCAAACAACAATCCCCC
2281
GGTAGAGGGGGATTGT
4050

TCTACC

TGTT

13782
13804
CCCCCTCTACCTAAAAC
2282
CTGTGAGTTTTAGGTA
4051

TCACAG

GAGG

13783
13805
CCCCTCTACCTAAAACT
2283
GCTGTGAGTTTTAGGT
4052

CACAGC

AGAG

13784
13806
CCCTCTACCTAAAACTC
2284
GGCTGTGAGTTTTAGG
4053

ACAGCC

TAGA

13785
13807
CCTCTACCTAAAACTCA
2285
GGGCTGTGAGTTTTAG
4054

CAGCCC

GTAG

13791
13813
CCTAAAACTCACAGCCC
2286
CAGCGAGGGCTGTGA
4055

TCGCTG

GTTTT

13805
13827
CCCTCGCTGTCACTTTC
2287
TCCTAGGAAAGTGACA
4056

CTAGGA

GCGA

13806
13828
CCTCGCTGTCACTTTCCT
2288
GTCCTAGGAAAGTGAC
4057

AGGAC

AGCG

13821
13843
CCTAGGACTTCTAACAG
2289
CTAGGGCTGTTAGAAG
4058

CCCTAG

TCCT

13838
13860
CCCTAGACCTCAACTAC
2290
GGTTAGGTAGTTGAGG
4059

CTAACC

TCTA

13839
13861
CCTAGACCTCAACTACC
2291
TGGTTAGGTAGTTGAG
4060

TAACCA

GTCT

13845
13867
CCTCAACTACCTAACCA
2292
GTTTGTTGGTTAGGTA
4061

ACAAAC

GTTG

13854
13876
CCTAACCAACAAACTTA
2293
TTATTTTAAGTTTGTTG
4062

AAATAA

GTT

13859
13881
CCAACAAACTTAAAATA
2294
GGATTTTATTTTAAGT
4063

AAATCC

TTGT

13880
13902
CCCCACTATGCACATTT
2295
GAAATAAAATGTGCAT
4064

TATTTC

AGTG

13881
13903
CCCACTATGCACATTTT
2296
AGAAATAAAATGTGC
4065

ATTTCT

ATAGT

13882
13904
CCACTATGCACATTTTA
2297
GAGAAATAAAATGTG
4066

TTTCTC

CATAG

13904
13926
CCAACATACTCGGATTC
2298
AGGGTAGAATCCGAGT
4067

TACCCT

ATGT

13923
13945
CCCTAGCATCACACACC
2299
TTGTGCGGTGTGTGAT
4068

GCACAA

GCTA

13924
13946
CCTAGCATCACACACCG
2300
ATTGTGCGGTGTGTGA
4069

CACAAT

TGCT

13938
13960
CCGCACAATCCCCTATC
2301
GGCCTAGATAGGGGAT
4070

TAGGCC

TGTG

13947
13969
CCCCTATCTAGGCCTTC
2302
TCGTAAGAAGGCCTAG
4071

TTACGA

ATAG

13948
13970
CCCTATCTAGGCCTTCT
2303
CTCGTAAGAAGGCCTA
4072

TACGAG

GATA

13949
13971
CCTATCTAGGCCTTCTT
2304
GCTCGTAAGAAGGCCT
4073

ACGAGC

AGAT

13959
13981
CCTTCTTACGAGCCAAA
2305
GCAGGTTTTGGCTCGT
4074

ACCTGC

AAGA

13971
13993
CCAAAACCTGCCCCTAC
2306
GGAGGAGTAGGGGCA
4075

TCCTCC

GGTTT

13977
13999
CCTGCCCCTACTCCTCC
2307
GGTCTAGGAGGAGTA
4076

TAGACC

GGGGC

13981
14003
CCCCTACTCCTCCTAGA
2308
GTTAGGTCTAGGAGGA
4077

CCTAAC

GTAG

13982
14004
CCCTACTCCTCCTAGAC
2309
GGTTAGGTCTAGGAGG
4078

CTAACC

AGTA

13983
14005
CCTACTCCTCCTAGACC
2310
AGGTTAGGTCTAGGAG
4079

TAACCT

GAGT

13989
14011
CCTCCTAGACCTAACCT
2311
CTAGTCAGGTTAGGTC
4080

GACTAG

TAGG

13992
14014
CCTAGACCTAACCTGAC
2312
TTTCTAGTCAGGTTAG
4081

TAGAAA

GTCT

13998
14020
CCTAACCTGACTAGAAA
2313
ATAGCTTTTCTAGTCA
4082

AGCTAT

GGTT

14003
14025
CCTGACTAGAAAAGCTA
2314
AGGTAATAGCTTTTCT
4083

TTACCT

AGTC

14023
14045
CCTAAAACAATTTCACA
2315
TGGTGCTGTGAAATTG
4084

GCACCA

TTTT

14043
14065
CCAAATCTCCACCTCCA
2316
TGATGATGGAGGTGGA
4085

TCATCA

GATT

14051
14073
CCACCTCCATCATCACC
2317
GGTTGAGGTGATGATG
4086

TCAACC

GAGG

14054
14076
CCTCCATCATCACCTCA
2318
TTGGGTTGAGGTGATG
4087

ACCCAA

ATGG

14057
14079
CCATCATCACCTCAACC
2319
TTTTTGGGTTGAGGTG
4088

CAAAAA

ATGA

14066
14088
CCTCAACCCAAAAAGGC
2320
AATTATGCCTTTTTGG
4089

ATAATT

GTTG

14072
14094
CCCAAAAAGGCATAATT
2321
AAGTTTAATTATGCCT
4090

AAACTT

TTTT

14073
14095
CCAAAAAGGCATAATTA
2322
AAAGTTTAATTATGCC
4091

AACTTT

TTTT

14100
14122
CCTCTCTTTCTTCTTCCC
2323
TGAGTGGGAAGAAGA
4092

ACTCA

AAGAG

14115
14137
CCCACTCATCCTAACCC
2324
GGAGTAGGGTTAGGAT
4093

TACTCC

GAGT

14116
14138
CCACTCATCCTAACCCT
2325
AGGAGTAGGGTTAGG
4094

ACTCCT

ATGAG

14124
14146
CCTAACCCTACTCCTAA
2326
ATGTGATTAGGAGTAG
4095

TCACAT

GGTT

14129
14151
CCCTACTCCTAATCACA
2327
AGGTTATGTGATTAGG
4096

TAACCT

AGTA

14130
14152
CCTACTCCTAATCACAT
2328
TAGGTTATGTGATTAG
4097

AACCTA

GAGT

14136
14158
CCTAATCACATAACCTA
2329
GGGGAATAGGTTATGT
4098

TTCCCC

GATT

14149
14171
CCTATTCCCCCGAGCAA
2330
TTGAGATTGCTCGGGG
4099

TCTCAA

GAAT

14155
14177
CCCCCGAGCAATCTCAA
2331
TTGTAATTGAGATTGC
4100

TTACAA

TCGG

14156
14178
CCCCGAGCAATCTCAAT
2332
ATTGTAATTGAGATTG
4101

TACAAT

CTCG

14157
14179
CCCGAGCAATCTCAATT
2333
TATTGTAATTGAGATT
4102

ACAATA

GCTC

14158
14180
CCGAGCAATCTCAATTA
2334
ATATTGTAATTGAGAT
4103

CAATAT

TGCT

14186
14208
CCAACAAACAATGTTCA
2335
ACTGGTTGAACATTGT
4104

ACCAGT

TTGT

14204
14226
CCAGTAACTACTACTAA
2336
CGTTGATTAGTAGTAG
4105

TCAACG

TTAC

14227
14249
CCCATAATCATACAAAG
2337
CGGGGGCTTTGTATGA
4106

CCCCCG

TTAT

14228
14250
CCATAATCATACAAAGC
2338
GCGGGGGCTTTGTATG
4107

CCCCGC

ATTA

14244
14266
CCCCCGCACCAATAGGA
2339
GGAGGATCCTATTGGT
4108

TCCTCC

GCGG

14245
14267
CCCCGCACCAATAGGAT
2340
GGGAGGATCCTATTGG
4109

CCTCCC

TGCG

14246
14268
CCCGCACCAATAGGATC
2341
CGGGAGGATCCTATTG
4110

CTCCCG

GTGC

14247
14269
CCGCACCAATAGGATCC
2342
TCGGGAGGATCCTATT
4111

TCCCGA

GGTG

14252
14274
CCAATAGGATCCTCCCG
2343
TTGATTCGGGAGGATC
4112

AATCAA

CTAT

14262
14284
CCTCCCGAATCAACCCT
2344
GGGGTCAGGGTTGATT
4113

GACCCC

CGGG

14265
14287
CCCGAATCAACCCTGAC
2345
AGAGGGGTCAGGGTT
4114

CCCTCT

GATTC

14266
14288
CCGAATCAACCCTGACC
2346
GAGAGGGGTCAGGGT
4115

CCTCTC

TGATT

14275
14297
CCCTGACCCCTCTCCTT
2347
TTTATGAAGGAGAGGG
4116

CATAAA

GTCA

14276
14298
CCTGACCCCTCTCCTTC
2348
ATTTATGAAGGAGAGG
4117

ATAAAT

GGTC

14281
14303
CCCCTCTCCTTCATAAA
2349
GAATAATTTATGAAGG
4118

TTATTC

AGAG

14282
14304
CCCTCTCCTTCATAAAT
2350
TGAATAATTTATGAAG
4119

TATTCA

GAGA

14283
14305
CCTCTCCTTCATAAATT
2351
CTGAATAATTTATGAA
4120

ATTCAG

GGAG

14288
14310
GCTTCATAAATTATTCA
2352
GGAAGCTGAATAATTT
4121

GCTTCC

ATGA

14309
14331
CCTACACTATTAAAGTT
2353
GTGGTAAACTTTAATA
4122

TACCAC

GTGT

14328
14350
CCACAACCACCACCCCA
2354
GTATGATGGGGTGGTG
4123

TCATAC

GTTG

14334
14356
CCACCACCCCATCATAC
2355
GAAAGAGTATGATGG
4124

TCTTTC

GGTGG

14337
14359
CCACCCCATCATACTCT
2356
GGTGAAAGAGTATGAT
4125

TTCACC

GGGG

14340
14362
CCCCATCATACTCTTTT
2357
CTGGGTGAAAGAGTAT
4126

ACCCAC

GATG

14341
14363
CCCATCATACTCTTTCA
2358
TGTGGGTGAAAGAGTA
4127

CCCACA

TGAT

14342
14364
CCATCATACTCTTTCAC
2359
CTGTGGGTGAAAGAGT
4128

CCACAG

ATGA

14358
14380
CCCACAGCACCAATCCT
2360
GGAGGTAGGATTGGTG
4129

ACCTCC

CTGT

14359
14381
CCACAGCACCAATCCTA
2361
TGGAGGTAGGATTGGT
4130

CCTCCA

GCTG

14367
14389
CCAATCCTACCTCCATC
2362
GTTAGCGATGGAGGTA
4131

GCTAAC

GGAT

14372
14394
CCTACCTCCATCGCTAA
2363
GTGGGGTTAGCGATGG
4132

CCCCAC

AGGT

14376
14398
CCTCCATCGCTAACCCC
2364
TTTAGTGGGGTTAGCG
4133

ACTAAA

ATGG

14379
14401
CCATCGCTAACCCCACT
2365
TGTTTTAGTGGGGTTA
4134

AAAACA

GCGA

14389
14411
CCCCACTAAAACACTCA
2366
TCTTGGTGAGTGTTTT
4135

CCAAGA

AGTG

14390
14412
CCCACTAAAACACTCAC
2367
GTCTTGGTGAGTGTTT
4136

CAAGAC

TAGT

14391
14413
CCACTAAAACACTCACC
2368
GGTCTTGGTGAGTGTT
4137

AAGACC

TTAG

14406
14428
CCAAGACCTCAACCCCT
2369
GGGGTCAGGGGTTGA
4138

GACCCC

GGTCT

14412
14434
CCTCAACCCCTGACCCC
2370
GGCATGGGGGTCAGG
4139

CATGCC

GGTTG

14418
14440
CCCCTGACCCCCATGCC
2371
TCCTGAGGCATGGGGG
4140

TCAGGA

TCAG

14419
14441
CCCTGACCCCCATGCCT
2372
ATCCTGAGGCATGGGG
4141

CAGGAT

GTCA

14420
14442
CCTGACCCCCATGCCTC
2373
TATCCTGAGGCATGGG
4142

AGGATA

GGTC

14425
14447
CCCCCATGCCTCAGGAT
2374
AGGAGTATCCTGAGGC
4143

ACTCCT

ATGG

14426
14448
CCCCATGCCTCAGGATA
2375
GAGGAGTATCCTGAGG
4144

CTCCTC

CATG

14427
14449
CCCATGCCTCAGGATAC
2376
TGAGGAGTATCCTGAG
4145

TCCTCA

GCAT

14428
14450
CCATGCCTCAGGATACT
2377
TTGAGGAGTATCCTGA
4146

CCTCAA

GGCA

14433
14455
CCTCAGGATACTCCTCA
2378
GGCTATTGAGGAGTAT
4147

ATAGCC

CCTG

14445
14467
CCTCAATAGCCATCGCT
2379
TACTACAGCGATGGCT
4148

GTAGTA

ATTG

14454
14476
CCATCGCTGTAGTATAT
2380
CTTTGGATATACTACA
4149

CCAAAG

GCGA

14471
14493
CCAAAGACAACCATCAT
2381
GGGGGAATGATGGTTG
4150

TCCCCC

TCTT

14481
14503
CCATCATTCCCCCTAAA
2382
AATTTATTTAGGGGGA
4151

TAAATT

ATGA

14489
14511
CCCCCTAAATAAATTAA
2383
GTTTTTTTAATTTATTT
4152

AAAAAC

AGG

14490
14512
CCCCTAAATAAATTAA
2384
AGTTTTTTTAATTTATT
4153

AAAACT

TAG

14491
14513
CCCTAAATAAATTAAAA
2385
TAGTTTTTTTAATTTAT
4154

AAACTA

TTA

14492
14514
CCTAAATAAATTAAAAA
2386
ATAGTTTTTTTAATTTA
4155

AACTAT

TTT

14519
14541
CCCATATAACCTCCCCC
2387
AATTTTGGGGGAGGTT
4156

AAAATT

ATAT

14520
14542
CCATATAACCTCCCCCA
2388
GAATTTTGGGGGAGGT
4157

AAATTC

TATA

14528
14550
CCTCCCCCAAAATTCAG
2389
ATTATTCTGAATTTTG
4158

AATAAT

GGGG

14531
14553
CCCCCAAAATTCAGAAT
2390
GTTATTATTCTGAATTT
4159

AATAAC

TGG

14532
14554
CCCCAAAATTCAGAATA
2391
TGTTATTATTCTGAATT
4160

ATAACA

TTG

14533
14555
CCCAAAATTCAGAATAA
2392
GTGTTATTATTCTGAA
4161

TAACAC

TTTT

14534
14556
CCAAAATTCAGAATAAT
2393
TGTGTTATTATTCTGA
4162

AACACA

ATTT

14557
14579
CCCGACCACACCGCTAA
2394
TGATTGTTAGCGGTGT
4163

CAATCA

GGTC

14558
14580
CCGACCACACCGCTAAC
2395
TTGATTGTTAGCGGTG
4164

AATCAA

TGGT

14562
1484
CCACACCGCTAACAATC
2396
AGTATTGATTGTTAGC
4165

AATACT

GGTG

14567
14589
CCGCTAACAATCAATAC
2397
GGTTTAGTATTGATTG
4166

TAAACC

TTAG

14588
14610
CCCCCATAAATAGGAGA
2398
AAGCCTTCTCCTATTT
4167

AGGCTT

ATGG

14589
14611
CCCCATAAATAGGAGA
2399
TAAGCCTTCTCCTATTT
4168

AGGCTTA

ATG

14590
14612
CCCATAAATAGGAGAA
2400
CTAAGCCTTCTCCTAT
4169

GGCTTAG

TTAT

14591
14613
CCATAAATAGGAGAAG
2401
TCTAAGCCTTCTCCTA
4170

GCTTAGA

TTTA

14620
14642
CCCCACAAACCCCATTA
2402
GTTTAGTAATGGGGTT
4171

CTAAAC

TGTG

14621
14643
CCCACAAACCCCATTAC
2403
GGTTTAGTAATGGGGT
4172

TAAACC

TTGT

14622
14644
CCACAAACCCCATTACT
2404
GGGTTTAGTAATGGGG
4173

AAACCC

TTTG

14629
14651
CCCCATTACTAAACCCA
2405
TGAGTGTGGGTTTAGT
4174

CACTCA

AATG

14630
14652
CCCATTACTAAACCCAC
2406
TTGAGTGTGGGTTTAG
4175

ACTCAA

TAAT

14631
14653
CCATTACTAAACCCACA
2407
GTTGAGTGTGGGTTTA
4176

CTCAAC

GTAA

14642
14664
CCCACACTCAACAGAAA
2408
GCTTTGTTTCTGTTGA
4177

CAAAGC

GTGT

14643
14665
CCACACTCAACAGAAAC
2409
TGCTTTGTTTCTGTTGA
4178

AAAGCA

GTG

14694
14716
CCACGACCAATGATATG
2410
GTTTTTCATATCATTG
4179

AAAAAC

GTCG

14700
14722
CCAATGATATGAAAAAC
2411
ACGATGGTTTTTCATA
4180

CATCGT

TCAT

14716
14738
CCATCTTGTATTTCAA
2412
TTGTAGTTGAAATACA
4181

CTACAA

ACGA

14744
14766
CCAATGACCCCAATACG
2413
GTTTTGCGTATTGGGG
4182

CAAAAC

TCAT

14751
14773
CCCCAATACGCAAAACT
2414
GGGGTTAGTTTTGCGT
4183

AACCCC

ATTG

14752
14774
CCCAATACGCAAAACTA
2415
GGGGGTTAGTTTTGCG
4184

ACCCCC

TATT

14753
14775
CCAATACGCAAAACTAA
2416
AGGGGGTTAGTTTTGC
4185

CCCCCT

GTAT

14770
14792
CCCCCTAATAAAATTAA
2417
GGTTAATTAATTTTAT
4186

TTAACC

TAGG

14771
14793
CCCCTAATAAAATTAAT
2418
TGGTTAATTAATTTTA
4187

TAACCA

TTAG

14772
14794
CCCTAATAAAATTAATT
2419
GTGGTTAATTAATTTT
4188

AACCAC

ATTA

14773
14795
CCTAATAAAATFAATTA
2420
AGTGGTTAATTAATTT
4189

ACCACT

TATT

14791
14813
CCACTCATTCATCGACC
2421
TGGGGAGGTCGATGA
4190

TCCCCA

ATGAG

14806
14828
CCTCCCCACCCCATCCA
2422
AGATGTTGGATGGGGT
4191

ACATCT

GGGG

14809
14831
CCCCACCCCATCCAACA
2423
CGGAGATGTTGGATGG
4192

TCTCCG

GGTG

14810
14832
CCCACCCCATCCAACAT
2424
GCGGAGATGTTGGATG
4193

CTCCGC

GGGT

14811
14833
CCACCCCATCCAACATC
2425
TGCGGAGATGTTGGAT
4194

TCCGCA

GGGG

14814
14836
CCCCATCCAACATCTCC
2426
TCATGCGGAGATGTTG
4195

GCATGA

GATG

14815
14837
CCCATCCAACATCTCCG
2427
ATCATGCGGAGATGTT
4196

CATGAT

GGAT

14816
14838
CCATCCAACATCTCCGC
2428
CATCATGCGGAGATGT
4197

ATGATG

TGGA

14820
14842
CCAACATCTCCGCATGA
2429
GTTTCATCATGCGGAG
4198

TGAAAC

ATGT

14829
14851
CCGCATGATGAAACTTC
2430
TGAGCCGAAGTTTCAT
4199

GGCTCA

CATG

14854
14876
CCTTGGCGCCTGCCTGA
2431
GGAGGATCAGGCAGG
4200

TCCTCC

CGCCA

14862
14884
CCTGCCTGATCCTCCAA
2432
GGTGATTTGGAGGATC
4201

ATCACC

AGGC

14866
14888
CCTGATCCTCCAAATCA
2433
CTGTGGTGATTTGGAG
4202

CCACAG

GATC

14872
14894
CCTCCAAATCACCACAG
2434
ATAGTCCTGTGGTGAT
4203

GACTAT

TTGG

14875
14897
CCAAATCACCACAGGAC
2435
GGAATAGTCCTGTGGT
4204

TATTCC

GATT

14883
14905
CCACAGGACTATTCCTA
2436
CATGGCTAGGAATAGT
4205

GCCATG

CCTG

14896
14918
CCTAGCCATGCACTACT
2437
CTGGTGAGTAGTGCAT
4206

CACCAG

GGCT

14901
14923
CCATGCACTACTCACCA
2438
GGCGTCTGGTGAGTAG
4207

GACGCC

TGCA

14915
14937
CCAGACGCCTCAACCGC
2439
GAAAAGGCGGTTGAG
4208

CTTTTC

GCGTC

14922
14944
CCTCAACCGCCTTTTCA
2440
GATTGATGAAAAGGC
4209

TCAATC

GGTTG

14928
14950
CCGCCTTTTCATCAATC
2441
GTGGGCGATTGATGAA
4210

GCCCAC

AAGG

14931
14953
CCTTTTCATCAATCGCC
2442
GATGTGGGCGATTGAT
4211

CACATC

GAAA

14946
14968
CCCACATCACTCGAGAC
2443
ATTTACGTCTCGAGTG
4212

GTAAAT

ATGT

14947
14969
CCACATCACTCGAGACG
2444
AATTTACGTCTCGAGT
4213

TAAATT

GATG

14983
15005
CCGCTACCTTCACGCCA
2445
CGCCATTGGCGTGAAG
4214

ATGGCG

GTAG

14989
15011
CCTTCACGCCAATGGCG
2446
TTGAGGCGCCATTGGC
4215

CCTCAA

GTGA

14997
15019
CCAATGGCGCCTCAATA
2447
AAAGAATATTGAGGC
4216

TTCTTT

GCCAT

15006
15028
CCTCAATATTCTTTATCT
2448
GAGGCAGATAAAGAA
4217

GCCTC

TATTG

15025
15047
CCTCTTCCTACACATCG
2449
CTCGCCCGATGTGTAG
4218

GGCGAG

GAAG

15031
15053
CCTACACATCGGGCGAG
2450
ATAGGCCTCGCCCGAT
4219

GCCTAT

GTGT

15049
15071
CCTATATTACGGATCAT
2451
AGAGAAATGATCCGTA
4220

TTCTCT

ATAT

15081
15103
CCTGAAACTTCGGCATT
2452
GAGGATAATGCCGATG
4221

ATCCTC

TTTC

15100
15122
CCTCCTGCTTGCAACTA
2453
TTGCTATAGTTGCAAG
4222

TAGCAA

CAGG

15103
15125
CCTGCTTGCAACTATAG
2454
CTGTTGCTATAGTTGC
4223

CAACAG

AAGC

15126
15148
CCTTCATAGGCTATGTC
2455
CGGGAGGACATAGCCT
4224

CTCCCG

ATGA

15142
15164
CCTCCCGTGAGGCCAAA
2456
ATGATATTTGGCCTCA
4225

TATCAT

CGGG

15145
15167
CCCGTGAGGCCAAATAT
2457
AGAATGATATTTGGCC
4226

CATTCT

TCAC

15146
15168
CCGTGAGGCCAAATATC
2458
CAGAATGATATTTGGC
4227

ATTCTG

CTCA

15154
15176
CCAAATATCATTCTGAG
2459
TGGCCCCTCAGAATGA
4228

GGGCCA

TATT

15174
15196
CCACAGTAATTACAAAC
2460
TAGTAAGTTTGTAATT
4229

TTACTA

ACTG

15198
15220
CCGCCATCCCATACATT
2461
TGTCCCAATGTATGGG
4230

GGGACA

ATGG

15201
15223
CCATCCCATACATTGGG
2462
GTCTGTCCCAATGTAT
4231

ACAGAC

GGGA

15205
15727
CCCATACATTGGGACAG
2463
CTAGGTCTGTCCCAAT
4232

ACCTAG

GTAT

15206
15228
CCATACATTGGGACAGA
2464
ACTAGGTCTGTCCCAA
4233

CCTAGT

TGTA

15223
15245
CCTAGTTCAATGAATCT
2465
CTCCTCAGATTCATTG
4234

GAGGAG

AACT

15263
15285
CCCACCCTCACACGATT
2466
GTAAAGAATCGTGTGA
4235

CTTTAC

GGGT

15264
15286
CCACCCTCACACGATTC
2467
GGTAAAGAATCGTGTG
4236

TTTACC

AGGG

15267
15289
CCCTCACACGATTCTTT
2468
AAAGGTAAAGAATCG
4237

ACCTTT

TGTGA

15268
15290
CCTCACACGATTCTTTA
2469
GAAAGGTAAAGAATC
4238

CCTTTC

GTGTG

15285
15307
CCTTTCACTTCATCTTGC
2470
GAAGGGCAAGATGAA
4239

CCTTC

GTGAA

15302
15324
CCCTTCATTATTGCAGC
2471
GCTAGGGCTGCAATAA
4240

CCTAGC

TGAA

15303
15325
CCTTCATTATTGCAGCC
2472
TGCTAGGGCTGCAATA
4241

CTAGCA

ATGA

15318
15340
CCCTAGCAACACTCCAC
2473
TAGGAGGTGGAGTGTT
4242

CTCCTA

GCTA

15319
15341
CCTAGCAACACTCCACC
2474
ATAGGAGGTGGAGTGT
4243

TCCTAT

TGCT

15331
15353
CCACCTCCTATTCTTGC
2475
TTTCGTGCAAGAATAG
4244

ACGAAA

GAGG

15334
15356
CCTCCTATTCTTGCACG
2476
CCGTTTCGTGCAAGAA
4245

AAACGG

TAGG

15337
15359
CCTATTCTTGCACGAAA
2477
ATCCCGTTTCGTGCAA
4246

CGGGAT

GAAT

15367
15389
CCCCCTAGGAATCACCT
2478
AATGGGAGGTGATTCC
4247

CCCATT

TAGG

15368
15390
CCCCTAGGAATCACCTC
2479
GAATGGGAGGTGATTC
4248

CCATTC

CTAG

15369
15391
CCCTAGGAATCACCTCC
2480
GGAATGGGAGGTGATT
4249

CATTCC

CCTA

15370
15392
CCTAGGAATCACCTCCC
2481
CGGAATGGGAGGTGA
4250

ATTCCG

TTCCT

15381
15403
CCTCCCATTCCGATAAA
2482
GGTGATTTTATCGGAA
4251

ATCACC

TGGG

15384
15406
CCCATTCCGATAAAATC
2483
GAAGGTGATTTTATCG
4252

ACCTTC

GAAT

15385
15407
CCATTCCGATAAAATCA
2484
GGAAGGTGATTTTATC
4253

CCTTCC

GGAA

15390
15412
CCGATAAAATCACCTTC
2485
AGGGTGGAAGGTGATT
4254

CACCCT

TTAT

15402
15424
CCTTCCACCCTTACTAC
2486
GATTGTGTAGTAAGGG
4255

ACAATC

TGGA

15406
15428
CCACCCTTACTACACAA
2487
CTTTGATTGTGTAGTA
4256

TCAAAG

AGGG

15409
15431
CCCTTACTACACAATCA
2488
CGTCTTTGATTGTGTA
4257

AAGACG

GTAA

15410
15432
CCTTACTACACAATCAA
2489
GCGTCTTTGATTGTGT
4258

AGACGC

AGTA

15432
15454
CCCTCGGCTTACTTCTCT
2490
AAGGAAGAGAAGTAA
4259

TCCTT

GCCGA

15433
15455
CCTCGGCTTACTTCTCTT
2491
GAAGGAAGAGAAGTA
4260

CCTTC

AGCCG

15451
15473
CCTTCTCTCCTTAATGA
2492
TTAATGTCATTAAGGA
4261

CATTAA

GAGA

15459
15481
CCTTAATGACATTAACA
2493
GAATAGTGTTAATGTC
4262

CTATTC

ATTA

15485
15507
CCAGACCTCCTAGGCGA
2494
TCTGGGTCGCCTAGGA
4263

CCCAGA

GGTC

15490
15512
CCTCCTAGGCGACCCAG
2495
AATTGTCTGGGTCGCC
4264

ACAATT

TAGG

15493
15515
CCTAGGCGACCCAGACA
2496
TATAATTGTCTGGGTC
4265

ATTATA

GCCT

15502
15524
CCCAGACAATTATACCC
2497
TGGCTAGGGTATAATT
4266

TAGCCA

GTCT

15503
15525
CCAGACAATTATACCCT
2498
TTGGCTAGGGTATAAT
4267

AGCCAA

TGTC

15516
15538
CCCTAGCCAACCCCTTA
2499
GGTGTTTAAGGGGTTG
4268

AACACC

GCTA

15517
15539
CCTAGCCAACCCCTTAA
2500
GGGTGTTTAAGGGGTT
4269

ACACCC

GGCT

15522
15544
CCAACCCCTTAAACACC
2501
GGGAGGGGTGTTTAAG
4270

CCTCCC

GGGT

15526
15548
CCCCTTAAACACCCCTC
2502
TGTGGGGAGGGGTGTT
4271

CCCACA

TAAG

15527
15549
CCCTTAAACACCCCTCC
2503
ATGTGGGGAGGGGTGT
4272

CCACAT

TTAA

15528
15550
CCTTAAACACCCCTCCC
2504
GATGTGGGGAGGGGT
4273

CACATC

GTTTA

15537
15559
CCCCTCCCCACATCAAG
2505
TTCGGGCTTGATGTGG
4274

CCCGAA

GGAG

15538
15560
CCCTCCCCACATCAAGC
2506
ATTCGGGCTTGATGTG
4275

CCGAAT

GGGA

15539
15561
CCTCCCCACATCAAGCC
2507
CATTCGGGCTTGATGT
4276

CGAATG

GGGG

15542
15564
CCCCACATCAAGCCCGA
2508
TATCATTCGGGCTTGA
4277

ATGATA

TGTG

15543
15565
CCCACATCAAGCCCGAA
2509
ATATCATTCGGGCTTG
4278

TGATAT

ATGT

15544
15566
CCACATCAAGCCCGAAT
2510
AATATCATCGGGCTT
4279

GATATT

GATG

15554
15576
CCCGAATGATATTTCCT
2511
GCGAATAGGAAATATC
4280

ATTCGC

ATTC

15555
15577
CCGAATGATATTTCCTA
2512
GGCGAATAGGAAATA
4281

TTCGCC

TCATT

15568
15590
CCTATTCGCCTACACAA
2513
GGAGAATTGTGTAGGC
4282

TTCTCC

GAAT

15576
15598
CCTACACAATTCTCCGA
2514
GACGGATCGGAGAATT
4283

GTGTGT

GTGT

15589
15611
CCGATCCGTCCCTAACA
2515
CTAGTTTGTTAGGGAC
4284

AACTAG

GGAT

15594
15616
CCGTCCCTAACAAACTA
2516
GCCTCCTAGTTTGTTA
4285

GGAGGC

GGGA

15598
15620
CCCTAACAAACTAGGAG
2517
GGACGCCTCCTAGTTT
4286

GCGTCC

GTTA

15599
15621
CCTAACAAACTAGGAG
2518
AGGACGCCTCCTAGTT
4287

GCGTCCT

TGTT

15619
15641
CCTTGCCCTATTACTAT
2519
GGATGGATAGTAATAG
4288

CCATCC

GGCA

15624
15646
CCCTATTACTATCCATC
2520
GATGAGGATGGATAGT
4289

CTCATC

AATA

15625
15647
CCTATTACTATCCATCC
2521
GGATGAGGATGGATA
4290

TCATCC

GTAAT

15636
15658
CCATCCTCATCCTAGCA
2522
GATTATTGCTAGGATG
4291

ATAATC

AGGA

15640
15662
CCTCATCCTAGCAATAA
2523
TGGGGATTATTGCTAG
4292

TCCCCA

GATG

15646
15668
CCTAGCAATAATCCCCA
2524
GGAGGATGGGGATTAT
4293

TCCTCC

TGCT

15658
15680
CCCCATCCTCCATATAT
2525
GTTTGGATATATGGAG
4294

CCAAAC

GATG

15659
15681
CCCATCCTCCATATATC
2526
TGTTTGGATATATGGA
4295

CAAACA

GGAT

15660
15682
CCATCCTCCATATATCC
2527
TTGTTTGGATATATGG
4296

AAACAA

AGGA

15664
15686
CCTCCATATATCCAAAC
2528
TTTGTTGTTTGGATAT
4297

AACAAA

ATGG

15667
15689
CCATATATCCAAACAAC
2529
TGCTTTGTTGTTTGGAT
4298

AAAGCA

ATA

15675
15697
CCAAACAACAAAGCAT
2530
AAATATTATGCTTTGT
4299

AATATTT

TGTT

15700
15722
CCCACTAAGCCAATCAC
2531
AATAAAGTGATTGGCT
4300

TTTATT

TAGT

15701
15723
CCACTAACCAATCACT
2532
CAATAAAGTGATTGGC
4301

TTATTG

TTAG

15709
15731
CCAATCACTTTATTGAC
2533
CTAGGAGTCAATAAAG
4302

TCCTAG

TGAT

15727
15749
CCTAGCCGCAGACCTCC
2534
GAATGAGGAGGTCTGC
4303

TCATTC

GGCT

15732
15754
CCGCAGACCTCCTCATT
2535
GGTTAGAATGAGGAG
4304

CTAACC

GTCTG

15739
15761
CCTCCTCATTCTAACCT
2536
CGATTCAGGTTAGAAT
4305

GAATCG

GAGG

15742
15764
CCTCATTCTAACCTGAA
2537
CTCCGATTCAGGTTAG
4306

TCGGAG

AATG

15753
15775
CCTGAATCGGAGGACA
2538
TACTGGTTGTCCTCCG
4307

ACCAGTA

ATTC

15770
15792
CCAGTAAGCTACCCTTT
2539
ATGGTAAAAGGGTAG
4308

TACCAT

CTTAC

15781
15803
CCCTTTTACCATCATTG
2540
CTTGTCCAATGATGGT
4309

GACAAG

AAAA

15782
15804
CCTTTTACCATCATTGG
2541
ACTTGTCCAATGATGG
4310

ACAAGT

TAAA

15789
15811
CCATCATTGGACAAGTA
2542
GGATGCTACTTGTCCA
4311

GCATCC

ATGA

15810
15832
CCGTACTATACTTCACA
2543
GATTGTTGTGAAGTAT
4312

ACAATC

AGTA

15832
15854
CCTAATCCTAATACCAA
2544
AGATAGTTGGTATTAG
4313

CTATCT

GATT

15838
15860
CCTAATACCAACTATCT
2545
TTAGGGAGATAGTTGG
4314

CCCTAA

TATT

15845
15867
CCAACTATCTCCCTAAT
2546
TTTTCAATTAGGGAGA
4315

TGAAAA

TAGT

15855
15877
CCCTAATTGAAAACAAA
2547
GAGTATTTTGTTTTCA
4316

ATACTC

ATTA

15856
15878
CCTAATTGAAAACAAAA
2548
TGAGTATTTTGTTTTCA
4317

TACTCA

ATT

15885
15907
CCTGTCCTTGTAGTATA
2549
TTAGTTTATACTACAA
4318

AACTAA

GGAC

15890
15912
CCTTGTAGTATAAACTA
2550
GTGTATTAGTTTATAC
4319

ATACAC

TACA

15912
15934
CCAGTCTTGTAAACCGG
2551
TCATCTCCGGTTTACA
4320

AGATGA

AGAC

15925
15947
CCGGAGATGAAAACCTT
2552
TGGAAAAAGGTTTTCA
4321

TTTCCA

TCTC

15938
15960
CCTTTTTCCAAGGACAA
2553
TCTGATTTGTCCTTGG
4322

ATCAGA

AAAA

15945
15967
CCAAGGACAAATCAGA
2554
CTTTTTCTCTGATTTGT
4323

GAAAAAG

CCT

15977
15999
CCACCATTAGCACCCAA
2555
TTAGCTTTGGGTGCTA
4324

AGCTAA

ATGG

15980
16002
CCATTAGCACCCAAAGC
2556
ATCTTAGCTTTGGGTG
4325

TAAGAT

CTAA

15989
16011
CCCAAAGCTAAGATTCT
2557
TAAATTAGAATCTTAG
4326

AATTTA

CTTT

15990
16012
CCAAAGCTAAGATTCTA
2558
TTAAATTAGAATCTTA
4327

ATTTAA

GCTT

16052
16074
CCACCCAAGTATTGACT
2559
TGGGTGAGTCAATACT
4328

CACCCA

TGGG

16055
16077
CCCAAGTATTGACTCAC
2560
TGATGGGTGAGTCAAT
4329

CCATCA

ACTT

16056
16078
CCAAGTATTGACTCACC
2561
TTGATGGGTGAGTCAA
4330

CATCAA

TACT

16071
16093
CCCATCAACAACCGCTA
2562
AATACATAGCGGTTGT
4331

TGTATT

TGAT

16072
16094
CCATCAACAACCGCTAT
2563
AAATACATAGCGGTTG
4332

GTATTT

TTGA

16082
16104
CCGCTATGTATTTCGTA
2564
GTAATGTACGAAATAC
4333

CATTAC

ATAG

16107
16129
CCAGCCACCATGAATAT
2565
CGTACAATATTCATGG
4334

TGTACG

TGGC

16111
16133
CCACCATGAATATTGTA
2566
GTACCGTACAATATTC
4335

CGGTAC

ATGG

16114
16136
CCATGAATATTGTACGG
2567
ATGGTACCGTACAATA
4336

TACCAT

TTCA

16133
16155
CCATAAATACTTGACCA
2568
TACAGGTGGTCAAGTA
4337

CCTGTA

TTTA

16147
16169
CCACCTGTAGTACATAA
2569
GGGTTTTTATGTACTA
4338

AAACCC

CAGG

16150
16172
CCTGTAGTACATAAAAA
2570
ATTGGGTTTTTATGTA
4339

CCCAAT

CTAC

16167
16189
CCCAATCCACATCAAAA
2571
AGGGGGTTTTGATGTG
4340

CCCCCT

GATT

16168
16190
CCAATCCACATCAAAAC
2572
GAGGGGGTTTTGATGT
4341

CCCCTC

GGAT

16173
16195
CCACATCAAAACCCCCT
2573
ATGGGGAGGGGGTTTT
4342

CCCCAT

GATG

16184
16206
CCCCCTCCCCATGCTTA
2574
TGCTTGTAAGCATGGG
4343

CAAGCA

GG

16185
16207
CCCCTCCCCATGCTTAC
2575
TTGCTTGTAAGCATGG
4344

AAGCAA

GGAG

16186
16208
CCCTCCCCATGCTTACA
2576
CTTGCTTGTAAGCATG
4345

AGCAAG

GGGA

16187
16209
CCTCCCCATGCTTACAA
2577
ACTTGCTTGTAAGCAT
4346

GCAAGT

GGGG

16190
16212
CCCCATGCTTACAAGCA
2578
TGTACTTGCTTGTAAG
4347

AGTACA

CATG

16191
16213
CCCATGCTTACAAGCAA
2579
CTGTACTTGCTTGTAA
4348

GTACAG

GCAT

16192
16214
CCATGCTTACAAGCAAG
2580
GCTGTACTTGCTTGTA
4349

TACAGC

AGCA

16221
16243
CCCTCAACTATCACACA
2581
AGTTGATGTGTGATAG
4350

TCAACT

TTGA

16222
16244
CCTCAACTATCACACAT
2582
CAGTTGATGTGTGATA
4351

CAACTG

GTTG

16250
16272
CCAAAGCCACCCCTCAC
2583
TAGTGGGTGAGGGGTG
4352

CCACTA

GCTT

16256
16278
CCACCCCTCACCCACTA
2584
GTATCCTAGTGGGTGA
4353

GGATAC

GGGG

16259
16281
CCCCTCACCCACTAGGA
2585
TTGGTATCCTAGTGGG
4354

TACCAA

TGAG

16260
16282
CCCTCACCCACTAGGAT
2586
GTTGGTATCCTAGTGG
4355

ACCAAC

GTGA

16261
16283
CCTCACCCACTAGGATA
2587
TGTTGGTATCCTAGTG
4356

CCAACA

GGTG

16266
16288
CCCACTAGGATACCAAC
2588
AGGTTTGTTGGTATCC
4357

AAACCT

TAGT

16267
16289
CCACTAGGATACCAACA
2589
TAGGTTTGTTGGTATC
4358

AACCTA

CTAG

16278
16300
CCAACAAACCTACCCAC
2590
TTAAGGGTGGGTAGGT
4359

CCTTAA

TTGT

16286
16308
CCTACCCACCCTTAACA
2591
ATGTACTGTTAAGGGT
4360

GTACAT

GGGT

16290
16312
CCCACCCTTAACAGTAC
2592
TACTATGTACTGTTAA
4361

ATAGTA

GGGT

16291
16313
CCACCCTTAACAGTACA
2593
GTACTATGTACTGTTA
4362

TAGTAC

AGGG

16294
16316
CCCTTAACAGTACATAG
2594
TATGTACTATGTACTG
4363

TACATA

TTAA

16295
16317
CCTTAACAGTACATAGT
2595
TTATGTACTATGTACT
4364

ACATAA

GTTA

16320
16342
CCATTTACCGTACATAG
2596
AATGTGCTATGTACGG
4365

CACATT

TAAA

16327
16349
CCGTACATAGCACATTA
2597
TGACTGTAATGTGCTA
4366

CAGTCA

TGTA

16353
16375
CCCTTCTCGTCCCCATG
2598
GTCATCCATGGGGACG
4367

GATGAC

AGAA

16354
16376
CCTTCTCGTCCCCATGG
2599
GGTCATCCATGGGGAC
4368

ATGACC

GAGA

16363
16385
CCCCATGGATGACCCCC
2600
TCTGAGGGGGGTCAT
4369

CTCAGA

CATG

16364
16386
CCCATGGATGACCCCCC
2601
ATCTGAGGGGGGTCAT
4370

TCAGAT

CCAT

16365
16387
CCATGGATGACCCCCCT
2602
TATCTGAGGGGGGTCA
4371

CAGATA

TCCA

16375
16397
CCCCCCTCAGATAGGGG
2603
AAGGGACCCCTATCTG
4372

TCCCTT

AGGG

16376
16398
CCCCCTCAGATAGGGGT
2604
CAAGGGACCCCTATCT
4373

CCCTTG

GAGG

16377
16399
CCCCTCAGATAGGGGTC
2605
TCAAGGGACCCCTATC
4374

CCTTGA

TGAG

16378
16400
CCCTCAGATAGGGGTCC
2606
GTCAAGGGACCCCTAT
4375

CTTGAC

CTGA

16379
16401
CCTCAGATAGGGGTCCC
2607
GGTCAAGGGACCCCTA
4376

TTGACC

TCTG

16393
16415
CCCTTGACCACCATCCT
2608
TCACGGAGGATGGTGG
4377

CCGTGA

TCAA

16394
16416
CCTTGACCACCATCCTC
2609
TTCACGGAGGATGGTG
4378

CGTGAA

GTCA

16400
16422
CCACCATCCTCCGTGAA
2610
ATTGATTTCACGGAGG
4379

ATCAAT

ATGG

16403
16425
CCATCCTCCGTGAAATC
2611
GATATTGATTTCACGG
4380

AATATC

AGGA

16407
16429
CCTCCGTGAAATCAATA
2612
GCGGGATATTGATTTC
4381

TCCCGC

ACGG

16410
16432
CCGTGAAATCAATATCC
2613
TGTGCGGGATATTGAT
4382

CGCACA

TTCA

16425
16447
CCCGCACAAGAGTGCTA
2614
GGAGAGTAGCACTCTT
4383

CTCTCC

GTGC

16426
16448
CCGCACAAGAGTGCTAC
2615
AGGAGAGTAGCACTCT
4384

TCTCCT

TGTG

16446
16468
CCTCGCTCCGGGCCCAT
2616
AGTGTTATGGGCCCGG
4385

AACACT

AGCG

16453
16475
CCGGGCCCATAACACTT
2617
ACCCCCAAGTGTTATG
4386

GGGGGT

GGCC

16458
16480
CCCATAACACTTGGGGG
2618
TAGCTACCCCCAAGTG
4387

TAGCTA

TTAT

16459
16481
CCATAACACTTGGGGGT
2619
TTAGCTACCCCCAAGT
4388

AGCTAA

GTTA

16494
16516
CCGACATCTGGTTCCTA
2620
CTGAAGTAGGAACCA
4389

CTTCAG

GATGT

16507
16529
CCTACTTCAGGGTCATA
2621
AGGCTTTATGACCCTG
4390

AAGCCT

AAGT

16527
16549
CCTAAATAGCCCACACG
2622
GGGGAACGTGTGGGCT
4391

TTCCCC

ATTT

16536
16558
CCCACACGTTCCCCTTA
2623
CTTATTTAAGGGGAAC
4392

AATAAG

GTGT

16537
16559
CCACACGTTCCCCTTAA
2624
TCTTATTTAAGGGGAA
4393

ATAAGA

CGTG

16546
16568
CCCCTTAAATAAGACAT
2625
ATCGTGATGTCTTATT
4394

CACGAT

TAAG

16547
16569
CCCTTAAATAAGACATC
2626
CATCGTGATGTCTTAT
4395

ACGATG

TT

16548
16570
CCTTAAATAAGACATCA
2627
CCATCGTGATGTCTTA
4396

CGATGG

TTTA

Applications

The gNAs (e.g., gRNAs) and collections of gNAs (e.g., gRNAs) provided herein are useful for a variety of applications, including depletion, partitioning, capture, or enrichment of target sequences of interest, genome-wide labeling; genome-wide editing, genome-wide function screens; and genome-wide regulation.

In one embodiment, the gNAs are selective for host nucleic acids in abiological sample from a host, but are not selective for non-host nucleic acids in the sample from a host. In one embodiment, the gNAs are selective for non-host nucleic acids from a biological sample from a host but are not selective for the host nucleic acids in the sample. In one embodiment, the gNAs are selective for both host nucleic acids and a subset of the non-host nucleic acids in abiological sample from a host. For example, where a complex biological sample comprises host nucleic acids and nucleic acids from more than one non-host organisms, the gRNAs may be selective for more than one of the non-host species. In such embodiments, the gNAs are used to serially deplete or partition the sequences that are not of interest. For example, saliva from a human contains human DNA, as well as the DNA of more than one bacterial species, but may also contain the genomic material of an unknown pathogenic organism. In such an embodiment, gNAs directed at the human DNA and the known bacteria can be used to serially deplete the human DNA, and the DNA of the known bacterial, thus resulting in a sample comprising the genomic material of the unknown pathogenic organism.

In an exemplary embodiment, the gNAs are selective for human host DNA obtained from a biological sample from the host, but do not hybridize with DNA from an unknown pathogen(s) also obtained from the sample.

In some embodiments, the gNAs are useful for depleting and partitioning of targeted sequences in a sample, enriching a sample for non-host nucleic acids, or serially depleting targeted nucleic acids in a sample comprising: providing nucleic acids extracted from a sample; and contacting the sample with a plurality of complexes comprising (i) any one of the collection of gNAs described herein and (ii) nucleic acid-guided nuclease (e.g., CRISPR/Cas) system proteins.

In some embodiments, the gNAs are useful for method of depletion and partitioning of targeted sequences in a sample comprising: providing nucleic acids extracted from a sample, wherein the extracted nucleic acids comprise sequences of interest and targeted sequences for one of depletion and partitioning; contacting the sample with a plurality of complexes comprising (i) a collection of gNAs provided herein; and (ii) nucleic acid-guided nuclease (e.g., CRISPR/Cas) system proteins, under conditions in which the nucleic acid-guided nuclease system proteins cleave the nucleic acids in the sample.

In some embodiments, the gNAs are useful for enriching a sample for non-host nucleic acids comprising: providing a sample comprising host nucleic acids and non-host nucleic acids; contacting the sample with a plurality of complexes comprising (i) a collection of gNAs provided herein comprising targeting sequences directed at the host nucleic acids; and (ii) nucleic acid-guided nuclease (e.g., CRISPR/Cas) system proteins, under conditions in which the nucleic acid-guided nuclease system proteins cleave the host nucleic acids in the sample, thereby depleting the sample of host nucleic acids, and allowing for the enrichment of non-host nucleic acids.

In some embodiments, the gNAs are useful for one method for serially depleting targeted nucleic acids in a sample comprising: providing a biological sample from a host comprising host nucleic acids and non-host nucleic acids, wherein the non-host nucleic acids comprise nucleic acids from at least one known non-host organism and nucleic acids from an unknown non-host organism; providing a plurality of complexes comprising (i) a collection of gNAs provided herein, directed at the host nucleic acids; and (ii) nucleic acid-guided nuclease (e.g., CRISPR/Cas) system proteins; mixing the nucleic acids from the biological sample with the gNA-nucleic acid-guided nuclease system protein complexes (e.g., gRNA-CRISPR/Cas system protein complexes) configured to hybridize to targeted sequences in the host nucleic acids, wherein at least a portion of the complexes hybridizes to the targeted sequences in the host nucleic acids, and wherein at least a portion of the host nucleic acids are cleaved; mixing the remaining nucleic acids from the biological sample with the gNA-nucleic acid-guided nuclease system protein complexes configured to hybridize to targeted sequences in the at least one known non-host nucleic acids, wherein at least a portion of the complexes hybridizes to the targeted sequences in the at least one non-host nucleic acids, and wherein at least a portion of the non-host nucleic acids are cleaved; and isolating the remaining nucleic acids from the unknown non-host organism and preparing for further analysis.

In some embodiments, the gNAs generated herein are used to perform genome-wide or targeted functional screens in a population of cells. In such an embodiment, libraries of in vitro-transcribed gNAs (e.g., gRNAs) or vectors encoding the gNAs can be introduced into a population of cells via transfection or other laboratory techniques known in the art, along with a nucleic acid-guided nuclease (e.g., CRISPR/Cas) system protein, in a way that gNA-directed nucleic acid-guided nuclease system protein editing can be achieved to sequences across the entire genome or to a specific region of the genome. In one embodiment, the nucleic acid-guided nuclease system protein can be introduced as a DNA. In one embodiment, the nucleic acid-guided nuclease system protein can be introduced as mRNA. In one embodiment, the nucleic acid-guided nuclease system protein can be introduced as protein. In one exemplary embodiment, the nucleic acid-guided nuclease system protein is Cas9.

In some embodiments, the gNAs generated herein are used for the selective capture and/or enrichment of nucleic acid sequences of interest. For example, in some embodiments, the gNAs generated herein are used for capturing target nucleic acid sequences comprising: providing a sample comprising a plurality of nucleic acids; and contacting the sample with a plurality of complexes comprising (i) a collection of gNAs provided herein; and (ii) nucleic acid-guided nuclease (e.g., CRISPR/Cas) system proteins. Once the sequences of interest are captured, they can be further ligated to create, for example, a sequencing library.

In some embodiments, the gNAs generated herein are used for introducing labeled nucleotides at targeted sites of interest comprising: (a) providing a sample comprising a plurality of nucleic acid fragments; (b) contacting the sample with a plurality of complexes comprising (i) a collection of gNAs provided herein; and (ii) nucleic acid-guided nuclease (e.g., CRISPR/Cas) system protein-nickases (e.g. Cas9-nickases), wherein the gNAs are complementary to targeted sites of interest in the nucleic acid fragments, thereby generating a plurality of nicked nucleic acid fragments at the targeted sites of interest; and (c) contacting the plurality of nicked nucleic acid fragments with an enzyme capable of initiating nucleic acid synthesis at a nicked site, and labeled nucleotides, thereby generating a plurality of nucleic acid fragments comprising labeled nucleotides in the targeted sites of interest.

In some embodiments, the gNAs generated herein are used for capturing target nucleic acid sequences of interest comprising: (a) providing a sample comprising a plurality of adapter-ligated nucleic acids, wherein the nucleic acids are ligated to a first adapter at one end and are ligated to a second adapter at the other end; and (b) contacting the sample with a collection of gNAs which comprise a plurality of dead nucleic acid-guided nuclease-gNA complexes (e.g., dCas9-gRNA complexes), wherein the dead nucleic acid-guided nuclease (e.g., dCas9) is fused to a transposase, wherein the gNAs are complementary to targeted sites of interest contained in a subset of the nucleic acids, and wherein the dead nucleic acid-guided nuclease-gNA transposase complexes (e.g., dCas9-gRNA transposase complexes) are loaded with a plurality of third adapters, to generate a plurality of nucleic acids fragments comprising either a first or second adapter at one end and a third adapter at the other end. In one embodiment the method further comprises amplifying the product of step (b) using first or second adapter and third adapter-specific PCR.

In some embodiments, the gNAs generated herein are used to perform genome-wide or targeted activation or repression in a population of cells. In such an embodiment, libraries of in vitro-transcribed gNAs (e.g., gRNAs) or vectors encoding the gNAs can be introduced into a population of cells via transfection or other laboratory techniques known in the art, along with a catalytically dead nucleic acid-guided nuclease (e.g., CRISPR/Cas) system protein fused to an activator or repressor domain (catalytically dead nucleic acid-guided nuclease system protein-fusion protein), in a way that gNA-directed catalytically dead nucleic acid-guided nuclease system protein-mediated activation or repression can be achieved at sequences across the entire genome or to a specific region of the genome. In one embodiment, the catalytically dead nucleic acid-guided nuclease system protein-fusion protein can be introduced as DNA. In one embodiment, the catalytically dead nucleic acid-guided nuclease system protein-fusion protein can be introduced as mRNA. In one embodiment, the catalytically dead nucleic acid-guided nuclease system protein-fusion protein can be introduced as protein. In some embodiments, the collection of gNAs or nucleic acids encoding for gNAs exhibit specificity for more than one nucleic acid-guided nuclease system protein. In one exemplary embodiment, the catalytically dead nucleic acid-guided nuclease system protein is dCas9.

In some embodiments, the collection comprises gRNAs or nucleic acids encoding for gRNAs with specificity for Cas9 and one or more CRISPR/Cas system proteins selected from selected from the group consisting of Cpf1, Cas3, Cas8a-c, Cas10, Cse1, Csy1, Csn2, Cas4, Csm2, and Cm5. In some embodiments, the collection comprises gRNAs or nucleic acids encoding for gRNAs with specificity for various catalytically dead CRISPR/Cas system proteins fused to different fluorophores, for example for use in the labeling and/or visualization of different genomes or portions of genomes, for use in the labeling and/or visualization of different chromosomal regions, or for use in the labeling and/or visualization of the integration of viral genes/genomes into a genome.

In some embodiments, the collection of gNAs (or nucleic acids encoding for gNAs) have specificity for different nucleic acid-guided nuclease (e.g., CRISPR/Cas) system proteins, and target different sequences of interest, for example from different species. For example, a first subset of gNAs from a collection of gNAs (or transcribed from a population of nucleic acids encoding such gNAs) targeting a genome from a first species can be first mixed with a first nucleic acid-guided nuclease system protein member (or an engineered version); and a second subset of gNAs from a collection of gNAs (or transcribed from a population of nucleic acids encoding such gNAs) targeting a genome from a second species can be mixed with a second different nucleic acid-guided nuclease system protein member (or an engineered version). In one embodiment, the nucleic acid-guided nuclease system proteins can be a catalytically dead version (for example dCas9) fused with different fluorophores, so that different targeted sequence of interest, e.g. different species genome, or different chromosomes of one species, can be labeled by different fluorescent labels. For example, different chromosomal regions can be labeled by different gRNA-targeted dCas9-fluorophores, for visualization of genetic translocations. For example, different viral genomes can be labeled by different gRNA-targeted dCas9-fluorophores, for visualization of integration of different viral genomes into the host genome. In another embodiment, the nucleic acid-guided nuclease system protein can be dCas9 fused with either activation or repression domain, so that different targeted sequence of interest, e.g. different chromosomes of a genome, can be differentially regulated. In another embodiment, the nucleic acid-guided nuclease system protein can be dCas9 fused different protein domain which can be recognized by different antibodies, so that different targeted sequence of interest, e.g. different DNA sequences within a sample mixture, can be differentially isolated.

Exemplary Compositions of the Invention

In one embodiment, provided herein is a composition comprising a nucleic acid fragment, a nickase nucleic acid-guided nuclease-gNA complex, and labeled nucleotides. In one exemplary embodiment, provided herein is a composition comprising a nucleic acid fragment, a nickase Cas9-gRNA complex, and labeled nucleotides. In such embodiments, the nucleic acid may comprise DNA. The nucleotides can be labeled, for example with biotin. The nucleotides can be part of an antibody-conjugate pair.

In one embodiment, provided herein is a composition comprising a nucleic acid fragment and a catalytically dead nucleic acid-guided nuclease-gNA complex, wherein the catalytically dead nucleic acid-guided nuclease is fused to a transposase. In one exemplary embodiment, provided herein is a composition comprising a DNA fragment and a dCas9-gRNA complex, wherein the dCas9 is fused to a transposase.

In one embodiment, provided herein is a composition comprising a nucleic acid fragment comprising methylated nucleotides, a nickase nucleic acid-guided nuclease-gNA complex, and unmethylated nucleotides. In an exemplary embodiment, provided herein is a composition comprising a DNA fragment comprising methylated nucleotides, a nickase Cas9-gRNA complex, and unmethylated nucleotides.

In one embodiment, provided herein is a gDNA complexed with a nucleic acid-guided-DNA endonuclease. In an exemplary embodiment, the nucleic acid-guided-DNA endonuclease is NgAgo.

In one embodiment, provided herein is a gDNA complexed with a nucleic acid-guided-RNA endonuclease.

In one embodiment, provided herin is a gRNA complexed with a nucleic acid-guided-DNA endonuclease.

In one embodiment, provided herein is a gRNA complexed with a nucleic acid-guided-RNA endonuclease. In one embodiment, the nucleic acid-guided-RNA endonuclease comprises C2c2.

Kits and Articles of Manufacture

The present application provides kits comprising any one or more of the compositions described herein, not limited to adapters, gNAs (e.g., gRNAs), gNA collections (e.g., gRNA collections), nucleic acid molecules encoding the gNA collections, and the like.

In one exemplary embodiment, the kit comprises a collection of DNA molecules capable of transcribing into a library of gRNAs wherein the gRNAs are targeted to human genomic or other sources of DNA sequences.

In one embodiment, the kit comprises a collection of gNAs wherein the gNAs are targeted to human genomic or other sources of DNA sequences.

In some embodiments, provided herein are kits comprising any of the collection of nucleic acids encoding gNAs, as described herein. In some embodiments, provided herein are kits comprising any of the collection of gNAs, as described herein.

The present application also provides all essential reagents and instructions for carrying out the methods of making the gNAs and the collection of nucleic acids encoding gNAs, as described herein. In some embodiments, provided herein are kits that comprise all essential reagents and instructions for carrying out the methods of making individual gNAs and collections of gNAs as described herein.

Also provided herein is computer software monitoring the information before and after contacting a sample with a gNA collection produced herein. In one exemplary embodiment, the software can compute and report the abundance of non-target sequence in the sample before and after providing gNA collection to ensure no off-target targeting occurs, and wherein the software can check the efficacy of targeted-depletion/encrichment/capture/partitioning/labeling/regulation/editing by comparing the abundance of the target sequence before and after providing gNA collection to the sample.

The following examples are included for illustrative purposes and are not intend to limit the scope of the invention.

Examples
Example 1: Construction of a gRNA Library from a T7 Promoter Human DNA Library
T7 Promoter Library Construction

Human genomic DNA (400 ng) was fragmented using an S2 Covaris sonicator (Covaris) for 8 cycles, to yield fragments of 200-300 bp in length. Fragmented DNA was repaired using the NEBNext End Repair Module (NEB) and incubated at 25° C. for 30 min, then heat inactivated at 75° C. for 20 min. To make T7 promoter adapters, oligos T7-1 (5′GCCTCGAGC*T*A*ATACGACTCACTATAGAG3′, * denotes a phosphorothioate backbone linkage)(SEQ ID NO: 4397) and T7-2 (sequence 5′Phos-CTCTATAGTGAGTCGTATTA3′) (SEQ ID NO: 4398) were admixed at 15 μM, heated to 98° C. for 3 min then cooled slowly (0.1° C./min) to 30° C. T7 promoter blunt adapters (15 pmol total) were then added to the blunt-ended human genomic DNA fragments, and incubated with Blunt/TA Ligase Master Mix (NEB) at 25° C. for 30 min ((2) in FIG. 1). Ligations were amplified with 2 μM oligo T7-1, using Hi-Fidelity 2× Master Mix (NEB) for 10 cycles of PCR (98° C. for 20 s, 63° C. for 20 s, 72° C. for 35 s). Amplification was verified by running a small aliquot on agarose gel electrophoresis. PCR amplified products were recovered using 0.6×AxyPrep beads (Axygen) according to the manufacturer's instructions, and resuspended in 15 μL of 10 mM Tris-HCl pH 8.

Digestion of DNA

PCR amplified T7 promoter DNA (2 μg total per digestion) was digested with 0.1 μL of Nt.CviPII (NEB) in 10 μL of NEB buffer 2 (50 mM NaCl, 10 mM Tris-HCl pH 7.9, 10 mM MgCl₂, 100 μg/mL BSA) for 10 min at 37° C. ((3) in FIG. 1), then heat inactivated at 75° C. for 20 min. An additional 10 μL of NEB buffer 2 with 1 μL of T7 Endonuclease I (NEB) was added to the reaction, and incubated at 37° C. for 20 min ((4) in FIG. 1). Enzymatic digestion of DNA was verified by agarose gel electrophoresis. Digested DNA was recovered by adding 0.6×AxyPrep beads (Axygen), according to the manufacturer's instructions, and resuspended in 15 μL of 10 mM Tris-HCl pH 8.

Ligation of Adapters and Removal of HGG

DNA was then blunted using T4 DNA Polymerase (NEB) for 20 min at 25° C., followed by heat inactivation at 75° C. for 20 min ((5) in FIG. 1).

To make MlyI adapters, oligos MlyI-1 (sequence 5′>3′, 5′Phos-GGGACTCGGATCCCTATAGTGATACAAAGACGATGACGACAAGCG) (SEQ ID NO: 4399) and MlyI-2 (sequence 5′>3′, TCACTATAGGGATCCGAGTCCC) (SEQ ID NO: 4400) were admixed at 15 μM, heated to 98° C. for 3 min then cooled slowly (0.1° C./min) to 30° C. MlyI adapters (15 pmol total) were then added to T4 DNA Polymerase-blunted DNA, and incubated with Blunt/TA Ligase Master Mix (NEB) at 25° C. for 30 min ((6) in FIG. 1). Ligations were heat inactivated at 75° C. for 20 min, then digested with MlyI and XhoI (NEB) for 1 hr at 37° C., so that HGG motifs are eliminated ((7) in FIG. 1). Digests were then cleaned using 0.8×AxyPrep beads (Axygen), and DNA was resuspended in 10 μL of 10 mM Tris-Cl pH 8.

To make StlgR adapters, oligos stlgR (sequence 5′>3′, 5′Phos-GTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCG AGTCGGTGCTTTTTTTGGATCCGATGC) (SEQ ID NO: 4401) and stlgRev (sequence 5′>3′, GGATCCAAAAAAAGCACCGACTCGGTGCCACUITTITCAAGTTGATAACGGACTAGCCTTATTTTAAC TTGCTATTTCTAGCTCTAAAAC) (SEQ ID NO: 4402) were admixed at 15 μM, heated to 98° C. for 3 min then cooled slowly (0.1° C./min) to 60° C. StlgR adapters (5 pmol total) were added to HGG-removed DNA fragments, and incubated with Blunt/TA Ligase Master Mix (NEB) at 25° C. for 30 min ((8) in FIG. 1). Ligations were then incubated with Hi-Fidelity 2× Master Mix (NEB), using 2 μM of both oligos T7-1 and gRU (sequence 5′>3′, AAAAAAAGCACCGACTCGGTG) (SEQ ID NO: 4403), and amplified using 20 cycles of PCR (98° C. for 20 s, 60° C. for 20 s, 72° C. for 35 s). Amplification was verified by running a small aliquot on agarose gel electrophoresis. PCR amplified products were recovered using 0.6×AxyPrep beads (Axygen) according to the manufacturer's instructions, and resuspended in 15 μL of 10 mM Tris-HCl pH 8.

In Vitro Transcription

The T7/gRU amplified library of PCR products was then used as template for in vitro transcription, using the HiScribe T7 In Vitro Transcription Kit (NEB). 500-1000 ng of template was incubated overnight at 37° C. according to the manufacturer's instructions. To transcribe the guide libraries into gRNAs, the following in vitro transcription reaction mixture was assembled: 10 μL of purified library (˜500 ng), 6.5 μL of H₂O, 2.25 μL of ATP, 2.25 μL of CTP, 2.25 μL of GTP, 2.25 μL of UTP, 2.25 μL of 10× reaction buffer (NEB) and 2.25 μL of T7 RNA Polymerase mix. The reaction was incubated at 37° C. for 24 hr, then purified using the RNA cleanup kit (Life Technologies), eluted with 100 μL of RNase-free water, quantified and stored at −20° C. until use.

Example 2: Construction of gRNA Library from Intact Human Genomic DNA
Digestion of DNA

Human genomic DNA ((1) in FIG. 2; 20 μg total per digestion) was digested with 0.1 μL of Nt.CviPII (NEB) in 40 μL of NEB buffer 2 (50 mM NaCl, 10 mM Tris-HC pH 7.9, 10 mM MgCl₂, 100 μg/mL BSA) for 10 min at 37° C., then heat inactivated at 75° C. for 20 min. An additional 40 μL of NEB buffer 2 and 1 μL of T7 Endonuclease I (NEB) was added to the reaction, with 20 min incubation at 37° C. (e.g., (2) in FIG. 2). Fragmentation of genomic DNA was verified with a small aliquot by agarose gel electrophoresis. DNA fragments between 200 and 600 bp were recovered by adding 0.3×AxyPrep beads (Axygen), incubating at 25° C. for 5 min, capturing beads on a magnetic stand and transferring the supernatant to a new tube. DNA fragments below 600 bp do not bind to beads at this bead/DNA ratio and remain in the supernatant. 0.7×AxyPrep beads (Axygen) were then added to the supernatant (this will bind all DNA molecules longer than 200 bp), allowed to bind for 5 min. Beads were captured on a magnetic stand and washed twice with 80% ethanol, air dried. DNA was then resuspended in 15 μL of 10 mM Tris-HCl pH 8. DNA concentration was determined using a Qbit assay (Life Technologies).

Ligation of Adapters

To make T7/MlyI adapters, oligos MlyI-1 (sequence 5′>3′, 5′Phos-GGGGGACTCGGATCCCTATAGTGATACAAAGACGATGACGACAAGCG) (SEQ ID NO: 4404) and T7-7 (sequence 5′>3′, GCCTCGAGC*T*A*ATACGACTCACTATAGGGATCCAAGTCCC, * denotes a phosphorothioate backbone linkage) (SEQ ID NO: 4405) were admixed at 15 μM, heated to 98° C. for 3 min then cooled slowly (0.1° C./min) to 30° C. The purified, Nt.CviPII/T7 Endonuclease I digested DNA (100 ng) was then ligated to 15 pmol of T7/MlyI adapters using Blunt/TA Ligase Master Mix (NEB) at 25° C. for 30 min ((3) in FIG. 2). Ligations were then amplified by 10 cycles of PCR (98° C. for 20 s, 60° C. for 20 s, 72° C. for 35 s) using Hi-Fidelity 2× Master Mix (NEB), and 2 μM of both oligos T7-17 (GCCTCGAGC*T*A*ATACGACTCACTATAGGG * denotes a phosphorothioate backbone linkage) (SEQ ID NO: 4406) and Flag (sequence 5′>3′, CGCTTGTCGTCATCGTCTTTGTA) (SEQ ID NO: 4407). PCR amplification increases the yield of DNA and, given the nature of the Y-shaped adapters we used, always resulted in T7 promoter being added distal to the HGG site and MlyI site being added next to the HGG motif ((4) in FIG. 2).

PCR products were then digested with MlyI and XhoI (NEB) for 1 hr at 37° C., and heat inactivated at 75° C. for 20 min ((5) in FIG. 2). Following that, 5 pmol of adapter StlgR (in Example 1) was ligated using Blunt/TA Ligase Master Mix (NEB) at 25° C. for 30 min ((6) in FIG. 2). Ligations were then amplified by PCR using Hi-Fidelity 2× Master Mix (NEB), 2 μM of both oligos T7-7 and gRU (in Example 1) and 20 cycles of PCR (98° C. for 20 s, 60° C. for 20 s, 72° C. for 35 s). Amplification was verified by running a small aliquot on agarose gel electrophoresis. PCR amplified products were recovered using 0.6×AxyPrep beads (Axygen) according to the manufacturer's instructions, and resuspended in 15 μL of 10 mM Tris-HCl pH 8.

Samples were then used as templates for in vitro transcription reaction as described in Example 1.

Example 3: Direct Cutting with CviPII

30 μg of human genomic DNA was digested with 2 units of NtCviPII (New England Biolabs) for 1 hour at 37° C., followed by heat inactivation at 75° C. for 20 minutes. The size of the fragments was verified to be 200-1,000 base pairs using a fragment analyzer instrument (Advanced Analytical). The 5′ or 3′ protruding ends (as shown, for example, in FIG. 3) were converted to blunt ends by adding 100 units of T4 DNA polymerase (New England Biolabs), 100 μM dNTPs and incubating at 12° C. for 30 minutes. DNA was then recovered using a PCR cleanup kit (Zymo) and eluted in 20 μL elution buffer. The DNA was then ligated to MlyI adapter (see, for example, Example 4) or BaeI/EcoP15I adapters (see, for example, Example 4) or BaeI/EcoP15I adapters (see, for example, Example 5)

Example 4: Use of MlyI Adapter

Adapter MlyI was made by combining 2 μmoles of MlyI Ad1 and MlyAd2 in 40 μL water. Adapter BsaXI/MmeI was made by combining 2 μmoles oligo BsMm-Ad1 and 2 μmoles oligo BsMm-Ad2 in 40 μL water. T7 adapter was made by combining 1.5 μmoles of T7-Ad1 and T7-Ad2 oligos in 100 μL water. Stem-loop adapter was made by combining 1.5 μmoles of gR-top and gR-bot oligos in 100 μL water. In all cases, after mixing adapters were heated to 98° C. for 3 min then cooled to room temperature at a cooling rate of 1° C./min in a thermal cycler.

TABLE 5

Oligonucleotides used with MlyI Adapter.

SEQ

ID
Oligo

NO
name
Sequence (5′>3′)
Modification

4408
MlyI-
gagatcagcttctgcattgatgccagcagcccgagtcag
none

Ad1

4409
MlyI-
ctgactcgggctgctgtacaaagacgatgacgacaagcgtta
5′phosphate

Ad2

4410
BsMm-
gagatcagcttctgcattgatgcGGAGCCGCAGTACACTATCCAAC
none

Ad1

4411
BsMm-
GTTGGATAGTGTACTGCGGCTCCtacaaagacgatgacgacaagcg
5′phosphate

Ad2

4412
T7-Ad1
gcctcgagctaatacgactcactatagagNN
none

4398
T7-Ad2
Ctctatagtgagtcgtatta
5′phosphate

4413
gR-top
ttagagctagaaatagcaagttaaaataaggctagtccgttatcaacttgaaaaagtggcaccgagtcggt
5′phosphate

gctttttt

4414
gR-bot
aaaaaagcaccgactcggtgccactttttcaagttgataacggactagccttattttaacttgctatttct
none

agctctaaaac

The DNA containing the CCD blunt ends (from earlier section) was then ligated to 50 pmoles of adapter MlyI, using the blunt/TA ligation master mix (New England Biolabs) at room temperature for 30 minutes. The DNA was then recovered by incubating with 0.6× Kapa SPRI beads (Kapa Biosystems) for 5 minutes, capturing the beads with a magnetic rack, washing twice with 80% ethanol, air drying the beads for 5 minutes and finally resuspending the DNA in 50 μL buffer 4 (50 mM potassium acetate, 20 mM Tris-acetate, 10 mM magnesium acetate, 100 μg/mL BSA, pH 7.9). These steps eliminate small (<100 nucleotides) DNA and MlyI adapter dimers.

Purified DNA was then digested by adding 20 units of MlyI (New England Biolabs) and incubating at 37° C. for 1 hour to eliminate both the adapter derived sequences and the CCD (and complementary HGG) motifs. DNA was recovered from the digest by incubating with 0.6× Kapa SPRI beads (Kapa Biosystems) for 5 minutes, capturing the beads with a magnetic rack, washing twice with 80% ethanol, air drying the beads for 5 minutes and finally resuspending the DNA in 30 μL buffer 4.

The purified DNA was then ligated to 50 pmoles of adapter BsaXI/MmeI, using the blunt/TA ligation master mix (New England Biolabs) at room temperature for 30 minutes. The DNA was then recovered by incubating with 0.6× Kapa SPRI beads (Kapa Biosystems) for 5 minutes, capturing the beads with a magnetic rack, washing twice with 80% ethanol, air drying the beads for 5 minutes and finally resuspending the DNA in 50 μL buffer 4 (50 mM potassium acetate, 20 mM Tris-acetate, 10 mM magnesium acetate, 100 μg/mL BSA, pH 7.9). DNA was then digested by addition of 20 units MmeI (New England Biolabs) and 40 pmol/μL SAM (S-adenosyl methionine) at 37° C. for 1 hour, followed by heat inactivation at 75° C. for 20 minutes. DNA was then ligated to 30 pmoles T7 adapter using the blunt/TA ligation master mix (New England Biolabs) at room temperature for 30 minutes. DNA was then recovered using a PCR cleanup kit (Zymo) and eluted in 20 μL buffer 4, then digested with 20 units of BsaXI for 1 hour at 37° C. The guide RNA stem-loop sequences were added by adding 15 pmoles stem-loop adapter and using the blunt/TA ligation master mix (New England Biolabs) at room temperature for 30 min. DNA was then recovered using a PCR cleanup kit (Zymo), eluted in 20 μL elution buffer and PCR amplified using HiFidelity 2× master mix (New England Biolabs). Primers T7-Ad1 and gRU (sequence 5′>3′ AAAAAAGCACCGACTCGGTG) (SEQ ID NO: 4419) were used to amplify with the following settings (98° C. 3 min; 98° C. for 20 sec, 60° C. for 30 secs, 72° C. for 20 sec, 30 cycles). The PCR amplicon was cleaned up using the PCR cleanup kit and verified by DNA sequencing, then used as template for an in vitro transcription reaction to generate guide RNAs.

Example 5: Use of BaeI/EcoP15I Adapter

Adapter Bae/EcoP15I was made by combining 2 μmoles of BE Ad1 and BE Ad2 in 40 μL water. T7-E adapter was made by combining 1.5 μmoles of T7-Ad3 and T7-Ad4 oligos in 100 μL water. In all cases, after mixing adapters were heated to 98° C. for 3 min then cooled to room temperature at a cooling rate of 1° C./min in a thermal cycler.

TABLE 6

Oligonucleotides used with BaeI/EcoP15I Adapter.

SEQ

ID
Oligo

NO:
name
Sequence (5′>3′)
Modification

4415
BE
ActgctgacACAAgtatcTTTTTTTTTTgtttaaacTTTTTTTTTTgatacACAAgtcagcagA
5′phosphate

Ad1

4416
Be
TagctgacTTGTgtatcAAAAAAAAAAgtttaaacAAAAAAAAAAgatacTTGTgtcagcagT
5′phosphate

Ad2

12
T7-
gcctcgagctaatacgactcactatagag
none

Ad3

4417
T7-
NNctctatagtgagtcgtatta
5′phosphate

Ad4

4418
stlgR
ttagagctagaaatagcaagttaaaataaggctagtccgttatcaacttgaaaaagtggcaccg
5′adenylation

agtcggtgctttttt

The DNA containing the CCD blunt ends (from earlier section) was then ligated to 50 pmoles of adapter BaeI/EcoP15I, using the blunt/TA ligation master mix (New England Biolabs) at room temperature for 30 minutes. The DNA was then recovered by incubating with 0.6× Kapa SPRI beads (Kapa Biosystems) for 5 minutes, capturing the beads with a magnetic rack, washing twice with 80% ethanol, air drying the beads for 5 minutes and finally resuspending the DNA in 50 μL buffer 4 (50 mM potassium acetate 20 mM Tris-acetate, 10 mM magnesium acetate, 100 μg/mL BSA, pH 7.9). Recovered DNA was then digested with 20 units PmeI for 30 min at 37° C.; DNA was then recovered by incubating with 1.2× Kapa SPRI beads (Kapa Biosystems) for 5 minutes, capturing the beads with a magnetic rack, washing twice with 80% ethanol, air drying the beads for 5 minutes and finally resuspending the DNA in 50 μL buffer 4. These steps eliminate small (<100 nucleotides) DNA and BaeI/EcoP15I adapter multimers.

DNA was then digested by addition of 20 units EcoP15I (New England Biolabs) and 1 mM ATP at 37° C. for 1 hour, followed by heat inactivation at 75° C. for 20 minutes. DNA was then ligated to 30 pmoles T7-E adapter using the blunt/TA ligation master mix (New England Biolabs) at room temperature for 30 minutes. DNA was then recovered using a PCR cleanup kit (Zymo) and eluted in 20 μL buffer 4.

Purified DNA was then digested by adding 20 units of BaeI (New England Biolabs), 40 pmol/μL SAM (S-adenosyl methionine) and incubating at 37° C. for 1 hour to eliminate both the adapter derived sequences and the CCD (and complementary HGG) motifs. DNA was then recovered using a PCR cleanup kit (Zymo) and eluted in 20 μL elution buffer.

Recovered DNA was then ligated to the stlgR oligo using Thermostable 5′ AppDNA/RNA Ligase

(New England Biolabs) by adding 20 units ligase, 20 pmol stlgR oligo, in 20 μL ss ligation buffer (10 mM Bis-Tris-Propane-HCl, 10 mM MgCl₂, 1 mM DTT, 2.5 mM MnCl₂, pH 7 @ 25° C.) and incubating at 65° C. for 1 hour followed by heat inactivation at 90° C. for 5 min. DNA product was then PCR amplified using HiFidelity 2× master mix (New England Biolabs). Primers T7-Ad3 and gRU (sequence 5′>3′ AAAAAAGCACCGACTCGGTG) (SEQ ID NO: 4419) were used to amplify with the following settings (98° C. 3 min; 98° C. for 20 sec, 60° C. for 30 secs, 72° C. for 20 see, 30 cycles). The PCR amplicon was cleaned up using the PCR cleanup kit and verified by DNA sequencing, then used as template for an in vitro transcription reaction to generate the guide RNAs.

Example 6: NEMDA Method

NEMDA (Nicking Endonuclease Mediated DNA Amplification) was performed using 50 ng of human genomic DNA. The DNA was incubated in 100 μL thermo polymerase buffer (20 mM Tris-HCl, 10 mM (NH₄)₂SO₄, 10 mM KCl, 6 mM MgSO₄, 0.1% Triton® X-100, pH 8.8) supplemented with 0.3 mM dNTPs, 40 units of Bst large fragment DNA polymerase, and 0.1 units of NtCviPII (New England Biolabs) at 55° C. for 45 min, followed by 65° C. for 30 min and finally 80° C. for 20 min in a thermal cycler.

The DNA was then diluted with 300 μL of buffer 4 supplemented with 200 pmoles of T7-RND8 oligo (sequence 5′>3′ gcctcgagctaatacgactcactatagagnnnnnnnn) (SEQ ID NO: 4420) and boiled at 98° C. for 10 min followed by rapid cooling to 10° C. for 5 min. The reaction was then supplemented with 40 units of E. coli DNA polymerase I and 0.1 mM dNTPs (New England Biolabs) and incubated at room temperature for 20 min followed by heat inactivation at 75° C. for 20 min. DNA was then recovered using a PCR cleanup kit (Zymo) and eluted in 30 μL elution buffer.

DNA was then ligated to 50 pmoles of adapter BaeI/EcoP15I, using the blunt/TA ligation master mix (New England Biolabs) at room temperature for 30 minutes. The DNA was then recovered by incubating with 0.6× Kapa SPRI beads (Kapa Biosystems) for 5 minutes, capturing the beads with a magnetic rack, washing twice with 80/o ethanol, air drying the beads for 5 minutes and finally resuspending the DNA in 50 μL buffer 4 (50 mM potassium acetate, 20 mM Tris-acetate, 10 mM magnesium acetate, 100 μg/mL BSA, pH 7.9). Recovered DNA was then digested with 20 units PmeI for 30 min at 37° C.; DNA was then recovered by incubating with 1.2× Kapa SPRI beads (Kapa Biosystems) for 5 minutes, capturing the beads with a magnetic rack, washing twice with 80% ethanol, air drying the beads for 5 minutes and finally resuspending the DNA in 50 μL buffer 4. These steps eliminate small (<100 nucleotides) DNA and BaeI/EcoP15I adapter multimers.

Recovered DNA was then ligated to the stlgR oligo using Thermostable 5′ AppDNA/RNA Ligase (New England Biolabs) by adding 20 units ligase, 20 pmol stlgR oligo, in 20 μL ss ligation buffer (10 mM Bis-Tris-Propane-HCl, 10 mM MgCl₂, 1 mM DTT, 2.5 mM MnCl₂. pH 7 @ 25° C.) and incubating at 65° C. for 1 hour followed by heat inactivation at 90° C. for 5 min. DNA product was then PCR amplified using HiFidelity 2× master mix (New England Biolabs). Primers T7-Ad3 (sequence 5′>3′ gctcgagctaatacgactcactatagag) (SEQ ID NO: 12) and gRU (sequence 5′>3′ AAAAAAGCACCGACTCGGTG) (SEQ ID NO: 4419) were used to amplify with the following settings (98° C. for 3 min; 98° C. for 20 sec, 60° C. for 30 secs, 72° C. for 20 sec, 30 cycles). The PCR amplicon was cleaned up using the PCR cleanup kit and verified by DNA sequencing, then used as template for an in vitro transcription reaction to generate the guide RNAs.

	Number	Date	Country
	62298963	Feb 2016	US
	62264262	Dec 2015	US

	Number	Date	Country
Parent	15742862	Jan 2018	US
Child	16995761		US

METHODS AND COMPOSITIONS FOR THE MAKING AND USING OF GUIDE NUCLEIC ACIDS

Information

Publication Number

Date Filed

Date Published

Inventors

Original Assignees

CPC

International Classifications

Abstract

Description

Claims

CROSS-REFERENCE

Provisional Applications (2)

Continuations (1)